{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from bs4 import BeautifulSoup\n",
    "import requests,json\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Through Request received the API Key to extract data from https://open.gsa.gov/api/regulationsgov/\n",
    "# Using requests package we extract the html content we further convert the data as readable using beautiful soup package\n",
    "api_key = \"qGZagngC6YxQ0mjBWRaZkS0xxLtP128IYII6C8Mu\"\n",
    "url = \"https://api.regulations.gov/v4/dockets?filter[searchTerm]=Tobacco Products&api_key=\" + api_key # creating the url\n",
    "result=requests.get(url,headers={\"User-Agent\":\"Mozilla/5.0\"})\n",
    "url_content = BeautifulSoup(result.text,'lxml')# Request for data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'id': 'FDA-2016-N-2527',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2017-08-31T12:18:39Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Tobacco Product Standard for N-nitrosonornicotine Level in Finished Smokeless Tobacco Products',\n",
       "   'objectId': '0b000064821987a7'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2016-N-2527'}},\n",
       " {'id': 'TTB-2013-0006',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2016-06-21T10:46:15Z',\n",
       "   'highlightedContent': 'TTB is issuing a temporary rule amending its regulations pertaining to permits for importers of tobacco…\\xa0products and processed tobacco by extending the duration of new permits from three years to five years…\\xa0temporary rule also makes several technical corrections by amending the definition of “Manufacturer of tobacco…\\xa0products” to reflect a recent statutory change, and by amending a reference to the sale price of large…\\xa0products, and minimum manufacturing and marking requirements for tobacco products and cigarette papers…\\xa0Through this temporary rule, the Alcohol and Tobacco Tax and Trade Bureau (TTB) is updating and reissuing…\\xa0regulations pertaining to minimum manufacturing, marking, and importer permit requirements for tobacco…\\xa0products and cigarette papers and tubes.',\n",
       "   'agencyId': 'TTB',\n",
       "   'title': 'Importer Permit Requirements for Tobacco Products and Processed Tobacco, and Other Requirements for Tobacco Products, Processed Tobacco, and Cigarette Papers and Tubes',\n",
       "   'objectId': '0b000064813344bd'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/TTB-2013-0006'}},\n",
       " {'id': 'TTB-2007-0024',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2011-06-12T21:24:06Z',\n",
       "   'highlightedContent': 'Tobacco products and cigarette papers and tubes; importation: Release procedures; CFR correction',\n",
       "   'agencyId': 'TTB',\n",
       "   'title': 'Importation of Tobacco Products and Cigarette Papers and Tubes',\n",
       "   'objectId': '0b000064802098cf'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/TTB-2007-0024'}},\n",
       " {'id': 'FDA-2016-N-0160',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2016-02-17T10:12:55Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Pilot Program for Tobacco Product Manufacturers; Center for Tobacco Products eSubmissions Portal',\n",
       "   'objectId': '0b00006481e0fcec'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2016-N-0160'}},\n",
       " {'id': 'FDA-2010-N-0074',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2022-01-05T01:04:05Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products',\n",
       "   'objectId': '0b00006480a88253'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2010-N-0074'}},\n",
       " {'id': 'FDA-2012-N-0386',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2022-03-28T10:21:36Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products.',\n",
       "   'objectId': '0b00006480ff4212'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2012-N-0386'}},\n",
       " {'id': 'FDA-2011-N-0467',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2012-02-23T13:51:22Z',\n",
       "   'highlightedContent': 'This rulemaking will address (1) Advertising, promotion, and marketing of tobacco products, and (2…\\xa0) sale and distribution of tobacco products involving Internet and mail-order transactions, and other…\\xa0Mail-order-e.g., a print ad in a magazine that includes a phone number and/or web address for ordering a tobacco…\\xa0product; and (b) Internet-e.g., standard websites, such as an official website of cigarette brand or',\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Non-Face-to-Face Sale and Distribution of Tobacco Products and Advertising, Promotion, and Marketing of Tobacco Products',\n",
       "   'objectId': '0b00006480e4f327'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2011-N-0467'}},\n",
       " {'id': 'FDA-2009-D-0524',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2022-02-17T21:26:35Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Listing of Ingredients in Tobacco Products',\n",
       "   'objectId': '0b00006480a4cdb7'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2009-D-0524'}},\n",
       " {'id': 'FDA-2015-D-2325',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2020-08-10T14:04:55Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Tobacco Product Master Files',\n",
       "   'objectId': '0b00006481b628af'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2015-D-2325'}},\n",
       " {'id': 'FDA-2014-N-0189',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2020-09-09T11:34:02Z',\n",
       "   'highlightedContent': 'The Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) provides the Food and…\\xa0Drug Administration (FDA) authority to regulate cigarettes, cigarette tobacco, roll-your-own tobacco,…\\xa0and smokeless tobacco.…\\xa0FDA to issue regulations deeming other tobacco products to be subject to the FD&C Act.…\\xa0This rule would deem additional products meeting the statutory definition of \"tobacco product\" to be',\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Deeming Tobacco Products To Be Subject to the Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products',\n",
       "   'objectId': '0b00006481554f10'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2014-N-0189'}},\n",
       " {'id': 'TTB-2010-0004',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2021-06-11T12:05:29Z',\n",
       "   'highlightedContent': 'In this rulemaking, TTB entends to establish standards to distinguish between pipe tobacco and roll-your-own…\\xa0tobacco for Federal excise tax purposes based upon certain physical characteristics of the two products…\\xa0The Department of the Treasury and the Alcohol and Tobacco Tax and Trade Bureau (TTB) are considering…\\xa0amending the TTB regulations with regard to the classification and labeling of pipe tobacco and roll-your-own…\\xa0tobacco for Federal excise tax purposes under the Internal Revenue Code of 1986.…\\xa0propose regulatory amendments to clarify the existing statutory definitions and set forth objective product',\n",
       "   'agencyId': 'TTB',\n",
       "   'title': 'Standards for Pipe Tobacco and Roll-Your-Own Tobacco',\n",
       "   'objectId': '0b00006480b1e6ef'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/TTB-2010-0004'}},\n",
       " {'id': 'FDA-2017-N-6565',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2019-10-30T15:15:59Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Regulation of Flavors in Tobacco Products',\n",
       "   'objectId': '0b00006482c91cc2'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2017-N-6565'}},\n",
       " {'id': 'FDA-2015-N-1514',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2021-12-13T15:24:35Z',\n",
       "   'highlightedContent': 'requirements for liquid nicotine and nicotine-containing e-liquid(s) that are made or derived from tobacco…\\xa0and intended for human consumption, and potentially for other tobacco products including, but not limited…\\xa0to, novel tobacco products such as dissolvables, lotions, gels, and drinks.…\\xa0the risks of acute toxicity due to accidental nicotine exposure from nicotine-containing e-liquids in tobacco…\\xa0products.',\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Nicotine Exposure Warnings and Child-Resistant Packaging for Liquid Nicotine, Nicotine-Containing E-Liquid(s), and Other Tobacco Products',\n",
       "   'objectId': '0b00006481ac84a3'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2015-N-1514'}},\n",
       " {'id': 'TTB-2009-0002',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2015-02-24T12:14:59Z',\n",
       "   'highlightedContent': 'This rulemaking concerns amendments to the TTB tobacco regulations in 27 CFR parts 40, 41, 44, and 45…\\xa0, which are required by the changes made to the tobacco provisions of the Internal Revenue Code of 1986…\\xa0Among other things, CHIPRA increased the Federal excise taxes on tobacco products, imposed a floor stocks…\\xa0tax, imposed new requirements on manufacturers and importers of processed tobacco, expanded the definition…\\xa0of roll-your-own tobacco, and changed the basis for denial, suspension, or revocation of permits.…\\xa0702, imposed permit, inventories, reports, and records requirements for manufacturers of processed tobacco…\\xa0permits; addressed the application of the Internal Revenue Code statute of limitations for alcohol and tobacco…\\xa0product excise taxes; expanded the definition of roll-your-own tobacco; set forth the time of tax for…\\xa0unlawfully manufactured tobacco products; and created a transitional rule for manufacturers of processed…\\xa0tobacco.',\n",
       "   'agencyId': 'TTB',\n",
       "   'title': 'Implementation of Statutory Amendments Requiring the Qualification of Manufacturers and Importers of Processed Tobacco and Other Amendments Related to Permit Requirements, and the Expanded Definition of Roll-Your-Own Tobacco',\n",
       "   'objectId': '0b000064809d1688'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/TTB-2009-0002'}},\n",
       " {'id': 'FDA-2017-N-4678',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2021-01-05T14:48:29Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Modified Risk Tobacco Product Applications: Applications for Six Camel Snus Smokeless Tobacco Products Submitted by R.J. Reynolds Tobacco Company',\n",
       "   'objectId': '0b0000648299b823'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2017-N-4678'}},\n",
       " {'id': 'FDA-2012-D-0071',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2018-04-17T15:37:30Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Modified Risk Tobacco Product Applications',\n",
       "   'objectId': '0b00006480f9c7be'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2012-D-0071'}},\n",
       " {'id': 'FDA-2012-N-0853',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2016-08-25T09:16:56Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Tobacco Product Manufacturing Facility Visits',\n",
       "   'objectId': '0b000064810c4e83'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2012-N-0853'}},\n",
       " {'id': 'FDA-2009-N-0294',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2022-01-05T01:03:47Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Regulation of Tobacco Products; Request for Comments',\n",
       "   'objectId': '0b000064809df146'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2009-N-0294'}},\n",
       " {'id': 'FDA-2019-D-4188',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2022-02-16T12:54:23Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies; Draft Guidance for Industry; Availability',\n",
       "   'objectId': '0b00006483f23220'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2019-D-4188'}},\n",
       " {'id': 'FDA-2011-N-0271',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2012-02-16T13:04:34Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Request for Comments',\n",
       "   'objectId': '0b00006480c2457d'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2011-N-0271'}},\n",
       " {'id': 'FDA-2009-D-0508',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2022-02-17T21:30:12Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments',\n",
       "   'objectId': '0b00006480a42536'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2009-D-0508'}},\n",
       " {'id': 'FDA-2012-N-0143',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2019-10-08T08:29:43Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List',\n",
       "   'objectId': '0b00006480fb2dc3'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2012-N-0143'}},\n",
       " {'id': 'FDA-2013-N-0521',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2014-04-01T13:17:54Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Menthol in Cigarettes, Tobacco Products; Request for Comments',\n",
       "   'objectId': '0b000064812b2390'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2013-N-0521'}},\n",
       " {'id': 'FDA-2014-N-0086',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Nonrulemaking',\n",
       "   'lastModifiedDate': '2020-09-15T09:25:33Z',\n",
       "   'highlightedContent': None,\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Potential Tobacco Product Reporting Violation Form',\n",
       "   'objectId': '0b00006481509f99'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2014-N-0086'}},\n",
       " {'id': 'FDA-2012-N-0920',\n",
       "  'type': 'dockets',\n",
       "  'attributes': {'docketType': 'Rulemaking',\n",
       "   'lastModifiedDate': '2016-05-10T11:38:18Z',\n",
       "   'highlightedContent': 'This rule will require manufacturers and importers of tobacco products to submit certain market share',\n",
       "   'agencyId': 'FDA',\n",
       "   'title': 'Tobacco Products, User Fees, Requirements for the Submission of Data Needed to Calculate User Fees for Manufacturers and Importers of Tobacco Products',\n",
       "   'objectId': '0b000064810e617f'},\n",
       "  'links': {'self': 'https://api.regulations.gov/v4/dockets/FDA-2012-N-0920'}}]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Json_data = json.loads(url_content.html.body.text)\n",
    "Json_data['data']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extracting the doket id and object ids \n",
    "docket_id = [i['id'] for i in Json_data['data']]\n",
    "docket_object_id = [i['attributes']['objectId'] for i in Json_data['data']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['0b000064821987a7',\n",
       " '0b000064813344bd',\n",
       " '0b000064802098cf',\n",
       " '0b00006481e0fcec',\n",
       " '0b00006480a88253',\n",
       " '0b00006480ff4212',\n",
       " '0b00006480e4f327',\n",
       " '0b00006480a4cdb7',\n",
       " '0b00006481b628af',\n",
       " '0b00006481554f10',\n",
       " '0b00006480b1e6ef',\n",
       " '0b00006482c91cc2',\n",
       " '0b00006481ac84a3',\n",
       " '0b000064809d1688',\n",
       " '0b0000648299b823',\n",
       " '0b00006480f9c7be',\n",
       " '0b000064810c4e83',\n",
       " '0b000064809df146',\n",
       " '0b00006483f23220',\n",
       " '0b00006480c2457d',\n",
       " '0b00006480a42536',\n",
       " '0b00006480fb2dc3',\n",
       " '0b000064812b2390',\n",
       " '0b00006481509f99',\n",
       " '0b000064810e617f']"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docket_object_id"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "# This cell will go through all the dockets and get their documents ids and object ids\n",
    "document_ids = []\n",
    "document_objectId = []\n",
    "for dockt in docket_id:\n",
    "    url = \"https://api.regulations.gov/v4/documents?filter[docketId]=\"+dockt+\"&api_key=\" + api_key\n",
    "    url_content = BeautifulSoup(requests.get(url).content, 'lxml')\n",
    "    data = json.loads(url_content.body.p.text)[\"data\"]\n",
    "    document_ids.extend([i['id'] for i in data]) # get document ids\n",
    "    document_objectId.extend([i['attributes']['objectId'] for i in data]) # get document object ids "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['FDA-2014-N-0189-83122',\n",
       " 'FDA-2010-N-0074-0003',\n",
       " 'FDA-2015-N-1514-0476',\n",
       " 'FDA-2012-N-0386-0008',\n",
       " 'FDA-2014-N-0189-83091',\n",
       " 'FDA-2017-N-6565-0008',\n",
       " 'TTB-2010-0004-0025',\n",
       " 'FDA-2017-N-6565-3064',\n",
       " 'FDA-2015-N-1514-0090',\n",
       " 'FDA-2015-N-1514-0002',\n",
       " 'FDA-2014-N-0189-82934',\n",
       " 'FDA-2012-N-0853-0004',\n",
       " 'FDA-2012-N-0853-0008',\n",
       " 'FDA-2012-N-0143-0019',\n",
       " 'FDA-2017-N-6565-12525',\n",
       " 'FDA-2012-N-0853-0019',\n",
       " 'FDA-2017-N-6565-0011',\n",
       " 'FDA-2013-N-0521-0025',\n",
       " 'FDA-2015-D-2325-0002',\n",
       " 'FDA-2009-D-0524-0027',\n",
       " 'FDA-2016-N-2527-2685',\n",
       " 'FDA-2015-N-1514-0415',\n",
       " 'FDA-2017-N-4678-0001',\n",
       " 'FDA-2016-N-2527-2653',\n",
       " 'FDA-2016-N-2527-2660',\n",
       " 'FDA-2014-N-0086-0003',\n",
       " 'FDA-2012-N-0853-0002',\n",
       " 'FDA-2009-D-0524-0032',\n",
       " 'FDA-2016-N-2527-0013',\n",
       " 'FDA-2012-N-0386-0005',\n",
       " 'FDA-2009-N-0294-1152',\n",
       " 'FDA-2016-N-2527-0078',\n",
       " 'FDA-2012-D-0071-1819',\n",
       " 'FDA-2009-N-0294-0613',\n",
       " 'FDA-2009-D-0524-0002',\n",
       " 'TTB-2013-0006-0010',\n",
       " 'FDA-2009-N-0294-0619',\n",
       " 'FDA-2009-N-0294-0618',\n",
       " 'FDA-2011-N-0467-0001',\n",
       " 'FDA-2012-N-0853-0005',\n",
       " 'FDA-2017-N-6565-4839',\n",
       " 'FDA-2012-N-0143-0060',\n",
       " 'FDA-2016-N-0160-0001',\n",
       " 'FDA-2013-N-0521-0097',\n",
       " 'FDA-2012-N-0143-0007',\n",
       " 'FDA-2012-N-0143-0018',\n",
       " 'FDA-2012-N-0386-0014',\n",
       " 'FDA-2017-N-6565-0029',\n",
       " 'TTB-2010-0004-0001',\n",
       " 'FDA-2012-N-0143-0013',\n",
       " 'FDA-2012-N-0143-0006',\n",
       " 'FDA-2014-N-0189-82978',\n",
       " 'FDA-2010-N-0074-0002',\n",
       " 'FDA-2014-N-0189-83138',\n",
       " 'FDA-2015-N-1514-0093',\n",
       " 'FDA-2012-N-0143-0001',\n",
       " 'FDA-2013-N-0521-0304',\n",
       " 'FDA-2014-N-0086-0005',\n",
       " 'FDA-2014-N-0189-83063',\n",
       " 'FDA-2012-N-0143-0011',\n",
       " 'TTB-2013-0006-0007',\n",
       " 'FDA-2012-N-0386-0007',\n",
       " 'FDA-2014-N-0189-82925',\n",
       " 'FDA-2012-N-0920-0013',\n",
       " 'FDA-2015-N-1514-0004',\n",
       " 'FDA-2009-D-0508-0009',\n",
       " 'FDA-2017-N-6565-0016',\n",
       " 'FDA-2012-N-0386-0011',\n",
       " 'FDA-2012-N-0853-0020',\n",
       " 'FDA-2012-N-0920-0001',\n",
       " 'FDA-2016-N-2527-0079',\n",
       " 'FDA-2012-N-0386-0003',\n",
       " 'FDA-2009-D-0508-0016',\n",
       " 'FDA-2015-N-1514-0091',\n",
       " 'FDA-2017-N-6565-0037',\n",
       " 'FDA-2014-N-0189-83016',\n",
       " 'FDA-2012-N-0143-0003',\n",
       " 'FDA-2014-N-0189-83052',\n",
       " 'FDA-2012-N-0853-0003',\n",
       " 'FDA-2009-D-0524-0033',\n",
       " 'FDA-2016-N-2527-2676',\n",
       " 'FDA-2012-N-0143-0015',\n",
       " 'FDA-2014-N-0086-0014',\n",
       " 'FDA-2012-N-0853-0006',\n",
       " 'FDA-2009-D-0508-0018',\n",
       " 'FDA-2009-D-0508-0013',\n",
       " 'FDA-2016-N-2527-2664',\n",
       " 'TTB-2009-0002-0001',\n",
       " 'FDA-2009-D-0508-0010',\n",
       " 'FDA-2015-N-1514-0092',\n",
       " 'FDA-2009-N-0294-0620',\n",
       " 'FDA-2016-N-2527-8037',\n",
       " 'FDA-2009-N-0294-0615',\n",
       " 'FDA-2012-N-0920-0017',\n",
       " 'FDA-2014-N-0189-82979',\n",
       " 'TTB-2009-0002-0019',\n",
       " 'FDA-2017-N-4678-0030',\n",
       " 'FDA-2009-D-0508-0015',\n",
       " 'FDA-2009-D-0524-0036',\n",
       " 'FDA-2012-N-0920-0014',\n",
       " 'FDA-2017-N-6565-0009',\n",
       " 'FDA-2013-N-0521-0400',\n",
       " 'FDA-2017-N-6565-0027',\n",
       " 'TTB-2013-0006-0009',\n",
       " 'FDA-2017-N-6565-4841',\n",
       " 'FDA-2016-N-2527-0111',\n",
       " 'FDA-2012-N-0143-0010',\n",
       " 'FDA-2011-N-0467-0003',\n",
       " 'FDA-2009-N-0294-0485',\n",
       " 'FDA-2012-N-0143-0005',\n",
       " 'FDA-2012-N-0143-0008',\n",
       " 'FDA-2017-N-6565-0038',\n",
       " 'FDA-2009-N-0294-0102',\n",
       " 'FDA-2012-D-0071-0001',\n",
       " 'FDA-2019-D-4188-0001',\n",
       " 'FDA-2016-N-2527-2663',\n",
       " 'FDA-2009-D-0524-0001',\n",
       " 'FDA-2016-N-2527-0064',\n",
       " 'FDA-2014-N-0086-0004',\n",
       " 'FDA-2009-D-0524-0024',\n",
       " 'TTB-2013-0006-0008',\n",
       " 'FDA-2017-N-6565-0006',\n",
       " 'FDA-2009-N-0294-1146',\n",
       " 'FDA-2012-N-0143-0009',\n",
       " 'FDA-2014-N-0086-0007',\n",
       " 'FDA-2014-N-0086-0010',\n",
       " 'FDA-2017-N-6565-4823',\n",
       " 'FDA-2014-N-0189-83132',\n",
       " 'FDA-2009-N-0294-0001',\n",
       " 'FDA-2009-N-0294-1155',\n",
       " 'FDA-2016-N-2527-2655',\n",
       " 'FDA-2009-D-0524-0041',\n",
       " 'FDA-2009-N-0294-1147',\n",
       " 'FDA-2009-D-0508-0002',\n",
       " 'FDA-2012-N-0386-0015',\n",
       " 'FDA-2009-N-0294-1078',\n",
       " 'FDA-2017-N-6565-4840',\n",
       " 'FDA-2015-D-2325-0001',\n",
       " 'FDA-2009-N-0294-0614',\n",
       " 'FDA-2012-N-0386-0004',\n",
       " 'FDA-2016-N-2527-2679',\n",
       " 'TTB-2013-0006-0002',\n",
       " 'FDA-2009-D-0524-0025',\n",
       " 'FDA-2012-N-0853-0023',\n",
       " 'FDA-2009-N-0294-1154',\n",
       " 'TTB-2013-0006-0013',\n",
       " 'FDA-2010-N-0074-0001',\n",
       " 'FDA-2011-N-0271-0001',\n",
       " 'FDA-2009-N-0294-1148',\n",
       " 'FDA-2014-N-0189-83117',\n",
       " 'FDA-2014-N-0189-83129',\n",
       " 'FDA-2014-N-0086-0001',\n",
       " 'FDA-2015-N-1514-0416',\n",
       " 'FDA-2012-N-0143-0016',\n",
       " 'TTB-2007-0024-0001',\n",
       " 'FDA-2016-N-2527-2656',\n",
       " 'FDA-2009-N-0294-0616',\n",
       " 'FDA-2013-N-0521-0031',\n",
       " 'FDA-2012-N-0386-0016',\n",
       " 'FDA-2014-N-0189-83021',\n",
       " 'FDA-2014-N-0086-0006',\n",
       " 'FDA-2014-N-0189-83195',\n",
       " 'FDA-2014-N-0189-83082',\n",
       " 'FDA-2016-N-2527-2652',\n",
       " 'FDA-2015-N-1514-0419',\n",
       " 'TTB-2009-0002-0026',\n",
       " 'FDA-2017-N-6565-0048',\n",
       " 'FDA-2012-N-0143-0012',\n",
       " 'FDA-2015-N-1514-0417',\n",
       " 'FDA-2012-N-0853-0032',\n",
       " 'FDA-2014-N-0189-83017',\n",
       " 'TTB-2009-0002-0003',\n",
       " 'FDA-2012-N-0853-0021',\n",
       " 'FDA-2017-N-6565-0057',\n",
       " 'FDA-2015-N-1514-0001',\n",
       " 'FDA-2012-N-0853-0001',\n",
       " 'FDA-2009-N-0294-0104',\n",
       " 'FDA-2013-N-0521-0023',\n",
       " 'FDA-2015-N-1514-0094',\n",
       " 'FDA-2016-N-2527-2682',\n",
       " 'FDA-2017-N-6565-0058',\n",
       " 'FDA-2009-N-0294-0101',\n",
       " 'FDA-2016-N-2527-2690',\n",
       " 'FDA-2012-N-0386-0010',\n",
       " 'FDA-2009-D-0524-0035',\n",
       " 'FDA-2012-N-0853-0007',\n",
       " 'FDA-2014-N-0189-83072',\n",
       " 'FDA-2009-N-0294-0612',\n",
       " 'FDA-2012-N-0386-0001',\n",
       " 'FDA-2012-N-0143-0004',\n",
       " 'FDA-2012-N-0920-0016',\n",
       " 'FDA-2017-N-6565-0054',\n",
       " 'FDA-2014-N-0189-83127',\n",
       " 'FDA-2017-N-6565-0055',\n",
       " 'FDA-2017-N-6565-2849',\n",
       " 'FDA-2017-N-6565-0018',\n",
       " 'FDA-2016-N-2527-2688',\n",
       " 'TTB-2013-0006-0001',\n",
       " 'FDA-2015-N-1514-0418',\n",
       " 'FDA-2009-N-0294-1080',\n",
       " 'FDA-2011-N-0467-0008',\n",
       " 'FDA-2016-N-2527-0053',\n",
       " 'FDA-2012-N-0143-0014',\n",
       " 'FDA-2014-N-0189-83201',\n",
       " 'FDA-2019-D-4188-0002',\n",
       " 'FDA-2011-N-0271-0028',\n",
       " 'FDA-2016-N-2527-2651',\n",
       " 'FDA-2013-N-0521-0001',\n",
       " 'TTB-2009-0002-0002',\n",
       " 'TTB-2009-0002-0010',\n",
       " 'FDA-2012-D-0071-0002',\n",
       " 'FDA-2015-N-1514-0005',\n",
       " 'FDA-2017-N-4678-0040',\n",
       " 'FDA-2013-N-0521-0273',\n",
       " 'FDA-2009-D-0508-0017',\n",
       " 'FDA-2012-N-0920-0019',\n",
       " 'FDA-2009-N-0294-1156',\n",
       " 'FDA-2016-N-2527-0008',\n",
       " 'TTB-2010-0004-0026',\n",
       " 'FDA-2017-N-6565-0065',\n",
       " 'FDA-2009-D-0508-0014',\n",
       " 'FDA-2009-D-0508-0001',\n",
       " 'FDA-2012-N-0920-0015',\n",
       " 'FDA-2014-N-0189-83131',\n",
       " 'FDA-2012-N-0920-0002',\n",
       " 'FDA-2017-N-6565-0013',\n",
       " 'FDA-2014-N-0086-0002',\n",
       " 'TTB-2013-0006-0012',\n",
       " 'FDA-2016-N-2527-0055',\n",
       " 'FDA-2009-N-0294-0617',\n",
       " 'FDA-2014-N-0189-82928',\n",
       " 'FDA-2009-D-0508-0012',\n",
       " 'FDA-2009-N-0294-1149',\n",
       " 'FDA-2013-N-0521-0079',\n",
       " 'FDA-2012-N-0386-0006',\n",
       " 'FDA-2015-N-1514-0003',\n",
       " 'FDA-2012-N-0853-0016',\n",
       " 'FDA-2014-N-0189-83112',\n",
       " 'FDA-2012-N-0853-0009',\n",
       " 'FDA-2012-N-0143-0017',\n",
       " 'TTB-2009-0002-0018',\n",
       " 'FDA-2012-N-0920-0018',\n",
       " 'FDA-2014-N-0189-83088',\n",
       " 'FDA-2009-D-0524-0026',\n",
       " 'FDA-2012-N-0143-0002',\n",
       " 'FDA-2012-N-0853-0017',\n",
       " 'FDA-2009-N-0294-1153',\n",
       " 'FDA-2016-N-2527-0003',\n",
       " 'FDA-2014-N-0189-82933',\n",
       " 'FDA-2016-N-2527-0226',\n",
       " 'FDA-2017-N-6565-2963']"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(set(document_ids))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['090000648235a83f',\n",
       " '0900006481baa560',\n",
       " '0900006481fbf693',\n",
       " '0900006480a2af9b',\n",
       " '0900006482cf3640',\n",
       " '090000648302dcdb',\n",
       " '09000064821f9e0f',\n",
       " '0900006482080b66',\n",
       " '0900006480a30f05',\n",
       " '0900006481fbf65c',\n",
       " '090000648302dcc0',\n",
       " '090000648248ea82',\n",
       " '0900006482605574',\n",
       " '090000648243d90e',\n",
       " '0900006481c5ee26',\n",
       " '0900006481fbf03a',\n",
       " '0900006482080b67',\n",
       " '0900006482053ab1',\n",
       " '0900006481fbf042',\n",
       " '090000648302e366',\n",
       " '090000648302e07e',\n",
       " '0900006480a0d2e2',\n",
       " '090000648148aed7',\n",
       " '0900006483df27eb',\n",
       " '090000648248ed71',\n",
       " '090000648248ce53',\n",
       " '0900006481fbf3fa',\n",
       " '0900006480acc698',\n",
       " '0900006480aa73d0',\n",
       " '0900006481fbf539',\n",
       " '090000648493a8e3',\n",
       " '0900006481141f57',\n",
       " '090000648260550a',\n",
       " '0900006480a2af9e',\n",
       " '09000064848599d6',\n",
       " '0900006481fbe855',\n",
       " '0900006483df2aab',\n",
       " '0900006480a6fa52',\n",
       " '090000648405b97b',\n",
       " '090000648203d492',\n",
       " '0900006482e4a6de',\n",
       " '090000648302e367',\n",
       " '09000064810fab5e',\n",
       " '0900006481fbf4d1',\n",
       " '0900006480a6eb72',\n",
       " '0900006480a2b14b',\n",
       " '0900006481e9fceb',\n",
       " '0900006480a2b02c',\n",
       " '0900006483df27e5',\n",
       " '0900006483df2ab0',\n",
       " '0900006480b1f09a',\n",
       " '0900006481379dc2',\n",
       " '09000064813447c0',\n",
       " '0900006480a4fef9',\n",
       " '090000648302e534',\n",
       " '0900006481fbf666',\n",
       " '090000648248ee89',\n",
       " '0900006483056b3c',\n",
       " '0900006481b9bb46',\n",
       " '0900006483229d77',\n",
       " '0900006483adf457',\n",
       " '09000064813e41fd',\n",
       " '090000648302e51c',\n",
       " '09000064810c08a4',\n",
       " '090000648111b5c2',\n",
       " '09000064821751e2',\n",
       " '0900006481e71486',\n",
       " '0900006481fbf51a',\n",
       " '0900006480edf695',\n",
       " '0900006481b8f45f',\n",
       " '0900006480a2b030',\n",
       " '0900006481fbf69c',\n",
       " '0900006480a55e69',\n",
       " '0900006484f4158e',\n",
       " '0900006480fe79cc',\n",
       " '0900006481fbf516',\n",
       " '0900006481c3442b',\n",
       " '0900006481b9bac7',\n",
       " '0900006482b4d198',\n",
       " '09000064809e8810',\n",
       " '0900006482605563',\n",
       " '09000064820611b4',\n",
       " '0900006480a47610',\n",
       " '0900006483df27ea',\n",
       " '090000648117620b',\n",
       " '090000648260550f',\n",
       " '09000064831aa404',\n",
       " '0900006480ae8a70',\n",
       " '0900006483df27e8',\n",
       " '0900006480fb85cc',\n",
       " '090000648248ea81',\n",
       " '0900006481fbea5b',\n",
       " '0900006481393562',\n",
       " '090000648248ebd5',\n",
       " '09000064820ddc30',\n",
       " '0900006480eebfec',\n",
       " '0900006480a6eb73',\n",
       " '090000648493940d',\n",
       " '0900006483df27e6',\n",
       " '0900006483df27ed',\n",
       " '0900006480eeb273',\n",
       " '0900006481cbe319',\n",
       " '0900006481508b4d',\n",
       " '090000648302dbf5',\n",
       " '090000648260535f',\n",
       " '0900006482605576',\n",
       " '090000648105c852',\n",
       " '0900006481c5ee24',\n",
       " '0900006481fbf039',\n",
       " '090000648114ed48',\n",
       " '0900006480a0d7a0',\n",
       " '090000648314d9c7',\n",
       " '090000648497f94a',\n",
       " '090000648408de02',\n",
       " '0900006482b4db28',\n",
       " '09000064828d1da9',\n",
       " '090000648243d2a5',\n",
       " '090000648302dc8b',\n",
       " '09000064816ab041',\n",
       " '0900006480a60dfe',\n",
       " '0900006481fbe15c',\n",
       " '09000064816ec95c',\n",
       " '09000064841282ab',\n",
       " '090000648302e363',\n",
       " '0900006481fbf695',\n",
       " '0900006482d3ab2c',\n",
       " '09000064823fe52b',\n",
       " '0900006483df0afa',\n",
       " '090000648302e0ef',\n",
       " '0900006480a741ef',\n",
       " '0900006481fbf647',\n",
       " '0900006482605360',\n",
       " '0900006482cf29f2',\n",
       " '090000648302e0f1',\n",
       " '090000648179ccd9',\n",
       " '0900006481c5ee25',\n",
       " '0900006480a7ffdb',\n",
       " '0900006482377b84',\n",
       " '09000064809fd662',\n",
       " '0900006481c5ee27',\n",
       " '0900006481fbdb4d',\n",
       " '0900006480a2b013',\n",
       " '0900006483df27ec',\n",
       " '09000064811419d8',\n",
       " '0900006481344726',\n",
       " '0900006481fbd96d',\n",
       " '0900006480bbe9b2',\n",
       " '0900006482064225',\n",
       " '0900006483df2aaa',\n",
       " '0900006481304148',\n",
       " '0900006482605560',\n",
       " '090000648248eeab',\n",
       " '0900006480a11a81',\n",
       " '0900006480f17d42',\n",
       " '0900006481ff9d65',\n",
       " '0900006481385aa7',\n",
       " '0900006480a472f0',\n",
       " '090000648383df97',\n",
       " '090000648302e364',\n",
       " '0900006483df27e7',\n",
       " '0900006481385aa4',\n",
       " '0900006481c5ee28',\n",
       " '0900006480acda88',\n",
       " '0900006483066207',\n",
       " '0900006482605507',\n",
       " '0900006481b92d2b',\n",
       " '0900006481fbf5bd',\n",
       " '09000064810fe576',\n",
       " '09000064809d55cb',\n",
       " '0900006481fbea5a',\n",
       " '09000064846f581e',\n",
       " '0900006481b63040',\n",
       " '090000648302dcc1',\n",
       " '0900006481b86293',\n",
       " '09000064823f71bd',\n",
       " '090000648179c7c3',\n",
       " '0900006480a505a5',\n",
       " '0900006483df2aad',\n",
       " '0900006481b86294',\n",
       " '0900006481385aa5',\n",
       " '090000648302dc8d',\n",
       " '090000648260550b',\n",
       " '0900006480f7c538',\n",
       " '09000064820b3edd',\n",
       " '090000648248edc9',\n",
       " '090000648248ee8b',\n",
       " '0900006481fbf03f',\n",
       " '09000064817e175d',\n",
       " '0900006480a71f9f',\n",
       " '0900006480a0d875',\n",
       " '0900006482605571',\n",
       " '0900006482c549c1',\n",
       " '0900006481fbf691',\n",
       " '090000648398914a',\n",
       " '090000648315001a',\n",
       " '090000648302dcc8',\n",
       " '0900006481b9bb47',\n",
       " '0900006480fe7870',\n",
       " '0900006482605508',\n",
       " '0900006480a55f9e',\n",
       " '0900006480fe7802',\n",
       " '0900006483df2ab1',\n",
       " '090000648179c80d',\n",
       " '09000064815767ff',\n",
       " '09000064824a3365',\n",
       " '0900006480f14d3c',\n",
       " '0900006481fbf644',\n",
       " '0900006480a2af4c',\n",
       " '090000648235ae4e',\n",
       " '090000648111b52c',\n",
       " '0900006481fbf3fb',\n",
       " '0900006480a734d3',\n",
       " '0900006481fbf696',\n",
       " '0900006483df2aaf',\n",
       " '090000648149da75',\n",
       " '09000064809e74eb',\n",
       " '0900006483145129',\n",
       " '09000064813b9402',\n",
       " '09000064831eb6c3',\n",
       " '09000064810daaf1',\n",
       " '0900006481ab114c',\n",
       " '0900006480a614f5',\n",
       " '09000064809d50dd',\n",
       " '0900006481385aa6',\n",
       " '090000648113d356',\n",
       " '0900006482080abe',\n",
       " '0900006480a2b001',\n",
       " '0900006483df2aac',\n",
       " '090000648100430f',\n",
       " '0900006483df2aae',\n",
       " '090000648305aca1',\n",
       " '0900006480a2aec8',\n",
       " '090000648132f28b',\n",
       " '0900006483df27e9',\n",
       " '090000648260527e',\n",
       " '0900006480a2afe5',\n",
       " '0900006481fbf661',\n",
       " '090000648260556e',\n",
       " '0900006481fbf515',\n",
       " '0900006482734d45',\n",
       " '0900006481b9bacb',\n",
       " '0900006481fbf4bd',\n",
       " '090000648302dcc5',\n",
       " '0900006483c80a18',\n",
       " '09000064813f31ff',\n",
       " '090000648020a90b',\n",
       " '09000064831aa577',\n",
       " '0900006481141620',\n",
       " '0900006480a71f99',\n",
       " '09000064813a5f6e',\n",
       " '0900006480a2b179']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(set(document_objectId))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "document_ids = list(set(document_ids)) # removing similar ids \n",
    "document_objectId = list(set(document_objectId)) # Removing similar object ids of documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0524-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-12-07T21:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006482361cb4\",\n",
      "      \"postedDate\" : \"2016-12-07T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-12-07T21:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648239188d\",\n",
      "      \"postedDate\" : \"2016-12-07T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-12-07T21:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Angela O.\",\n",
      "      \"objectId\" : \"09000064823a437c\",\n",
      "      \"postedDate\" : \"2016-12-07T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-12-07T21:36:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz et al\",\n",
      "      \"objectId\" : \"09000064823c5135\",\n",
      "      \"postedDate\" : \"2016-12-07T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0031\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 4,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 4,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 4,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 4,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 4,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0508-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-02-18T02:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edie Payleitner\",\n",
      "      \"objectId\" : \"0900006483f5773d\",\n",
      "      \"postedDate\" : \"2019-09-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0019\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0524-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2017-05-05T13:43:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from SEVIA USA (Keller and Heckman LLP)\",\n",
      "      \"objectId\" : \"09000064825880ae\",\n",
      "      \"postedDate\" : \"2017-05-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-07-03T17:48:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Fred Wo\",\n",
      "      \"objectId\" : \"0900006483423f0f\",\n",
      "      \"postedDate\" : \"2018-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-07-03T17:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Trisha Davidson\",\n",
      "      \"objectId\" : \"090000648344571a\",\n",
      "      \"postedDate\" : \"2018-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-02-10T17:59:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edie Payleitner,\",\n",
      "      \"objectId\" : \"0900006483f57736\",\n",
      "      \"postedDate\" : \"2019-09-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0042\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 4,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 4,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 4,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 4,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 4,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2019-D-4188-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-10-29T11:18:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Christofer Parker,\",\n",
      "      \"objectId\" : \"090000648493c0dc\",\n",
      "      \"postedDate\" : \"2020-10-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-10-29T11:19:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648493d8be\",\n",
      "      \"postedDate\" : \"2020-10-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-11-02T19:28:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Albert Peers\",\n",
      "      \"objectId\" : \"0900006484945fa4\",\n",
      "      \"postedDate\" : \"2020-11-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-05T17:26:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Winooski Partnership for Prevention\",\n",
      "      \"objectId\" : \"090000648495a90a\",\n",
      "      \"postedDate\" : \"2020-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:17:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from University of South Carolina\",\n",
      "      \"objectId\" : \"09000064849af2ed\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:17:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Philip Morris International\",\n",
      "      \"objectId\" : \"09000064849af418\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:18:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stacey McCaffrey\",\n",
      "      \"objectId\" : \"09000064849b67af\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:18:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Truth Iniative\",\n",
      "      \"objectId\" : \"09000064849cc39b\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:18:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Academy of Pediatrics, et al\",\n",
      "      \"objectId\" : \"09000064849cbeff\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:18:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lauterbach and Associates, LLC\",\n",
      "      \"objectId\" : \"09000064849cd9f5\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment for S M Iftekhar Uddin\",\n",
      "      \"objectId\" : \"09000064849ce7a5\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-06T14:19:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Foundation for a Smoke-Free World\",\n",
      "      \"objectId\" : \"09000064849ce7ff\",\n",
      "      \"postedDate\" : \"2021-01-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2019-D-4188-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-02-16T17:54:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lauren Lempert et al.\",\n",
      "      \"objectId\" : \"09000064849b312b\",\n",
      "      \"postedDate\" : \"2020-12-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2019-D-4188-0015\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 13,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 13,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 13,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 13,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 13,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2015-D-2325-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-08-10T18:04:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Montrenia English\",\n",
      "      \"objectId\" : \"09000064847e7d6f\",\n",
      "      \"postedDate\" : \"2020-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-D-2325-0003\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0853-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-27T14:10:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648204e692\",\n",
      "      \"postedDate\" : \"2016-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-27T14:10:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Avail Vapor LLC\",\n",
      "      \"objectId\" : \"0900006482045fec\",\n",
      "      \"postedDate\" : \"2016-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-27T14:10:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Daniel Jurez\",\n",
      "      \"objectId\" : \"090000648204567a\",\n",
      "      \"postedDate\" : \"2016-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-27T14:10:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cyclops Vapor\",\n",
      "      \"objectId\" : \"0900006482042313\",\n",
      "      \"postedDate\" : \"2016-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-27T14:10:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Reedhill Ventures LLC\",\n",
      "      \"objectId\" : \"0900006482040c67\",\n",
      "      \"postedDate\" : \"2016-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-27T14:10:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Andrae Spencer\",\n",
      "      \"objectId\" : \"0900006482054b89\",\n",
      "      \"postedDate\" : \"2016-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T13:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Roger\",\n",
      "      \"objectId\" : \"090000648215ccb7\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T13:11:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006482166c63\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T19:53:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from Benjamin L. England &amp; Associates, LLC\",\n",
      "      \"objectId\" : \"0900006482074bdb\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T19:55:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from Joshua Tongco, Juice Roll Upz, Inc.\",\n",
      "      \"objectId\" : \"090000648208490f\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:00:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from RAI Services Company\",\n",
      "      \"objectId\" : \"0900006482154104\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:02:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from Phill Green, Sutiff Tobacco Company, LLC\",\n",
      "      \"objectId\" : \"090000648215894e\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:03:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from Altria Client Services LLC\",\n",
      "      \"objectId\" : \"0900006482171676\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:04:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from Altria Client Services LLC\",\n",
      "      \"objectId\" : \"0900006482171910\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:04:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from James  Davenport, Vape Manufacturing Labs, Inc.\",\n",
      "      \"objectId\" : \"0900006482172011\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:05:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Request for Participation from Vape Manufacturing Labs, Inc.\",\n",
      "      \"objectId\" : \"09000064821760fb\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0853-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-08-25T20:09:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Paul Rebel\",\n",
      "      \"objectId\" : \"0900006482156895\",\n",
      "      \"postedDate\" : \"2016-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0853-0025\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 17,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 17,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 17,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 17,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 17,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-1820\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-02-21T15:12:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James White\",\n",
      "      \"objectId\" : \"0900006482f47b6e\",\n",
      "      \"postedDate\" : \"2018-02-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1820\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1821\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-07T15:10:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from RAI Services Company\",\n",
      "      \"objectId\" : \"0900006482f918ee\",\n",
      "      \"postedDate\" : \"2018-03-07T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1821\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1822\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-19T14:36:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thienan Phan\",\n",
      "      \"objectId\" : \"0900006483019b98\",\n",
      "      \"postedDate\" : \"2018-03-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1822\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1823\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-19T14:37:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648301c527\",\n",
      "      \"postedDate\" : \"2018-03-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1823\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1824\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-19T14:38:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648301eeee\",\n",
      "      \"postedDate\" : \"2018-03-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1824\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1825\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-19T14:38:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sean Springer\",\n",
      "      \"objectId\" : \"0900006483020340\",\n",
      "      \"postedDate\" : \"2018-03-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1825\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1826\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-19T14:38:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas May\",\n",
      "      \"objectId\" : \"0900006483021270\",\n",
      "      \"postedDate\" : \"2018-03-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1826\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1828\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-23T16:24:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Raymond Johnson\",\n",
      "      \"objectId\" : \"090000648303a30c\",\n",
      "      \"postedDate\" : \"2018-03-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1828\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1829\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-26T14:15:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Aaron Arant\",\n",
      "      \"objectId\" : \"090000648304c762\",\n",
      "      \"postedDate\" : \"2018-03-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1829\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1830\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-04-02T14:53:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Altria Client Services LLC\",\n",
      "      \"objectId\" : \"0900006483050505\",\n",
      "      \"postedDate\" : \"2018-04-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1830\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 10,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 10,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 10,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 10,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 10,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"TTB-2009-0002-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:17:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by the Campaign for Tobacco-Free Kids (Myers, Matthew L.)\",\n",
      "      \"objectId\" : \"0900006480a5d39e\",\n",
      "      \"postedDate\" : \"2009-12-01T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0024\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"TTB-2010-0004-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-07-11T20:00:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 16:  Rumbo, Tiffany D.\",\n",
      "      \"objectId\" : \"0900006480b5423a\",\n",
      "      \"postedDate\" : \"2010-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-25T20:01:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : true,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 1:  Gammons, Jerry W.\",\n",
      "      \"objectId\" : \"0900006480b1fad6\",\n",
      "      \"postedDate\" : \"2010-08-30T00:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-25T20:07:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 4:  Veitch,  Roger\",\n",
      "      \"objectId\" : \"0900006480b2a737\",\n",
      "      \"postedDate\" : \"2010-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-25T20:10:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 5:  Coffey, Robert J.\",\n",
      "      \"objectId\" : \"0900006480b2b8a6\",\n",
      "      \"postedDate\" : \"2010-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-25T20:12:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 6:  Ribarich, Dominique C.\",\n",
      "      \"objectId\" : \"0900006480b30124\",\n",
      "      \"postedDate\" : \"2010-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-25T20:14:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 7:  Vander Ploeg, Nick\",\n",
      "      \"objectId\" : \"0900006480b37a9d\",\n",
      "      \"postedDate\" : \"2010-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-26T18:22:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 10:  King, Lucie\",\n",
      "      \"objectId\" : \"0900006480b4b4fd\",\n",
      "      \"postedDate\" : \"2010-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-26T18:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 13:  Campaign for Tobacco-Free Kids\",\n",
      "      \"objectId\" : \"0900006480b5414c\",\n",
      "      \"postedDate\" : \"2010-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-26T18:38:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 14:  King, P.\",\n",
      "      \"objectId\" : \"0900006480b47abe\",\n",
      "      \"postedDate\" : \"2010-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-31T14:03:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 2:  Gulish, Nancy J.\",\n",
      "      \"objectId\" : \"0900006480b1fb55\",\n",
      "      \"postedDate\" : \"2010-08-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-31T14:05:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 3:  Donofry, Joseph F.\",\n",
      "      \"objectId\" : \"0900006480b270c3\",\n",
      "      \"postedDate\" : \"2010-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-31T14:11:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 24:  Wilson, Teresa G.\",\n",
      "      \"objectId\" : \"0900006480f061bf\",\n",
      "      \"postedDate\" : \"2011-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-31T14:11:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 25:  Wagner, Robert\",\n",
      "      \"objectId\" : \"0900006480f06d1a\",\n",
      "      \"postedDate\" : \"2011-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-09-15T13:59:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 26:  Kroesser, John L.\",\n",
      "      \"objectId\" : \"0900006480f134f6\",\n",
      "      \"postedDate\" : \"2011-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T14:46:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 28:  Mullen, Wes W.\",\n",
      "      \"objectId\" : \"0900006480f1d8d2\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 29:  Deerfield, Richard P.\",\n",
      "      \"objectId\" : \"0900006480b52cb8\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:17:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 30:  Dry Leaf Tobacco (Fite, Thomas E.)\",\n",
      "      \"objectId\" : \"0900006480f20653\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:17:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 31:  Kreklow, Kelly Lee\",\n",
      "      \"objectId\" : \"0900006480f22cf6\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:17:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 32:  Boensch, Richard\",\n",
      "      \"objectId\" : \"0900006480f233b2\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:17:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 33:  Miller, Neil\",\n",
      "      \"objectId\" : \"0900006480f23e53\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 34:  Sibert, Sandra L.\",\n",
      "      \"objectId\" : \"0900006480f26822\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 35:  Rodrigue, Kurt M.\",\n",
      "      \"objectId\" : \"0900006480f26929\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 36:  Grider, Karen C.\",\n",
      "      \"objectId\" : \"0900006480f27324\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 37:  Beckman, William H.\",\n",
      "      \"objectId\" : \"0900006480f27baf\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 38:  Amos James A.\",\n",
      "      \"objectId\" : \"0900006480f27f90\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 39:  Burnham, Glenn\",\n",
      "      \"objectId\" : \"0900006480f281a6\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T15:29:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 40:  Daniels, Ken\",\n",
      "      \"objectId\" : \"0900006480f2863d\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:11:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 41:  Akins, Vicki L.\",\n",
      "      \"objectId\" : \"0900006480f2867b\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:11:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 42:  Kollock, Jamie\",\n",
      "      \"objectId\" : \"0900006480f28732\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:11:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 43:  Soulier, William J.\",\n",
      "      \"objectId\" : \"0900006480f28b17\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:11:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 44:  Andrews, Dorothy A.\",\n",
      "      \"objectId\" : \"0900006480f28d14\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:11:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 45:  Giles, Debby\",\n",
      "      \"objectId\" : \"0900006480f28da9\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 46:  Morse, Gary\",\n",
      "      \"objectId\" : \"0900006480f28e67\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 47:  Vosburgh, Deborah A.\",\n",
      "      \"objectId\" : \"0900006480f28ef8\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 48:  Gotham, Barbara\",\n",
      "      \"objectId\" : \"0900006480f28f5d\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 49:  Charles, Robert\",\n",
      "      \"objectId\" : \"0900006480f2956b\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 50:  Fitzpatrick, Paul M.\",\n",
      "      \"objectId\" : \"0900006480f296b1\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 51:  Mcintosh, James\",\n",
      "      \"objectId\" : \"0900006480f2971f\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:25:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 52:  Cauldwell, Mark\",\n",
      "      \"objectId\" : \"0900006480f297fa\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:25:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 53:  Arias, Christopher J.\",\n",
      "      \"objectId\" : \"0900006480f299c3\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:25:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 54:  Allen, Jody V.\",\n",
      "      \"objectId\" : \"0900006480f29d32\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:25:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 55:  Machardt, Toni\",\n",
      "      \"objectId\" : \"0900006480f29d4d\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:32:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 56:  Lesick, Sandie\",\n",
      "      \"objectId\" : \"0900006480f29e14\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:32:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 57:  Tarnaski, Megan\",\n",
      "      \"objectId\" : \"0900006480f2a008\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:32:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 58:  Chadwick, Gene D.\",\n",
      "      \"objectId\" : \"0900006480f2a053\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:32:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 59:  Chadwick, Natasha\",\n",
      "      \"objectId\" : \"0900006480f2a099\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:32:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 60:  Smith, Cody\",\n",
      "      \"objectId\" : \"0900006480f2a09c\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:41:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 61:  Salerno, Barbara A.\",\n",
      "      \"objectId\" : \"0900006480f2a09e\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:41:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 62:  Prevratil, Charles\",\n",
      "      \"objectId\" : \"0900006480f2a222\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:41:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 63:  Honecker, J.\",\n",
      "      \"objectId\" : \"0900006480f2a393\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:41:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 64:  Winter, Carla\",\n",
      "      \"objectId\" : \"0900006480f2a573\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:41:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 65:  Whyte, Marlene A.\",\n",
      "      \"objectId\" : \"0900006480f2a674\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 66:  Simoneau, Nelson S.\",\n",
      "      \"objectId\" : \"0900006480f2a927\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 67:  Southworth, Johnny\",\n",
      "      \"objectId\" : \"0900006480f2a948\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 68:  Hand, Bob\",\n",
      "      \"objectId\" : \"0900006480f2aa2e\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 69:  Hunt, Leslie A.\",\n",
      "      \"objectId\" : \"0900006480f2aa59\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T18:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 70:  Hoffman, Jeff L.\",\n",
      "      \"objectId\" : \"0900006480f2adfa\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:03:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 71:  Davis, Andrew W.\",\n",
      "      \"objectId\" : \"0900006480f2aeab\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:03:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 72:  Johnson, Melissa R.\",\n",
      "      \"objectId\" : \"0900006480f2b00c\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:03:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 73:  Unger, Robert\",\n",
      "      \"objectId\" : \"0900006480f2b213\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:03:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 74:  Clinton, Timothy P.\",\n",
      "      \"objectId\" : \"0900006480f2b325\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:03:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 75:  Kirchon, Frank\",\n",
      "      \"objectId\" : \"0900006480f2b930\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0079\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 76:  Fernandes, Susan B.\",\n",
      "      \"objectId\" : \"0900006480f2bf6c\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0079\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 77:  Southcott, Mary\",\n",
      "      \"objectId\" : \"0900006480f2bfc5\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 78:  Fisher, Mary F.\",\n",
      "      \"objectId\" : \"0900006480f2c916\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 79:  Jordan, Elise M.\",\n",
      "      \"objectId\" : \"0900006480f2cab4\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 80:  Lewis, Bonnie B.\",\n",
      "      \"objectId\" : \"0900006480f2cc4e\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:22:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 81:  Jordan, Corliss D.\",\n",
      "      \"objectId\" : \"0900006480f2cf72\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:22:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 82:  Trentman, Debbie\",\n",
      "      \"objectId\" : \"0900006480f2d030\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:22:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 83:  Harvey, Rose M.\",\n",
      "      \"objectId\" : \"0900006480f2e74f\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 84:  Marvicsin, Gail P.\",\n",
      "      \"objectId\" : \"0900006480f2eaf6\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 85:  Myers, Mark O.\",\n",
      "      \"objectId\" : \"0900006480f2ebbf\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 86:  Stuckey, Robert\",\n",
      "      \"objectId\" : \"0900006480f2ec4d\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0090\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 87: Lipke, Diana\",\n",
      "      \"objectId\" : \"0900006480f2edeb\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0090\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0091\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 88:  Lipke, Jimmy\",\n",
      "      \"objectId\" : \"0900006480f2ee88\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0091\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0092\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 89:  McClure, Sandra J.\",\n",
      "      \"objectId\" : \"0900006480f31b6b\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0092\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0093\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 90:  Schmidt, Wendy\",\n",
      "      \"objectId\" : \"0900006480f35b47\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0093\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0094\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:37:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 91:  Fiumano, Wanda L.\",\n",
      "      \"objectId\" : \"0900006480f35b91\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0094\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:37:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 92:  Canfield, Kevin B.\",\n",
      "      \"objectId\" : \"0900006480f35be7\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:37:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 93:  Green, Dan\",\n",
      "      \"objectId\" : \"0900006480f36549\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0097\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:37:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 94:  Pezanowski, Patricia\",\n",
      "      \"objectId\" : \"0900006480f38b08\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0097\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:37:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 95:  Santiago, LaVita E.\",\n",
      "      \"objectId\" : \"0900006480f3d125\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:46:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 96:  Cella, Michele\",\n",
      "      \"objectId\" : \"0900006480f3e337\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:46:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 97:  Boring, Terry L.\",\n",
      "      \"objectId\" : \"0900006480f3e379\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0101\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:46:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 98:  Demick, Joanne\",\n",
      "      \"objectId\" : \"0900006480f3e6d8\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0101\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0102\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:46:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 99:  Volpe, John A.\",\n",
      "      \"objectId\" : \"0900006480f3eb7e\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0102\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0103\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:46:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 100:  Sager, Keith R.\",\n",
      "      \"objectId\" : \"0900006480f3f21c\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0103\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0104\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:54:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 101:  Zervos, Basil\",\n",
      "      \"objectId\" : \"0900006480f3f368\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0104\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:54:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 102:  Krotinis, Lisa\",\n",
      "      \"objectId\" : \"0900006480f3fb1d\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:54:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 103:  Huntsman, David\",\n",
      "      \"objectId\" : \"0900006480f40646\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:54:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 104:  Pezanowski, Robert\",\n",
      "      \"objectId\" : \"0900006480f40788\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T19:54:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 105:  Parker, Jeff\",\n",
      "      \"objectId\" : \"0900006480f40a00\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T20:04:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 106:  Stone, Renate W.\",\n",
      "      \"objectId\" : \"0900006480f40b06\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T20:04:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 107:  Messina, Karen A.\",\n",
      "      \"objectId\" : \"0900006480f40dd5\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0110\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0111\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T20:04:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 108:  Larrimore, Deborah B.\",\n",
      "      \"objectId\" : \"0900006480f40e73\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0111\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0112\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T20:04:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 109:  Daniels, Kevin\",\n",
      "      \"objectId\" : \"0900006480f4152e\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0112\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0113\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-24T20:04:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 110:  Cohen, Matthew\",\n",
      "      \"objectId\" : \"0900006480f417be\",\n",
      "      \"postedDate\" : \"2011-10-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0113\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0114\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:24:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 111:  Brady, Betty S.\",\n",
      "      \"objectId\" : \"0900006480f41b75\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0114\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0115\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:24:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 112:  Schuster, Becky A.\",\n",
      "      \"objectId\" : \"0900006480f42f25\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0115\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0116\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:24:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 113:  Barton, Jane\",\n",
      "      \"objectId\" : \"0900006480f43032\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0116\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0117\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:24:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 114:  Campbell, Mary Lou\",\n",
      "      \"objectId\" : \"0900006480f436ce\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0117\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0118\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:24:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 115:  Lowry, Howard S.\",\n",
      "      \"objectId\" : \"0900006480f438d7\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0118\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0119\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 116:  Matthews, Heather M.\",\n",
      "      \"objectId\" : \"0900006480f4419e\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0119\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0120\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 117:  Cunningham, William C. Jr.\",\n",
      "      \"objectId\" : \"0900006480f44526\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0120\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0121\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 118:  Hunt, Thomas A.\",\n",
      "      \"objectId\" : \"0900006480f44a1e\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0121\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0122\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:36:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 119:  Dugan, Richard\",\n",
      "      \"objectId\" : \"0900006480f4700f\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0122\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0123\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:36:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 120:  Mclaren, Michael\",\n",
      "      \"objectId\" : \"0900006480f497b4\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0123\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0124\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:47:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 121:  Clark, Steven T.\",\n",
      "      \"objectId\" : \"0900006480f49888\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0124\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0125\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:47:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 122:  Delcasale, Nellie\",\n",
      "      \"objectId\" : \"0900006480f4a293\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0125\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0126\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:47:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 123:  Jackson, Lydia\",\n",
      "      \"objectId\" : \"0900006480f4a7e1\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0126\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0127\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:47:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 124:  Hanshaw, Ron\",\n",
      "      \"objectId\" : \"0900006480f4ad49\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0127\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0128\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:47:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 125:  St. Peter, Julie\",\n",
      "      \"objectId\" : \"0900006480f4aebb\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0128\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0129\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:54:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 126:  Kovalick, Colleen C.\",\n",
      "      \"objectId\" : \"0900006480f4ba51\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0129\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0130\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:54:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 127:  Park, Kathlene J.\",\n",
      "      \"objectId\" : \"0900006480f4bac8\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0130\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0131\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:54:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 128:  Diaz, Kim\",\n",
      "      \"objectId\" : \"0900006480f4bc22\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0131\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0132\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:55:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 129:  Bush, John\",\n",
      "      \"objectId\" : \"0900006480f4bcf7\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0132\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0133\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T13:55:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 130:  Bush, Bonnie\",\n",
      "      \"objectId\" : \"0900006480f4bcfb\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0133\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0134\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:04:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 131:  Kaselitz, Sharon L.\",\n",
      "      \"objectId\" : \"0900006480f4bdb7\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0134\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0135\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:04:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 132:  Cleaver, Trina\",\n",
      "      \"objectId\" : \"0900006480f4d166\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0135\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0136\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:04:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 133:  Barrett, Jamie L.\",\n",
      "      \"objectId\" : \"0900006480f4d1d1\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0136\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0137\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:04:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 134:  Sickler, Danna J.\",\n",
      "      \"objectId\" : \"0900006480f4db47\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0137\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0138\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:04:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 135:  Richards, Brandie B.\",\n",
      "      \"objectId\" : \"0900006480f4ed93\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0138\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0139\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:24:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 136:  Diefenderfer, David K.\",\n",
      "      \"objectId\" : \"0900006480f4edf0\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0139\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0140\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:24:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 137:  Jewell, Jeanne\",\n",
      "      \"objectId\" : \"0900006480f4f4e7\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0140\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0141\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:24:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 138:  Porter, Gerald R.\",\n",
      "      \"objectId\" : \"0900006480f4f6c5\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0141\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0142\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:24:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 139:  Helm, Wanda\",\n",
      "      \"objectId\" : \"0900006480f4f7e3\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0142\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0143\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:24:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 140:  Beall, Bonny\",\n",
      "      \"objectId\" : \"0900006480f4f7f9\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0143\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0144\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 141:  Velez, Valarie B.\",\n",
      "      \"objectId\" : \"0900006480f4fe2c\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0144\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 142:  Rocque, Lori\",\n",
      "      \"objectId\" : \"0900006480f4fe49\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0146\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 143:  Pouncey, Nancy S.\",\n",
      "      \"objectId\" : \"0900006480f4fe5c\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0146\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0147\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:33:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 144:  Bhula, Kirit\",\n",
      "      \"objectId\" : \"0900006480f50485\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0147\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0148\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:33:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 145:  Cornell &amp; Diehl, Inc. (Tarler, Craig C.)\",\n",
      "      \"objectId\" : \"0900006480f505a5\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0148\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0149\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 146:  Clark, Gayle A.\",\n",
      "      \"objectId\" : \"0900006480f5066e\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0149\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 147:  VanDyck, Robert J.\",\n",
      "      \"objectId\" : \"0900006480f51320\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 148:  Rubin, Judith M.\",\n",
      "      \"objectId\" : \"0900006480f51d0b\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0151\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0152\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 149:  Parent, Richard T.\",\n",
      "      \"objectId\" : \"0900006480f51d51\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0152\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0153\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T14:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 150:  Welbes, Laura\",\n",
      "      \"objectId\" : \"0900006480f520e1\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0153\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0154\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:08:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 151:  Doucet, Mike\",\n",
      "      \"objectId\" : \"0900006480f522e9\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0154\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0155\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:08:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 152:  Elliott, George C.\",\n",
      "      \"objectId\" : \"0900006480f52a23\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0155\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0156\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:08:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 153:  Hagen, Marlene J.\",\n",
      "      \"objectId\" : \"0900006480f53b16\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0156\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0157\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:08:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 154:  Warner, M. J.\",\n",
      "      \"objectId\" : \"0900006480f5406f\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0157\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0158\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:08:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 155:  Irons, Robert G.\",\n",
      "      \"objectId\" : \"0900006480f55299\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0158\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0159\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:16:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 156:  Gilson, Elizabeth M.\",\n",
      "      \"objectId\" : \"0900006480f553ba\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0159\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0160\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:16:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 157:  Gentry, Bonnie\",\n",
      "      \"objectId\" : \"0900006480f55902\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0160\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0161\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:16:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 158:  Parsons, Larry E.\",\n",
      "      \"objectId\" : \"0900006480f5973d\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0161\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0162\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:16:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 159:  Chamberlain, Calvin J.\",\n",
      "      \"objectId\" : \"0900006480f59890\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0162\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0163\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-25T15:20:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 160:  Muse, Wanda\",\n",
      "      \"objectId\" : \"0900006480f5abe6\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0163\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T13:44:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 12:  Prime Time International Company (1st Comment)\",\n",
      "      \"objectId\" : \"0900006480b53483\",\n",
      "      \"postedDate\" : \"2010-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T13:48:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 11:  International Premuim Cigar &amp; Pipe Retailers Association\",\n",
      "      \"objectId\" : \"0900006480b51ebe\",\n",
      "      \"postedDate\" : \"2010-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:02:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 19:  Top Tobacco, LP (1st Comment)\",\n",
      "      \"objectId\" : \"0900006480b5c72b\",\n",
      "      \"postedDate\" : \"2010-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:04:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 27:  Top Tobacco, LP (2nd Comment)\",\n",
      "      \"objectId\" : \"0900006480f1cd0b\",\n",
      "      \"postedDate\" : \"2011-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:14:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 22:  Lane Limited (1st Comment; Reynolds American, Inc.)\",\n",
      "      \"objectId\" : \"0900006480b6f299\",\n",
      "      \"postedDate\" : \"2010-10-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:26:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 23:  Liggett Vector Brands (1st Comment)\",\n",
      "      \"objectId\" : \"0900006480ebf11d\",\n",
      "      \"postedDate\" : \"2011-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0164\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:33:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 161:  National Association of Convenience Stores\",\n",
      "      \"objectId\" : \"0900006480f5b9eb\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0164\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:35:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 162:  Custom Blends Farm Fresh Tobacco\",\n",
      "      \"objectId\" : \"0900006480f59da9\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0165\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:39:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 8:  Fantasia Distribution, Inc. (Jacob, Randy)\",\n",
      "      \"objectId\" : \"0900006480b3df22\",\n",
      "      \"postedDate\" : \"2010-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:44:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 9:  Pipe Tobacco Council, Inc. (1st Comment)\",\n",
      "      \"objectId\" : \"0900006480b53429\",\n",
      "      \"postedDate\" : \"2010-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:49:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 17:  SX Brands, Inc.\",\n",
      "      \"objectId\" : \"0900006480b5423d\",\n",
      "      \"postedDate\" : \"2010-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:53:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 18:  Bailey's Family Tobacco (S &amp; M Brands, Inc.)\",\n",
      "      \"objectId\" : \"0900006480b5be19\",\n",
      "      \"postedDate\" : \"2010-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T14:59:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 20:  Daughters &amp; Ryan, Inc. (D &amp; R Tobacco)\",\n",
      "      \"objectId\" : \"0900006480b5c814\",\n",
      "      \"postedDate\" : \"2010-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0166\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:36:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 163:  Pipe Tobacco Council, Inc. (2nd Comment)\",\n",
      "      \"objectId\" : \"0900006480f5a64f\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0166\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0167\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:38:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 164:  Prime Time International Company (2nd Comment)\",\n",
      "      \"objectId\" : \"0900006480f5a49b\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0167\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0168\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:39:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 165:  Liggett Vector Brands (2nd Comment)\",\n",
      "      \"objectId\" : \"0900006480f5aee7\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0168\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:40:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 15:  National Tobacco Company (1st Comment)\",\n",
      "      \"objectId\" : \"0900006480b53df3\",\n",
      "      \"postedDate\" : \"2010-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0169\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:44:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 166:  National Tobacco Company (2nd Comment)\",\n",
      "      \"objectId\" : \"0900006480f5afea\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0169\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0170\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:46:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 167:  Lane Limited (2nd Comment; Scandinavian Tobacco Group)\",\n",
      "      \"objectId\" : \"0900006480f5b026\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0170\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0171\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:47:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 168:  East Carolina RYO, LLC\",\n",
      "      \"objectId\" : \"0900006480f5ba00\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0171\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-26T15:48:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 21: John Middleton Co. (1st Comment)\",\n",
      "      \"objectId\" : \"0900006480b5c816\",\n",
      "      \"postedDate\" : \"2010-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0173\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-03-08T21:00:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 170:  Bailey's Family Tobacco (S &amp; M Brands, Inc.) Letter of 9/16/2011\",\n",
      "      \"objectId\" : \"0900006480fd232f\",\n",
      "      \"postedDate\" : \"2012-03-08T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0173\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2010-0004-0172\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-29T19:14:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 169:  John Middleton Co. (2nd Comment)\",\n",
      "      \"objectId\" : \"0900006480f5ba0c\",\n",
      "      \"postedDate\" : \"2011-10-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2010-0004-0172\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 170,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 170,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 170,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 170,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 170,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2013-N-0521-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephen A Haering - Comment\",\n",
      "      \"objectId\" : \"090000648137a06a\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"George Alvin Haws - Comment\",\n",
      "      \"objectId\" : \"090000648137a081\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Folan - Comment\",\n",
      "      \"objectId\" : \"090000648137a7ee\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Richard Jacobsen - Comment\",\n",
      "      \"objectId\" : \"090000648137a7f4\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Spatarella - Comment\",\n",
      "      \"objectId\" : \"090000648137a8e8\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Fardellone, DNP, RN - Comment\",\n",
      "      \"objectId\" : \"090000648137ac45\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-12T21:29:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Phil Konigsberg - Comment\",\n",
      "      \"objectId\" : \"090000648137b6eb\",\n",
      "      \"postedDate\" : \"2013-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela I Wagner - Comment\",\n",
      "      \"objectId\" : \"090000648137fda8\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Oliva - Comment\",\n",
      "      \"objectId\" : \"0900006481380d22\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joshua Dyme - Comment\",\n",
      "      \"objectId\" : \"090000648138106d\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joshua Dyme - Comment\",\n",
      "      \"objectId\" : \"090000648138106e\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John R. Polito - Comment\",\n",
      "      \"objectId\" : \"0900006481381895\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia McGeary - Comment\",\n",
      "      \"objectId\" : \"090000648138386b\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katherine Donald - Comment\",\n",
      "      \"objectId\" : \"0900006481385c8a\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:54:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diana Inagaki - Comment\",\n",
      "      \"objectId\" : \"090000648138626c\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:55:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Harold Farber, MD - Comment\",\n",
      "      \"objectId\" : \"09000064813863b1\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:55:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648138b1d1\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:55:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tompkins County Health Department - Comment\",\n",
      "      \"objectId\" : \"090000648138b931\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:55:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tammy - Comment\",\n",
      "      \"objectId\" : \"090000648138c6b5\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:55:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"First District Health Unit - Comment\",\n",
      "      \"objectId\" : \"090000648138f1b9\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T15:55:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tobacco Prevention Coalition of Contra Costa - Comment\",\n",
      "      \"objectId\" : \"090000648138f20e\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T16:08:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Academy of Family Physicians (AAFP) - Comment\",\n",
      "      \"objectId\" : \"09000064813a4e5b\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T16:15:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brian Davis - Comment\",\n",
      "      \"objectId\" : \"09000064813aa295\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T16:15:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelvin Choi - Comment\",\n",
      "      \"objectId\" : \"09000064813aca5e\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-13T16:15:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064813aeead\",\n",
      "      \"postedDate\" : \"2013-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-16T20:18:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorelei Wagner - Comment\",\n",
      "      \"objectId\" : \"09000064813af88e\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-16T20:18:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Warren - Comment\",\n",
      "      \"objectId\" : \"09000064813b36a9\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-08-21T16:17:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barry Castleman - Comment\",\n",
      "      \"objectId\" : \"09000064813bbe49\",\n",
      "      \"postedDate\" : \"2013-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T14:01:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danial Johnson (AMCON Distributing Co) - Comment\",\n",
      "      \"objectId\" : \"09000064813c022e\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T14:04:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Minnesota Department of Health - Comment\",\n",
      "      \"objectId\" : \"09000064813c0424\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T14:08:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Atlantic Dominion Distributors - Comment\",\n",
      "      \"objectId\" : \"09000064813c1569\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T14:14:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Philadelphia Department of Public Health - Comment\",\n",
      "      \"objectId\" : \"09000064813c159e\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T14:16:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eugene Naydovich (JN Distributor) - Comment\",\n",
      "      \"objectId\" : \"09000064813c15a1\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T14:21:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tobacco Control Partners - Comment\",\n",
      "      \"objectId\" : \"09000064813c18f2\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T15:45:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Wood Johnson Foundation (RWJF) - Comment\",\n",
      "      \"objectId\" : \"09000064813c1acf\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-03T15:46:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064813c1d73\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erin Dionne, RRT, TTS - Comment\",\n",
      "      \"objectId\" : \"09000064813c788a\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bev Benda - Comment\",\n",
      "      \"objectId\" : \"09000064813c7c54\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Debbie - Comment\",\n",
      "      \"objectId\" : \"09000064813c7e43\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Teresa K. Barber - Comment\",\n",
      "      \"objectId\" : \"09000064813c82ba\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Virginia Retail Merchants Association (VRMA) - Comment\",\n",
      "      \"objectId\" : \"09000064813ca0fc\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eby-Brown Co., L.L.C. - Comment\",\n",
      "      \"objectId\" : \"09000064813cb494\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"George Smith - Comment\",\n",
      "      \"objectId\" : \"09000064813cdc02\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sammie Turner - Comment\",\n",
      "      \"objectId\" : \"09000064813cdd5e\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:57:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon Fischer - Comment\",\n",
      "      \"objectId\" : \"09000064813cde45\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-05T15:58:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Council of Independent Tobacco Manufacturers (CITMA) - Comment\",\n",
      "      \"objectId\" : \"09000064813ce8ad\",\n",
      "      \"postedDate\" : \"2013-09-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064813cebfd\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David How - Comment\",\n",
      "      \"objectId\" : \"09000064813cfd7b\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paul Carey III - Comment\",\n",
      "      \"objectId\" : \"09000064813d0443\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alabama State Trooper Association - Comment\",\n",
      "      \"objectId\" : \"09000064813d2147\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mike Robertson - Comment\",\n",
      "      \"objectId\" : \"09000064813d2215\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Illinois Retail Merchants Association (IRMA) - Comment\",\n",
      "      \"objectId\" : \"09000064813d2a22\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Sawyer - Comment\",\n",
      "      \"objectId\" : \"09000064813d5f7a\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Bunte - Comment\",\n",
      "      \"objectId\" : \"09000064813d6f6c\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ara Thompson - Comment\",\n",
      "      \"objectId\" : \"09000064813d6f83\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T16:32:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rick Brown - Comment\",\n",
      "      \"objectId\" : \"09000064813d6fc6\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T21:34:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Southern - Comment\",\n",
      "      \"objectId\" : \"09000064813d738b\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T21:34:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Becky Wallace - Comment\",\n",
      "      \"objectId\" : \"09000064813d738d\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-06T21:34:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tennessee Commercial Warehouse - Comment\",\n",
      "      \"objectId\" : \"09000064813d778c\",\n",
      "      \"postedDate\" : \"2013-09-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NYS American Academy of Pediatrics - Comment\",\n",
      "      \"objectId\" : \"09000064813d779d\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"City-County Health District Board - Comment\",\n",
      "      \"objectId\" : \"09000064813d77f3\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vermont Grocersâ€™ Association - Comment\",\n",
      "      \"objectId\" : \"09000064813d7e03\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Quintin T Berry - Comment\",\n",
      "      \"objectId\" : \"09000064813d7f01\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Ledford - Comment\",\n",
      "      \"objectId\" : \"09000064813d808d\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie R Greene - Comment\",\n",
      "      \"objectId\" : \"09000064813d81a5\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Multinational Business Services, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813d81aa\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chad S Coulter - Comment\",\n",
      "      \"objectId\" : \"09000064813d81df\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Keith Latham - Comment\",\n",
      "      \"objectId\" : \"09000064813d83d9\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:34:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mona L Krochmal - Comment\",\n",
      "      \"objectId\" : \"09000064813d84e5\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-09T21:35:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carrie A Beal - Comment\",\n",
      "      \"objectId\" : \"09000064813d8564\",\n",
      "      \"postedDate\" : \"2013-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-10T16:31:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Efren Benavidez - Comment\",\n",
      "      \"objectId\" : \"09000064813d9a0b\",\n",
      "      \"postedDate\" : \"2013-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-10T16:31:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Americans for Limited Government - Comment\",\n",
      "      \"objectId\" : \"09000064813da5ea\",\n",
      "      \"postedDate\" : \"2013-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-10T16:31:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The American Council on Science and Health (ACSH) - Comment\",\n",
      "      \"objectId\" : \"09000064813dc017\",\n",
      "      \"postedDate\" : \"2013-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Scott Shepherd - Comment\",\n",
      "      \"objectId\" : \"09000064813dc8bf\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeff Smith, III - Comment\",\n",
      "      \"objectId\" : \"09000064813dc8d3\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Randall Long - Comment\",\n",
      "      \"objectId\" : \"09000064813dce67\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tommy Stine - Comment\",\n",
      "      \"objectId\" : \"09000064813dd619\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Bauermeister - Comment\",\n",
      "      \"objectId\" : \"09000064813dd83d\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Corporate Accountability International - Comment\",\n",
      "      \"objectId\" : \"09000064813dd991\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Scott Wiener - Comment\",\n",
      "      \"objectId\" : \"09000064813ddf46\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Sparrow - Comment\",\n",
      "      \"objectId\" : \"09000064813ddfe0\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Howell - Comment\",\n",
      "      \"objectId\" : \"09000064813de95d\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diane S. Dranginis - Comment\",\n",
      "      \"objectId\" : \"09000064813df867\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0090\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"F. McConnell &amp; Sons, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813e0e5a\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0090\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0091\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Randy Hagler - Comment\",\n",
      "      \"objectId\" : \"09000064813e146e\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0091\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0092\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:50:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Conservative Union - Comment\",\n",
      "      \"objectId\" : \"09000064813e2731\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0092\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0093\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-11T16:51:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"PA Distributors Association, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813e3938\",\n",
      "      \"postedDate\" : \"2013-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0093\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0094\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-16T15:18:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina Retail Merchants Association - Comment\",\n",
      "      \"objectId\" : \"09000064813dda6f\",\n",
      "      \"postedDate\" : \"2013-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0094\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-20T16:19:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Northern Virginia Cigarette Tax Board - Comment\",\n",
      "      \"objectId\" : \"09000064813da61b\",\n",
      "      \"postedDate\" : \"2013-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-09-20T16:21:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Burns &amp; Burns, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813da8fb\",\n",
      "      \"postedDate\" : \"2013-09-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0101\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-04T20:56:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mississippi House of Representatives Ways &amp; Means Committee - Comment\",\n",
      "      \"objectId\" : \"090000648142bd41\",\n",
      "      \"postedDate\" : \"2013-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0101\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0102\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-04T21:01:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"F. McConnell and Sons - Comment\",\n",
      "      \"objectId\" : \"090000648142bd45\",\n",
      "      \"postedDate\" : \"2013-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0102\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0103\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-04T21:04:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richmond Master Distributors, Inc. - Comment\",\n",
      "      \"objectId\" : \"090000648142bd4e\",\n",
      "      \"postedDate\" : \"2013-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0103\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0104\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-07T19:21:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Terry Schmitz Tobacco Outlet Plus (Kwik Trip Inc.) - Comment\",\n",
      "      \"objectId\" : \"09000064813f2f15\",\n",
      "      \"postedDate\" : \"2013-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0104\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-07T19:21:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mississippi Retail &amp; Grocers Association - Comment\",\n",
      "      \"objectId\" : \"09000064813ef255\",\n",
      "      \"postedDate\" : \"2013-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-07T19:21:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patrick Donoho, Maryland Retailers Association - Comment\",\n",
      "      \"objectId\" : \"09000064813eeacf\",\n",
      "      \"postedDate\" : \"2013-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-07T19:21:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joel L. Nitzkin, MD, MPH, DPA  - Comment\",\n",
      "      \"objectId\" : \"09000064813ed660\",\n",
      "      \"postedDate\" : \"2013-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Q Mart Marketplace - Comment\",\n",
      "      \"objectId\" : \"09000064813f4ddb\",\n",
      "      \"postedDate\" : \"2013-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0112\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:36:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"State of Indiana, Senator Ronnie J. Alting - Comment\",\n",
      "      \"objectId\" : \"09000064814077a0\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0112\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0113\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:38:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"State of Connecticut House of Representatives, the Honorable Anthony J. D'Amelio - Comment\",\n",
      "      \"objectId\" : \"09000064814077a1\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0113\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0114\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:42:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Georgia Association of Convenience Stores (GACS) - Comment\",\n",
      "      \"objectId\" : \"0900006481434802\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0114\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0115\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:43:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Zoe Lofgren, House of Representatives - Comment\",\n",
      "      \"objectId\" : \"09000064814487b5\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0115\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0116\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:44:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"H.T. Hackney, Columbus, Kevin Cook - Comment\",\n",
      "      \"objectId\" : \"09000064814487b6\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0116\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0117\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-08T22:45:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Flichia Wholesale Distributing, Dave McCarter - Comment\",\n",
      "      \"objectId\" : \"09000064814487b7\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0117\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0119\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-10T19:32:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ohio Grocers Association - Comment\",\n",
      "      \"objectId\" : \"090000648144a049\",\n",
      "      \"postedDate\" : \"2013-10-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0119\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0121\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-10T19:37:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shamrock  Specialty Papers, LTD - Comment\",\n",
      "      \"objectId\" : \"090000648144a041\",\n",
      "      \"postedDate\" : \"2013-10-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0121\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0122\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-10T19:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Treofan America, Inc - Comment\",\n",
      "      \"objectId\" : \"090000648144a043\",\n",
      "      \"postedDate\" : \"2013-10-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0122\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0126\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T03:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Estes Express Lines - Comment\",\n",
      "      \"objectId\" : \"090000648144f1e3\",\n",
      "      \"postedDate\" : \"2013-10-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0126\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0125\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T03:36:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Southern Association Wholesale Distributors - Comment\",\n",
      "      \"objectId\" : \"090000648144ebac\",\n",
      "      \"postedDate\" : \"2013-10-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0125\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0124\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T03:37:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Lynn Wachtmann, State Reprensentative State of Ohio - Comment\",\n",
      "      \"objectId\" : \"090000648144eba9\",\n",
      "      \"postedDate\" : \"2013-10-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0124\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0127\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T16:24:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Rick Jones, Senate , State of Michigan - Comment\",\n",
      "      \"objectId\" : \"090000648144f8b0\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0127\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0128\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T17:23:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Flash Foods - Comment\",\n",
      "      \"objectId\" : \"090000648144f925\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0128\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0129\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T17:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina Petroleum &amp; Convenience Marketers (NCPCM) - Comment\",\n",
      "      \"objectId\" : \"090000648144f926\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0129\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0131\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T19:57:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Gary A. Chism - Comment\",\n",
      "      \"objectId\" : \"090000648144f927\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0131\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0132\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-16T19:59:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Senator Lydia Chassaniol - Comment\",\n",
      "      \"objectId\" : \"090000648144f928\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0132\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0149\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-23T16:29:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dupont 76 Grocery - Comment\",\n",
      "      \"objectId\" : \"090000648144a5dd\",\n",
      "      \"postedDate\" : \"2013-10-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0149\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0193\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-01T21:43:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J. Ed. Morgan, Department of Revenue, Office of the Comissioner - Comment\",\n",
      "      \"objectId\" : \"090000648141385d\",\n",
      "      \"postedDate\" : \"2013-11-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0193\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0194\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-01T21:57:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mundet - Comment\",\n",
      "      \"objectId\" : \"09000064814147bc\",\n",
      "      \"postedDate\" : \"2013-11-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0194\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0195\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-01T21:59:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alliance One International - Comment\",\n",
      "      \"objectId\" : \"090000648141582f\",\n",
      "      \"postedDate\" : \"2013-11-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0195\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0196\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T05:42:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064813c280a\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0196\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0197\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T05:45:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bill and Valerie Corrigan - Comment\",\n",
      "      \"objectId\" : \"09000064813c354c\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0197\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0198\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T05:48:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tom Perkins - Comment\",\n",
      "      \"objectId\" : \"09000064813c4656\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0198\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0199\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T05:50:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Zanatta - Comment\",\n",
      "      \"objectId\" : \"09000064813c80e4\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0199\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0200\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T05:55:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula Glidewell, Oklahoma Wholesale Marketers Association - Comment\",\n",
      "      \"objectId\" : \"09000064813e015f\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0200\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0218\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T21:54:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Charles M Sargent, Jr House of Representatives State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"0900006481425fdd\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0218\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0219\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T21:55:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Liberty USA Inc - Comment\",\n",
      "      \"objectId\" : \"0900006481426bb3\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0219\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0220\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T21:56:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ohio Wholesale Marketers Association (OWMA) - Comment\",\n",
      "      \"objectId\" : \"090000648142794a\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0220\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0222\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T22:02:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Grand Forks Public Health Department - Comment\",\n",
      "      \"objectId\" : \"090000648142a00a\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0222\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0223\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T22:03:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Schweitzer-Mauduit International (SWM), Inc. - Comment\",\n",
      "      \"objectId\" : \"090000648142a553\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0223\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0224\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T22:04:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Petroleum &amp; Convenience Marketers of Alabama - Comment\",\n",
      "      \"objectId\" : \"090000648142a7e9\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0224\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0225\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T22:05:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Key Display LLC - Comment\",\n",
      "      \"objectId\" : \"0900006481430cfc\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0225\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0226\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T22:06:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Smoker Friendly International, LLC - Comment\",\n",
      "      \"objectId\" : \"0900006481432b5f\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0226\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0227\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-12T22:07:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Streamline Plastics - Comment\",\n",
      "      \"objectId\" : \"09000064814339c5\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0227\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0253\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T03:17:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lake Bluff Station - Comment\",\n",
      "      \"objectId\" : \"090000648140692c\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0253\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0254\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T03:18:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kyle Jewell (Fast For You Exxon) - Comment\",\n",
      "      \"objectId\" : \"090000648140779a\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0254\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0255\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T03:18:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathryn E Coughlin - Comment\",\n",
      "      \"objectId\" : \"09000064814077ac\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0255\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0256\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T03:19:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Myrietta Esau - Comment\",\n",
      "      \"objectId\" : \"0900006481425325\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0256\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T03:24:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard (re United Refining Company of Pennsylvania Multiple Submitters= ) - Comment\",\n",
      "      \"objectId\" : \"0900006481445812\",\n",
      "      \"postedDate\" : \"2013-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0258\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T16:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Virginia Manufacturers Association (VMA) - Comment\",\n",
      "      \"objectId\" : \"0900006481444855\",\n",
      "      \"postedDate\" : \"2013-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0258\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0259\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T19:38:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"South Carolina Retail Association (SCRA) - Comment\",\n",
      "      \"objectId\" : \"0900006481444d40\",\n",
      "      \"postedDate\" : \"2013-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0259\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0260\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-18T19:51:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Frank P. Corso, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481444d99\",\n",
      "      \"postedDate\" : \"2013-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0260\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0279\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-21T00:13:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"AKINET, INC. - Comment\",\n",
      "      \"objectId\" : \"0900006481445ac3\",\n",
      "      \"postedDate\" : \"2013-11-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0279\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0221\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-21T01:11:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Santa Clara County Public Health Department - Comment\",\n",
      "      \"objectId\" : \"0900006481428ffb\",\n",
      "      \"postedDate\" : \"2013-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0221\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0281\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-21T01:36:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rose Mary Slate (Slate Marketing Inc.) - Comment\",\n",
      "      \"objectId\" : \"0900006481429f6d\",\n",
      "      \"postedDate\" : \"2013-11-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0281\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0280\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-21T01:37:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashli Nicks (Slate Marketing, Inc.) - Comment\",\n",
      "      \"objectId\" : \"0900006481429e99\",\n",
      "      \"postedDate\" : \"2013-11-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0280\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0130\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T02:00:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 4 (re Slate Marketing, Inc, Multiple Submitters=6 Total) - Form Letter Comment\",\n",
      "      \"objectId\" : \"090000648144eeab\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0130\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0133\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T02:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 2 (Multiple Signatures= 5 Total) - Form Letter Comment\",\n",
      "      \"objectId\" : \"0900006481416771\",\n",
      "      \"postedDate\" : \"2013-10-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0133\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T07:43:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Darleen Cook re Lorillard Tobacco Company\",\n",
      "      \"objectId\" : \"09000064813c30e0\",\n",
      "      \"postedDate\" : \"2013-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0294\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-24T15:41:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ross Amundson (M Amundson Cigar &amp; Candy CO)\",\n",
      "      \"objectId\" : \"09000064814328c3\",\n",
      "      \"postedDate\" : \"2013-11-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0294\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0120\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-27T15:47:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 3 (re Avrett Free Ginsberg (AFG&amp;),Multiple Submitters=25 Total) - Form Letter Comment\",\n",
      "      \"objectId\" : \"090000648144a107\",\n",
      "      \"postedDate\" : \"2013-10-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0120\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0360\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-08T22:56:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Terry G Kilgore Virginia House of Delegates\",\n",
      "      \"objectId\" : \"0900006481402483\",\n",
      "      \"postedDate\" : \"2014-01-08T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0360\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:11:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorraine Reitzel - Comment\",\n",
      "      \"objectId\" : \"09000064813e67e4\",\n",
      "      \"postedDate\" : \"2013-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0243\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:29:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mississippi House of Representatives Appropriations Committee - Comment\",\n",
      "      \"objectId\" : \"0900006481415456\",\n",
      "      \"postedDate\" : \"2013-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0243\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0201\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T21:35:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Bunch, E.J. Pope &amp; Son, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813eb790\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0201\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0202\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T21:47:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jere Van Puffelen - Comment\",\n",
      "      \"objectId\" : \"09000064813f0a46\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0202\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0118\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T22:09:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Southern Association of Wholesale Distributors, Inc. - Comment\",\n",
      "      \"objectId\" : \"090000648140764c\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0118\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0192\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T22:17:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable John Horhn Senator State of Mississippi - Comment\",\n",
      "      \"objectId\" : \"0900006481412cd7\",\n",
      "      \"postedDate\" : \"2013-11-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0192\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0264\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:03:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donald Powell - Comment\",\n",
      "      \"objectId\" : \"09000064814291c3\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0264\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0261\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:35:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonnie Buchert - Comment\",\n",
      "      \"objectId\" : \"0900006481426e9a\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0261\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0263\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:58:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JR Tobacco of America, Inc., JR Tobacco NC, Inc., JR Statesville, Inc., (Daughtry, Woodard, Lawrence &amp; Starling) - Comment\",\n",
      "      \"objectId\" : \"090000648142814c\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0263\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0290\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:00:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Audrey Dericho - Comment\",\n",
      "      \"objectId\" : \"090000648142841e\",\n",
      "      \"postedDate\" : \"2013-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0290\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0296\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:29:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Frank Johnson\",\n",
      "      \"objectId\" : \"0900006481432ecf\",\n",
      "      \"postedDate\" : \"2013-11-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0296\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0295\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:31:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John kay\",\n",
      "      \"objectId\" : \"0900006481432e8f\",\n",
      "      \"postedDate\" : \"2013-11-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0295\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0266\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:37:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina Department of Agriculture and Consumer Services - Comment\",\n",
      "      \"objectId\" : \"0900006481432a3e\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0266\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0262\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:40:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481427026\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0262\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0265\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:36:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina State AFL-CIO - Comment\",\n",
      "      \"objectId\" : \"090000648142bf93\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0265\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:42:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dresco Belting Company, Inc - Comment\",\n",
      "      \"objectId\" : \"09000064813f4fa9\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0110\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0111\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:09:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alabama State Senate, The Honorable Roger Bedford - Comment\",\n",
      "      \"objectId\" : \"09000064813f523f\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0111\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:38:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mississippi House Ways and Means Committee, The Honorable Jeffery C. (Jeff) Smith - Comment\",\n",
      "      \"objectId\" : \"09000064813f48f2\",\n",
      "      \"postedDate\" : \"2013-10-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0282\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T03:09:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark Flanigan (Consolidated Trucking, Inc.) - Comment\",\n",
      "      \"objectId\" : \"090000648142f1e3\",\n",
      "      \"postedDate\" : \"2013-11-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0282\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0287\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-01-28T13:38:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 1 (Multiple Submitters=35,437 Total) - Form Letter Comment\",\n",
      "      \"objectId\" : \"09000064813caa83\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0287\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0302\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-01-28T13:39:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from The Honorable Ronnie Chance Georgia State Senate\",\n",
      "      \"objectId\" : \"090000648141618c\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0302\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0123\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-01-28T13:39:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Reality Check - Comment\",\n",
      "      \"objectId\" : \"09000064814346d8\",\n",
      "      \"postedDate\" : \"2013-10-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0123\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 173,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 173,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 173,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 173,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 173,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"TTB-2013-0006-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-07-07T17:49:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment 1:  Uvezian, Jeffrey Avo\",\n",
      "      \"objectId\" : \"09000064813c3cf5\",\n",
      "      \"postedDate\" : \"2013-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2013-0006-0011\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0524-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-06T14:29:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Legacy - Comment\",\n",
      "      \"objectId\" : \"0900006480a518b1\",\n",
      "      \"postedDate\" : \"2009-11-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-06T19:47:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Legacy Foundation - Comment\",\n",
      "      \"objectId\" : \"0900006480a52b91\",\n",
      "      \"postedDate\" : \"2009-11-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-06T21:45:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Latham &amp; Watkins, LLP - Comment\",\n",
      "      \"objectId\" : \"0900006480a52c31\",\n",
      "      \"postedDate\" : \"2009-11-06T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-13T16:54:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"James F Nooney - Comment\",\n",
      "      \"objectId\" : \"0900006480a56e7d\",\n",
      "      \"postedDate\" : \"2009-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-13T19:59:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"RAI Services Company - Comment\",\n",
      "      \"objectId\" : \"0900006480a563c1\",\n",
      "      \"postedDate\" : \"2009-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-13T21:00:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauterbach &amp; Associates, LLC - Comment\",\n",
      "      \"objectId\" : \"0900006480a5714e\",\n",
      "      \"postedDate\" : \"2009-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-13T21:30:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services Inc - Comment\",\n",
      "      \"objectId\" : \"0900006480a56402\",\n",
      "      \"postedDate\" : \"2009-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-16T14:07:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard Tobacco Company - Comment\",\n",
      "      \"objectId\" : \"0900006480a57208\",\n",
      "      \"postedDate\" : \"2009-11-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-16T14:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JT International U.S.A., Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a57218\",\n",
      "      \"postedDate\" : \"2009-11-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-16T14:13:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Campaign for Tobacco-Free Kids - Comment\",\n",
      "      \"objectId\" : \"0900006480a57225\",\n",
      "      \"postedDate\" : \"2009-11-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-16T14:18:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Troutman Sanders LLP for Virginia Brands, LLC - Comment\",\n",
      "      \"objectId\" : \"0900006480a5649f\",\n",
      "      \"postedDate\" : \"2009-11-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-17T21:59:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David M. Burns, M.D.., (University of California, San Diego) - Comment\",\n",
      "      \"objectId\" : \"0900006480a56f7a\",\n",
      "      \"postedDate\" : \"2009-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-19T01:16:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JT International U.S.A., Inc. (Holland &amp; Knight) - Comment re FDA-2009-D-0524-0014\",\n",
      "      \"objectId\" : \"0900006480a57f5c\",\n",
      "      \"postedDate\" : \"2009-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-19T01:19:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Philip Morris USA, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a59527\",\n",
      "      \"postedDate\" : \"2009-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-12-01T16:20:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tabacos USA, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a5c781\",\n",
      "      \"postedDate\" : \"2009-12-01T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0023\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 15,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 15,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 15,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 15,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 15,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2011-N-0271-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-09-29T18:43:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donald Eugene Patterson - Comment\",\n",
      "      \"objectId\" : \"0900006480f27f73\",\n",
      "      \"postedDate\" : \"2011-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-09-29T18:43:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"todd shrager - Comment\",\n",
      "      \"objectId\" : \"0900006480f28678\",\n",
      "      \"postedDate\" : \"2011-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-19T20:34:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Imperial Tobacco Group Company (ITG) - Comment\",\n",
      "      \"objectId\" : \"0900006480f54119\",\n",
      "      \"postedDate\" : \"2011-10-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-31T19:54:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Star Scientific, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480f4d630\",\n",
      "      \"postedDate\" : \"2011-10-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Star Scientific, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480f4789e\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"British American Tobacco (Investments) Ltd - Comment\",\n",
      "      \"objectId\" : \"0900006480f4d94e\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NYC Department of Health &amp; Mental Hygiene - Comment\",\n",
      "      \"objectId\" : \"0900006480f4d998\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"GAMA - Global Acetate Manufacturers' Association - Comment\",\n",
      "      \"objectId\" : \"0900006480f4fd7a\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Imperial Tobacco Limited - Comment\",\n",
      "      \"objectId\" : \"0900006480f4fd90\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NiPERA, Inc - Comment\",\n",
      "      \"objectId\" : \"0900006480f4fda8\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eastman Chemical Company - Comment\",\n",
      "      \"objectId\" : \"0900006480f4fe67\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Arista Laboratories - Comment\",\n",
      "      \"objectId\" : \"0900006480f4fe5f\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CEFIC Sector Group Phenol &amp; Acetone Producers - Comment\",\n",
      "      \"objectId\" : \"0900006480f50059\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Swedish Match AB - Comment\",\n",
      "      \"objectId\" : \"0900006480f50049\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Keller and Heckman LLP - Comment\",\n",
      "      \"objectId\" : \"0900006480f503b3\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nigel Gray - Comment\",\n",
      "      \"objectId\" : \"0900006480f504a4\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"GlaxoSmithKline Consumer Healthcare - Comment\",\n",
      "      \"objectId\" : \"0900006480f504a6\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ACS CAN, AHA, Legacy, ALA and CTFK - Comment\",\n",
      "      \"objectId\" : \"0900006480f505bc\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SWM International - Comment\",\n",
      "      \"objectId\" : \"0900006480f505d1\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"King Maker Marketing, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480f506df\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services; R. J. Reynolds Tobacco Co.; Lorillard Tobacco Company - Comment\",\n",
      "      \"objectId\" : \"0900006480f506e9\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William T Godshall - Comment\",\n",
      "      \"objectId\" : \"0900006480f50745\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Council of Independent Tobacco Manufacturers of America (CITMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480f50792\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-15T21:55:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Council of Independent Manufacturers of America (CITMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480f507be\",\n",
      "      \"postedDate\" : \"2011-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-16T19:41:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"International Premium Cigar &amp; Pipe Retailers Association (IPCPR) - Comment\",\n",
      "      \"objectId\" : \"0900006480f83615\",\n",
      "      \"postedDate\" : \"2011-12-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0271-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-28T22:05:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 1 - [re International Premium Cigar &amp; Pipe Retailers Association and Cigar Rights of America Multiple Submitters=42] - Form Letter Comment\",\n",
      "      \"objectId\" : \"0900006480f8483f\",\n",
      "      \"postedDate\" : \"2011-12-28T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0271-0027\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 26,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 26,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 26,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 26,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 26,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0386-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-03-28T14:21:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006484fd5816\",\n",
      "      \"postedDate\" : \"2022-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0386-0017\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"label\" : \"Last 90 Days\",\n",
      "        \"fromDate\" : \"2022-01-28 00:00:00\",\n",
      "        \"toDate\" : \"2022-04-27 23:59:59\"\n",
      "      } ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"label\" : \"Last 90 Days\",\n",
      "        \"fromDate\" : \"2022-01-28 00:00:00\",\n",
      "        \"toDate\" : \"2022-04-27 23:59:59\"\n",
      "      } ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-04-12T20:08:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jonathan Bradley Chaffee - Comment\",\n",
      "      \"objectId\" : \"0900006480fec009\",\n",
      "      \"postedDate\" : \"2012-04-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:02:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Swedish Match AB - Comment\",\n",
      "      \"objectId\" : \"090000648100f187\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0580\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-25T16:13:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Manuppello - Comment\",\n",
      "      \"objectId\" : \"09000064810301b5\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0580\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1661\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard - Comment\",\n",
      "      \"objectId\" : \"0900006481025ed4\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1661\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1706\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:07:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stanton Arnold Glantz - Comment\",\n",
      "      \"objectId\" : \"090000648102bce7\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1706\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1781\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T14:42:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"GlaxoSmithKline Consumer Healthcare - Comment\",\n",
      "      \"objectId\" : \"0900006481030255\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1781\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1796\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:23:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Lung Association - Comment\",\n",
      "      \"objectId\" : \"09000064810317b4\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1796\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1797\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:26:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Venable LLP - Comment\",\n",
      "      \"objectId\" : \"09000064810314a9\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1797\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1802\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:20:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Campaign For Tobacco Free Kids - Comment\",\n",
      "      \"objectId\" : \"09000064810325b5\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1802\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1803\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:26:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Philip Morris International Management S.A. - Comment\",\n",
      "      \"objectId\" : \"09000064810325ca\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1803\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1806\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:30:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Physicians Committee for Responsible Medicine - Comment\",\n",
      "      \"objectId\" : \"09000064810335b6\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1806\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1816\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T19:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Washington Legal Foundation - Comment\",\n",
      "      \"objectId\" : \"0900006481033871\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1816\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1817\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T19:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Latino Tobacco Control Network (NLTCN) - Comment\",\n",
      "      \"objectId\" : \"090000648105ce7a\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1817\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1818\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2016-01-12T16:57:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from People for the Ethical Treatment of Animals (PETA) and Physicians Committee for Responsible Medicine\",\n",
      "      \"objectId\" : \"090000648166ae76\",\n",
      "      \"postedDate\" : \"2016-01-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1818\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1827\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-23T16:23:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from M Gibbons\",\n",
      "      \"objectId\" : \"090000648302e5f7\",\n",
      "      \"postedDate\" : \"2018-03-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1827\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1831\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-04-17T19:37:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Logic Technology Development LLC\",\n",
      "      \"objectId\" : \"0900006483090af3\",\n",
      "      \"postedDate\" : \"2018-04-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1831\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 16,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 16,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 16,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 16,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 16,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2015-N-1514-0242\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-01T18:41:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Janette Merrill, AACR/ASCO\",\n",
      "      \"objectId\" : \"0900006481c3ea76\",\n",
      "      \"postedDate\" : \"2015-09-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0242\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0243\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-01T18:43:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Deborah Heeszel\",\n",
      "      \"objectId\" : \"0900006481c42389\",\n",
      "      \"postedDate\" : \"2015-09-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0243\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0255\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T20:01:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edward  Ehlinger, Minnesota Department of Health\",\n",
      "      \"objectId\" : \"0900006481c46f0b\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0255\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0256\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T20:01:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Annette Torres, Paso del Norte Tobacco Control Network\",\n",
      "      \"objectId\" : \"0900006481c48b5d\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0256\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0257\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T20:01:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Association of State and Territorial Health Officials\",\n",
      "      \"objectId\" : \"0900006481c54f43\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0257\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0258\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T20:01:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Harold\",\n",
      "      \"objectId\" : \"0900006481c5cdb3\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0258\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0259\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T20:01:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gina Sassi\",\n",
      "      \"objectId\" : \"0900006481c60a8f\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0259\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0260\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-10T11:21:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Suzann  Young\",\n",
      "      \"objectId\" : \"0900006481c63f4a\",\n",
      "      \"postedDate\" : \"2015-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0260\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0261\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-10T11:22:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kristy Crawford\",\n",
      "      \"objectId\" : \"0900006481c64520\",\n",
      "      \"postedDate\" : \"2015-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0261\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0262\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-11T17:43:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cole Jeznach\",\n",
      "      \"objectId\" : \"0900006481c66fd7\",\n",
      "      \"postedDate\" : \"2015-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0262\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0263\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-16T15:41:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Charles Miller\",\n",
      "      \"objectId\" : \"0900006481c71113\",\n",
      "      \"postedDate\" : \"2015-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0263\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0264\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-16T15:41:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from The Vaporist LLC\",\n",
      "      \"objectId\" : \"0900006481c713e7\",\n",
      "      \"postedDate\" : \"2015-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0264\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0265\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-16T15:43:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dewayne Tucker\",\n",
      "      \"objectId\" : \"0900006481c7147d\",\n",
      "      \"postedDate\" : \"2015-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0265\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0266\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-16T15:43:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ev Du\",\n",
      "      \"objectId\" : \"0900006481c71619\",\n",
      "      \"postedDate\" : \"2015-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0266\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0267\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Benjamin Kerensa\",\n",
      "      \"objectId\" : \"0900006481c7b721\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0267\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0268\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jody Bray\",\n",
      "      \"objectId\" : \"0900006481c7d448\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0268\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0269\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Christine James\",\n",
      "      \"objectId\" : \"0900006481c7f9a3\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0269\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0270\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Martin Neameyer\",\n",
      "      \"objectId\" : \"0900006481c867cc\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0270\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0271\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dr. James Weeks\",\n",
      "      \"objectId\" : \"0900006481c86811\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0271\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0272\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Triptow\",\n",
      "      \"objectId\" : \"0900006481c86f1c\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0272\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0273\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Troy Abraham\",\n",
      "      \"objectId\" : \"0900006481c8a390\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0273\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0274\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from RAI Services Company\",\n",
      "      \"objectId\" : \"0900006481c8e49a\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0274\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0275\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Debra Plocher\",\n",
      "      \"objectId\" : \"0900006481c8ec09\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0275\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0276\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Katy Matthews\",\n",
      "      \"objectId\" : \"0900006481c8eff7\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0276\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0277\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nirmala Vadde\",\n",
      "      \"objectId\" : \"0900006481c8effb\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0277\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0278\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Serena Yang\",\n",
      "      \"objectId\" : \"0900006481c8effc\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0278\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0279\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Marsha Spitzer\",\n",
      "      \"objectId\" : \"0900006481c8ec48\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0279\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0280\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Quinlan King\",\n",
      "      \"objectId\" : \"0900006481c8f040\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0280\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0281\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ian Wright\",\n",
      "      \"objectId\" : \"0900006481c8eca3\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0281\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0282\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Juan Walterspiel MD, FAAP\",\n",
      "      \"objectId\" : \"0900006481c8f042\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0282\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0283\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Markus Renno\",\n",
      "      \"objectId\" : \"0900006481c8eca6\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0283\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0284\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Wayne Levin\",\n",
      "      \"objectId\" : \"0900006481c8eca8\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0284\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0285\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Maureen Novak\",\n",
      "      \"objectId\" : \"0900006481c8f063\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0285\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0286\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gregory Hagan, MD, FAAP\",\n",
      "      \"objectId\" : \"0900006481c8f0fd\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0286\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0287\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edward Aizen\",\n",
      "      \"objectId\" : \"0900006481c8f500\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0287\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0288\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joshua Raschi\",\n",
      "      \"objectId\" : \"0900006481c8f589\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0288\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0289\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Corinn Cross\",\n",
      "      \"objectId\" : \"0900006481c8f58b\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0289\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0290\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Margaret Stager\",\n",
      "      \"objectId\" : \"0900006481c8f590\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0290\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0291\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tiffany Kimbrough\",\n",
      "      \"objectId\" : \"0900006481c8f5c6\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0291\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0292\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alexander Fiks\",\n",
      "      \"objectId\" : \"0900006481c8f431\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0292\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0293\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brian Jenssen\",\n",
      "      \"objectId\" : \"0900006481c8f70d\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0293\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0294\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kristin Dayton\",\n",
      "      \"objectId\" : \"0900006481c8f726\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0294\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0295\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Legal Resource Center for Public Health Policy\",\n",
      "      \"objectId\" : \"0900006481c8f75d\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0295\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0296\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brittney Kearney\",\n",
      "      \"objectId\" : \"0900006481c8f974\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0296\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0297\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alice Chan-Yip\",\n",
      "      \"objectId\" : \"0900006481c8fbf7\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0297\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0298\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Derrick\",\n",
      "      \"objectId\" : \"0900006481c8f8d0\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0298\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0299\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ernest Krug\",\n",
      "      \"objectId\" : \"0900006481c8fd02\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0299\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0300\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Matthew Kreth\",\n",
      "      \"objectId\" : \"0900006481c8fcfb\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0300\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0301\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from William Underwood, MD\",\n",
      "      \"objectId\" : \"0900006481c8fdcb\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0301\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0302\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Fr. Jack Kearney, M.Div., CATC IV\",\n",
      "      \"objectId\" : \"0900006481c9089a\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0302\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0303\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Janice L. Pelletier, MD, FAAP\",\n",
      "      \"objectId\" : \"0900006481c90f71\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0303\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0304\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dr. Elizabeth Susan Hodgson, MD FAAP\",\n",
      "      \"objectId\" : \"0900006481c90f72\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0304\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0305\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Roopa Thakur\",\n",
      "      \"objectId\" : \"0900006481c90c47\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0305\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0306\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bruce Chandler\",\n",
      "      \"objectId\" : \"0900006481c90c5f\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0306\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0307\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Christine D'Ambrosio\",\n",
      "      \"objectId\" : \"0900006481c91154\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0307\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0308\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dale Schenk\",\n",
      "      \"objectId\" : \"0900006481c91a16\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0308\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0309\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c91b41\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0309\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0310\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Carolyn Cleary\",\n",
      "      \"objectId\" : \"0900006481c9233c\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0310\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0311\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lyn Ranta\",\n",
      "      \"objectId\" : \"0900006481c92d08\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0311\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0312\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kimberly Montez\",\n",
      "      \"objectId\" : \"0900006481c92e69\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0312\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0313\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ryan Hassan\",\n",
      "      \"objectId\" : \"0900006481c93116\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0313\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0314\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nicopure Labs LLC\",\n",
      "      \"objectId\" : \"0900006481c9370f\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0314\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0315\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Richard Bennett\",\n",
      "      \"objectId\" : \"0900006481c93941\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0315\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0316\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lorrie Covington\",\n",
      "      \"objectId\" : \"0900006481c93c6d\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0316\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0317\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Sumerix\",\n",
      "      \"objectId\" : \"0900006481c93c7c\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0317\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0318\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Barbara E.\",\n",
      "      \"objectId\" : \"0900006481c93ca9\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0318\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0319\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-24T20:39:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tami Brooks\",\n",
      "      \"objectId\" : \"0900006481c94415\",\n",
      "      \"postedDate\" : \"2015-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0319\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0320\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-29T16:41:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert  Gunther, MD\",\n",
      "      \"objectId\" : \"0900006481c9cd3a\",\n",
      "      \"postedDate\" : \"2015-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0320\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0322\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Courtnie Richards\",\n",
      "      \"objectId\" : \"0900006481ca2ff4\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0322\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0323\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas Carrasco\",\n",
      "      \"objectId\" : \"0900006481ca2f59\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0323\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0324\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas Carrasco\",\n",
      "      \"objectId\" : \"0900006481ca2de5\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0324\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0325\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alisa Borek\",\n",
      "      \"objectId\" : \"0900006481ca2de2\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0325\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0326\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Fontem Ventures\",\n",
      "      \"objectId\" : \"0900006481ca2dd0\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0326\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0327\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bryan Mih\",\n",
      "      \"objectId\" : \"0900006481ca2dcd\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0327\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0328\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Rolando Herrera\",\n",
      "      \"objectId\" : \"0900006481ca2dde\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0328\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0329\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jan Parcel\",\n",
      "      \"objectId\" : \"0900006481ca3145\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0329\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0330\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Zach Boyle\",\n",
      "      \"objectId\" : \"0900006481ca313e\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0330\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0331\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alex Juel\",\n",
      "      \"objectId\" : \"0900006481ca3122\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0331\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0332\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kim Possible\",\n",
      "      \"objectId\" : \"0900006481ca2d84\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0332\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0333\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bruce Bowler\",\n",
      "      \"objectId\" : \"0900006481ca2c93\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0333\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0334\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Christopher Valore\",\n",
      "      \"objectId\" : \"0900006481ca2d80\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0334\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0335\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from TROY ABRAHAM\",\n",
      "      \"objectId\" : \"0900006481ca2bfd\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0335\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0336\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas Maroon\",\n",
      "      \"objectId\" : \"0900006481ca2c0e\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0336\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0337\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Rebecca Harris\",\n",
      "      \"objectId\" : \"0900006481ca2bd1\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0337\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0338\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Krista Boyer\",\n",
      "      \"objectId\" : \"0900006481ca2bcf\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0338\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0339\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ryan Quinn\",\n",
      "      \"objectId\" : \"0900006481ca28e9\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0339\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0340\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeanne Clifford, MD\",\n",
      "      \"objectId\" : \"0900006481ca2d37\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0340\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0341\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca2b6f\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0341\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0342\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alan Mabee\",\n",
      "      \"objectId\" : \"0900006481ca2b6b\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0342\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0344\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nina  Morrison\",\n",
      "      \"objectId\" : \"0900006481ca29a3\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0344\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0345\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from anonymous\",\n",
      "      \"objectId\" : \"0900006481ca29a0\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0345\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0346\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Daniel Abrams\",\n",
      "      \"objectId\" : \"0900006481ca296d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0346\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0347\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Hollers\",\n",
      "      \"objectId\" : \"0900006481ca296c\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0347\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0348\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca24ca\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0348\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0349\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Daniel Miller\",\n",
      "      \"objectId\" : \"0900006481ca2915\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0349\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0350\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert\",\n",
      "      \"objectId\" : \"0900006481ca290d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0350\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0351\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Holly\",\n",
      "      \"objectId\" : \"0900006481ca2475\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0351\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0352\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Chris Hughes\",\n",
      "      \"objectId\" : \"0900006481ca2464\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0352\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0353\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Justin Roman\",\n",
      "      \"objectId\" : \"0900006481ca245d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0353\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0354\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kristen Winkler\",\n",
      "      \"objectId\" : \"0900006481ca21de\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0354\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0355\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comments from North Dakota Center for Tobacco Prevention and Control Policy\",\n",
      "      \"objectId\" : \"0900006481ca1c54\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0355\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0356\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from DK H\",\n",
      "      \"objectId\" : \"0900006481ca1cbe\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0356\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0357\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ray PG Yeates\",\n",
      "      \"objectId\" : \"0900006481ca1c11\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0357\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0358\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca1bac\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0358\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0359\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Skrabacz\",\n",
      "      \"objectId\" : \"0900006481ca1d98\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0359\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0360\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Laura Catron\",\n",
      "      \"objectId\" : \"0900006481ca19a3\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0360\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0361\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca19a2\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0361\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0362\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Toth\",\n",
      "      \"objectId\" : \"0900006481ca18ed\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0362\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0364\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Betty Greene\",\n",
      "      \"objectId\" : \"0900006481ca199d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0364\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0365\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stephen Miller\",\n",
      "      \"objectId\" : \"0900006481ca1916\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0365\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0366\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Adelina Soto-Thomas\",\n",
      "      \"objectId\" : \"0900006481ca17ce\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0366\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0367\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Riddle\",\n",
      "      \"objectId\" : \"0900006481ca171d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0367\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0368\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lisa Bell\",\n",
      "      \"objectId\" : \"0900006481ca138a\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0368\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0369\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kevin Moon\",\n",
      "      \"objectId\" : \"0900006481ca1212\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0369\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0370\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Logic Technology Development LLC\",\n",
      "      \"objectId\" : \"0900006481ca0a60\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0370\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0371\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kay Inoue\",\n",
      "      \"objectId\" : \"0900006481ca0a5b\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0371\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0372\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Amanda Jichlinski\",\n",
      "      \"objectId\" : \"0900006481ca0069\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0372\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0373\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Eric Wieber\",\n",
      "      \"objectId\" : \"0900006481ca03ed\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0373\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0374\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lyndsey Garcia\",\n",
      "      \"objectId\" : \"0900006481ca01cb\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0374\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0375\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from C. Elizabeth  Trefts\",\n",
      "      \"objectId\" : \"0900006481ca0180\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0375\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0376\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jessica K\",\n",
      "      \"objectId\" : \"0900006481c9f7f5\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0376\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0377\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ryan Mulhern\",\n",
      "      \"objectId\" : \"0900006481c9f443\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0377\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0378\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Penny Gugino\",\n",
      "      \"objectId\" : \"0900006481c9ecea\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0378\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0379\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Louis DiNicola\",\n",
      "      \"objectId\" : \"0900006481c9eaae\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0379\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0380\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Desmond Jenson\",\n",
      "      \"objectId\" : \"0900006481c9e051\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0380\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0381\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stuart  Sweet\",\n",
      "      \"objectId\" : \"0900006481c9da06\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0381\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0382\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Julia Rosenberg\",\n",
      "      \"objectId\" : \"0900006481c9cfe7\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0382\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0383\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Patricia Ortiz\",\n",
      "      \"objectId\" : \"0900006481c9d1f8\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0383\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0384\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Claire Cifaloglio\",\n",
      "      \"objectId\" : \"0900006481c9ce1e\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0384\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0385\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Carl Phillips\",\n",
      "      \"objectId\" : \"0900006481c9cdd0\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0385\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0386\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Theresa Swarny\",\n",
      "      \"objectId\" : \"0900006481c9c4d4\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0386\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0387\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Angela Fugler\",\n",
      "      \"objectId\" : \"0900006481c9c4d1\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0387\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0388\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kelly Riche\",\n",
      "      \"objectId\" : \"0900006481c9c121\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0388\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0389\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Catherine Taylor\",\n",
      "      \"objectId\" : \"0900006481c9bbb5\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0389\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0390\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Moranda Neer\",\n",
      "      \"objectId\" : \"0900006481c9b336\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0390\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0391\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from George Cohen\",\n",
      "      \"objectId\" : \"0900006481c9b004\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0391\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0392\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Shannon Arthur\",\n",
      "      \"objectId\" : \"0900006481c9ad62\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0392\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0393\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Taylor Nelson, NA\",\n",
      "      \"objectId\" : \"0900006481c97ba5\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0393\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0394\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c9a287\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0394\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0395\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brandon Johnson\",\n",
      "      \"objectId\" : \"0900006481c9a23d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0395\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0396\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:41:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jean Junior\",\n",
      "      \"objectId\" : \"0900006481c9a247\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0396\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0397\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gerald Harris, M.D\",\n",
      "      \"objectId\" : \"0900006481c97d40\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0397\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0398\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Landon Krantz\",\n",
      "      \"objectId\" : \"0900006481c97414\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0398\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0399\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Consumer Goods LLC d/b/a Tasty Vapor\",\n",
      "      \"objectId\" : \"0900006481c97566\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0399\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0400\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from OK State Department of Health\",\n",
      "      \"objectId\" : \"0900006481c96439\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0400\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0401\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Klein\",\n",
      "      \"objectId\" : \"0900006481c95739\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0401\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0402\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Arthur D'Harlingue\",\n",
      "      \"objectId\" : \"0900006481c955fb\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0402\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0403\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Scott Covington\",\n",
      "      \"objectId\" : \"0900006481c94e34\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0403\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0404\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jacob Rosenberg\",\n",
      "      \"objectId\" : \"0900006481c94dcf\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0404\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0405\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Hugo Scornik, MD\",\n",
      "      \"objectId\" : \"0900006481c94c1d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0405\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0406\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mike Deighan\",\n",
      "      \"objectId\" : \"0900006481c94bf7\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0406\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0407\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Pam Shaw\",\n",
      "      \"objectId\" : \"0900006481c948a0\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0407\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0408\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jessica Simkins\",\n",
      "      \"objectId\" : \"0900006481c94ab4\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0408\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0409\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:42:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alexander Hamling\",\n",
      "      \"objectId\" : \"0900006481c94813\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0409\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0410\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:52:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lou Ritter, AEMSA\",\n",
      "      \"objectId\" : \"0900006481ca5073\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0410\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0411\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:52:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from NicQuid\",\n",
      "      \"objectId\" : \"0900006481ca4e1d\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0411\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0412\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:52:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Andrew Leonard\",\n",
      "      \"objectId\" : \"0900006481ca4e17\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0412\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0413\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:52:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Corey Sanders\",\n",
      "      \"objectId\" : \"0900006481ca30c1\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0413\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0414\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T15:52:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Truth Initiative\",\n",
      "      \"objectId\" : \"0900006481ca113a\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0414\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0420\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T19:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from RAI Services Company\",\n",
      "      \"objectId\" : \"0900006481c92a36\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0420\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0421\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T19:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Andrew Albrecht\",\n",
      "      \"objectId\" : \"0900006481ca50ed\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0421\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0422\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T19:58:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from E-Alternative Solutions, LLC\",\n",
      "      \"objectId\" : \"0900006481ca55f0\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0422\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0423\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T12:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Damon Young\",\n",
      "      \"objectId\" : \"0900006481ca59e8\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0423\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0424\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T12:41:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Walter Johnson\",\n",
      "      \"objectId\" : \"0900006481ca58d5\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0424\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0425\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T12:49:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Heart Association\",\n",
      "      \"objectId\" : \"0900006481ca5a88\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0425\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0426\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T12:52:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Goers\",\n",
      "      \"objectId\" : \"0900006481ca5a8c\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0426\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0427\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T12:54:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Wally Shalash\",\n",
      "      \"objectId\" : \"0900006481ca5b3b\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0427\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0428\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:04:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Coalition of Independent Tobacco Manufacturers of America\",\n",
      "      \"objectId\" : \"0900006481ca5ec8\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0428\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0429\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brad Sudmann\",\n",
      "      \"objectId\" : \"0900006481ca5991\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0429\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0430\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca5943\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0430\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0431\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cathy Haut (National Association of Pediatric Nurse Practitioners)\",\n",
      "      \"objectId\" : \"0900006481ca54d2\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0431\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0432\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nicoventures U.S. Limited\",\n",
      "      \"objectId\" : \"0900006481ca540e\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0432\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0433\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Attebury, NA\",\n",
      "      \"objectId\" : \"0900006481ca53b2\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0433\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0434\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca535e\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0434\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0435\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Corey McNees\",\n",
      "      \"objectId\" : \"0900006481ca5358\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0435\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0436\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:10:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael  Ligon (Universal Leaf Tobacco Company, Inc.)\",\n",
      "      \"objectId\" : \"0900006481ca5eca\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0436\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0437\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:12:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Adam Susser (Small Manufacturers Association for the Reasonable Treatment of Tobacco Products)\",\n",
      "      \"objectId\" : \"0900006481ca5ed1\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0437\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0438\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:23:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James Dillard (Altria Client Services)\",\n",
      "      \"objectId\" : \"0900006481ca5f0b\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0438\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0439\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:28:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Frank Swiader\",\n",
      "      \"objectId\" : \"0900006481ca5c4d\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0439\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0440\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:29:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jose Badillo\",\n",
      "      \"objectId\" : \"0900006481ca5f59\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0440\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0441\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:31:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca5cd7\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0441\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0442\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:32:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeff Reynolds\",\n",
      "      \"objectId\" : \"0900006481ca5f83\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0442\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0443\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:41:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Lung Association\",\n",
      "      \"objectId\" : \"0900006481ca603e\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0443\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0444\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T13:43:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jason Bain\",\n",
      "      \"objectId\" : \"0900006481ca6532\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0444\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0363\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T14:44:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from State Attorney General\",\n",
      "      \"objectId\" : \"0900006481ca186a\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0363\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0445\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T15:42:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from LaMar Hasbrouck (National Association of County and City Health Officials)\",\n",
      "      \"objectId\" : \"0900006481ca6538\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0445\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0446\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:10:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Marc Sylvestre\",\n",
      "      \"objectId\" : \"0900006481ca6562\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0446\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0447\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:15:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anna Claypool\",\n",
      "      \"objectId\" : \"0900006481ca636f\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0447\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0448\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:16:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Princy George\",\n",
      "      \"objectId\" : \"0900006481ca6420\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0448\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0449\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ben Fenner ( Ho-Chunk, Inc.)\",\n",
      "      \"objectId\" : \"0900006481ca6447\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0449\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0450\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:27:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kim  La Croix (Oregon Health Authority)\",\n",
      "      \"objectId\" : \"0900006481ca6457\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0450\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0451\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:33:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas J.  Norby (CB Distributors, Inc.)\",\n",
      "      \"objectId\" : \"0900006481ca64a8\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0451\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0452\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:34:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca6743\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0452\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0453\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T16:38:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Susanne Tanski\",\n",
      "      \"objectId\" : \"0900006481ca64ad\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0453\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0454\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T20:04:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca64c6\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0454\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0455\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-01T20:08:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brian Carter (Consumer Advocates for Smoke-free Alternatives Association)\",\n",
      "      \"objectId\" : \"0900006481ca677b\",\n",
      "      \"postedDate\" : \"2015-10-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0455\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0456\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T14:38:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anthony Green (Safe Kids Worldwide)\",\n",
      "      \"objectId\" : \"0900006481ca67af\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0456\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0457\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T14:41:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alex Brill (American Enterprise Institute)\",\n",
      "      \"objectId\" : \"0900006481ca680f\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0457\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0458\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T14:47:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca6812\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0458\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0459\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T14:50:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cati Brown-Johnson\",\n",
      "      \"objectId\" : \"0900006481ca692a\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0459\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0460\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T14:54:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Russell Wishtart\",\n",
      "      \"objectId\" : \"0900006481ca685d\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0460\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0461\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:00:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous (Smoke-Free Alternatives Trade Association)\",\n",
      "      \"objectId\" : \"0900006481ca6891\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0461\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0462\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:02:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Annie Anderson\",\n",
      "      \"objectId\" : \"0900006481ca687f\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0462\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0463\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tanya Wade\",\n",
      "      \"objectId\" : \"0900006481ca6881\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0463\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0343\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:07:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Academy of Pediatrics\",\n",
      "      \"objectId\" : \"0900006481ca27e0\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0343\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0464\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:20:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Keith Nelson, TVECA\",\n",
      "      \"objectId\" : \"0900006481ca68c4\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0464\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0465\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:26:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous (Georgia State University Tobacco Center of Regulatory Science)\",\n",
      "      \"objectId\" : \"0900006481ca689a\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0465\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0466\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T15:31:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John  Wiesehan, Jr. (Ballantyne Brands LLC)\",\n",
      "      \"objectId\" : \"0900006481ca69d9\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0466\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0467\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:26:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Aaron Brainard\",\n",
      "      \"objectId\" : \"0900006481ca68d9\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0467\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0468\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:27:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca69ee\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0468\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0469\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:29:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Andy Tan\",\n",
      "      \"objectId\" : \"0900006481ca68df\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0469\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0470\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:29:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481ca68f6\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0470\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0471\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:30:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ana Alvarado\",\n",
      "      \"objectId\" : \"0900006481ca6a37\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0471\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0472\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:32:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James Gelfand (March of Dimes)\",\n",
      "      \"objectId\" : \"0900006481ca6d1c\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0472\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0473\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:34:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from William Wallace (Consumers Union)\",\n",
      "      \"objectId\" : \"0900006481ca6d2c\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0473\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0474\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:37:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Josh Krane (Craft Vapery)\",\n",
      "      \"objectId\" : \"0900006481ca6a99\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0474\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0475\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-02T16:38:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from LaMar  Hasbrouck (National Association of County and City Health Officials)\",\n",
      "      \"objectId\" : \"0900006481ca86f2\",\n",
      "      \"postedDate\" : \"2015-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0475\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0477\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-20T20:02:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from RAI Services Company\",\n",
      "      \"objectId\" : \"0900006481c8ea72\",\n",
      "      \"postedDate\" : \"2015-10-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0477\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0478\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-20T20:03:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Rutgers, Center for Tobacco Studies\",\n",
      "      \"objectId\" : \"0900006481cafbcd\",\n",
      "      \"postedDate\" : \"2015-10-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0478\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0321\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-10-20T20:06:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Attorney General Pam Bondi\",\n",
      "      \"objectId\" : \"0900006481ca3a3f\",\n",
      "      \"postedDate\" : \"2015-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0321\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 220,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 220,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 220,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 220,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 220,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0508-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-02T15:01:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SMARTT Coalition - Comment\",\n",
      "      \"objectId\" : \"0900006480a4eb89\",\n",
      "      \"postedDate\" : \"2009-11-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0508-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-12T20:04:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Council of Independent Tobacco Manufacturers of America (CITMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a56185\",\n",
      "      \"postedDate\" : \"2009-11-12T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0011\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 2,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2014-N-0086-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-11-25T16:08:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"09000064841a1510\",\n",
      "      \"postedDate\" : \"2019-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2014-N-0086-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2014-N-0086-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-12-19T16:29:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Truth Initiative\",\n",
      "      \"objectId\" : \"0900006484207ce6\",\n",
      "      \"postedDate\" : \"2019-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2014-N-0086-0009\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 2,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2017-N-4678-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2017-12-21T15:52:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Scott Moell\",\n",
      "      \"objectId\" : \"0900006482d4a200\",\n",
      "      \"postedDate\" : \"2017-12-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-02-15T15:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz\",\n",
      "      \"objectId\" : \"0900006482d3aad7\",\n",
      "      \"postedDate\" : \"2018-02-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-02-15T16:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Smith\",\n",
      "      \"objectId\" : \"0900006482e72a36\",\n",
      "      \"postedDate\" : \"2018-02-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-02-15T16:48:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Smith\",\n",
      "      \"objectId\" : \"0900006482e72a38\",\n",
      "      \"postedDate\" : \"2018-02-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-09T15:24:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006482fca370\",\n",
      "      \"postedDate\" : \"2018-03-09T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-23T16:02:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lars Ramstrm\",\n",
      "      \"objectId\" : \"0900006483017ab7\",\n",
      "      \"postedDate\" : \"2018-03-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-03-23T16:03:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Raymond Calore\",\n",
      "      \"objectId\" : \"0900006483019a15\",\n",
      "      \"postedDate\" : \"2018-03-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-07-03T19:57:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Steve Troxler\",\n",
      "      \"objectId\" : \"0900006483463654\",\n",
      "      \"postedDate\" : \"2018-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-08-14T16:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Philip Morris USA Inc. (Altria Client Services LLC)\",\n",
      "      \"objectId\" : \"09000064835f1cc6\",\n",
      "      \"postedDate\" : \"2018-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stephen Higgins\",\n",
      "      \"objectId\" : \"0900006483638471\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Benjamin Chaffee\",\n",
      "      \"objectId\" : \"090000648364fb9f\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gideon St.Helen\",\n",
      "      \"objectId\" : \"090000648364fbe9\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bonnie Halpern-Felsher\",\n",
      "      \"objectId\" : \"090000648364fc0c\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lucy Popova\",\n",
      "      \"objectId\" : \"090000648364fdb8\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Wendy Max\",\n",
      "      \"objectId\" : \"090000648364fe04\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz\",\n",
      "      \"objectId\" : \"090000648364fcc8\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz\",\n",
      "      \"objectId\" : \"09000064836506d8\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:56:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006483668b2e\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:57:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gregory Conley\",\n",
      "      \"objectId\" : \"0900006483676395\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:57:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Scott Ballin\",\n",
      "      \"objectId\" : \"09000064836f3e2c\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Carrie Wade\",\n",
      "      \"objectId\" : \"0900006483705c4a\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:57:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz\",\n",
      "      \"objectId\" : \"090000648371e16d\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-09-21T14:57:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Scott Ballin\",\n",
      "      \"objectId\" : \"090000648372046f\",\n",
      "      \"postedDate\" : \"2018-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-12-20T17:11:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David Abrams\",\n",
      "      \"objectId\" : \"090000648373e036\",\n",
      "      \"postedDate\" : \"2018-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-12-20T17:11:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sven-Eric Jordt\",\n",
      "      \"objectId\" : \"09000064837a716a\",\n",
      "      \"postedDate\" : \"2018-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-12-20T17:11:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David Abrams\",\n",
      "      \"objectId\" : \"09000064837afd4b\",\n",
      "      \"postedDate\" : \"2018-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-12-20T17:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from William Denny\",\n",
      "      \"objectId\" : \"090000648393e66c\",\n",
      "      \"postedDate\" : \"2018-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-02-26T13:39:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from New York Association of Convenience Stores\",\n",
      "      \"objectId\" : \"0900006483aa7060\",\n",
      "      \"postedDate\" : \"2019-02-26T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-03-15T14:49:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Janet Gorman\",\n",
      "      \"objectId\" : \"0900006483adf939\",\n",
      "      \"postedDate\" : \"2019-03-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-03-15T14:50:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Steven Scallion\",\n",
      "      \"objectId\" : \"0900006483ae7080\",\n",
      "      \"postedDate\" : \"2019-03-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-03-27T16:14:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Hermann Harnisch\",\n",
      "      \"objectId\" : \"0900006483b337ef\",\n",
      "      \"postedDate\" : \"2019-03-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-04-03T19:35:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006483b58834\",\n",
      "      \"postedDate\" : \"2019-04-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-07-23T15:15:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Campaign for Tobacco-Free Kids et al\",\n",
      "      \"objectId\" : \"0900006483c72e91\",\n",
      "      \"postedDate\" : \"2019-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-07-23T15:15:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from O'Neill Institute for National &amp; Global Health Law\",\n",
      "      \"objectId\" : \"0900006483c753cb\",\n",
      "      \"postedDate\" : \"2019-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-07-23T15:15:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from O'Neill Institute for National &amp; Global Health Law\",\n",
      "      \"objectId\" : \"0900006483c76913\",\n",
      "      \"postedDate\" : \"2019-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-07-23T15:15:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Consumer Advocates for Smoke-free Alternatives Association (CASAA)\",\n",
      "      \"objectId\" : \"0900006483c78547\",\n",
      "      \"postedDate\" : \"2019-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-07-23T15:15:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from The Consumer Advocates for Smoke-free Alternatives Association\",\n",
      "      \"objectId\" : \"0900006483c77fde\",\n",
      "      \"postedDate\" : \"2019-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-12-02T15:51:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Woods\",\n",
      "      \"objectId\" : \"0900006484980517\",\n",
      "      \"postedDate\" : \"2020-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-05T19:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from National Center for Health Research\",\n",
      "      \"objectId\" : \"09000064849d2054\",\n",
      "      \"postedDate\" : \"2021-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-05T19:39:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Association for Dental Research\",\n",
      "      \"objectId\" : \"09000064849d2eff\",\n",
      "      \"postedDate\" : \"2021-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-05T19:44:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Byron, M. Justin\",\n",
      "      \"objectId\" : \"09000064849d5dc5\",\n",
      "      \"postedDate\" : \"2021-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-4678-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2021-01-05T19:48:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Physicians Committee for Responsible Medicine\",\n",
      "      \"objectId\" : \"09000064849d507b\",\n",
      "      \"postedDate\" : \"2021-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-4678-0045\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 42,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 42,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 42,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 42,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 42,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0143-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-08-12T19:59:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Richard Riva\",\n",
      "      \"objectId\" : \"0900006483e20f58\",\n",
      "      \"postedDate\" : \"2019-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-08-13T14:33:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edgardo\",\n",
      "      \"objectId\" : \"0900006483e3987f\",\n",
      "      \"postedDate\" : \"2019-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-08-15T14:07:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from George Harakas\",\n",
      "      \"objectId\" : \"0900006483e502ba\",\n",
      "      \"postedDate\" : \"2019-08-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:29:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mike Grimm\",\n",
      "      \"objectId\" : \"0900006483e5e87c\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:30:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mary Townsend\",\n",
      "      \"objectId\" : \"0900006483e632ba\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:31:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dwain Sparks\",\n",
      "      \"objectId\" : \"0900006483e6754d\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:32:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mary Townsend\",\n",
      "      \"objectId\" : \"0900006483edd742\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:33:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nathan Affield\",\n",
      "      \"objectId\" : \"0900006483eea011\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:34:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gregory Roberti\",\n",
      "      \"objectId\" : \"0900006483eea64b\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-09T14:35:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cathleen Reese\",\n",
      "      \"objectId\" : \"0900006483e5cde3\",\n",
      "      \"postedDate\" : \"2019-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-17T15:07:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Fran Forbes\",\n",
      "      \"objectId\" : \"0900006483f42359\",\n",
      "      \"postedDate\" : \"2019-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-17T15:07:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Amber  Cooper\",\n",
      "      \"objectId\" : \"0900006483f65311\",\n",
      "      \"postedDate\" : \"2019-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-25T10:49:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Paul Hartig\",\n",
      "      \"objectId\" : \"0900006483fabfb6\",\n",
      "      \"postedDate\" : \"2019-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-25T10:49:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Betty Faust\",\n",
      "      \"objectId\" : \"0900006483fc0cc7\",\n",
      "      \"postedDate\" : \"2019-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-09-30T12:00:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Emily Austin\",\n",
      "      \"objectId\" : \"0900006483fe39b2\",\n",
      "      \"postedDate\" : \"2019-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-02T14:55:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Preston Campbell\",\n",
      "      \"objectId\" : \"0900006483ff4943\",\n",
      "      \"postedDate\" : \"2019-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-02T14:55:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Janis Jeffreys\",\n",
      "      \"objectId\" : \"0900006484000646\",\n",
      "      \"postedDate\" : \"2019-10-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-03T12:49:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lauren Lempert\",\n",
      "      \"objectId\" : \"090000648400898e\",\n",
      "      \"postedDate\" : \"2019-10-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-03T12:49:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Adrian Torres\",\n",
      "      \"objectId\" : \"0900006484006701\",\n",
      "      \"postedDate\" : \"2019-10-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-03T20:26:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Philip Morris Products S.A.\",\n",
      "      \"objectId\" : \"0900006484010937\",\n",
      "      \"postedDate\" : \"2019-10-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Schlesinger Law Offices, P.A.\",\n",
      "      \"objectId\" : \"0900006484022bec\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Thoracic Society\",\n",
      "      \"objectId\" : \"0900006484021751\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Academy of Pediatrics\",\n",
      "      \"objectId\" : \"0900006484021650\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from RAI Services Company\",\n",
      "      \"objectId\" : \"0900006484021428\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jonathan Golden\",\n",
      "      \"objectId\" : \"090000648401b0bc\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Elizabeth Camp\",\n",
      "      \"objectId\" : \"090000648401b052\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:51:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mario Danek\",\n",
      "      \"objectId\" : \"090000648401aecf\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-04T17:54:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Chemistry Council\",\n",
      "      \"objectId\" : \"0900006484023a8c\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Duke University School of Medicine\",\n",
      "      \"objectId\" : \"090000648402939b\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Duke University School of Medicine\",\n",
      "      \"objectId\" : \"0900006484029396\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Duke University Yale University\",\n",
      "      \"objectId\" : \"0900006484029393\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Oliva Cigar Co.\",\n",
      "      \"objectId\" : \"090000648402b21f\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Al Fakher\",\n",
      "      \"objectId\" : \"090000648402926e\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cigar Rights of America Premium Cigar Association\",\n",
      "      \"objectId\" : \"090000648402a5c6\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Flavor and Extract Manufacturers Association of the United States\",\n",
      "      \"objectId\" : \"090000648402a2bb\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"09000064840289b5\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Chemistry Council\",\n",
      "      \"objectId\" : \"0900006484026e46\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-07T14:46:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Altria\",\n",
      "      \"objectId\" : \"0900006484026dc8\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-08T19:08:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cigar Rights of America and Premium Cigar Association\",\n",
      "      \"objectId\" : \"090000648402a02e\",\n",
      "      \"postedDate\" : \"2019-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0143-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-10-09T16:32:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from The Ohio State University\",\n",
      "      \"objectId\" : \"090000648401afba\",\n",
      "      \"postedDate\" : \"2019-10-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0143-0046\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 40,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 40,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 40,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 40,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 40,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0920-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:46:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tantus Tobacco Sales - Comment\",\n",
      "      \"objectId\" : \"090000648132d5f6\",\n",
      "      \"postedDate\" : \"2013-06-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:46:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CITMA - Comment\",\n",
      "      \"objectId\" : \"09000064813b3358\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:46:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SMARTT Coalition - Comment\",\n",
      "      \"objectId\" : \"09000064813b2481\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:46:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mike Copperman - Comment\",\n",
      "      \"objectId\" : \"09000064813b24fd\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:47:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cigar Association of America, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813afdbd\",\n",
      "      \"postedDate\" : \"2013-08-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:47:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services - Comment\",\n",
      "      \"objectId\" : \"09000064813b202b\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:47:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813b2366\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:47:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pipe Tobaccco Council, Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813af6c3\",\n",
      "      \"postedDate\" : \"2013-08-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:47:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ECIG - Comment\",\n",
      "      \"objectId\" : \"09000064813aff84\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0920-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-07-10T13:47:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"RAI Services Company - Comment\",\n",
      "      \"objectId\" : \"09000064813b1b1d\",\n",
      "      \"postedDate\" : \"2013-08-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0920-0007\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 10,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 10,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 10,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 10,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 10,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0508-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-02T15:00:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services - Comment\",\n",
      "      \"objectId\" : \"0900006480a4eb04\",\n",
      "      \"postedDate\" : \"2009-11-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0508-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-02T15:00:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"RAI Services Company - Comment\",\n",
      "      \"objectId\" : \"0900006480a4eb86\",\n",
      "      \"postedDate\" : \"2009-11-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0508-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-02T15:01:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richard Pitchie - Comment\",\n",
      "      \"objectId\" : \"0900006480a4ebe1\",\n",
      "      \"postedDate\" : \"2009-11-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0508-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-04T16:30:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Universal Corporation (McGuireWoods) - Comment\",\n",
      "      \"objectId\" : \"0900006480a4d0f8\",\n",
      "      \"postedDate\" : \"2009-11-04T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0508-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-06T02:19:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services - Comment\",\n",
      "      \"objectId\" : \"0900006480a505b9\",\n",
      "      \"postedDate\" : \"2009-11-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0508-0008\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 5,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 5,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 5,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 5,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 5,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0386-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-11-23T14:56:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Richard Gommert\",\n",
      "      \"objectId\" : \"09000064838f566a\",\n",
      "      \"postedDate\" : \"2018-11-23T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0386-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-N-0386-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2019-01-30T21:54:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from nick ray\",\n",
      "      \"objectId\" : \"09000064839b4e60\",\n",
      "      \"postedDate\" : \"2019-01-30T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0386-0013\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 2,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2017-N-6565-14937\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-07T16:59:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Randy Owen\",\n",
      "      \"objectId\" : \"090000648321276b\",\n",
      "      \"postedDate\" : \"2018-06-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-14937\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-6565-14938\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-07T16:59:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from P M\",\n",
      "      \"objectId\" : \"09000064831d3dca\",\n",
      "      \"postedDate\" : \"2018-06-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-14938\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-6565-14941\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-07T16:59:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"09000064831c061a\",\n",
      "      \"postedDate\" : \"2018-06-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-14941\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 3,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 3,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 3,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 3,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 3,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"TTB-2009-0002-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-17T19:49:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by John Middleton Company\",\n",
      "      \"objectId\" : \"0900006480a0b7c7\",\n",
      "      \"postedDate\" : \"2009-08-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-06-11T18:02:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by Adams, Grace C.\",\n",
      "      \"objectId\" : \"0900006480a0ba74\",\n",
      "      \"postedDate\" : \"2009-08-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-06-11T18:02:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by Venable, LLP (Bigart, Andrew E.)\",\n",
      "      \"objectId\" : \"0900006480a0c993\",\n",
      "      \"postedDate\" : \"2009-08-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-06-11T18:03:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by Fletcher, Karen P.\",\n",
      "      \"objectId\" : \"09000064809e9a81\",\n",
      "      \"postedDate\" : \"2009-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-06-11T18:03:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by the South Dakota Attorney General's Office (Rank, Bobbi)\",\n",
      "      \"objectId\" : \"0900006480a0f36c\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:18:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by the Pipe Tobacco Council\",\n",
      "      \"objectId\" : \"09000064809f17b0\",\n",
      "      \"postedDate\" : \"2009-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:19:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment Extension Request by John Middleton Co., et. al.\",\n",
      "      \"objectId\" : \"0900006480a0ce4e\",\n",
      "      \"postedDate\" : \"2009-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:20:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by Customs Advisory Services, Inc. (Keller, George M.)\",\n",
      "      \"objectId\" : \"0900006480a0f576\",\n",
      "      \"postedDate\" : \"2009-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:20:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by Universal Leaf Tobacco Co., Inc.\",\n",
      "      \"objectId\" : \"0900006480a0f75e\",\n",
      "      \"postedDate\" : \"2009-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:20:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Additional Comment by Pipe Tobacco Council, Inc.\",\n",
      "      \"objectId\" : \"0900006480a0f318\",\n",
      "      \"postedDate\" : \"2009-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:20:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by R. J. Reynolds Tobacco Company\",\n",
      "      \"objectId\" : \"0900006480a0f33d\",\n",
      "      \"postedDate\" : \"2009-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:21:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by National Tobacco Company, LP\",\n",
      "      \"objectId\" : \"0900006480a0f366\",\n",
      "      \"postedDate\" : \"2009-09-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:21:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"2nd Comment by Customs Advisory Services, Inc. (Keller, George M.)\",\n",
      "      \"objectId\" : \"0900006480a25de2\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:22:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by John Middleton Co., Philip Morris USA Inc., and U.S. Smokeless Tobacco Manufacturing Company LLC\",\n",
      "      \"objectId\" : \"0900006480a45529\",\n",
      "      \"postedDate\" : \"2009-10-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:35:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment of 10-19-2009 by Altadis USA (via Schaevitz, Barry S.)\",\n",
      "      \"objectId\" : \"0900006480a45642\",\n",
      "      \"postedDate\" : \"2009-10-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:37:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Schweitzer-Mauduit International, Inc. (Martinez, Wilfred A.)\",\n",
      "      \"objectId\" : \"0900006480a46000\",\n",
      "      \"postedDate\" : \"2009-10-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:37:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment by Boren, Barry\",\n",
      "      \"objectId\" : \"0900006480a5e058\",\n",
      "      \"postedDate\" : \"2009-11-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"TTB-2009-0002-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-08-24T19:38:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"TTB\",\n",
      "      \"title\" : \"Comment of 10-15-2009 by Altadis USA (via Feller, Peter B.)\",\n",
      "      \"objectId\" : \"0900006480a65eac\",\n",
      "      \"postedDate\" : \"2009-12-07T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/TTB-2009-0002-0025\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 18,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 18,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 18,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 18,\n",
      "        \"value\" : \"TTB\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 18,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2014-N-0086-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-07-17T20:49:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006484772102\",\n",
      "      \"postedDate\" : \"2020-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2014-N-0086-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2014-N-0086-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-07-17T20:51:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Samir Musallam\",\n",
      "      \"objectId\" : \"09000064847786e5\",\n",
      "      \"postedDate\" : \"2020-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2014-N-0086-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2014-N-0086-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2020-07-17T20:52:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648477ee79\",\n",
      "      \"postedDate\" : \"2020-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2014-N-0086-0013\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 3,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 3,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 3,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 3,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 3,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2015-N-1514-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Vivian Huang\",\n",
      "      \"objectId\" : \"0900006481b67599\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lauren Herbert\",\n",
      "      \"objectId\" : \"0900006481b6bd3b\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Healthy King County Coalition\",\n",
      "      \"objectId\" : \"0900006481b73599\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481b7c8b6\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jessica Neely\",\n",
      "      \"objectId\" : \"0900006481b8d8d4\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Association of Poison Control Centers (AAPCC)\",\n",
      "      \"objectId\" : \"0900006481b8e1b4\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mary Applegate\",\n",
      "      \"objectId\" : \"0900006481b9fb7d\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michigan Department of Health and Human Services\",\n",
      "      \"objectId\" : \"0900006481bc1472\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-05T19:59:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Luke\",\n",
      "      \"objectId\" : \"0900006481bc51a2\",\n",
      "      \"postedDate\" : \"2015-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:24:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481bc6507\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:25:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481bc9925\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:25:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481bc99bb\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:29:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz\",\n",
      "      \"objectId\" : \"0900006481c1b88b\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:30:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Heather Coale\",\n",
      "      \"objectId\" : \"0900006481c1d083\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:31:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kevin Davis\",\n",
      "      \"objectId\" : \"0900006481c1d200\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:31:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gregory Stark\",\n",
      "      \"objectId\" : \"0900006481c1d45f\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:32:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Chris Catani\",\n",
      "      \"objectId\" : \"0900006481c1d4f0\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:32:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from G.j. Cox\",\n",
      "      \"objectId\" : \"0900006481c1dd4e\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from George Tackett\",\n",
      "      \"objectId\" : \"0900006481bbad52\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jenn Daniels\",\n",
      "      \"objectId\" : \"0900006481bb7b13\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Greg Dessert\",\n",
      "      \"objectId\" : \"0900006481bb336e\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Vernon Sproul\",\n",
      "      \"objectId\" : \"0900006481bb0468\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bob Wilson\",\n",
      "      \"objectId\" : \"0900006481baeba8\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Eli\",\n",
      "      \"objectId\" : \"0900006481bac83e\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeff Moody\",\n",
      "      \"objectId\" : \"0900006481baca8b\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edward Sweeney\",\n",
      "      \"objectId\" : \"0900006481baca88\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Terry Mohs\",\n",
      "      \"objectId\" : \"0900006481baca37\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Demetrius Revelas\",\n",
      "      \"objectId\" : \"0900006481bac9e5\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Steve\",\n",
      "      \"objectId\" : \"0900006481bac677\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brandon Ermita\",\n",
      "      \"objectId\" : \"0900006481bac32b\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ralph Bronson\",\n",
      "      \"objectId\" : \"0900006481bac27f\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Billy Shrewsbury\",\n",
      "      \"objectId\" : \"0900006481bac234\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joseph French\",\n",
      "      \"objectId\" : \"0900006481ba94fc\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joshua Penosky\",\n",
      "      \"objectId\" : \"0900006481ba94f9\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Allen Parker\",\n",
      "      \"objectId\" : \"0900006481ba9b3d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brian Slonka\",\n",
      "      \"objectId\" : \"0900006481ba9b3c\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from William  Miskokomon\",\n",
      "      \"objectId\" : \"0900006481b858d0\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tom Simpson\",\n",
      "      \"objectId\" : \"0900006481b8293a\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alan Savoy\",\n",
      "      \"objectId\" : \"0900006481b7c62d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Amber Gransee\",\n",
      "      \"objectId\" : \"0900006481b7c26f\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Crispin Pierce\",\n",
      "      \"objectId\" : \"0900006481b7c245\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Morgan\",\n",
      "      \"objectId\" : \"0900006481b76fcc\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Josh Hill\",\n",
      "      \"objectId\" : \"0900006481b70015\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from kathryn (heyitskat) johnson\",\n",
      "      \"objectId\" : \"0900006481b6ce05\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nick Ignatowski\",\n",
      "      \"objectId\" : \"0900006481b6ce03\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mike Mckenzie\",\n",
      "      \"objectId\" : \"0900006481b6cd34\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Autumn Burns\",\n",
      "      \"objectId\" : \"0900006481b6c55a\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from jason bain\",\n",
      "      \"objectId\" : \"0900006481b6bef6\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from dewayne tucker\",\n",
      "      \"objectId\" : \"0900006481b6bd43\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Yousha\",\n",
      "      \"objectId\" : \"0900006481b6bc4d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robyn Morell\",\n",
      "      \"objectId\" : \"0900006481b6bc05\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Leanna Miller\",\n",
      "      \"objectId\" : \"0900006481b6ba1c\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James Schmidt\",\n",
      "      \"objectId\" : \"0900006481b6ad56\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Marvin Rhone\",\n",
      "      \"objectId\" : \"0900006481b6ad55\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from ethan carson\",\n",
      "      \"objectId\" : \"0900006481b6ad54\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481b6ad51\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from chris willey\",\n",
      "      \"objectId\" : \"0900006481b6aac1\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Matthew  Gregory\",\n",
      "      \"objectId\" : \"0900006481b6aa8f\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lori  Dancy\",\n",
      "      \"objectId\" : \"0900006481b6aa8e\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Chris Carothers\",\n",
      "      \"objectId\" : \"0900006481b6aa8d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Shawnte Westfall\",\n",
      "      \"objectId\" : \"0900006481b6a8cd\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from LESTER HARTMAN\",\n",
      "      \"objectId\" : \"0900006481b6aa4d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481b6a982\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Claire Simard\",\n",
      "      \"objectId\" : \"0900006481b6a58d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Maxwell S\",\n",
      "      \"objectId\" : \"0900006481b69c32\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Scott Rule\",\n",
      "      \"objectId\" : \"0900006481b69aca\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Orville  Dunfield\",\n",
      "      \"objectId\" : \"0900006481b69d8f\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481b69d15\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Keith Mikell\",\n",
      "      \"objectId\" : \"0900006481b6928b\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kyle Redding\",\n",
      "      \"objectId\" : \"0900006481b68d6e\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jill  Chaplin\",\n",
      "      \"objectId\" : \"0900006481b68cd0\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mary Chandra\",\n",
      "      \"objectId\" : \"0900006481b68b2e\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from brad wager\",\n",
      "      \"objectId\" : \"0900006481b687ab\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0079\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Serena Black\",\n",
      "      \"objectId\" : \"0900006481b65e04\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0079\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481b663eb\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jane\",\n",
      "      \"objectId\" : \"0900006481b6654d\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Laureen Murphree\",\n",
      "      \"objectId\" : \"0900006481b655c4\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brandon Mccollum\",\n",
      "      \"objectId\" : \"0900006481b64b51\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Donna Snyder\",\n",
      "      \"objectId\" : \"0900006481b647b2\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Daniel Voyles\",\n",
      "      \"objectId\" : \"0900006481b64a73\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeffrey Seeds\",\n",
      "      \"objectId\" : \"0900006481b64382\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Judy  Guiler\",\n",
      "      \"objectId\" : \"0900006481b637ca\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joe Watkins\",\n",
      "      \"objectId\" : \"0900006481b634b1\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-13T16:33:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David Grams\",\n",
      "      \"objectId\" : \"0900006481b63b60\",\n",
      "      \"postedDate\" : \"2015-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-25T19:26:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from T.C. Bradford\",\n",
      "      \"objectId\" : \"0900006481c1f10d\",\n",
      "      \"postedDate\" : \"2015-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-25T19:31:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Candice Couch\",\n",
      "      \"objectId\" : \"0900006481c1f952\",\n",
      "      \"postedDate\" : \"2015-08-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0097\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c30dba\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0097\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jan Kilby\",\n",
      "      \"objectId\" : \"0900006481c2f9e3\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James Tucker\",\n",
      "      \"objectId\" : \"0900006481c2f659\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jacob Crews\",\n",
      "      \"objectId\" : \"0900006481c2ec97\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0101\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kevin Fleming\",\n",
      "      \"objectId\" : \"0900006481c2ec23\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0101\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0102\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c2e84f\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0102\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0103\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Christine Sogn\",\n",
      "      \"objectId\" : \"0900006481c2e7d1\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0103\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0104\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Liz Wilhelm\",\n",
      "      \"objectId\" : \"0900006481c2e65a\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0104\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sean Yates\",\n",
      "      \"objectId\" : \"0900006481c2dcb9\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Don Muehlbauer\",\n",
      "      \"objectId\" : \"0900006481c2de9e\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James Gauthier\",\n",
      "      \"objectId\" : \"0900006481c2c772\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c2bc57\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Janet Armstrong\",\n",
      "      \"objectId\" : \"0900006481c2bc0a\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Pamela Phifield\",\n",
      "      \"objectId\" : \"0900006481c2bfcb\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0110\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0111\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c2b5b8\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0111\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0112\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Helen Dunlap\",\n",
      "      \"objectId\" : \"0900006481c2abd4\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0112\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0113\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ondrej Dyck\",\n",
      "      \"objectId\" : \"0900006481c2a7cb\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0113\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0114\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeff Porter\",\n",
      "      \"objectId\" : \"0900006481c29a36\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0114\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0115\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Angel Tibbs\",\n",
      "      \"objectId\" : \"0900006481c29a0c\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0115\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0116\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Terry Mohs\",\n",
      "      \"objectId\" : \"0900006481c295ca\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0116\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0117\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cathy Nirenberg\",\n",
      "      \"objectId\" : \"0900006481c29582\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0117\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0118\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas McCormick\",\n",
      "      \"objectId\" : \"0900006481c29038\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0118\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0119\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Garvin\",\n",
      "      \"objectId\" : \"0900006481c28bcd\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0119\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0120\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Valerie Nagoshiner\",\n",
      "      \"objectId\" : \"0900006481c28746\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0120\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0121\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c285ce\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0121\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0122\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jody St Pierre\",\n",
      "      \"objectId\" : \"0900006481c281bf\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0122\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0123\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sherry Barney\",\n",
      "      \"objectId\" : \"0900006481c281b9\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0123\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0124\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James F Currie\",\n",
      "      \"objectId\" : \"0900006481c27d67\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0124\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0125\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Atakan Befrits\",\n",
      "      \"objectId\" : \"0900006481c26772\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0125\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0126\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Shawn Hoefer\",\n",
      "      \"objectId\" : \"0900006481c2676d\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0126\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0127\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Matt Slavit\",\n",
      "      \"objectId\" : \"0900006481c2693b\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0127\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0128\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from T McClain\",\n",
      "      \"objectId\" : \"0900006481c26466\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0128\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0129\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c260b5\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0129\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0130\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gary Perniciaro\",\n",
      "      \"objectId\" : \"0900006481c26032\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0130\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0131\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c26005\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0131\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0132\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c257d5\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0132\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0133\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stephen Knight, Vapejoose, Inc\",\n",
      "      \"objectId\" : \"0900006481c256ea\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0133\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0134\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Victor Torres\",\n",
      "      \"objectId\" : \"0900006481c259db\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0134\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0135\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kenneth  Willis\",\n",
      "      \"objectId\" : \"0900006481c2546c\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0135\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0136\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Derek Romano\",\n",
      "      \"objectId\" : \"0900006481c24feb\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0136\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0137\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Phyllis Steging\",\n",
      "      \"objectId\" : \"0900006481c23c3e\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0137\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0138\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from John Challis\",\n",
      "      \"objectId\" : \"0900006481c23dcd\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0138\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0139\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lesley Leung\",\n",
      "      \"objectId\" : \"0900006481c23d4f\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0139\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0140\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tony Grippando\",\n",
      "      \"objectId\" : \"0900006481c2386f\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0140\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0141\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Walter Tedder\",\n",
      "      \"objectId\" : \"0900006481c235ea\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0141\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0142\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Peter Russell\",\n",
      "      \"objectId\" : \"0900006481c230ea\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0142\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0143\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gary Miller\",\n",
      "      \"objectId\" : \"0900006481c230e9\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0143\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0144\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Victoria Plasse, Casaa\",\n",
      "      \"objectId\" : \"0900006481c2321a\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0144\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Noland Tucker\",\n",
      "      \"objectId\" : \"0900006481c22dd0\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0146\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Daniel Gibson, Vapefog Reviews\",\n",
      "      \"objectId\" : \"0900006481c224ce\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0146\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0147\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kent B. Marshall\",\n",
      "      \"objectId\" : \"0900006481c224cd\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0147\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0148\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jerry Jones\",\n",
      "      \"objectId\" : \"0900006481c22b3b\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0148\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0149\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kathy Hoppe\",\n",
      "      \"objectId\" : \"0900006481c2244a\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0149\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeffrey Kramlich\",\n",
      "      \"objectId\" : \"0900006481c22434\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Russell Gamble\",\n",
      "      \"objectId\" : \"0900006481c225f9\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0151\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0152\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous Anonymous\",\n",
      "      \"objectId\" : \"0900006481c225f7\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0152\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0153\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dave Rumbaugh\",\n",
      "      \"objectId\" : \"0900006481c2204b\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0153\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0154\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tyler Kustek\",\n",
      "      \"objectId\" : \"0900006481c21fbc\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0154\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0155\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Matthew Keown\",\n",
      "      \"objectId\" : \"0900006481c21fbb\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0155\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0156\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Shawn Owens\",\n",
      "      \"objectId\" : \"0900006481c21fe4\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0156\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0157\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jennifer Sigler\",\n",
      "      \"objectId\" : \"0900006481c22190\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0157\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0158\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Roland Pelletier\",\n",
      "      \"objectId\" : \"0900006481c21f57\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0158\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0159\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Pam Van Dieren\",\n",
      "      \"objectId\" : \"0900006481c21e76\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0159\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0160\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tracy Musgrove\",\n",
      "      \"objectId\" : \"0900006481c21e46\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0160\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0161\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:55:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Caitlin McNeice\",\n",
      "      \"objectId\" : \"0900006481c21c4d\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0161\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0162\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dan Bennett\",\n",
      "      \"objectId\" : \"0900006481c21495\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0162\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0163\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Suzann Young\",\n",
      "      \"objectId\" : \"0900006481c21ae9\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0163\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0164\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dale Lalka\",\n",
      "      \"objectId\" : \"0900006481c2166e\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0164\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Benedict\",\n",
      "      \"objectId\" : \"0900006481c21060\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0165\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0166\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tom Madden\",\n",
      "      \"objectId\" : \"0900006481c21057\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0166\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0167\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous Anonymous\",\n",
      "      \"objectId\" : \"0900006481c20c35\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0167\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0168\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Russell Best, CASAA\",\n",
      "      \"objectId\" : \"0900006481c20b02\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0168\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0169\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from stacie ortego\",\n",
      "      \"objectId\" : \"0900006481c20afe\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0169\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0170\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous Anonymous\",\n",
      "      \"objectId\" : \"0900006481c20afc\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0170\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0171\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Susan Wilson\",\n",
      "      \"objectId\" : \"0900006481c20a82\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0171\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0172\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alexander Cuomo\",\n",
      "      \"objectId\" : \"0900006481c20a7d\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0172\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0173\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kim Kiejzik\",\n",
      "      \"objectId\" : \"0900006481c20e15\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0173\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0174\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Patricia Johnson\",\n",
      "      \"objectId\" : \"0900006481c20e14\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0174\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0175\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Christian B.\",\n",
      "      \"objectId\" : \"0900006481c20e13\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0175\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0176\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ryan P\",\n",
      "      \"objectId\" : \"0900006481c20db7\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0176\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0177\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brian Anonymous, Consumer Advocates for Smoke-free Alternatives Association\",\n",
      "      \"objectId\" : \"0900006481c20da2\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0177\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0178\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Raymond Ingling\",\n",
      "      \"objectId\" : \"0900006481c20db4\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0178\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0179\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Steven Ash\",\n",
      "      \"objectId\" : \"0900006481c20da1\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0179\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0180\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from michael koczan\",\n",
      "      \"objectId\" : \"0900006481c203f5\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0180\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0181\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Laszko\",\n",
      "      \"objectId\" : \"0900006481c20524\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0181\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0182\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Sidaway, CASAA- THE CONSUMER ADVOCATES FOR SMOKE-FREE ALTERNATIVES ASSOCIATION\",\n",
      "      \"objectId\" : \"0900006481c20382\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0182\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0183\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Charles D. Hauser\",\n",
      "      \"objectId\" : \"0900006481c2037f\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0183\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0184\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Eric Althouse\",\n",
      "      \"objectId\" : \"0900006481c1fc3b\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0184\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0185\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Darryl Shurgin\",\n",
      "      \"objectId\" : \"0900006481c1ffa1\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0185\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0186\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kieron Haney\",\n",
      "      \"objectId\" : \"0900006481c1fbd4\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0186\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0187\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gerard DeCicco\",\n",
      "      \"objectId\" : \"0900006481c1fed8\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0187\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0188\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Katherine Brunty\",\n",
      "      \"objectId\" : \"0900006481c1fb98\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0188\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0189\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Jacobson\",\n",
      "      \"objectId\" : \"0900006481c1fed1\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0189\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0190\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Richard Legg\",\n",
      "      \"objectId\" : \"0900006481c1fe89\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0190\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0191\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mitchell  Henderson\",\n",
      "      \"objectId\" : \"0900006481c1fe87\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0191\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0192\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from James Scott\",\n",
      "      \"objectId\" : \"0900006481c1fb4a\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0192\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0193\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Chuck W.\",\n",
      "      \"objectId\" : \"0900006481c1fb46\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0193\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0194\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lance Levitan\",\n",
      "      \"objectId\" : \"0900006481c1fe3d\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0194\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0195\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edward Aizen\",\n",
      "      \"objectId\" : \"0900006481c1fb2e\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0195\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0196\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sean Matthews\",\n",
      "      \"objectId\" : \"0900006481c1fe39\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0196\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0197\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from gregory savage\",\n",
      "      \"objectId\" : \"0900006481c1fb1a\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0197\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0198\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bryan Justice\",\n",
      "      \"objectId\" : \"0900006481c1fe14\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0198\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0199\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David Dickerson\",\n",
      "      \"objectId\" : \"0900006481c1fb14\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0199\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0200\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c1fb11\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0200\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0201\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Paul Trowe\",\n",
      "      \"objectId\" : \"0900006481c1fdd4\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0201\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0202\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kevin DeBauch\",\n",
      "      \"objectId\" : \"0900006481c1fdd2\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0202\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0203\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Armando DiBernardo\",\n",
      "      \"objectId\" : \"0900006481c1fdc5\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0203\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0204\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Deborah Glass\",\n",
      "      \"objectId\" : \"0900006481c1fdc4\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0204\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0205\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Randy George\",\n",
      "      \"objectId\" : \"0900006481c1fdcf\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0205\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0206\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Daniel A\",\n",
      "      \"objectId\" : \"0900006481c1fdce\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0206\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0207\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ben Williamson\",\n",
      "      \"objectId\" : \"0900006481c1fdc2\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0207\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0208\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Becky Zenner\",\n",
      "      \"objectId\" : \"0900006481c1fdbf\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0208\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0209\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael  Marandola\",\n",
      "      \"objectId\" : \"0900006481c1fab3\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0209\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0210\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-26T19:56:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Theresa Dill\",\n",
      "      \"objectId\" : \"0900006481c1fab2\",\n",
      "      \"postedDate\" : \"2015-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0210\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0211\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from chris koch\",\n",
      "      \"objectId\" : \"0900006481c3c7c7\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0211\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0212\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joey  Wright\",\n",
      "      \"objectId\" : \"0900006481c3c7ac\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0212\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0213\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Denise Carr\",\n",
      "      \"objectId\" : \"0900006481c3c47e\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0213\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0214\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Thomas Merrill, NYC Department of Health &amp; Mental Hygiene\",\n",
      "      \"objectId\" : \"0900006481c3b91f\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0214\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0215\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stephanie George\",\n",
      "      \"objectId\" : \"0900006481c3a409\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0215\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0216\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Justin McPherson\",\n",
      "      \"objectId\" : \"0900006481c3938e\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0216\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0217\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ellen Hahn, Kentucky Center for Smoke-free Policy\",\n",
      "      \"objectId\" : \"0900006481c3882c\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0217\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0218\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Walter Morris\",\n",
      "      \"objectId\" : \"0900006481c387e3\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0218\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0219\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c36582\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0219\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0220\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michel Barillet\",\n",
      "      \"objectId\" : \"0900006481c35efc\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0220\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0221\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Maher Karam-Hage, MD\",\n",
      "      \"objectId\" : \"0900006481c34d5f\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0221\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0222\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ted Green\",\n",
      "      \"objectId\" : \"0900006481c34897\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0222\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0223\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Martin\",\n",
      "      \"objectId\" : \"0900006481c338cc\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0223\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0224\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from dale jean clare orndorff\",\n",
      "      \"objectId\" : \"0900006481c3358d\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0224\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0225\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Barish\",\n",
      "      \"objectId\" : \"0900006481c32c30\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0225\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0226\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Erik Tangeros\",\n",
      "      \"objectId\" : \"0900006481c32b3d\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0226\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0227\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Nathan Smith\",\n",
      "      \"objectId\" : \"0900006481c32d8b\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0227\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0228\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from christopher  burns\",\n",
      "      \"objectId\" : \"0900006481c322f1\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0228\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0229\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David  Hansen\",\n",
      "      \"objectId\" : \"0900006481c31c97\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0229\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0230\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c31d62\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0230\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0231\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Marissa Crockett\",\n",
      "      \"objectId\" : \"0900006481c31d38\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0231\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0232\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joshua Jones\",\n",
      "      \"objectId\" : \"0900006481c31d19\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0232\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0233\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anton Oleson\",\n",
      "      \"objectId\" : \"0900006481c3183c\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0233\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0234\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c3181b\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0234\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0235\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from ian wellsby\",\n",
      "      \"objectId\" : \"0900006481c319b5\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0235\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0236\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joseph H\",\n",
      "      \"objectId\" : \"0900006481c3152c\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0236\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0237\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Darren  Keser\",\n",
      "      \"objectId\" : \"0900006481c30f86\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0237\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0238\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:22:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Abby Lindsay\",\n",
      "      \"objectId\" : \"0900006481c30f12\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0238\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0239\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:56:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ofelia Alvarado\",\n",
      "      \"objectId\" : \"0900006481c3f028\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0239\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0240\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:56:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brandi Markle\",\n",
      "      \"objectId\" : \"0900006481c3e53c\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0240\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0241\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-08-28T14:56:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Holly Brown, Kentucky Center for Smoke-free Policy\",\n",
      "      \"objectId\" : \"0900006481c3df05\",\n",
      "      \"postedDate\" : \"2015-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0241\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0245\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Bennett, American Academy of Family Physicians\",\n",
      "      \"objectId\" : \"0900006481c416fa\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0245\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0246\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tim Meredith\",\n",
      "      \"objectId\" : \"0900006481c42208\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0246\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0247\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous, County of Santa Clara\",\n",
      "      \"objectId\" : \"0900006481c42580\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0247\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0248\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c43116\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0248\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0249\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jennifer Squier\",\n",
      "      \"objectId\" : \"0900006481c436f7\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0249\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0250\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Trevor Anonymous\",\n",
      "      \"objectId\" : \"0900006481c43b94\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0250\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0251\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Barbara Davis, Talbot Lab\",\n",
      "      \"objectId\" : \"0900006481c445a5\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0251\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0252\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Brad McGowan\",\n",
      "      \"objectId\" : \"0900006481c44c91\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0252\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0253\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tri-County Health Department\",\n",
      "      \"objectId\" : \"0900006481c47e07\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0253\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0254\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-09T19:54:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"0900006481c48e39\",\n",
      "      \"postedDate\" : \"2015-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0254\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2015-N-1514-0244\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-30T19:48:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Shiv Patel (Sai Shiva, LLC) Write-In Campaign Multiple Submitters = 694\",\n",
      "      \"objectId\" : \"0900006481c4be38\",\n",
      "      \"postedDate\" : \"2015-09-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2015-N-1514-0244\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 242,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 242,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 242,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 242,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 242,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0524-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-09T13:48:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"UCSD School of Medicine - Comment\",\n",
      "      \"objectId\" : \"0900006480a53b94\",\n",
      "      \"postedDate\" : \"2009-11-09T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-13T16:05:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Council of Independent Tobacco Manufacturers of America (CITMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a56349\",\n",
      "      \"postedDate\" : \"2009-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-13T19:52:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Harvard School of Public Health - Comment\",\n",
      "      \"objectId\" : \"0900006480a57093\",\n",
      "      \"postedDate\" : \"2009-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-16T14:10:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SMARTT Coalition - Comment\",\n",
      "      \"objectId\" : \"0900006480a5642e\",\n",
      "      \"postedDate\" : \"2009-11-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-16T14:16:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Law Offices of Leonard Violi - Comment\",\n",
      "      \"objectId\" : \"0900006480a5643b\",\n",
      "      \"postedDate\" : \"2009-11-16T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-18T23:48:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Universal Corporation (McGuireWoods, LLP) - Comment\",\n",
      "      \"objectId\" : \"0900006480a56d76\",\n",
      "      \"postedDate\" : \"2009-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0020\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 6,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 6,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 6,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 6,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 6,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2011-N-0467-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:11:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"christopher robert kemp - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d22f\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:14:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Edward Arrow - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d6d1\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:14:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paul A. Gobourne - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d2e0\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:31:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"douglas pasquale montano - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d8d1\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:31:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marc Hanson - Comment\",\n",
      "      \"objectId\" : \"0900006480f7dd7d\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paul Thomas Sycalik - Comment\",\n",
      "      \"objectId\" : \"0900006480f7da16\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:37:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f7dc64\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:00:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Northerner Scandinavia Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480f7e294\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:00:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Trey Meadors - Comment\",\n",
      "      \"objectId\" : \"0900006480f7e53e\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:00:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert William Gregorchuk - Comment\",\n",
      "      \"objectId\" : \"0900006480f7e649\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:00:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"BRANDEE LYNN SMITH - Comment\",\n",
      "      \"objectId\" : \"0900006480f7e92b\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:21:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Burch - Comment\",\n",
      "      \"objectId\" : \"0900006480f7f07b\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:21:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shane Allan Welch - Comment\",\n",
      "      \"objectId\" : \"0900006480f81868\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:21:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bianca Garcia - Comment\",\n",
      "      \"objectId\" : \"0900006480f84d32\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:21:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael J Gibson - Comment\",\n",
      "      \"objectId\" : \"0900006480f84ddc\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:21:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeff William Nehring - Comment\",\n",
      "      \"objectId\" : \"0900006480f84df3\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mildred E. Gilmore - Comment\",\n",
      "      \"objectId\" : \"0900006480f8796f\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charles Barrett - Comment\",\n",
      "      \"objectId\" : \"0900006480f88590\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Pursell - Comment\",\n",
      "      \"objectId\" : \"0900006480f885bd\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jonathan Langdon - Comment\",\n",
      "      \"objectId\" : \"0900006480f8bdfb\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeffrey David Cooper - Comment\",\n",
      "      \"objectId\" : \"0900006480f8d560\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Wehlage - Comment\",\n",
      "      \"objectId\" : \"0900006480f8d952\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Warren Wilburn Turner - Comment\",\n",
      "      \"objectId\" : \"0900006480f8ea54\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dorean Page - Comment\",\n",
      "      \"objectId\" : \"0900006480f900e7\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"James M Kristie - Comment\",\n",
      "      \"objectId\" : \"0900006480f906a3\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f91503\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480f92f13\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cameron Koorangi - Comment\",\n",
      "      \"objectId\" : \"0900006480f97053\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chuck brasfield grant - Comment\",\n",
      "      \"objectId\" : \"0900006480f977ce\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Stone - Comment\",\n",
      "      \"objectId\" : \"0900006480f985ff\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-13T23:12:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jason L. Snellgrove - Comment\",\n",
      "      \"objectId\" : \"0900006480f98613\",\n",
      "      \"postedDate\" : \"2012-02-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca Maisel - Comment\",\n",
      "      \"objectId\" : \"0900006480f98c3a\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f98cc5\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thomas Hartman - Comment\",\n",
      "      \"objectId\" : \"0900006480f9911b\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jimmy Kane - Comment\",\n",
      "      \"objectId\" : \"0900006480f997eb\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janet Lee Christian - Comment\",\n",
      "      \"objectId\" : \"0900006480f999e8\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brian Pyatt - Comment\",\n",
      "      \"objectId\" : \"0900006480f99b5f\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0079\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"j r c - Comment\",\n",
      "      \"objectId\" : \"0900006480f99d91\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0079\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Electronic Cigarette Industry Group, Inc. (ECIG) - Comment\",\n",
      "      \"objectId\" : \"0900006480f99bb2\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tiffany Lawson - Comment\",\n",
      "      \"objectId\" : \"0900006480f99e1b\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Howard Beahrs - Comment\",\n",
      "      \"objectId\" : \"0900006480f99c49\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah Mendzef - Comment\",\n",
      "      \"objectId\" : \"0900006480f9a112\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joey Irelan - Comment\",\n",
      "      \"objectId\" : \"0900006480f99fe4\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Association of Convenience Stores (NACS) - Comment\",\n",
      "      \"objectId\" : \"0900006480f9a534\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Prudence Ann Wolff - Comment\",\n",
      "      \"objectId\" : \"0900006480f9a0fb\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f9a5e0\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Roosevelt Weaver - Comment\",\n",
      "      \"objectId\" : \"0900006480f9a74f\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Roosevelt Weaver - Comment\",\n",
      "      \"objectId\" : \"0900006480f9a750\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0090\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"T - Comment\",\n",
      "      \"objectId\" : \"0900006480f9ae5e\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0090\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0091\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T17:40:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gregory Carter Miller - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b1bc\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0091\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0092\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b1f4\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0092\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0093\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"doyle allen chadwick - Comment\",\n",
      "      \"objectId\" : \"0900006480f9afea\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0093\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0094\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ANTHONY C COLSON - Comment\",\n",
      "      \"objectId\" : \"0900006480f9afec\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0094\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Campaign for Tobacco Free Kids - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b53f\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Society of Independent Gasoline Marketers of America (SIGMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b242\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0097\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rick E Solchenberger - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b5d0\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0097\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert James Brassell, Jr., N.P. - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b657\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cigar Rights of America - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b3bb\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"University of North Carolina at Chapel Hill - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b777\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0101\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b4cf\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0101\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0102\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jeff brett floyd - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b94d\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0102\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0103\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cigars International, Inc. et al - Comment\",\n",
      "      \"objectId\" : \"0900006480f9b96b\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0103\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0104\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shane Charles Bates - Comment\",\n",
      "      \"objectId\" : \"0900006480f9c1c3\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0104\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altadis U.S.A., Inc. (Latham &amp; Watkins) - Comment\",\n",
      "      \"objectId\" : \"0900006480f9ba17\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ruth E Malone - Comment\",\n",
      "      \"objectId\" : \"0900006480f9bb37\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Penny Gugino - Comment\",\n",
      "      \"objectId\" : \"0900006480f9c3b2\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cynthia Schafer - Comment\",\n",
      "      \"objectId\" : \"0900006480f9c3cd\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-14T21:09:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Consumer Advocates for Smoke-free Alternatives Association - Comment\",\n",
      "      \"objectId\" : \"0900006480f9c526\",\n",
      "      \"postedDate\" : \"2012-02-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-23T18:51:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Association of Attorneys General (NAAG) - Comment\",\n",
      "      \"objectId\" : \"0900006480f9cd31\",\n",
      "      \"postedDate\" : \"2012-02-23T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0110\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 69,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 69,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 69,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 69,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 69,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0524-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-02-18T01:56:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous Anonymous\",\n",
      "      \"objectId\" : \"0900006483f58121\",\n",
      "      \"postedDate\" : \"2019-09-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-02-18T01:57:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edie Payleitner\",\n",
      "      \"objectId\" : \"0900006483f57ff9\",\n",
      "      \"postedDate\" : \"2019-09-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0043\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 2,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 2,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 2,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-D-0524-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-04-25T19:32:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lauren Lempert et al\",\n",
      "      \"objectId\" : \"09000064831bd96d\",\n",
      "      \"postedDate\" : \"2018-04-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-07-03T17:52:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from William Smith\",\n",
      "      \"objectId\" : \"090000648343d3ad\",\n",
      "      \"postedDate\" : \"2018-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-D-0524-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2022-02-18T02:26:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Edie Payleitner\",\n",
      "      \"objectId\" : \"0900006483f57fcf\",\n",
      "      \"postedDate\" : \"2019-09-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-D-0524-0045\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 3,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 3,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 3,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 3,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 3,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa E. Bell - Comment\",\n",
      "      \"objectId\" : \"0900006480ff44c5\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandy Foster - Comment\",\n",
      "      \"objectId\" : \"0900006481008250\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jonathan Bradley Chaffee - Comment\",\n",
      "      \"objectId\" : \"090000648100836b\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claudia Marrapodi - Comment\",\n",
      "      \"objectId\" : \"090000648100e23f\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Parra - Comment\",\n",
      "      \"objectId\" : \"090000648100df90\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jill Crouch - Comment\",\n",
      "      \"objectId\" : \"090000648100df95\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648100e044\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-14T21:00:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jake Cohen - Comment\",\n",
      "      \"objectId\" : \"090000648100e3ca\",\n",
      "      \"postedDate\" : \"2012-05-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648100e0a3\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tanner P. - Comment\",\n",
      "      \"objectId\" : \"090000648100e40f\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Casale - Comment\",\n",
      "      \"objectId\" : \"090000648100e455\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Jade Van Huss - Comment\",\n",
      "      \"objectId\" : \"090000648100e56c\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lester Smiley - Comment\",\n",
      "      \"objectId\" : \"090000648100e585\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648100e592\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Luther Ed Landrum - Comment\",\n",
      "      \"objectId\" : \"090000648100e5cc\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mary C. robinson - Comment\",\n",
      "      \"objectId\" : \"090000648100e93d\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula Andrea - Comment\",\n",
      "      \"objectId\" : \"090000648100e5de\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Randi Holland - Comment\",\n",
      "      \"objectId\" : \"090000648100e5f2\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer - Comment\",\n",
      "      \"objectId\" : \"090000648100e5fa\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alexandra - Comment\",\n",
      "      \"objectId\" : \"090000648100e648\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Brittany Saxon - Comment\",\n",
      "      \"objectId\" : \"090000648100ea25\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Lynn Dunaway - Comment\",\n",
      "      \"objectId\" : \"090000648100e6b3\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lis Santibanes - Comment\",\n",
      "      \"objectId\" : \"090000648100eadd\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gena Anderson - Comment\",\n",
      "      \"objectId\" : \"090000648100eb75\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T20:01:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Taryn Kurz - Comment\",\n",
      "      \"objectId\" : \"090000648100ed9b\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"KlÃ¡ra - Comment\",\n",
      "      \"objectId\" : \"090000648100ef5e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shawn Earlene Baty - Comment\",\n",
      "      \"objectId\" : \"090000648100f20e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Magdalena Mazurek - Comment\",\n",
      "      \"objectId\" : \"090000648100f025\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Magdalena Mazurek - Comment\",\n",
      "      \"objectId\" : \"090000648100f04e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jaime Marie Stalnaker - Comment\",\n",
      "      \"objectId\" : \"090000648100f0db\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William G. Gonzalez - Comment\",\n",
      "      \"objectId\" : \"090000648100f331\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richard Zufelt - Comment\",\n",
      "      \"objectId\" : \"090000648100f55b\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Jane Harris - Comment\",\n",
      "      \"objectId\" : \"090000648100f40e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Malini Basu Shires - Comment\",\n",
      "      \"objectId\" : \"090000648100f459\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christopher Collins - Comment\",\n",
      "      \"objectId\" : \"090000648100f486\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chloe Shae Mosley - Comment\",\n",
      "      \"objectId\" : \"090000648100f6b7\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jen Mathews - Comment\",\n",
      "      \"objectId\" : \"090000648100f72e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rona - Comment\",\n",
      "      \"objectId\" : \"090000648100f793\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"elsa helen figueredo - Comment\",\n",
      "      \"objectId\" : \"090000648100f9c2\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Easton Joel Brassfield - Comment\",\n",
      "      \"objectId\" : \"090000648100fa17\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Holly Sentel Bullard - Comment\",\n",
      "      \"objectId\" : \"090000648100f86d\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Madison Dara Ferguson - Comment\",\n",
      "      \"objectId\" : \"090000648100fa7f\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marna - Comment\",\n",
      "      \"objectId\" : \"090000648100faa9\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"pamela fonseca - Comment\",\n",
      "      \"objectId\" : \"090000648100fb65\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648100fb9d\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Lee Young - Comment\",\n",
      "      \"objectId\" : \"090000648100feb3\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katrina Annamaria Stahl - Comment\",\n",
      "      \"objectId\" : \"090000648100fefd\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeanette diane taylor - Comment\",\n",
      "      \"objectId\" : \"090000648100fc39\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claire Frances Lloyd - Comment\",\n",
      "      \"objectId\" : \"090000648100ff0f\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648100fcbd\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"trish gug - Comment\",\n",
      "      \"objectId\" : \"090000648100ff6e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rolando Nino - Comment\",\n",
      "      \"objectId\" : \"0900006481010180\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margo Aronoff - Comment\",\n",
      "      \"objectId\" : \"0900006481010616\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Frances Ann Trew - Comment\",\n",
      "      \"objectId\" : \"0900006481010617\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"keely lowman - Comment\",\n",
      "      \"objectId\" : \"0900006481010777\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leticia Seda - Comment\",\n",
      "      \"objectId\" : \"090000648101077f\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Chappell - Comment\",\n",
      "      \"objectId\" : \"090000648101078c\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Zaha - Comment\",\n",
      "      \"objectId\" : \"0900006481010224\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catalina Orostegui - Comment\",\n",
      "      \"objectId\" : \"090000648101078d\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Russ Seekatz - Comment\",\n",
      "      \"objectId\" : \"0900006481010225\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vincelee Stevens - Comment\",\n",
      "      \"objectId\" : \"090000648101078e\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Marie Sommese - Comment\",\n",
      "      \"objectId\" : \"0900006481010227\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ken Johnston - Comment\",\n",
      "      \"objectId\" : \"0900006481010790\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Bell - Comment\",\n",
      "      \"objectId\" : \"0900006481010792\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karin Kowalski - Comment\",\n",
      "      \"objectId\" : \"0900006481010793\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ariane R Hoffman - Comment\",\n",
      "      \"objectId\" : \"0900006481010795\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Kyler - Comment\",\n",
      "      \"objectId\" : \"0900006481010799\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nina Dabbieri - Comment\",\n",
      "      \"objectId\" : \"090000648101079d\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"tim brown - Comment\",\n",
      "      \"objectId\" : \"0900006481010232\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Abby cROFT - Comment\",\n",
      "      \"objectId\" : \"0900006481010235\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Barry - Comment\",\n",
      "      \"objectId\" : \"09000064810107b6\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Varun Wadhwa - Comment\",\n",
      "      \"objectId\" : \"090000648101023a\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"christa - Comment\",\n",
      "      \"objectId\" : \"090000648101023b\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katarzyna Biskupska - Comment\",\n",
      "      \"objectId\" : \"09000064810107ba\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0079\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen R Hall - Comment\",\n",
      "      \"objectId\" : \"090000648101023c\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0079\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janet White - Comment\",\n",
      "      \"objectId\" : \"09000064810107bb\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-17T22:32:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Skinner - Comment\",\n",
      "      \"objectId\" : \"0900006481010230\",\n",
      "      \"postedDate\" : \"2012-05-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carole A Russo - Comment\",\n",
      "      \"objectId\" : \"09000064810107bc\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Monique Miller - Comment\",\n",
      "      \"objectId\" : \"09000064810107bf\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tonya E Samples - Comment\",\n",
      "      \"objectId\" : \"090000648101023f\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stuart Watson - Comment\",\n",
      "      \"objectId\" : \"0900006481010240\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Grifo - Comment\",\n",
      "      \"objectId\" : \"09000064810107c0\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erica Howard - Comment\",\n",
      "      \"objectId\" : \"09000064810107c1\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Isabel Vanover - Comment\",\n",
      "      \"objectId\" : \"0900006481010244\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carla Patricia DuPont - Comment\",\n",
      "      \"objectId\" : \"0900006481010245\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0090\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Anthony - Comment\",\n",
      "      \"objectId\" : \"09000064810107c4\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0090\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0091\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"emily daye - Comment\",\n",
      "      \"objectId\" : \"0900006481010247\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0091\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0092\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tanya Irby - Comment\",\n",
      "      \"objectId\" : \"0900006481010248\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0092\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0093\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J L Anderson - Comment\",\n",
      "      \"objectId\" : \"09000064810107c7\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0093\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0094\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michalina Mae Carpenter - Comment\",\n",
      "      \"objectId\" : \"090000648101024b\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0094\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tina J Brannon - Comment\",\n",
      "      \"objectId\" : \"09000064810107cb\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jackie Zubak - Comment\",\n",
      "      \"objectId\" : \"090000648101024c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0097\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patti Stinson - Comment\",\n",
      "      \"objectId\" : \"0900006481010250\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0097\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah Woodcock - Comment\",\n",
      "      \"objectId\" : \"09000064810107cd\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maria Todeschini - Comment\",\n",
      "      \"objectId\" : \"0900006481010252\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robin Ann Merritt - Comment\",\n",
      "      \"objectId\" : \"09000064810107cf\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0101\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Mack - Comment\",\n",
      "      \"objectId\" : \"09000064810107d0\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0101\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0102\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Larisa Alvarado - Comment\",\n",
      "      \"objectId\" : \"0900006481010253\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0102\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0103\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Casey F Ducharme - Comment\",\n",
      "      \"objectId\" : \"0900006481010254\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0103\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0104\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sheila Shigley - Comment\",\n",
      "      \"objectId\" : \"09000064810107d4\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0104\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"rose faltin - Comment\",\n",
      "      \"objectId\" : \"09000064810107d8\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"susan louise steenrod - Comment\",\n",
      "      \"objectId\" : \"0900006481010256\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"peggy henry - Comment\",\n",
      "      \"objectId\" : \"09000064810107d9\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melinda White - Comment\",\n",
      "      \"objectId\" : \"0900006481010257\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laurie M Allen - Comment\",\n",
      "      \"objectId\" : \"0900006481010258\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Figurski - Comment\",\n",
      "      \"objectId\" : \"09000064810107db\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0110\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0111\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela D. Watson - Comment\",\n",
      "      \"objectId\" : \"090000648101025d\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0111\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0112\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Shprintzen - Comment\",\n",
      "      \"objectId\" : \"09000064810107dc\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0112\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0113\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lane Hunsinger - Comment\",\n",
      "      \"objectId\" : \"09000064810107dd\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0113\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0114\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charlotte Orth - Comment\",\n",
      "      \"objectId\" : \"09000064810107e1\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0114\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0115\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Debra K Gordon - Comment\",\n",
      "      \"objectId\" : \"0900006481010263\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0115\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0116\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Ruth Murphy - Comment\",\n",
      "      \"objectId\" : \"0900006481010269\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0116\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0117\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"maria delguercio - Comment\",\n",
      "      \"objectId\" : \"090000648101026a\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0117\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0118\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CRISTINA TURCOTTE - Comment\",\n",
      "      \"objectId\" : \"090000648101026c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0118\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0119\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mirisa R - Comment\",\n",
      "      \"objectId\" : \"09000064810107f1\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0119\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0120\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Delizia Ann Donohue - Comment\",\n",
      "      \"objectId\" : \"09000064810107f3\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0120\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0121\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mel - Comment\",\n",
      "      \"objectId\" : \"09000064810107f6\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0121\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0122\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Raya Engler - Comment\",\n",
      "      \"objectId\" : \"0900006481010805\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0122\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0123\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Law - Comment\",\n",
      "      \"objectId\" : \"0900006481010807\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0123\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0124\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Meghan Kay - Comment\",\n",
      "      \"objectId\" : \"0900006481010808\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0124\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0125\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chealie Pugh - Comment\",\n",
      "      \"objectId\" : \"0900006481010271\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0125\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0126\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"elizabeth ferrari - Comment\",\n",
      "      \"objectId\" : \"090000648101027c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0126\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0127\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julia Sancho Smith - Comment\",\n",
      "      \"objectId\" : \"090000648101027f\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0127\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0128\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cathy Elaine - Comment\",\n",
      "      \"objectId\" : \"0900006481010280\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0128\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0129\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jerl Levi McCollum - Comment\",\n",
      "      \"objectId\" : \"090000648101080d\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0129\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0130\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathy Dabanian - Comment\",\n",
      "      \"objectId\" : \"0900006481010282\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0130\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0131\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy M Ledner - Comment\",\n",
      "      \"objectId\" : \"0900006481010827\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0131\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0132\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marla Gail Hargrove - Comment\",\n",
      "      \"objectId\" : \"0900006481010828\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0132\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0133\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JEWEL COURVILLE - Comment\",\n",
      "      \"objectId\" : \"090000648101082a\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0133\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0134\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CARL - Comment\",\n",
      "      \"objectId\" : \"090000648101082b\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0134\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0135\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melisa Caprio - Comment\",\n",
      "      \"objectId\" : \"090000648101028c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0135\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0136\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy Gusmano - Comment\",\n",
      "      \"objectId\" : \"090000648101028e\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0136\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0137\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101082d\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0137\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0138\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Joanne Bay - Comment\",\n",
      "      \"objectId\" : \"090000648101028f\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0138\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0139\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LouAnn Stropoli - Comment\",\n",
      "      \"objectId\" : \"0900006481010291\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0139\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0140\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hope Anne Harris - Comment\",\n",
      "      \"objectId\" : \"0900006481010292\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0140\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0141\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy Strack - Comment\",\n",
      "      \"objectId\" : \"0900006481010834\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0141\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0142\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah A Warren - Comment\",\n",
      "      \"objectId\" : \"090000648101029c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0142\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0143\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ana Rowling - Comment\",\n",
      "      \"objectId\" : \"090000648101083b\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0143\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0144\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kacey Mullaney - Comment\",\n",
      "      \"objectId\" : \"0900006481010849\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0144\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mackenzie Michele campbell - Comment\",\n",
      "      \"objectId\" : \"090000648101029d\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0146\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Camila Muniz Ferreira - Comment\",\n",
      "      \"objectId\" : \"090000648101084d\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0146\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0147\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Weddle - Comment\",\n",
      "      \"objectId\" : \"090000648101084e\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0147\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0148\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"wanda lynn mckay - Comment\",\n",
      "      \"objectId\" : \"0900006481010850\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0148\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0149\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kia Miller - Comment\",\n",
      "      \"objectId\" : \"0900006481010876\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0149\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"john cielukowski - Comment\",\n",
      "      \"objectId\" : \"090000648101087a\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Frances Ybarra - Comment\",\n",
      "      \"objectId\" : \"090000648101087e\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0151\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0152\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"cynthia hodge - Comment\",\n",
      "      \"objectId\" : \"090000648101087f\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0152\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0153\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Manpreet Kaur Johl - Comment\",\n",
      "      \"objectId\" : \"0900006481010880\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0153\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0154\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kym Nye - Comment\",\n",
      "      \"objectId\" : \"0900006481010881\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0154\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0155\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kerry Alvord - Comment\",\n",
      "      \"objectId\" : \"09000064810102b6\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0155\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0156\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ana Paola Mendez-Avaroma - Comment\",\n",
      "      \"objectId\" : \"0900006481010883\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0156\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0157\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Ann Morris - Comment\",\n",
      "      \"objectId\" : \"09000064810102c0\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0157\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0158\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810102c1\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0158\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0159\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Clark - Comment\",\n",
      "      \"objectId\" : \"09000064810102c4\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0159\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0160\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Norena A McMeel - Comment\",\n",
      "      \"objectId\" : \"090000648101088c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0160\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0161\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"KAREN MARIE OWENS - Comment\",\n",
      "      \"objectId\" : \"09000064810102c5\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0161\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0162\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer J Jarvis - Comment\",\n",
      "      \"objectId\" : \"0900006481010890\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0162\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0163\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Antonia Maria Centeno - Comment\",\n",
      "      \"objectId\" : \"09000064810102da\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0163\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0164\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Smith - Comment\",\n",
      "      \"objectId\" : \"09000064810102db\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0164\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jennifer stevens girvin - Comment\",\n",
      "      \"objectId\" : \"09000064810102dc\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0165\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0166\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"pamela geisinger - Comment\",\n",
      "      \"objectId\" : \"09000064810102dd\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0166\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0167\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Peter - Comment\",\n",
      "      \"objectId\" : \"0900006481010897\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0167\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0168\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Belniak - Comment\",\n",
      "      \"objectId\" : \"0900006481010899\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0168\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0169\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melody Paris - Comment\",\n",
      "      \"objectId\" : \"09000064810102ea\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0169\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0170\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DONNAH S BARRAGAN - Comment\",\n",
      "      \"objectId\" : \"09000064810102eb\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0170\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0171\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristina Ann Barnety - Comment\",\n",
      "      \"objectId\" : \"09000064810102ec\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0171\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0172\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jill Forster - Comment\",\n",
      "      \"objectId\" : \"090000648101089b\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0172\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0173\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley J Wirthlin - Comment\",\n",
      "      \"objectId\" : \"090000648101089c\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0173\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0174\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara Marie Keesling - Comment\",\n",
      "      \"objectId\" : \"09000064810102ed\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0174\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0175\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Reyes - Comment\",\n",
      "      \"objectId\" : \"09000064810102ef\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0175\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0176\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linnea - Comment\",\n",
      "      \"objectId\" : \"09000064810102f4\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0176\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0177\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tarah Polattie - Comment\",\n",
      "      \"objectId\" : \"09000064810102f6\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0177\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0178\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy k Van Reeth - Comment\",\n",
      "      \"objectId\" : \"090000648101089f\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0178\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0179\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"bettina conklin - Comment\",\n",
      "      \"objectId\" : \"09000064810102f7\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0179\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0180\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Wade - Comment\",\n",
      "      \"objectId\" : \"09000064810108b3\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0180\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0181\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-18T21:48:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mike Berry - Comment\",\n",
      "      \"objectId\" : \"09000064810108b5\",\n",
      "      \"postedDate\" : \"2012-05-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0181\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0182\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorey Lavery - Comment\",\n",
      "      \"objectId\" : \"0900006481010302\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0182\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0183\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Cosme - Comment\",\n",
      "      \"objectId\" : \"09000064810108be\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0183\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0184\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dee Pratscher - Comment\",\n",
      "      \"objectId\" : \"09000064810108c0\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0184\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0185\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Treudt - Comment\",\n",
      "      \"objectId\" : \"09000064810108c4\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0185\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0186\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Anne Christenson - Comment\",\n",
      "      \"objectId\" : \"0900006481010306\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0186\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0187\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katherine DeWitt Lee - Comment\",\n",
      "      \"objectId\" : \"0900006481010307\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0187\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0188\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ann fouret - Comment\",\n",
      "      \"objectId\" : \"09000064810108cb\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0188\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0189\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bezayzichna Ksenya Aleksandrovna - Comment\",\n",
      "      \"objectId\" : \"09000064810108cd\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0189\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0190\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"siegrid berman - Comment\",\n",
      "      \"objectId\" : \"09000064810108cf\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0190\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0191\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mihir Shah - Comment\",\n",
      "      \"objectId\" : \"09000064810108d2\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0191\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0192\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tim E Wilson - Comment\",\n",
      "      \"objectId\" : \"090000648101030e\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0192\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0193\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emily Wilkinson - Comment\",\n",
      "      \"objectId\" : \"090000648101030f\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0193\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0194\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Helen Feit - Comment\",\n",
      "      \"objectId\" : \"09000064810108e2\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0194\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0195\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tabitha Walker - Comment\",\n",
      "      \"objectId\" : \"09000064810108e3\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0195\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0196\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claire Delevingne - Comment\",\n",
      "      \"objectId\" : \"09000064810108e4\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0196\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0197\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"karen merrill - Comment\",\n",
      "      \"objectId\" : \"09000064810108e5\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0197\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0198\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"elizabeth krumov - Comment\",\n",
      "      \"objectId\" : \"0900006481010312\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0198\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0199\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tara Sonia Lulla - Comment\",\n",
      "      \"objectId\" : \"09000064810108e6\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0199\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0200\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Victoria Ann Ebin - Comment\",\n",
      "      \"objectId\" : \"0900006481010326\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0200\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0201\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Latham-Magee - Comment\",\n",
      "      \"objectId\" : \"0900006481010329\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0201\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0202\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donna Jean Sherbutte - Comment\",\n",
      "      \"objectId\" : \"09000064810108e9\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0202\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0203\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Albert - Comment\",\n",
      "      \"objectId\" : \"090000648101032a\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0203\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0204\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patrizia Sammartino - Comment\",\n",
      "      \"objectId\" : \"090000648101032b\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0204\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0205\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"archana chandraprakash - Comment\",\n",
      "      \"objectId\" : \"090000648101032c\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0205\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0206\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"May Freidman - Comment\",\n",
      "      \"objectId\" : \"09000064810108fc\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0206\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0207\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark A Swain - Comment\",\n",
      "      \"objectId\" : \"0900006481010336\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0207\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0208\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melanie C Pudelko - Comment\",\n",
      "      \"objectId\" : \"0900006481010338\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0208\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0209\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Castillo - Comment\",\n",
      "      \"objectId\" : \"09000064810108fd\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0209\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0210\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"meredith ashley rucker - Comment\",\n",
      "      \"objectId\" : \"090000648101033b\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0210\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0211\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tammy Aharony - Comment\",\n",
      "      \"objectId\" : \"0900006481010900\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0211\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0212\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen N Schreiber - Comment\",\n",
      "      \"objectId\" : \"0900006481010903\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0212\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0213\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Ostrovitz - Comment\",\n",
      "      \"objectId\" : \"0900006481010907\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0213\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0214\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lydian Green - Comment\",\n",
      "      \"objectId\" : \"0900006481010341\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0214\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0215\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amanda Murphy - Comment\",\n",
      "      \"objectId\" : \"0900006481010344\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0215\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0216\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Wolf - Comment\",\n",
      "      \"objectId\" : \"090000648101090a\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0216\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0217\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beverly Williamson-Pecori - Comment\",\n",
      "      \"objectId\" : \"090000648101090b\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0217\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0218\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy Cayias - Comment\",\n",
      "      \"objectId\" : \"0900006481010357\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0218\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0219\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa Q Walker - Comment\",\n",
      "      \"objectId\" : \"0900006481010920\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0219\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0220\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kamren Briane - Comment\",\n",
      "      \"objectId\" : \"0900006481010921\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0220\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0221\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beatrice Williams-Rude - Comment\",\n",
      "      \"objectId\" : \"0900006481010936\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0221\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0222\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"sarah fathauer - Comment\",\n",
      "      \"objectId\" : \"0900006481010937\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0222\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0223\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kayla Coleman - Comment\",\n",
      "      \"objectId\" : \"0900006481010938\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0223\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0224\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Armando Atticus Garcia - Comment\",\n",
      "      \"objectId\" : \"0900006481010362\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0224\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0225\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"michelle m schilla - Comment\",\n",
      "      \"objectId\" : \"0900006481010363\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0225\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0226\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vicky - Comment\",\n",
      "      \"objectId\" : \"090000648101093a\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0226\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0227\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alex Fernandez - Comment\",\n",
      "      \"objectId\" : \"0900006481010371\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0227\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0228\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie Davies - Comment\",\n",
      "      \"objectId\" : \"090000648101093b\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0228\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0229\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara a Fields - Comment\",\n",
      "      \"objectId\" : \"090000648101093f\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0229\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0230\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bernard Frank Cullen - Comment\",\n",
      "      \"objectId\" : \"090000648101094e\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0230\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0231\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Michael, BSN, RN - Comment\",\n",
      "      \"objectId\" : \"0900006481010379\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0231\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0232\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karla D Mailloux - Comment\",\n",
      "      \"objectId\" : \"0900006481010389\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0232\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0233\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John J Shields - Comment\",\n",
      "      \"objectId\" : \"090000648101038c\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0233\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0234\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Elizabeth Shakley - Comment\",\n",
      "      \"objectId\" : \"0900006481010954\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0234\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0235\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maria Cristina Machado - Comment\",\n",
      "      \"objectId\" : \"0900006481010393\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0235\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0236\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erin Lamparter - Comment\",\n",
      "      \"objectId\" : \"0900006481010394\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0236\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0237\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janine Eagon - Comment\",\n",
      "      \"objectId\" : \"0900006481010955\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0237\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0238\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rick Wilson Roberson - Comment\",\n",
      "      \"objectId\" : \"0900006481010970\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0238\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0239\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula Nowels - Comment\",\n",
      "      \"objectId\" : \"0900006481010975\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0239\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0240\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Hammerle - Comment\",\n",
      "      \"objectId\" : \"0900006481010976\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0240\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0241\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie Davies - Comment\",\n",
      "      \"objectId\" : \"0900006481010984\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0241\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0242\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Johsnon - Comment\",\n",
      "      \"objectId\" : \"09000064810103a7\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0242\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0243\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katie V Rosebrock - Comment\",\n",
      "      \"objectId\" : \"09000064810103b3\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0243\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0244\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-21T22:07:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kara Horstman - Comment\",\n",
      "      \"objectId\" : \"0900006481010999\",\n",
      "      \"postedDate\" : \"2012-05-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0244\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0245\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Scheinman - Comment\",\n",
      "      \"objectId\" : \"09000064810109a4\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0245\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0246\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Ann Ramthun - Comment\",\n",
      "      \"objectId\" : \"09000064810109aa\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0246\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0247\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Burroughs - Comment\",\n",
      "      \"objectId\" : \"09000064810103c3\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0247\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0248\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"April Michelle Rentz - Comment\",\n",
      "      \"objectId\" : \"09000064810103c4\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0248\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0249\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810109c6\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0249\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0250\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Starkie - Comment\",\n",
      "      \"objectId\" : \"09000064810109c7\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0250\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0251\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eric Freeman - Comment\",\n",
      "      \"objectId\" : \"09000064810103d2\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0251\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0252\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bridget C Annee - Comment\",\n",
      "      \"objectId\" : \"09000064810109d0\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0252\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0253\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jennifer pies - Comment\",\n",
      "      \"objectId\" : \"09000064810109d4\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0253\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0254\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charlotte Dennis - Comment\",\n",
      "      \"objectId\" : \"09000064810103d9\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0254\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-0255\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"W Scott - Comment\",\n",
      "      \"objectId\" : \"09000064810103db\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0255\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0256\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"a w b - Comment\",\n",
      "      \"objectId\" : \"09000064810103f8\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0256\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0257\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Erwin - Comment\",\n",
      "      \"objectId\" : \"09000064810103ff\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0257\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0258\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patty Kim Thompson - Comment\",\n",
      "      \"objectId\" : \"09000064810109f0\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0258\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0259\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christopher Koonce - Comment\",\n",
      "      \"objectId\" : \"0900006481010404\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0259\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0260\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kenneth Giles - Comment\",\n",
      "      \"objectId\" : \"09000064810109f6\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0260\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0261\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Christine Olsen - Comment\",\n",
      "      \"objectId\" : \"09000064810109f9\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0261\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0262\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Wheeler - Comment\",\n",
      "      \"objectId\" : \"09000064810109fa\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0262\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0263\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ursula Kehaulani - Comment\",\n",
      "      \"objectId\" : \"0900006481010406\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0263\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0264\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Crystal Ann Rhines - Comment\",\n",
      "      \"objectId\" : \"09000064810109fe\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0264\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0265\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara Syswerda - Comment\",\n",
      "      \"objectId\" : \"09000064810109ff\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0265\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0266\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nanette Isabelle Merson - Comment\",\n",
      "      \"objectId\" : \"090000648101041d\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0266\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0267\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bronwyn O'Brien - Comment\",\n",
      "      \"objectId\" : \"0900006481010a08\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0267\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0268\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Irsida Banx - Comment\",\n",
      "      \"objectId\" : \"0900006481010a09\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0268\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0269\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jolene Turner - Comment\",\n",
      "      \"objectId\" : \"0900006481010a0a\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0269\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0270\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gabrielle Puccini - Comment\",\n",
      "      \"objectId\" : \"0900006481010424\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0270\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0271\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren - Comment\",\n",
      "      \"objectId\" : \"0900006481010425\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0271\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0272\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Birgitta Gerd Borgstrom - Comment\",\n",
      "      \"objectId\" : \"0900006481010428\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0272\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0273\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shayna Weinstein - Comment\",\n",
      "      \"objectId\" : \"0900006481010429\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0273\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0274\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"monica dudeck - Comment\",\n",
      "      \"objectId\" : \"0900006481010a1d\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0274\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0275\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Milena Escobar - Comment\",\n",
      "      \"objectId\" : \"0900006481010436\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0275\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0276\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hannah Zinman - Comment\",\n",
      "      \"objectId\" : \"0900006481010438\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0276\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0277\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kaitlin Blakemore - Comment\",\n",
      "      \"objectId\" : \"0900006481010a20\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0277\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0278\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ljubica Sarenac - Comment\",\n",
      "      \"objectId\" : \"0900006481010a23\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0278\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0279\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jorge rene belloso-curiel - Comment\",\n",
      "      \"objectId\" : \"0900006481010446\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0279\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0280\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara Ann Callaway - Comment\",\n",
      "      \"objectId\" : \"090000648101044d\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0280\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0281\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jenny McKeown - Comment\",\n",
      "      \"objectId\" : \"0900006481010453\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0281\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0282\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"savannah scarborough - Comment\",\n",
      "      \"objectId\" : \"0900006481010a3c\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0282\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0283\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathy Davis - Comment\",\n",
      "      \"objectId\" : \"0900006481010a3e\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0283\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0284\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jane Midling - Comment\",\n",
      "      \"objectId\" : \"0900006481010a41\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0284\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0285\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marilynn K Jacobs - Comment\",\n",
      "      \"objectId\" : \"0900006481010466\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0285\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0286\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DEBRA L OWENS - Comment\",\n",
      "      \"objectId\" : \"0900006481010a48\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0286\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0287\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janel Myers - Comment\",\n",
      "      \"objectId\" : \"090000648101046e\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0287\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0288\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robin Craft - Comment\",\n",
      "      \"objectId\" : \"0900006481010473\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0288\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0289\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Marie Weibler - Comment\",\n",
      "      \"objectId\" : \"0900006481010a8b\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0289\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0290\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Veronica Diaz - Comment\",\n",
      "      \"objectId\" : \"0900006481010494\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0290\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0291\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joanna Lisa Crompton - Comment\",\n",
      "      \"objectId\" : \"090000648101049d\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0291\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0292\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gail M Ling - Comment\",\n",
      "      \"objectId\" : \"0900006481010aad\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0292\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0293\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Green - Comment\",\n",
      "      \"objectId\" : \"0900006481010ab3\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0293\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0294\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claire Kirpal Ramsey - Comment\",\n",
      "      \"objectId\" : \"09000064810104a8\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0294\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0295\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Krystina Renee Farah - Comment\",\n",
      "      \"objectId\" : \"0900006481010ab7\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0295\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0296\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy E Dillon - Comment\",\n",
      "      \"objectId\" : \"09000064810104a9\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0296\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0297\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Elaine Maddox - Comment\",\n",
      "      \"objectId\" : \"09000064810104aa\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0297\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0298\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juliet Benson Dorn - Comment\",\n",
      "      \"objectId\" : \"0900006481010abb\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0298\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0299\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauri L Green - Comment\",\n",
      "      \"objectId\" : \"09000064810104ac\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0299\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0300\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jenny L Carter - Comment\",\n",
      "      \"objectId\" : \"0900006481010acb\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0300\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0301\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vic Bostock - Comment\",\n",
      "      \"objectId\" : \"09000064810104bc\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0301\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0302\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Nichols - Comment\",\n",
      "      \"objectId\" : \"09000064810104be\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0302\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0303\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Allyson Brown - Comment\",\n",
      "      \"objectId\" : \"09000064810104bf\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0303\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0304\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jake fierro - Comment\",\n",
      "      \"objectId\" : \"0900006481010ada\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0304\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0305\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Partyka - Comment\",\n",
      "      \"objectId\" : \"09000064810104c5\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0305\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0306\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bridget Lewis - Comment\",\n",
      "      \"objectId\" : \"0900006481010ae0\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0306\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0307\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jane Jones - Comment\",\n",
      "      \"objectId\" : \"0900006481010ae1\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0307\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0308\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donna MV - Comment\",\n",
      "      \"objectId\" : \"09000064810104d0\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0308\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0309\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C Merwin - Comment\",\n",
      "      \"objectId\" : \"0900006481010aee\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0309\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0310\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Debra Lynn Picard - Comment\",\n",
      "      \"objectId\" : \"0900006481010af0\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0310\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0311\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa A Aresco - Comment\",\n",
      "      \"objectId\" : \"09000064810104e0\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0311\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0312\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nichole Diamond - Comment\",\n",
      "      \"objectId\" : \"09000064810104e3\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0312\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0313\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Palladine - Comment\",\n",
      "      \"objectId\" : \"09000064810104e5\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0313\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0314\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481010af6\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0314\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0315\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adrienne Burgess - Comment\",\n",
      "      \"objectId\" : \"09000064810104ef\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0315\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0316\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristi Rosseau - Comment\",\n",
      "      \"objectId\" : \"09000064810104f2\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0316\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0317\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shara Krogh - Comment\",\n",
      "      \"objectId\" : \"09000064810104f3\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0317\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0318\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susy Coco Kurittu - Comment\",\n",
      "      \"objectId\" : \"0900006481010afc\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0318\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0319\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juliette Moore - Comment\",\n",
      "      \"objectId\" : \"0900006481010afe\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0319\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0320\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"alex h john - Comment\",\n",
      "      \"objectId\" : \"0900006481010b00\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0320\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0321\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Mark Sanders - Comment\",\n",
      "      \"objectId\" : \"0900006481010d11\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0321\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0322\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracy A Sloan - Comment\",\n",
      "      \"objectId\" : \"0900006481010d12\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0322\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0323\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Valentine - Comment\",\n",
      "      \"objectId\" : \"0900006481010d13\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0323\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0324\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"pamela A schaub - Comment\",\n",
      "      \"objectId\" : \"0900006481010b06\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0324\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0325\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kriste ann duff - Comment\",\n",
      "      \"objectId\" : \"0900006481010d14\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0325\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0326\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Azure Carter - Comment\",\n",
      "      \"objectId\" : \"0900006481010b09\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0326\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0327\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shanna Straut - Comment\",\n",
      "      \"objectId\" : \"0900006481010d18\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0327\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0328\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Angelone - Comment\",\n",
      "      \"objectId\" : \"0900006481010d29\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0328\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0329\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jackie N - Comment\",\n",
      "      \"objectId\" : \"0900006481010b15\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0329\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0330\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley DeBoer - Comment\",\n",
      "      \"objectId\" : \"0900006481010d2d\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0330\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0331\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-22T22:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jennifer lynn Spirakis Dziurka - Comment\",\n",
      "      \"objectId\" : \"0900006481010d2f\",\n",
      "      \"postedDate\" : \"2012-05-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0331\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0332\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"cymone anna simmons - Comment\",\n",
      "      \"objectId\" : \"0900006481010d3d\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0332\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0333\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"EDWARD J. CUBERO - Comment\",\n",
      "      \"objectId\" : \"0900006481010b2d\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0333\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0334\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"joaquin black - Comment\",\n",
      "      \"objectId\" : \"0900006481010b4e\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0334\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0335\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonny Donnelly - Comment\",\n",
      "      \"objectId\" : \"0900006481010b50\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0335\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0336\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley A Pifer - Comment\",\n",
      "      \"objectId\" : \"0900006481010b54\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0336\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0337\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Per Hyttfors - Comment\",\n",
      "      \"objectId\" : \"0900006481010b58\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0337\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0338\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Kennedy - Comment\",\n",
      "      \"objectId\" : \"0900006481010b5e\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0338\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0339\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"elizabeth renee hall - Comment\",\n",
      "      \"objectId\" : \"0900006481010b60\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0339\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0340\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Elizabeth Micek - Comment\",\n",
      "      \"objectId\" : \"0900006481010d6d\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0340\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0341\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Nethersole - Comment\",\n",
      "      \"objectId\" : \"0900006481010b70\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0341\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0342\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"bj donaheu - Comment\",\n",
      "      \"objectId\" : \"0900006481010b74\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0342\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0343\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"marg n. higgins - Comment\",\n",
      "      \"objectId\" : \"0900006481010b75\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0343\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0344\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leo Ahumada - Comment\",\n",
      "      \"objectId\" : \"0900006481010d81\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0344\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0345\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marge Rooyakkers - Comment\",\n",
      "      \"objectId\" : \"0900006481010b77\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0345\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0346\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"BARBARA SEXTON - Comment\",\n",
      "      \"objectId\" : \"0900006481010d84\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0346\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0347\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jl massa - Comment\",\n",
      "      \"objectId\" : \"0900006481010b7a\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0347\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0348\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C.J. Sage - Comment\",\n",
      "      \"objectId\" : \"0900006481010d87\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0348\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0349\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Renee Peck - Comment\",\n",
      "      \"objectId\" : \"0900006481010b82\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0349\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0350\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mercedes franklin - Comment\",\n",
      "      \"objectId\" : \"0900006481010d8b\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0350\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0351\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lyn J Williams - Comment\",\n",
      "      \"objectId\" : \"0900006481010d8f\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0351\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0352\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Horace Gray - Comment\",\n",
      "      \"objectId\" : \"0900006481010d94\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0352\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0353\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katherine Hicks - Comment\",\n",
      "      \"objectId\" : \"0900006481010da2\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0353\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0354\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristopher Andrew Green - Comment\",\n",
      "      \"objectId\" : \"0900006481010da3\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0354\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0355\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Felicity Villeda - Comment\",\n",
      "      \"objectId\" : \"0900006481010dac\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0355\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0356\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"vanessa torres - Comment\",\n",
      "      \"objectId\" : \"0900006481010daf\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0356\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0357\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cynthia - Comment\",\n",
      "      \"objectId\" : \"0900006481010b9d\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0357\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0358\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robbie lynn Cirello - Comment\",\n",
      "      \"objectId\" : \"0900006481010ba1\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0358\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0359\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"p. rollo - Comment\",\n",
      "      \"objectId\" : \"0900006481010db2\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0359\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0360\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bruce G Krider - Comment\",\n",
      "      \"objectId\" : \"0900006481010db3\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0360\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0361\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gina Marie - Comment\",\n",
      "      \"objectId\" : \"0900006481010db5\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0361\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0362\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"tanya Lavrenov - Comment\",\n",
      "      \"objectId\" : \"0900006481010ba7\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0362\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0363\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donna Carol Miller - Comment\",\n",
      "      \"objectId\" : \"0900006481010bc5\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0363\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0364\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Penelope - Comment\",\n",
      "      \"objectId\" : \"0900006481010bcb\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0364\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0365\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Frank R Andrade - Comment\",\n",
      "      \"objectId\" : \"0900006481010dbc\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0365\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0366\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richard B Spratley - Comment\",\n",
      "      \"objectId\" : \"0900006481010bce\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0366\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0367\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sally Ann Schimp - Comment\",\n",
      "      \"objectId\" : \"0900006481010dd2\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0367\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0368\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bruce Gearld Chaundy - Comment\",\n",
      "      \"objectId\" : \"0900006481010df4\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0368\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0369\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marissa Sutter - Comment\",\n",
      "      \"objectId\" : \"0900006481010be2\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0369\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0370\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nino Getts - Comment\",\n",
      "      \"objectId\" : \"0900006481010e09\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0370\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0371\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-23T21:47:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Britta Lorraine Wilson - Comment\",\n",
      "      \"objectId\" : \"0900006481010e71\",\n",
      "      \"postedDate\" : \"2012-05-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0371\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0372\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Schade - Comment\",\n",
      "      \"objectId\" : \"0900006481010e73\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0372\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0373\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shawn Kelly Clement - Comment\",\n",
      "      \"objectId\" : \"0900006481010bff\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0373\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0374\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"M. Diane Ryan - Comment\",\n",
      "      \"objectId\" : \"0900006481010e85\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0374\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0375\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah JÃ net Valdez - Comment\",\n",
      "      \"objectId\" : \"0900006481010e96\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0375\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0376\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mitzi Foster - Comment\",\n",
      "      \"objectId\" : \"0900006481010e97\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0376\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0377\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"maryam peterson - Comment\",\n",
      "      \"objectId\" : \"0900006481010ea8\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0377\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0378\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"joni jones jones - Comment\",\n",
      "      \"objectId\" : \"0900006481010eaa\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0378\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0379\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Evelyn Marie Arndt - Comment\",\n",
      "      \"objectId\" : \"0900006481010c26\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0379\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0380\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Aishuan Lin - Comment\",\n",
      "      \"objectId\" : \"0900006481010eac\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0380\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0381\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Samantha larsen - Comment\",\n",
      "      \"objectId\" : \"0900006481010eb0\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0381\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0382\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karyn Christine Boatman - Comment\",\n",
      "      \"objectId\" : \"0900006481010c3d\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0382\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0383\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tricia Satifka - Comment\",\n",
      "      \"objectId\" : \"0900006481010c42\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0383\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0384\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Orla Bobo - Comment\",\n",
      "      \"objectId\" : \"0900006481010c4e\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0384\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0385\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mariela De Gregorio - Comment\",\n",
      "      \"objectId\" : \"0900006481010c4f\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0385\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0386\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Whitfield - Comment\",\n",
      "      \"objectId\" : \"0900006481010c50\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0386\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0387\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michal A. - Comment\",\n",
      "      \"objectId\" : \"0900006481010f4a\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0387\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0388\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claudia Grasso - Comment\",\n",
      "      \"objectId\" : \"0900006481010c52\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0388\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0389\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Smith - Comment\",\n",
      "      \"objectId\" : \"0900006481010f4d\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0389\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0390\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen M Smith - Comment\",\n",
      "      \"objectId\" : \"0900006481010f4e\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0390\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0391\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mindy - Comment\",\n",
      "      \"objectId\" : \"0900006481010f51\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0391\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0392\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dino Vlachos - Comment\",\n",
      "      \"objectId\" : \"0900006481010f5a\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0392\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0393\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annie McMahon - Comment\",\n",
      "      \"objectId\" : \"0900006481010c64\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0393\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0394\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MISHA CHEEMA - Comment\",\n",
      "      \"objectId\" : \"0900006481010c69\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0394\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0395\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LYNDA DARO - Comment\",\n",
      "      \"objectId\" : \"0900006481010c6a\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0395\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0396\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Holly Schaeffer - Comment\",\n",
      "      \"objectId\" : \"0900006481010c6d\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0396\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0397\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jolene Ballard Matthews - Comment\",\n",
      "      \"objectId\" : \"0900006481010c6e\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0397\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0398\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"arno t herwerth - Comment\",\n",
      "      \"objectId\" : \"0900006481010c71\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0398\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0399\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Kwan Mo - Comment\",\n",
      "      \"objectId\" : \"0900006481010fd1\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0399\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0400\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Fegert - Comment\",\n",
      "      \"objectId\" : \"0900006481010fdd\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0400\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0401\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rolyn - Comment\",\n",
      "      \"objectId\" : \"0900006481010c7c\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0401\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0402\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marie Lorge - Comment\",\n",
      "      \"objectId\" : \"0900006481010fe9\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0402\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0403\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"debra l. herrera-kitchin - Comment\",\n",
      "      \"objectId\" : \"0900006481010c8f\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0403\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0404\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dianne Croft - Comment\",\n",
      "      \"objectId\" : \"0900006481010c9d\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0404\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0405\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juliet M - Comment\",\n",
      "      \"objectId\" : \"0900006481010fff\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0405\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0406\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashleigh Foultner - Comment\",\n",
      "      \"objectId\" : \"0900006481011102\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0406\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0407\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tiffany Goforth - Comment\",\n",
      "      \"objectId\" : \"090000648101100e\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0407\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0408\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ginger Clayton - Comment\",\n",
      "      \"objectId\" : \"090000648101112a\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0408\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0409\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"gail - Comment\",\n",
      "      \"objectId\" : \"0900006481011031\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0409\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0410\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LORETTA CLARA BROWN - Comment\",\n",
      "      \"objectId\" : \"0900006481011032\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0410\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0411\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jim P Gayden - Comment\",\n",
      "      \"objectId\" : \"0900006481011132\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0411\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0412\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mailyn Samantha Klein - Comment\",\n",
      "      \"objectId\" : \"090000648101103a\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0412\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0413\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lois Marie Christensen - Comment\",\n",
      "      \"objectId\" : \"0900006481011044\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0413\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0414\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tiffany Guerra - Comment\",\n",
      "      \"objectId\" : \"0900006481011047\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0414\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0415\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bradley Allan Crisp - Comment\",\n",
      "      \"objectId\" : \"090000648101114d\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0415\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0416\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen leigh McCormick - Comment\",\n",
      "      \"objectId\" : \"0900006481011154\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0416\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0417\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"dena nelson lenard - Comment\",\n",
      "      \"objectId\" : \"090000648101115e\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0417\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0418\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mark porter - Comment\",\n",
      "      \"objectId\" : \"090000648101107b\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0418\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0419\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristie Noel O'Keefe - Comment\",\n",
      "      \"objectId\" : \"090000648101108d\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0419\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0420\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Filene Lori Lehman - Comment\",\n",
      "      \"objectId\" : \"0900006481011090\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0420\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0421\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"aisling wollerton - Comment\",\n",
      "      \"objectId\" : \"0900006481011094\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0421\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0422\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christina - Comment\",\n",
      "      \"objectId\" : \"090000648101117b\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0422\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0423\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ginger Reyna Thomas - Comment\",\n",
      "      \"objectId\" : \"0900006481011098\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0423\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0424\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mona elias - Comment\",\n",
      "      \"objectId\" : \"09000064810110a2\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0424\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0425\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"cory Boyd - Comment\",\n",
      "      \"objectId\" : \"0900006481011195\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0425\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0426\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"sid shapiro - Comment\",\n",
      "      \"objectId\" : \"09000064810110c2\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0426\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0427\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janet Adelfio - Comment\",\n",
      "      \"objectId\" : \"09000064810110c4\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0427\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0428\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Yvonne Green - Comment\",\n",
      "      \"objectId\" : \"09000064810110e4\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0428\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0429\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"janice Napolitano - Comment\",\n",
      "      \"objectId\" : \"09000064810111c5\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0429\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0430\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Abbie Marie Urquia - Comment\",\n",
      "      \"objectId\" : \"09000064810111cb\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0430\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0431\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sherry R Polite - Comment\",\n",
      "      \"objectId\" : \"090000648101152e\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0431\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0432\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sally Eastey - Comment\",\n",
      "      \"objectId\" : \"09000064810111fb\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0432\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0433\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracy McCowan - Comment\",\n",
      "      \"objectId\" : \"09000064810111fc\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0433\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0434\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Woo - Comment\",\n",
      "      \"objectId\" : \"090000648101155b\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0434\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0435\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Hardy - Comment\",\n",
      "      \"objectId\" : \"0900006481011565\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0435\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0436\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kim sears - Comment\",\n",
      "      \"objectId\" : \"0900006481011214\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0436\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0437\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Tarantino - Comment\",\n",
      "      \"objectId\" : \"0900006481011218\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0437\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0438\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Morillo - Comment\",\n",
      "      \"objectId\" : \"090000648101157f\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0438\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0439\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-24T16:41:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SAMANTHA FEHER - Comment\",\n",
      "      \"objectId\" : \"0900006481011581\",\n",
      "      \"postedDate\" : \"2012-05-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0439\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0440\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lori marie Gulbranson - Comment\",\n",
      "      \"objectId\" : \"090000648101122a\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0440\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0441\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"s b - Comment\",\n",
      "      \"objectId\" : \"0900006481011231\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0441\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0442\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"marni montanez - Comment\",\n",
      "      \"objectId\" : \"0900006481011246\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0442\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0443\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Valarie Ianniello - Comment\",\n",
      "      \"objectId\" : \"0900006481011249\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0443\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0444\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Valenti - Comment\",\n",
      "      \"objectId\" : \"09000064810115a6\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0444\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0445\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Teresa P Cambridge - Comment\",\n",
      "      \"objectId\" : \"090000648101124b\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0445\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0446\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Shriver - Comment\",\n",
      "      \"objectId\" : \"09000064810115b5\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0446\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0447\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Lambeau - Comment\",\n",
      "      \"objectId\" : \"090000648101124c\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0447\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0448\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anthony Angelo Lombardi - Comment\",\n",
      "      \"objectId\" : \"09000064810115bc\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0448\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0449\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Satya Vayu - Comment\",\n",
      "      \"objectId\" : \"0900006481011265\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0449\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0450\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tammy Lynn Springer - Comment\",\n",
      "      \"objectId\" : \"0900006481011266\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0450\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0451\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret C Rigsby - Comment\",\n",
      "      \"objectId\" : \"0900006481011267\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0451\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0452\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lee Miller - Comment\",\n",
      "      \"objectId\" : \"09000064810115fd\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0452\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0453\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joel Jay Westfahl - Comment\",\n",
      "      \"objectId\" : \"09000064810112d8\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0453\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0454\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"linda lou frederick - Comment\",\n",
      "      \"objectId\" : \"0900006481011604\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0454\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0455\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca Lynn Fisher - Comment\",\n",
      "      \"objectId\" : \"090000648101160c\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0455\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0456\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hugo Mira - Comment\",\n",
      "      \"objectId\" : \"090000648101161c\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0456\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0457\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan L Chandler - Comment\",\n",
      "      \"objectId\" : \"0900006481011416\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0457\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0458\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481011417\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0458\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0459\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Flynn - Comment\",\n",
      "      \"objectId\" : \"0900006481011627\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0459\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0460\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101141b\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0460\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0461\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anita S Garrison - Comment\",\n",
      "      \"objectId\" : \"090000648101141d\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0461\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0462\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula J Olejnik - Comment\",\n",
      "      \"objectId\" : \"0900006481011420\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0462\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0463\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"neysa murray - Comment\",\n",
      "      \"objectId\" : \"0900006481011425\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0463\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0464\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashton Christine Grizzell - Comment\",\n",
      "      \"objectId\" : \"0900006481011630\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0464\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0465\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"eileen griffin - Comment\",\n",
      "      \"objectId\" : \"0900006481011633\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0465\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0466\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachael Fortney - Comment\",\n",
      "      \"objectId\" : \"0900006481011643\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0466\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0467\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stefan Kozinski - Comment\",\n",
      "      \"objectId\" : \"090000648101143a\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0467\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0468\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elina - Comment\",\n",
      "      \"objectId\" : \"090000648101165b\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0468\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0469\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa M Swartz - Comment\",\n",
      "      \"objectId\" : \"0900006481011445\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0469\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0470\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bryan - Comment\",\n",
      "      \"objectId\" : \"0900006481011662\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0470\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0471\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Taffy Williams - Comment\",\n",
      "      \"objectId\" : \"0900006481011663\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0471\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0472\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maribel Bravo - Comment\",\n",
      "      \"objectId\" : \"0900006481011665\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0472\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0473\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481011451\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0473\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0474\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adrienne Marie Norton - Comment\",\n",
      "      \"objectId\" : \"0900006481011453\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0474\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0475\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Magenta Loera - Comment\",\n",
      "      \"objectId\" : \"0900006481011675\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0475\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0476\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie M Reyes - Comment\",\n",
      "      \"objectId\" : \"0900006481011465\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0476\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0477\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Donna Moore - Comment\",\n",
      "      \"objectId\" : \"0900006481011699\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0477\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0478\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Colleen May Connor - Comment\",\n",
      "      \"objectId\" : \"090000648101169d\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0478\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0479\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"hadel toma - Comment\",\n",
      "      \"objectId\" : \"090000648101169f\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0479\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0480\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kip Allan Massett - Comment\",\n",
      "      \"objectId\" : \"09000064810116b8\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0480\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0481\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ronald Dean Lemmert - Comment\",\n",
      "      \"objectId\" : \"0900006481011481\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0481\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0482\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"nichelle lee - Comment\",\n",
      "      \"objectId\" : \"0900006481011484\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0482\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0483\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bina Aitchison Robinson - Comment\",\n",
      "      \"objectId\" : \"090000648101148b\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0483\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0484\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"carol j clover - Comment\",\n",
      "      \"objectId\" : \"09000064810116ce\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0484\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0485\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"KELLY ROGERS - Comment\",\n",
      "      \"objectId\" : \"09000064810116d7\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0485\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0486\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sindy Avilez - Comment\",\n",
      "      \"objectId\" : \"09000064810116d8\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0486\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0487\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eric Smith - Comment\",\n",
      "      \"objectId\" : \"09000064810114a1\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0487\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0488\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DEBORAH LYNN STEWART - Comment\",\n",
      "      \"objectId\" : \"09000064810116e7\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0488\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0489\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"glenda l cologero - Comment\",\n",
      "      \"objectId\" : \"09000064810114aa\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0489\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0490\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kevin Hughes - Comment\",\n",
      "      \"objectId\" : \"0900006481011705\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0490\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0491\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katie Lynn Doyle - Comment\",\n",
      "      \"objectId\" : \"09000064810114c8\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0491\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0492\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"erica miller - Comment\",\n",
      "      \"objectId\" : \"0900006481011713\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0492\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0493\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"hadel toma - Comment\",\n",
      "      \"objectId\" : \"09000064810114d5\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0493\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0494\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rafael Albarran - Comment\",\n",
      "      \"objectId\" : \"09000064810114d9\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0494\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0495\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Meehan - Comment\",\n",
      "      \"objectId\" : \"09000064810114db\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0495\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0496\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Manning - Comment\",\n",
      "      \"objectId\" : \"0900006481011757\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0496\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0497\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101193c\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0497\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0498\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paul Nahay - Comment\",\n",
      "      \"objectId\" : \"0900006481011950\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0498\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0499\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"barbara pearce - Comment\",\n",
      "      \"objectId\" : \"09000064810117c8\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0499\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0500\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Utter - Comment\",\n",
      "      \"objectId\" : \"09000064810117cf\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0500\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0501\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marle Kath Lakin - Comment\",\n",
      "      \"objectId\" : \"090000648101197e\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0501\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0502\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-25T16:23:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Corene M Wickland - Comment\",\n",
      "      \"objectId\" : \"09000064810117e8\",\n",
      "      \"postedDate\" : \"2012-05-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0502\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0503\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jason W Kabel - Comment\",\n",
      "      \"objectId\" : \"0900006481011803\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0503\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0504\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"julia wathers - Comment\",\n",
      "      \"objectId\" : \"09000064810119af\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0504\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-0505\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Ray DonaldsonII - Comment\",\n",
      "      \"objectId\" : \"0900006481011814\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0505\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0506\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jamie Leigh Rose Kabel - Comment\",\n",
      "      \"objectId\" : \"09000064810119b7\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0506\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0507\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tove P. Reese - Comment\",\n",
      "      \"objectId\" : \"090000648101181e\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0507\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0508\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracy Marie McNeiley - Comment\",\n",
      "      \"objectId\" : \"0900006481011823\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0508\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0509\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Evan Dwyer - Comment\",\n",
      "      \"objectId\" : \"09000064810119c5\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0509\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0510\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Rachel Fox - Comment\",\n",
      "      \"objectId\" : \"0900006481011828\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0510\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0511\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Desiree D Burdick - Comment\",\n",
      "      \"objectId\" : \"09000064810119dd\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0511\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0512\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Debra A Durante - Comment\",\n",
      "      \"objectId\" : \"09000064810119e7\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0512\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0513\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Miranda Traw - Comment\",\n",
      "      \"objectId\" : \"0900006481011848\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0513\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0514\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Miranda Traw - Comment\",\n",
      "      \"objectId\" : \"090000648101184e\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0514\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0515\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Miranda Traw - Comment\",\n",
      "      \"objectId\" : \"0900006481011851\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0515\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0516\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Lankenau - Comment\",\n",
      "      \"objectId\" : \"09000064810119ed\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0516\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0517\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Forsythe Diamond - Comment\",\n",
      "      \"objectId\" : \"0900006481011860\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0517\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0518\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy Lynn Gantos - Comment\",\n",
      "      \"objectId\" : \"0900006481011862\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0518\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0519\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Carter Fulcher - Comment\",\n",
      "      \"objectId\" : \"0900006481011a03\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0519\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0520\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brittany Lavin - Comment\",\n",
      "      \"objectId\" : \"090000648101187b\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0520\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0521\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chris gordon nahas - Comment\",\n",
      "      \"objectId\" : \"0900006481011a30\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0521\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0522\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Howard - Comment\",\n",
      "      \"objectId\" : \"0900006481011a40\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0522\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0523\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katrina Lynn DePaepe - Comment\",\n",
      "      \"objectId\" : \"090000648101189e\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0523\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0524\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Barraza - Comment\",\n",
      "      \"objectId\" : \"09000064810118a4\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0524\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0525\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-29T22:10:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natasha Rott - Comment\",\n",
      "      \"objectId\" : \"09000064810118b2\",\n",
      "      \"postedDate\" : \"2012-05-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0525\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0526\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:09:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Aquila - Comment\",\n",
      "      \"objectId\" : \"09000064810118b5\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0526\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0527\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:09:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vanessa - Comment\",\n",
      "      \"objectId\" : \"0900006481011a64\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0527\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0528\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Briana Wagner - Comment\",\n",
      "      \"objectId\" : \"09000064810118ca\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0528\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0529\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481011a7b\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0529\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0530\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alex - Comment\",\n",
      "      \"objectId\" : \"09000064810118e5\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0530\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0531\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DENNIS I BORDERS - Comment\",\n",
      "      \"objectId\" : \"0900006481011a86\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0531\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0532\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robin Lee Allen - Comment\",\n",
      "      \"objectId\" : \"09000064810118e8\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0532\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0533\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Abraham Hoffman - Comment\",\n",
      "      \"objectId\" : \"0900006481011a89\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0533\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0534\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracie - Comment\",\n",
      "      \"objectId\" : \"09000064810118eb\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0534\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0535\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ana Liz Peguri - Comment\",\n",
      "      \"objectId\" : \"09000064810118ec\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0535\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0536\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"debbie gorman - Comment\",\n",
      "      \"objectId\" : \"0900006481011a92\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0536\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0537\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jackie Quinones - Comment\",\n",
      "      \"objectId\" : \"09000064810118f0\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0537\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0538\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"cynthia - Comment\",\n",
      "      \"objectId\" : \"0900006481011d02\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0538\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0539\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Arthur Calvin - Comment\",\n",
      "      \"objectId\" : \"0900006481011ace\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0539\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0540\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donald Angell - Comment\",\n",
      "      \"objectId\" : \"0900006481011d1e\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0540\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0541\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebekah B. - Comment\",\n",
      "      \"objectId\" : \"0900006481011ad3\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0541\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0542\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Magali Nardi - Comment\",\n",
      "      \"objectId\" : \"0900006481011d23\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0542\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0543\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"carol ono kyer - Comment\",\n",
      "      \"objectId\" : \"0900006481011ada\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0543\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0544\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stacey Larson - Comment\",\n",
      "      \"objectId\" : \"0900006481011ae5\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0544\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0545\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Desiree Harpe - Comment\",\n",
      "      \"objectId\" : \"0900006481011b05\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0545\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0546\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"BARBARA SEXTON - Comment\",\n",
      "      \"objectId\" : \"0900006481011d6f\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0546\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0547\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Hernandez - Comment\",\n",
      "      \"objectId\" : \"0900006481011b33\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0547\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0548\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Doris LaDonna Cloud - Comment\",\n",
      "      \"objectId\" : \"0900006481011d8f\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0548\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0549\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah Lisa Barrette - Comment\",\n",
      "      \"objectId\" : \"0900006481011b6f\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0549\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0550\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Lynn Matthews - Comment\",\n",
      "      \"objectId\" : \"0900006481011b7e\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0550\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0551\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susie K Petersen - Comment\",\n",
      "      \"objectId\" : \"0900006481011dda\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0551\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0552\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eva Stapleton - Comment\",\n",
      "      \"objectId\" : \"0900006481011baa\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0552\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0553\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Hale - Comment\",\n",
      "      \"objectId\" : \"0900006481011df1\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0553\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0554\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Irina Brener - Comment\",\n",
      "      \"objectId\" : \"0900006481011df2\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0554\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0555\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Raymond De Antonio - Comment\",\n",
      "      \"objectId\" : \"0900006481011df3\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0555\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0556\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SHERRI PASQUALE - Comment\",\n",
      "      \"objectId\" : \"0900006481011e08\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0556\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0557\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Isadora Oquaye - Comment\",\n",
      "      \"objectId\" : \"0900006481011c27\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0557\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0558\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deb Lillian Fahey - Comment\",\n",
      "      \"objectId\" : \"0900006481011e3a\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0558\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0559\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Skye M Tucker - Comment\",\n",
      "      \"objectId\" : \"0900006481011c3b\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0559\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0560\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"GUADALUPE SERRATA - Comment\",\n",
      "      \"objectId\" : \"0900006481011e5b\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0560\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0561\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ann lynette mayo - Comment\",\n",
      "      \"objectId\" : \"0900006481011ecf\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0561\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0562\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Irene Mele - Comment\",\n",
      "      \"objectId\" : \"0900006481011cf0\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0562\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0563\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"erin Boettger - Comment\",\n",
      "      \"objectId\" : \"090000648101217b\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0563\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0564\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-30T22:10:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tosha Schumacher Elseth - Comment\",\n",
      "      \"objectId\" : \"09000064810121ac\",\n",
      "      \"postedDate\" : \"2012-05-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0564\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0565\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:15:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sam M Minker - Comment\",\n",
      "      \"objectId\" : \"09000064810122ea\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0565\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0566\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:19:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Proudfoot - Comment\",\n",
      "      \"objectId\" : \"0900006481011fb7\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0566\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0567\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:21:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Artists' Studio - Comment\",\n",
      "      \"objectId\" : \"0900006481012309\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0567\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0568\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:35:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danielle Saunders - Comment\",\n",
      "      \"objectId\" : \"0900006481012063\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0568\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0569\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:45:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula Y. Purvis - Comment\",\n",
      "      \"objectId\" : \"09000064810124a1\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0569\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0570\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:46:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Helana McDonnell - Comment\",\n",
      "      \"objectId\" : \"0900006481012090\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0570\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0571\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T19:52:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Peter Doonis - Comment\",\n",
      "      \"objectId\" : \"09000064810120a6\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0571\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0572\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T20:07:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tiffany M Wayman - Comment\",\n",
      "      \"objectId\" : \"09000064810120bb\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0572\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0573\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-05-31T20:27:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marcello Borges - Comment\",\n",
      "      \"objectId\" : \"090000648101295c\",\n",
      "      \"postedDate\" : \"2012-05-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0573\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0574\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-01T13:06:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beckie Hall - Comment\",\n",
      "      \"objectId\" : \"090000648101263e\",\n",
      "      \"postedDate\" : \"2012-06-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0574\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0575\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-01T13:11:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alejandro  Peregrina - Comment\",\n",
      "      \"objectId\" : \"090000648101264c\",\n",
      "      \"postedDate\" : \"2012-06-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0575\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0576\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-04T18:36:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Alix - Comment\",\n",
      "      \"objectId\" : \"09000064810129da\",\n",
      "      \"postedDate\" : \"2012-06-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0576\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0577\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-15T19:27:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Ann Rundle - Comment\",\n",
      "      \"objectId\" : \"09000064810129e4\",\n",
      "      \"postedDate\" : \"2012-06-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0577\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0578\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-15T19:49:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"S. Logan - Comment\",\n",
      "      \"objectId\" : \"09000064810126c0\",\n",
      "      \"postedDate\" : \"2012-06-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0578\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0579\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-15T19:55:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jason Kaas - Comment\",\n",
      "      \"objectId\" : \"09000064810129e9\",\n",
      "      \"postedDate\" : \"2012-06-15T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0579\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0581\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T21:31:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Michelle  Ward -Comment\",\n",
      "      \"objectId\" : \"09000064810129f5\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0581\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0583\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T21:38:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Manning - Comment\",\n",
      "      \"objectId\" : \"09000064810126d8\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0583\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0584\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T21:49:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810126de\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0584\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0585\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T21:52:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mechthild Nagel - Comment\",\n",
      "      \"objectId\" : \"09000064810126df\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0585\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0586\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T21:54:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Armin Sebran -  Comment\",\n",
      "      \"objectId\" : \"0900006481012a08\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0586\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0587\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T21:56:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonynmous - Comment\",\n",
      "      \"objectId\" : \"09000064810126e6\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0587\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0588\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T22:03:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melanie Ramirez-Weaver - Comment\",\n",
      "      \"objectId\" : \"09000064810126ea\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0588\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0589\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T22:35:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer H. - Comment\",\n",
      "      \"objectId\" : \"0900006481012a13\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0589\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0590\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-18T22:45:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jared Cornelia - Comment\",\n",
      "      \"objectId\" : \"09000064810126ee\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0590\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0591\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"P  Turick - Comment\",\n",
      "      \"objectId\" : \"0900006481012a16\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0591\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0592\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Conway - Comment\",\n",
      "      \"objectId\" : \"09000064810126f2\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0592\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0593\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joanna Manzi- Sakuma - Comment\",\n",
      "      \"objectId\" : \"0900006481012a20\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0593\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0594\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481012709\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0594\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0595\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JENNIFER CIAMBRONE - Comment\",\n",
      "      \"objectId\" : \"090000648101270a\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0595\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0596\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Markus van Alphen - Comment\",\n",
      "      \"objectId\" : \"090000648101270f\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0596\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0597\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dawn Corby - Comment\",\n",
      "      \"objectId\" : \"0900006481012a26\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0597\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0598\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dianna Jill Kozloski - Comment\",\n",
      "      \"objectId\" : \"0900006481012710\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0598\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0599\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481012711\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0599\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0600\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine M Olson - Comment\",\n",
      "      \"objectId\" : \"0900006481012712\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0600\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0601\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gabriele Hoenschel - Comment\",\n",
      "      \"objectId\" : \"0900006481012a2c\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0601\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0602\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda S. Trzybinski - Comment\",\n",
      "      \"objectId\" : \"0900006481012a2f\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0602\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0603\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-19T22:11:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jean Marie Davis - Comment\",\n",
      "      \"objectId\" : \"0900006481012a31\",\n",
      "      \"postedDate\" : \"2012-06-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0603\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0604\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robin Stephens - Comment\",\n",
      "      \"objectId\" : \"0900006481012729\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0604\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0605\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Attila - Comment\",\n",
      "      \"objectId\" : \"090000648101272f\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0605\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0606\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chrystal Jansz - Comment\",\n",
      "      \"objectId\" : \"0900006481012732\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0606\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0607\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon Parkinson - Comment\",\n",
      "      \"objectId\" : \"0900006481012734\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0607\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0608\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eva Burnett - Comment\",\n",
      "      \"objectId\" : \"0900006481012a44\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0608\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0609\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carla Lois Hounsel - Comment\",\n",
      "      \"objectId\" : \"0900006481012735\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0609\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0610\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julia Joshpe - Comment\",\n",
      "      \"objectId\" : \"0900006481012738\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0610\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0611\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CLIFFORD/CHRISTINE SCHMUTZ - Comment\",\n",
      "      \"objectId\" : \"0900006481012747\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0611\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0612\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Edward Jasiewicz - Comment\",\n",
      "      \"objectId\" : \"0900006481012a47\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0612\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0613\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"deanna smith - Comment\",\n",
      "      \"objectId\" : \"0900006481012a5a\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0613\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0614\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Sullivan - Comment\",\n",
      "      \"objectId\" : \"0900006481012a5b\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0614\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0615\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah Ann Rankin - Comment\",\n",
      "      \"objectId\" : \"090000648101274a\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0615\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0616\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorraine e Dooley - Comment\",\n",
      "      \"objectId\" : \"090000648101274c\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0616\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0617\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Onofrio - Comment\",\n",
      "      \"objectId\" : \"0900006481012750\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0617\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0618\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"vicki sue ginoli - Comment\",\n",
      "      \"objectId\" : \"0900006481012a77\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0618\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0619\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolina De Sousa - Comment\",\n",
      "      \"objectId\" : \"0900006481012a95\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0619\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0620\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marie Manser-Dixon - Comment\",\n",
      "      \"objectId\" : \"0900006481012a96\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0620\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0621\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kurt William - Comment\",\n",
      "      \"objectId\" : \"0900006481012a97\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0621\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0622\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Jean Liston - Comment\",\n",
      "      \"objectId\" : \"0900006481012a9a\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0622\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0623\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adam Kamenman - Comment\",\n",
      "      \"objectId\" : \"0900006481012ab2\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0623\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0624\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeffrey Rosenberg - Comment\",\n",
      "      \"objectId\" : \"0900006481012775\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0624\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0625\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Douglas Frank - Comment\",\n",
      "      \"objectId\" : \"090000648101277c\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0625\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0626\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-20T22:06:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"nathalie watteau - Comment\",\n",
      "      \"objectId\" : \"0900006481012ab6\",\n",
      "      \"postedDate\" : \"2012-06-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0626\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0627\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"marguery lee zucker - Comment\",\n",
      "      \"objectId\" : \"0900006481012780\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0627\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0628\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mike Rossa - Comment\",\n",
      "      \"objectId\" : \"0900006481012781\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0628\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0629\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michela Teresa Rebuli - Comment\",\n",
      "      \"objectId\" : \"0900006481012783\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0629\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0630\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cindy jean - Comment\",\n",
      "      \"objectId\" : \"0900006481012abe\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0630\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0631\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sally J Polen - Comment\",\n",
      "      \"objectId\" : \"0900006481012787\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0631\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0632\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniela Delgado Gilbert - Comment\",\n",
      "      \"objectId\" : \"0900006481012ac1\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0632\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0633\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steve Treble - Comment\",\n",
      "      \"objectId\" : \"090000648101278d\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0633\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0634\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MA Cotroneo - Comment\",\n",
      "      \"objectId\" : \"0900006481012ac3\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0634\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0635\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christopher Panayi - Comment\",\n",
      "      \"objectId\" : \"090000648101278e\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0635\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0636\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rosamund Downing - Comment\",\n",
      "      \"objectId\" : \"09000064810127c8\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0636\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0637\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Noah-D.M. Sanchez - Comment\",\n",
      "      \"objectId\" : \"09000064810127ca\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0637\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0638\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Noah-D.M. Sanchez - Comment\",\n",
      "      \"objectId\" : \"09000064810127cc\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0638\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0639\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Martine Michelle - Comment\",\n",
      "      \"objectId\" : \"0900006481012ac7\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0639\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0640\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy F - Comment\",\n",
      "      \"objectId\" : \"0900006481012ad6\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0640\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0641\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maureen Sullivan - Comment\",\n",
      "      \"objectId\" : \"09000064810127ce\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0641\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0642\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"marina segovia - Comment\",\n",
      "      \"objectId\" : \"0900006481012ad8\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0642\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0643\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-21T21:42:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cara Maragni - Comment\",\n",
      "      \"objectId\" : \"09000064810127d0\",\n",
      "      \"postedDate\" : \"2012-06-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0643\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0644\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah Metzger - Comment\",\n",
      "      \"objectId\" : \"09000064810127d2\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0644\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0645\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nichlas Rehnstam - Comment\",\n",
      "      \"objectId\" : \"09000064810127d5\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0645\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0646\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Allen - Comment\",\n",
      "      \"objectId\" : \"09000064810127d8\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0646\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0647\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven Lawrence Kostis - Comment\",\n",
      "      \"objectId\" : \"09000064810127db\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0647\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0648\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy Jane Forster - Comment\",\n",
      "      \"objectId\" : \"09000064810127e7\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0648\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0649\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Samantha queen - Comment\",\n",
      "      \"objectId\" : \"09000064810127e8\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0649\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0650\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Lesins - Comment\",\n",
      "      \"objectId\" : \"0900006481012b0f\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0650\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0651\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jill A Dains - Comment\",\n",
      "      \"objectId\" : \"09000064810127ee\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0651\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0652\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amanda - Comment\",\n",
      "      \"objectId\" : \"0900006481012b1c\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0652\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0653\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lily Lopez - Comment\",\n",
      "      \"objectId\" : \"09000064810127f7\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0653\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0654\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"anju mehta - Comment\",\n",
      "      \"objectId\" : \"0900006481012b1f\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0654\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0655\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natalie Alexander - Comment\",\n",
      "      \"objectId\" : \"0900006481012807\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0655\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0656\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erin A Cleere - Comment\",\n",
      "      \"objectId\" : \"0900006481012808\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0656\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0657\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ramona Miller - Comment\",\n",
      "      \"objectId\" : \"0900006481012b21\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0657\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0658\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hellen Cano - Comment\",\n",
      "      \"objectId\" : \"0900006481012b22\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0658\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0659\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"gina sanzenbacher - Comment\",\n",
      "      \"objectId\" : \"0900006481012b24\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0659\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0660\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Val Harp - Comment\",\n",
      "      \"objectId\" : \"0900006481012b2a\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0660\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0661\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-22T19:37:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Priscilla Romanowski - Comment\",\n",
      "      \"objectId\" : \"0900006481012b31\",\n",
      "      \"postedDate\" : \"2012-06-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0661\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0662\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Montierth - Comment\",\n",
      "      \"objectId\" : \"0900006481012b34\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0662\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0663\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"laurie geller - Comment\",\n",
      "      \"objectId\" : \"0900006481012b35\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0663\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0664\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"maria perez - Comment\",\n",
      "      \"objectId\" : \"090000648101283b\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0664\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0665\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danielly Pinto Bucci - Comment\",\n",
      "      \"objectId\" : \"0900006481012b39\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0665\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0666\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marcia Ostrowski - Comment\",\n",
      "      \"objectId\" : \"0900006481012b48\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0666\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0667\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gianna Macias - Comment\",\n",
      "      \"objectId\" : \"0900006481012b4a\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0667\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0668\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Esther Gass - Comment\",\n",
      "      \"objectId\" : \"0900006481012b4c\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0668\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0669\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alexis aida Nazario - Comment\",\n",
      "      \"objectId\" : \"0900006481012b4e\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0669\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0670\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natalie Dunsmuir - Comment\",\n",
      "      \"objectId\" : \"0900006481012b4f\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0670\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0671\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pressiana Vassileva - Comment\",\n",
      "      \"objectId\" : \"090000648101284e\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0671\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0672\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Machael Cronin - Comment\",\n",
      "      \"objectId\" : \"0900006481012b5d\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0672\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0673\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heather Morrison - Comment\",\n",
      "      \"objectId\" : \"0900006481012b5f\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0673\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0674\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ginger Hill - Comment\",\n",
      "      \"objectId\" : \"0900006481012b60\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0674\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0675\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Yesenia Covarrubias - Comment\",\n",
      "      \"objectId\" : \"090000648101285b\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0675\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0676\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"pamela m cote - Comment\",\n",
      "      \"objectId\" : \"090000648101285e\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0676\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0677\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SUMMER PARKER - Comment\",\n",
      "      \"objectId\" : \"090000648101285f\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0677\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0678\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Malcolm Groome - Comment\",\n",
      "      \"objectId\" : \"0900006481012862\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0678\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0679\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Monteith Davives - Comment\",\n",
      "      \"objectId\" : \"0900006481012876\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0679\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0680\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"anna louise bellin - Comment\",\n",
      "      \"objectId\" : \"0900006481012b66\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0680\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0681\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Veronica DS Figueiredo - Comment\",\n",
      "      \"objectId\" : \"0900006481012b67\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0681\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0682\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481012b69\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0682\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0683\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"muralidharan T - Comment\",\n",
      "      \"objectId\" : \"0900006481012b6e\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0683\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0684\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Isla Maria McGuire - Comment\",\n",
      "      \"objectId\" : \"0900006481012b83\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0684\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0685\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maya C. Kurtz - Comment\",\n",
      "      \"objectId\" : \"090000648101288a\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0685\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0686\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Keely Smith - Comment\",\n",
      "      \"objectId\" : \"0900006481012b89\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0686\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0687\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nichola Rogers - Comment\",\n",
      "      \"objectId\" : \"090000648101288d\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0687\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0688\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"April A Manuel - Comment\",\n",
      "      \"objectId\" : \"0900006481012b8b\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0688\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0689\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"dina frigo - Comment\",\n",
      "      \"objectId\" : \"090000648101288e\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0689\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0690\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gayle Moore - Comment\",\n",
      "      \"objectId\" : \"0900006481012b8d\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0690\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0691\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Alan Harris - Comment\",\n",
      "      \"objectId\" : \"0900006481012b9a\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0691\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0692\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jenna parodi - Comment\",\n",
      "      \"objectId\" : \"090000648101289d\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0692\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0693\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"anna blumen - Comment\",\n",
      "      \"objectId\" : \"090000648101289e\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0693\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0694\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Martinez - Comment\",\n",
      "      \"objectId\" : \"0900006481012b9c\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0694\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0695\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Morna Dare - Comment\",\n",
      "      \"objectId\" : \"09000064810128a4\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0695\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0696\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Martinez - Comment\",\n",
      "      \"objectId\" : \"0900006481012b9d\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0696\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0697\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jean johnson - Comment\",\n",
      "      \"objectId\" : \"0900006481012b9f\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0697\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0698\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vicki Schlenker - Comment\",\n",
      "      \"objectId\" : \"0900006481012ba8\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0698\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0699\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Xuan Mai T Pham- Comment\",\n",
      "      \"objectId\" : \"09000064810128ad\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0699\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0700\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donna C Swensen - Comment\",\n",
      "      \"objectId\" : \"09000064810128c7\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0700\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0701\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diana - Comment\",\n",
      "      \"objectId\" : \"0900006481012bc4\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0701\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0702\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tina Bowers - Comment\",\n",
      "      \"objectId\" : \"09000064810128cd\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0702\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0703\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Keri O'Connell - Comment\",\n",
      "      \"objectId\" : \"09000064810128ce\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0703\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0704\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lori Michelle Westman - Comment\",\n",
      "      \"objectId\" : \"0900006481012bc7\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0704\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0705\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Weiss - Comment\",\n",
      "      \"objectId\" : \"0900006481012bc8\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0705\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0706\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sudhir Pandit - Comment\",\n",
      "      \"objectId\" : \"09000064810128d4\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0706\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0707\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-27T21:45:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy E Morris - Comment\",\n",
      "      \"objectId\" : \"09000064810128d5\",\n",
      "      \"postedDate\" : \"2012-06-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0707\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0708\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bronwyn Elizabeth Slater - Comment\",\n",
      "      \"objectId\" : \"09000064810128d9\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0708\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0709\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura K Gurrad - Comment\",\n",
      "      \"objectId\" : \"09000064810128da\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0709\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0710\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thali Leal Sampaio - Comment\",\n",
      "      \"objectId\" : \"0900006481012be2\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0710\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0711\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon M Lukachevich - Comment\",\n",
      "      \"objectId\" : \"0900006481012be4\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0711\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0712\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Oswald - Comment\",\n",
      "      \"objectId\" : \"0900006481012be7\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0712\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0713\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"judy PIZARRO - Comment\",\n",
      "      \"objectId\" : \"09000064810128f1\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0713\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0714\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sonia Monique Geerlings - Comment\",\n",
      "      \"objectId\" : \"0900006481012be8\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0714\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0715\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Evelyn Ball - Comment\",\n",
      "      \"objectId\" : \"09000064810128f2\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0715\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0716\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon M Lukachevich - Comment\",\n",
      "      \"objectId\" : \"0900006481012be9\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0716\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0717\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"wandis danita wilcox - Comment\",\n",
      "      \"objectId\" : \"0900006481012bea\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0717\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0718\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"peter solt - Comment\",\n",
      "      \"objectId\" : \"09000064810128f4\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0718\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0719\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Inge Wolf - Comment\",\n",
      "      \"objectId\" : \"09000064810128f9\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0719\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0720\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Allen Louis Corte' - Comment\",\n",
      "      \"objectId\" : \"09000064810128fb\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0720\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0721\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Denisse Delgado - Comment\",\n",
      "      \"objectId\" : \"0900006481012d05\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0721\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0722\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Silvia Wolff - Comment\",\n",
      "      \"objectId\" : \"0900006481012bff\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0722\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0723\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Max Calvin Sampson - Comment\",\n",
      "      \"objectId\" : \"0900006481012d15\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0723\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0724\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"miriam mairen montero - Comment\",\n",
      "      \"objectId\" : \"0900006481012c06\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0724\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0725\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathakali Sinha - Comment\",\n",
      "      \"objectId\" : \"0900006481012d29\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0725\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0726\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heidi Ludwick - Comment\",\n",
      "      \"objectId\" : \"0900006481012d2b\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0726\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0727\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Francesco DiCosmo - Comment\",\n",
      "      \"objectId\" : \"0900006481012d2e\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0727\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0728\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"elizabeth mcmahon - Comment\",\n",
      "      \"objectId\" : \"0900006481012d35\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0728\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0729\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christopher Joseph Gendron - Comment\",\n",
      "      \"objectId\" : \"0900006481012c31\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0729\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0730\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"L. McGannon - Comment\",\n",
      "      \"objectId\" : \"0900006481012d3f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0730\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0731\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Scott - Comment\",\n",
      "      \"objectId\" : \"0900006481012d40\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0731\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0732\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juergen Markus Teuschl - Comment\",\n",
      "      \"objectId\" : \"0900006481012d4b\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0732\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0733\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sherry Azzara - Comment\",\n",
      "      \"objectId\" : \"0900006481012d50\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0733\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0734\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Renee Fiorentini - Comment\",\n",
      "      \"objectId\" : \"0900006481012c54\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0734\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0735\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jacqueline Jackie Lopez - Comment\",\n",
      "      \"objectId\" : \"0900006481012d56\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0735\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0736\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DONNA KATHLENE WARNER - Comment\",\n",
      "      \"objectId\" : \"0900006481012c56\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0736\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0737\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Meghan Martin kern - Comment\",\n",
      "      \"objectId\" : \"0900006481012d5b\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0737\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0738\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricio Saldivar - Comment\",\n",
      "      \"objectId\" : \"0900006481012c5f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0738\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0739\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dana Sindona - Comment\",\n",
      "      \"objectId\" : \"0900006481012c60\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0739\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0740\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ruben Ruben Londono - Comment\",\n",
      "      \"objectId\" : \"0900006481012c62\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0740\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0741\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Jean Lippner - Comment\",\n",
      "      \"objectId\" : \"0900006481012d60\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0741\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0742\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandi Jo Shocket - Comment\",\n",
      "      \"objectId\" : \"0900006481012c66\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0742\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0743\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andy Auyeung - Comment\",\n",
      "      \"objectId\" : \"0900006481012d62\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0743\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0744\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LUIS ARTURO FRANCO - Comment\",\n",
      "      \"objectId\" : \"0900006481012c6f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0744\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0745\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Sharp - Comment\",\n",
      "      \"objectId\" : \"0900006481012c88\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0745\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0746\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gwen S - Comment\",\n",
      "      \"objectId\" : \"0900006481012d75\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0746\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0747\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brigitte James - Comment\",\n",
      "      \"objectId\" : \"0900006481012c8d\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0747\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0748\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kina A. Wagner-Canjar - Comment\",\n",
      "      \"objectId\" : \"0900006481012de9\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0748\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0749\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maureen Gibbons - Comment\",\n",
      "      \"objectId\" : \"0900006481012dea\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0749\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0750\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brigitte M Baumann, MD, MSCE - Comment\",\n",
      "      \"objectId\" : \"0900006481012c98\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0750\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0751\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chris gruber - Comment\",\n",
      "      \"objectId\" : \"0900006481012c9f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0751\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0752\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bill Beck - Comment\",\n",
      "      \"objectId\" : \"0900006481012e08\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0752\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0753\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark Jordan - Comment\",\n",
      "      \"objectId\" : \"0900006481012e09\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0753\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0754\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"saibh mc mahon - Comment\",\n",
      "      \"objectId\" : \"0900006481012cca\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0754\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0755\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Louis Bertolino - Comment\",\n",
      "      \"objectId\" : \"0900006481012e1e\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0755\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0756\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patty Bradbery - Comment\",\n",
      "      \"objectId\" : \"0900006481012cdc\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0756\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 3,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-0757\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lucy Fox - Comment\",\n",
      "      \"objectId\" : \"0900006481012e1f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0757\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0758\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susanne Vaz - Comment\",\n",
      "      \"objectId\" : \"0900006481012cf4\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0758\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0759\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Jordan - Comment\",\n",
      "      \"objectId\" : \"0900006481012e40\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0759\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0760\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MEAGAN E GILL - Comment\",\n",
      "      \"objectId\" : \"0900006481012e41\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0760\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0761\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anja Biezeman - Comment\",\n",
      "      \"objectId\" : \"0900006481012cf5\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0761\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0762\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Taylor - Comment\",\n",
      "      \"objectId\" : \"0900006481012cf8\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0762\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0763\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NK Acevedo - Comment\",\n",
      "      \"objectId\" : \"0900006481013101\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0763\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0764\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Elseroad - Comment\",\n",
      "      \"objectId\" : \"0900006481012e49\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0764\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0765\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marilyn P. Hammett - Comment\",\n",
      "      \"objectId\" : \"0900006481013104\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0765\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0766\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cristina Gomes Fernandes - Comment\",\n",
      "      \"objectId\" : \"0900006481012e5c\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0766\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0767\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natasha Routledge - Comment\",\n",
      "      \"objectId\" : \"0900006481012e5f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0767\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0768\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer McWhorter - Comment\",\n",
      "      \"objectId\" : \"0900006481012e65\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0768\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0769\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Annamarie Wood - Comment\",\n",
      "      \"objectId\" : \"0900006481012e76\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0769\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0770\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sofia G - Comment\",\n",
      "      \"objectId\" : \"0900006481012e79\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0770\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0771\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara Wittenberg - Comment\",\n",
      "      \"objectId\" : \"09000064810132cd\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0771\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0772\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481012e84\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0772\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0773\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"terri armao - Comment\",\n",
      "      \"objectId\" : \"0900006481012e88\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0773\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0774\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Querze - Comment\",\n",
      "      \"objectId\" : \"09000064810132d4\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0774\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0775\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Matthew Cordero Rosa - Comment\",\n",
      "      \"objectId\" : \"0900006481012e8f\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0775\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0776\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Formigo Botía - Comment\",\n",
      "      \"objectId\" : \"0900006481012e90\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0776\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0777\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Colette Ann Hulett - Comment\",\n",
      "      \"objectId\" : \"0900006481012e94\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0777\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0778\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maria Sacristan - Comment\",\n",
      "      \"objectId\" : \"09000064810132ed\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0778\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0779\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stewart Rosenkrantz - Comment\",\n",
      "      \"objectId\" : \"09000064810132f7\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0779\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0780\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anita OConnor - Comment\",\n",
      "      \"objectId\" : \"0900006481012ead\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0780\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0781\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Constance - Comment\",\n",
      "      \"objectId\" : \"0900006481013304\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0781\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0782\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hanan Rogers - Comment\",\n",
      "      \"objectId\" : \"0900006481013305\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0782\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0783\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Henry Weinberg - Comment\",\n",
      "      \"objectId\" : \"0900006481012eb4\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0783\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0784\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Merryl Felice Goldman - Comment\",\n",
      "      \"objectId\" : \"0900006481012ebf\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0784\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0785\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelsey Elizabeth Driedger - Comment\",\n",
      "      \"objectId\" : \"0900006481013311\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0785\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0786\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Jean Turner - Comment\",\n",
      "      \"objectId\" : \"0900006481012ec1\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0786\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0787\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracy Anne Doherty - Comment\",\n",
      "      \"objectId\" : \"0900006481013316\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0787\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0788\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"felipe vieira passos - Comment\",\n",
      "      \"objectId\" : \"0900006481012ecd\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0788\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0789\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven - Comment\",\n",
      "      \"objectId\" : \"0900006481013332\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0789\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0790\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Errikka Chandra Jordan - Comment\",\n",
      "      \"objectId\" : \"0900006481013333\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0790\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0791\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ANDREA C RAMIREZ - Comment\",\n",
      "      \"objectId\" : \"0900006481012ed1\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0791\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0792\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Victoria Gaynor - Comment\",\n",
      "      \"objectId\" : \"0900006481012ed8\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0792\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0793\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathryn Corbett - Comment\",\n",
      "      \"objectId\" : \"0900006481013350\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0793\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0794\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Adkins - Comment\",\n",
      "      \"objectId\" : \"0900006481013357\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0794\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0795\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joyce A. Cavallo - Comment\",\n",
      "      \"objectId\" : \"0900006481012ef0\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0795\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0796\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"s s s - Comment\",\n",
      "      \"objectId\" : \"0900006481012ef1\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0796\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0797\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Pernot - Comment\",\n",
      "      \"objectId\" : \"0900006481012ef5\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0797\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0798\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-28T21:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathryn Dalenberg - Comment\",\n",
      "      \"objectId\" : \"090000648101335e\",\n",
      "      \"postedDate\" : \"2012-06-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0798\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0799\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"zoe louise tolley - Comment\",\n",
      "      \"objectId\" : \"0900006481012ef7\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0799\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0800\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chris Montalbano - Comment\",\n",
      "      \"objectId\" : \"0900006481012efa\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0800\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0801\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Summer Kachigian - Comment\",\n",
      "      \"objectId\" : \"0900006481012efc\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0801\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0802\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dixie J Duff - Comment\",\n",
      "      \"objectId\" : \"0900006481012f02\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0802\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0803\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Madeleine A Fisher Kern - Comment\",\n",
      "      \"objectId\" : \"0900006481013364\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0803\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0804\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Sullivan - Comment\",\n",
      "      \"objectId\" : \"0900006481012f05\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0804\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0805\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vicki S Nosal - Comment\",\n",
      "      \"objectId\" : \"0900006481013388\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0805\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0806\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"fetica costiana - Comment\",\n",
      "      \"objectId\" : \"0900006481012f14\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0806\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0807\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol Lee Collins - Comment\",\n",
      "      \"objectId\" : \"090000648101338f\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0807\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0808\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mondelle gail greene - Comment\",\n",
      "      \"objectId\" : \"0900006481012f39\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0808\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0809\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mr/Mrs James Lee Denison - Comment\",\n",
      "      \"objectId\" : \"09000064810133a6\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0809\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0810\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rhonda D Watson - Comment\",\n",
      "      \"objectId\" : \"0900006481012f3a\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0810\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0811\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hanna Erkel - Comment\",\n",
      "      \"objectId\" : \"09000064810133a9\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0811\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0812\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NICHOLLE SANCHEZ - Comment\",\n",
      "      \"objectId\" : \"09000064810133ad\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0812\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0813\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robin Medley - Comment\",\n",
      "      \"objectId\" : \"0900006481012f8a\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0813\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0814\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tobi Seats - Comment\",\n",
      "      \"objectId\" : \"0900006481012fa1\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0814\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0815\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"linda masciola - Comment\",\n",
      "      \"objectId\" : \"09000064810133d3\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0815\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0816\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-06-29T21:58:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juanita Marion Bowen - Comment\",\n",
      "      \"objectId\" : \"09000064810133d8\",\n",
      "      \"postedDate\" : \"2012-06-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0816\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0817\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T18:33:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Kate Shadrock, PETA - Comment\",\n",
      "      \"objectId\" : \"090000648101351c\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0817\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0818\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T18:44:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Camila Nedjelka Ortega, PETA - Comment\",\n",
      "      \"objectId\" : \"09000064810130b8\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0818\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0819\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T18:48:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DNA - Comment\",\n",
      "      \"objectId\" : \"09000064810130b9\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0819\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0820\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Grete S - Comment\",\n",
      "      \"objectId\" : \"0900006481012fba\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0820\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0821\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Casey D Smith - Comment\",\n",
      "      \"objectId\" : \"0900006481012fbd\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0821\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0822\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marliese Bonk - Comment\",\n",
      "      \"objectId\" : \"09000064810133f4\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0822\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0823\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"anita m johnson - Comment\",\n",
      "      \"objectId\" : \"0900006481012fdb\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0823\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0824\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon Boxley - Comment\",\n",
      "      \"objectId\" : \"09000064810133fd\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0824\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0825\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Iris D. Smith - Comment\",\n",
      "      \"objectId\" : \"090000648101341a\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0825\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0826\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kerry Aileen Marley - Comment\",\n",
      "      \"objectId\" : \"090000648101341c\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0826\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0827\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"greg j. seminack - Comment\",\n",
      "      \"objectId\" : \"0900006481012ff1\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0827\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0828\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Renee Beauvais - Comment\",\n",
      "      \"objectId\" : \"090000648101342e\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0828\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0829\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandra Cornell - Comment\",\n",
      "      \"objectId\" : \"0900006481013434\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0829\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0830\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Casey Patrick - Comment\",\n",
      "      \"objectId\" : \"0900006481013438\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0830\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0831\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"nivia guadalupe ordaz - Comment\",\n",
      "      \"objectId\" : \"0900006481013005\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0831\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0832\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Provost - Comment\",\n",
      "      \"objectId\" : \"0900006481013441\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0832\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0833\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Youngseo Emily Park - Comment\",\n",
      "      \"objectId\" : \"0900006481013020\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0833\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0834\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pamela Sue Green - Comment\",\n",
      "      \"objectId\" : \"0900006481013022\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0834\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0835\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Peg Kishel - Comment\",\n",
      "      \"objectId\" : \"0900006481013026\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0835\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0836\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa A Walker - Comment\",\n",
      "      \"objectId\" : \"090000648101345f\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0836\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0837\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniela Bernardes Venticinque Menezes - Comment\",\n",
      "      \"objectId\" : \"0900006481013460\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0837\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0838\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara Williams - Comment\",\n",
      "      \"objectId\" : \"0900006481013040\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0838\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0839\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Lynn Zellmer - Comment\",\n",
      "      \"objectId\" : \"090000648101346c\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0839\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0840\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marie McDonald - Comment\",\n",
      "      \"objectId\" : \"090000648101346f\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0840\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0841\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heidi Hamed - Comment\",\n",
      "      \"objectId\" : \"090000648101304b\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0841\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0842\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amanda Mikalson - Comment\",\n",
      "      \"objectId\" : \"0900006481013482\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0842\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0843\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"michele mcgill - Comment\",\n",
      "      \"objectId\" : \"0900006481013486\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0843\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0844\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ruby Martinez - Comment\",\n",
      "      \"objectId\" : \"09000064810134cb\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0844\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0845\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Kail - Comment\",\n",
      "      \"objectId\" : \"09000064810134d1\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0845\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0846\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ryan A Lee - Comment\",\n",
      "      \"objectId\" : \"0900006481013078\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0846\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0847\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Navid Bayar - Comment\",\n",
      "      \"objectId\" : \"090000648101307c\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0847\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0848\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Helen Diane Smith - Comment\",\n",
      "      \"objectId\" : \"0900006481013081\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0848\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0849\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"noel frégie - Comment\",\n",
      "      \"objectId\" : \"0900006481013087\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0849\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0850\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dawn Richdoll - Comment\",\n",
      "      \"objectId\" : \"09000064810134e8\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0850\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0851\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gavin Martin John Bornholtz - Comment\",\n",
      "      \"objectId\" : \"09000064810134ee\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0851\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0852\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Yvonne Fast - Comment\",\n",
      "      \"objectId\" : \"090000648101308d\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0852\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0853\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Zoe Van de Zande - Comment\",\n",
      "      \"objectId\" : \"0900006481013531\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0853\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0854\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kay - Comment\",\n",
      "      \"objectId\" : \"0900006481013533\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0854\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0855\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nanci Lee Stevens - Comment\",\n",
      "      \"objectId\" : \"09000064810130c8\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0855\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0856\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marjorie Helen Bergen - Comment\",\n",
      "      \"objectId\" : \"09000064810130c9\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0856\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0857\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:07:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alyssa Folden - Comment\",\n",
      "      \"objectId\" : \"0900006481013544\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0857\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0858\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T19:24:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joyce  A August- PETA - Comment\",\n",
      "      \"objectId\" : \"09000064810130d4\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0858\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0859\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T20:13:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr Rosalie Triolo - Comment\",\n",
      "      \"objectId\" : \"09000064810130e5\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0859\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0860\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tahnee Renee Lardner - Comment\",\n",
      "      \"objectId\" : \"0900006481013585\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0860\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0861\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Richard - Comment\",\n",
      "      \"objectId\" : \"090000648101391c\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0861\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0862\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Lawless - Comment\",\n",
      "      \"objectId\" : \"0900006481013592\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0862\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0863\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jocelyn Vallery - Comment\",\n",
      "      \"objectId\" : \"0900006481013928\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0863\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0864\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Glenda Clark - Comment\",\n",
      "      \"objectId\" : \"0900006481013593\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0864\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0865\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alison Jane - Comment\",\n",
      "      \"objectId\" : \"0900006481013594\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0865\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0866\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"trish gug - Comment\",\n",
      "      \"objectId\" : \"090000648101392f\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0866\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0867\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steve D. - Comment\",\n",
      "      \"objectId\" : \"090000648101359f\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0867\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0868\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dusty Washburn - Comment\",\n",
      "      \"objectId\" : \"0900006481013934\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0868\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0869\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael C Farner, MD - Comment\",\n",
      "      \"objectId\" : \"0900006481013938\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0869\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0870\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charlotte Rose Fuller - Comment\",\n",
      "      \"objectId\" : \"090000648101393b\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0870\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0871\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cristie Torrey - Comment\",\n",
      "      \"objectId\" : \"090000648101393d\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0871\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0872\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"alice lohrentz - Comment\",\n",
      "      \"objectId\" : \"09000064810135b6\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0872\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0873\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beatriz Gomes - Comment\",\n",
      "      \"objectId\" : \"09000064810135c0\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0873\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0874\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Alexandro Caceres - Comment\",\n",
      "      \"objectId\" : \"09000064810135c5\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0874\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0875\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Anthony Sebastian - Comment\",\n",
      "      \"objectId\" : \"090000648101395d\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0875\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0876\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Loreli Cavaluzzi - Comment\",\n",
      "      \"objectId\" : \"090000648101395f\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0876\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0877\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481013962\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0877\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0878\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Delecty Ann Prosence - Comment\",\n",
      "      \"objectId\" : \"09000064810135dd\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0878\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0879\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julija Merljak - Comment\",\n",
      "      \"objectId\" : \"090000648101396c\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0879\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0880\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pamela Payne - Comment\",\n",
      "      \"objectId\" : \"09000064810135e1\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0880\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0881\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonnie Bennett - Comment\",\n",
      "      \"objectId\" : \"09000064810135e3\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0881\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0882\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"zoe kelli simon - Comment\",\n",
      "      \"objectId\" : \"09000064810135e6\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0882\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0883\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cliff Josephson - Comment\",\n",
      "      \"objectId\" : \"0900006481013974\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0883\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0884\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Perry M. Smith - Comment\",\n",
      "      \"objectId\" : \"09000064810135e7\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0884\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0885\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Anne Adams - Comment\",\n",
      "      \"objectId\" : \"09000064810135ea\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0885\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0886\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maggie Bloom - Comment\",\n",
      "      \"objectId\" : \"09000064810135fd\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0886\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0887\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Trang - Comment\",\n",
      "      \"objectId\" : \"0900006481013986\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0887\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0888\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alicia Bastien - Comment\",\n",
      "      \"objectId\" : \"090000648101361c\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0888\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0889\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101399d\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0889\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0890\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Roberta Tomeucci - Comment\",\n",
      "      \"objectId\" : \"09000064810139a5\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0890\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0891\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:01:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rose Wedlund - Comment\",\n",
      "      \"objectId\" : \"090000648101362b\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0891\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0892\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jill Kyriakopulos - Comment\",\n",
      "      \"objectId\" : \"09000064810139b7\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0892\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0893\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kerry Martret - Comment\",\n",
      "      \"objectId\" : \"09000064810139b8\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0893\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0894\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diane R Beelman - Comment\",\n",
      "      \"objectId\" : \"09000064810139bc\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0894\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0895\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"gary r leigh - Comment\",\n",
      "      \"objectId\" : \"090000648101362e\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0895\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0896\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"E Eisenberg - Comment\",\n",
      "      \"objectId\" : \"09000064810139e3\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0896\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0897\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Victoria Cooper - Comment\",\n",
      "      \"objectId\" : \"0900006481013683\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0897\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0898\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adriana Silva Rodriguez - Comment\",\n",
      "      \"objectId\" : \"0900006481013a05\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0898\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0899\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"norhella patricia lofthouse - Comment\",\n",
      "      \"objectId\" : \"09000064810136a1\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0899\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0900\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nadia Kossman - Comment\",\n",
      "      \"objectId\" : \"09000064810136a7\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0900\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0901\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susanne - Comment\",\n",
      "      \"objectId\" : \"09000064810136a9\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0901\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0902\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lucy Almeida - Comment\",\n",
      "      \"objectId\" : \"0900006481013a20\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0902\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0903\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Juarez - Comment\",\n",
      "      \"objectId\" : \"09000064810136b7\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0903\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0904\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810136b9\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0904\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0905\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emily Vaughton - Comment\",\n",
      "      \"objectId\" : \"0900006481013a2f\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0905\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0906\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cathy T Karr - Comment\",\n",
      "      \"objectId\" : \"0900006481013a30\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0906\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0907\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rita Basto - Comment\",\n",
      "      \"objectId\" : \"09000064810136bc\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0907\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0908\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"shelly m. dages - Comment\",\n",
      "      \"objectId\" : \"0900006481013a34\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0908\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0909\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rosemary Webster - Comment\",\n",
      "      \"objectId\" : \"09000064810136c3\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0909\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0910\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Siebke - Comment\",\n",
      "      \"objectId\" : \"0900006481013a37\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0910\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0911\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andi Karen Klein - Comment\",\n",
      "      \"objectId\" : \"0900006481013a44\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0911\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0912\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Carrales - Comment\",\n",
      "      \"objectId\" : \"0900006481013a49\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0912\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0913\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Zaida Jorat - Comment\",\n",
      "      \"objectId\" : \"09000064810136ce\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0913\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0914\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vanessa AnnaMae Brown - Comment\",\n",
      "      \"objectId\" : \"09000064810136d0\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0914\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0915\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tina Jaime - Comment\",\n",
      "      \"objectId\" : \"09000064810136d1\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0915\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0916\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claudia Lilia Hernandez - Comment\",\n",
      "      \"objectId\" : \"0900006481013a50\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0916\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0917\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chris S Thomas - Comment\",\n",
      "      \"objectId\" : \"0900006481013a55\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0917\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0918\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bri Hays - Comment\",\n",
      "      \"objectId\" : \"09000064810136d3\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0918\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0919\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gabrielle Leigh Sekuterski - Comment\",\n",
      "      \"objectId\" : \"09000064810136d5\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0919\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0920\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Valerie Peters - Comment\",\n",
      "      \"objectId\" : \"09000064810136da\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0920\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0921\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"George H. Campbell - Comment\",\n",
      "      \"objectId\" : \"0900006481013a67\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0921\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0922\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Cronk - Comment\",\n",
      "      \"objectId\" : \"09000064810136de\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0922\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0923\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"joe samuel brennan - Comment\",\n",
      "      \"objectId\" : \"09000064810136e1\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0923\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0924\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen A Schnitzer - Comment\",\n",
      "      \"objectId\" : \"09000064810136eb\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0924\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0925\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"matt r peake - Comment\",\n",
      "      \"objectId\" : \"09000064810136ec\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0925\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0926\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ruby Wang - Comment\",\n",
      "      \"objectId\" : \"09000064810136f2\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0926\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0927\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"TANYA ARDEL SHAW - Comment\",\n",
      "      \"objectId\" : \"0900006481013a71\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0927\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0928\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kate - Comment\",\n",
      "      \"objectId\" : \"09000064810136f6\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0928\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0929\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wendy Marie Hoofnagle - Comment\",\n",
      "      \"objectId\" : \"0900006481013a77\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0929\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0930\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"eric philip ryan - Comment\",\n",
      "      \"objectId\" : \"09000064810136f9\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0930\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0931\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Valerie Lynn Whitty-Mullin - Comment\",\n",
      "      \"objectId\" : \"0900006481013a7c\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0931\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0932\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrei Krik - Comment\",\n",
      "      \"objectId\" : \"0900006481013a7d\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0932\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0933\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heather - Comment\",\n",
      "      \"objectId\" : \"09000064810136fd\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0933\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0934\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pam Harris - Comment\",\n",
      "      \"objectId\" : \"0900006481013a83\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0934\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0935\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karishma J Khoja - Comment\",\n",
      "      \"objectId\" : \"0900006481013701\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0935\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0936\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Jane Shedden - Comment\",\n",
      "      \"objectId\" : \"0900006481013a84\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0936\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0937\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"lauren - Comment\",\n",
      "      \"objectId\" : \"0900006481013705\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0937\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0938\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ANDRES F. TRIANA - Comment\",\n",
      "      \"objectId\" : \"0900006481013a89\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0938\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0939\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David L Murphy - Comment\",\n",
      "      \"objectId\" : \"0900006481013a8a\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0939\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0940\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hnub Vang - Comment\",\n",
      "      \"objectId\" : \"0900006481013a8c\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0940\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0941\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Renata Kater Manowitz - Comment\",\n",
      "      \"objectId\" : \"090000648101370c\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0941\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0942\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ken and Jan Livingston - Comment\",\n",
      "      \"objectId\" : \"090000648101370f\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0942\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0943\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sunni Wigand - Comment\",\n",
      "      \"objectId\" : \"0900006481013a93\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0943\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0944\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LEAH - Comment\",\n",
      "      \"objectId\" : \"0900006481013a94\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0944\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0945\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole K Carson - Comment\",\n",
      "      \"objectId\" : \"0900006481013723\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0945\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0946\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Greg Rosas - Comment\",\n",
      "      \"objectId\" : \"0900006481013aa8\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0946\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0947\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sanj Gabriel - Comment\",\n",
      "      \"objectId\" : \"0900006481013726\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0947\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0948\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Teagan Raye Stratton - Comment\",\n",
      "      \"objectId\" : \"0900006481013ab1\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0948\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0949\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-05T22:02:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Santiago Cormane - Comment\",\n",
      "      \"objectId\" : \"090000648101372d\",\n",
      "      \"postedDate\" : \"2012-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0949\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0950\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481013730\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0950\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0951\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Weitzel - Comment\",\n",
      "      \"objectId\" : \"0900006481013732\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0951\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0952\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Weitzel - Comment\",\n",
      "      \"objectId\" : \"0900006481013733\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0952\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0953\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Weitzel - Comment\",\n",
      "      \"objectId\" : \"0900006481013735\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0953\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0954\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"farideh davani - Comment\",\n",
      "      \"objectId\" : \"0900006481013acb\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0954\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0955\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SETH HIRSH - Comment\",\n",
      "      \"objectId\" : \"0900006481013ade\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0955\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0956\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Mari-Dale - Comment\",\n",
      "      \"objectId\" : \"0900006481013adf\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0956\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0957\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Austin James Abrego - Comment\",\n",
      "      \"objectId\" : \"0900006481013ae2\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0957\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0958\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:38:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle L. Roesch - Comment\",\n",
      "      \"objectId\" : \"090000648101375f\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0958\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0959\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"paul john parsons - Comment\",\n",
      "      \"objectId\" : \"0900006481013761\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0959\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0960\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"deborah van damme - Comment\",\n",
      "      \"objectId\" : \"090000648101376f\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0960\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0961\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ROBERTA ANN CLAYPOOL - Comment\",\n",
      "      \"objectId\" : \"0900006481013af9\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0961\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0962\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C B - Comment\",\n",
      "      \"objectId\" : \"0900006481013afe\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0962\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0963\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly S Larsen - Comment\",\n",
      "      \"objectId\" : \"0900006481013b0f\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0963\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0964\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chiara Sarenas - Comment\",\n",
      "      \"objectId\" : \"0900006481013b11\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0964\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0965\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"stephen corey benjamin - Comment\",\n",
      "      \"objectId\" : \"0900006481013b12\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0965\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0966\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"alicia rowe - Comment\",\n",
      "      \"objectId\" : \"0900006481013b14\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0966\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0967\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marcy Cap - Comment\",\n",
      "      \"objectId\" : \"090000648101378b\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0967\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0968\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Licea - Comment\",\n",
      "      \"objectId\" : \"0900006481013b1b\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0968\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0969\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Maria McWilliams - Comment\",\n",
      "      \"objectId\" : \"0900006481013b2f\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0969\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0970\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren H Ford - Comment\",\n",
      "      \"objectId\" : \"0900006481013b35\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0970\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0971\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alicia Quintero - Comment\",\n",
      "      \"objectId\" : \"09000064810137a4\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0971\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0972\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jose E Perez V - Comment\",\n",
      "      \"objectId\" : \"0900006481013b49\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0972\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0973\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marcos Ramírez Cordero - Comment\",\n",
      "      \"objectId\" : \"0900006481013b59\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0973\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0974\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LINDA MARCELLE CAMPBELL - Comment\",\n",
      "      \"objectId\" : \"09000064810137ca\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0974\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0975\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cassandra Reuss - Comment\",\n",
      "      \"objectId\" : \"09000064810137d0\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0975\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0976\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481013b76\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0976\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0977\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert New - Comment\",\n",
      "      \"objectId\" : \"09000064810137f6\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0977\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0978\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"L D Pratt - Comment\",\n",
      "      \"objectId\" : \"09000064810137f7\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0978\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0979\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CAROL VALENTINE COLCLASURE - Comment\",\n",
      "      \"objectId\" : \"090000648101380e\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0979\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0980\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tara Marie Cufaude - Comment\",\n",
      "      \"objectId\" : \"0900006481013bb3\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0980\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0981\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elizabeth Morelli - Comment\",\n",
      "      \"objectId\" : \"0900006481013bbc\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0981\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0982\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jennifer lynn dunkle - Comment\",\n",
      "      \"objectId\" : \"0900006481013bbd\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0982\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0983\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marina Blanche Munoz - Comment\",\n",
      "      \"objectId\" : \"0900006481013839\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0983\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0984\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ksenia Asatryan - Comment\",\n",
      "      \"objectId\" : \"0900006481013856\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0984\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0985\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joni M Brora-Tawesson - Comment\",\n",
      "      \"objectId\" : \"0900006481013859\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0985\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0986\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ester Bredenhand - Comment\",\n",
      "      \"objectId\" : \"0900006481013bf1\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0986\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0987\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Marie - Comment\",\n",
      "      \"objectId\" : \"090000648101386e\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0987\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0988\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nuno Gustavo Correia d'Oliveira; DDS, Msd - Comment\",\n",
      "      \"objectId\" : \"0900006481013878\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0988\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0989\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hiroe Watanabe - Comment\",\n",
      "      \"objectId\" : \"0900006481013c02\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0989\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0990\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amelie S Shadout - Comment\",\n",
      "      \"objectId\" : \"0900006481013c06\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0990\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0991\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole-Ann Thomas - Comment\",\n",
      "      \"objectId\" : \"0900006481013c0a\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0991\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0992\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Yasiu Kruszynski - Comment\",\n",
      "      \"objectId\" : \"0900006481013884\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0992\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0993\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-06T21:39:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniel Walesiak - Comment\",\n",
      "      \"objectId\" : \"0900006481013c1c\",\n",
      "      \"postedDate\" : \"2012-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0993\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0994\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-09T18:22:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Women Against Cruelty  - Comment\",\n",
      "      \"objectId\" : \"0900006481013d1e\",\n",
      "      \"postedDate\" : \"2012-07-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0994\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0995\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-09T18:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"People for The Ethical Treatment of Animals - Comment\",\n",
      "      \"objectId\" : \"0900006481013cfa\",\n",
      "      \"postedDate\" : \"2012-07-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0995\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0996\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Phyllis Huang - Comment\",\n",
      "      \"objectId\" : \"090000648101389a\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0996\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0997\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"federica furlan - Comment\",\n",
      "      \"objectId\" : \"09000064810138a8\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0997\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0998\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claire Devin Neely - Comment\",\n",
      "      \"objectId\" : \"09000064810138ae\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0998\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0999\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jane Ashton - Comment\",\n",
      "      \"objectId\" : \"09000064810138b1\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0999\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1000\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca - Comment\",\n",
      "      \"objectId\" : \"09000064810138ba\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1000\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1001\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"israel diaz ortiz - Comment\",\n",
      "      \"objectId\" : \"09000064810138e4\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1001\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandra Tetenburg - Comment\",\n",
      "      \"objectId\" : \"09000064810138e5\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nike Theodora Cacoullos - Comment\",\n",
      "      \"objectId\" : \"09000064810138fd\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"garnet lynn warthan - Comment\",\n",
      "      \"objectId\" : \"0900006481013d00\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annette Poerschke - Comment\",\n",
      "      \"objectId\" : \"0900006481013c8e\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jenny Rose - Comment\",\n",
      "      \"objectId\" : \"0900006481013d03\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1006\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 4,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-1007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alexandre Manuel Miranda Pereira - Comment\",\n",
      "      \"objectId\" : \"0900006481013c9a\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annette Poerschke - Comment\",\n",
      "      \"objectId\" : \"0900006481013c9b\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael James Springthorpe - Comment\",\n",
      "      \"objectId\" : \"0900006481013ca7\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julianne Maxwell Bonasera - Comment\",\n",
      "      \"objectId\" : \"0900006481013d88\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Geoffrey Pyne Campbell - Comment\",\n",
      "      \"objectId\" : \"0900006481013d90\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Shumaker - Comment\",\n",
      "      \"objectId\" : \"0900006481013da1\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vanessa Butlim Porto - Comment\",\n",
      "      \"objectId\" : \"0900006481013db2\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ellen A. Bruce - Comment\",\n",
      "      \"objectId\" : \"0900006481013dbf\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Terry Callow - Comment\",\n",
      "      \"objectId\" : \"0900006481013deb\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"doug krause - Comment\",\n",
      "      \"objectId\" : \"0900006481013dfd\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-10T21:56:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"sezar ciu - Comment\",\n",
      "      \"objectId\" : \"0900006481013e26\",\n",
      "      \"postedDate\" : \"2012-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"shira s chalmers - Comment\",\n",
      "      \"objectId\" : \"0900006481013f81\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Ann Petrini - Comment\",\n",
      "      \"objectId\" : \"0900006481013f82\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shirin Bunting - Comment\",\n",
      "      \"objectId\" : \"090000648101432b\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Linda Kennedy - Comment\",\n",
      "      \"objectId\" : \"0900006481014339\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert B. Keiser - Comment\",\n",
      "      \"objectId\" : \"0900006481014365\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Aurore Zimon Terzian - Comment\",\n",
      "      \"objectId\" : \"0900006481014368\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jamie L Green - Comment\",\n",
      "      \"objectId\" : \"0900006481013fde\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Samantha Sinclair - Comment\",\n",
      "      \"objectId\" : \"09000064810143a3\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christa - Comment\",\n",
      "      \"objectId\" : \"09000064810143a5\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vivien Jennifer Smith - Comment\",\n",
      "      \"objectId\" : \"09000064810143a9\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Matt Luce - Comment\",\n",
      "      \"objectId\" : \"0900006481014053\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lyn Lazarevic - Comment\",\n",
      "      \"objectId\" : \"0900006481014063\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-11T21:58:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Barrett - Comment\",\n",
      "      \"objectId\" : \"09000064810143dc\",\n",
      "      \"postedDate\" : \"2012-07-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CARL - Comment\",\n",
      "      \"objectId\" : \"0900006481014404\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leann - Comment\",\n",
      "      \"objectId\" : \"0900006481014087\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suanne Cheri Schmidt - Comment\",\n",
      "      \"objectId\" : \"090000648101408c\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christina Michele Bovaird - Comment\",\n",
      "      \"objectId\" : \"090000648101445b\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeanne C Bradbury - Comment\",\n",
      "      \"objectId\" : \"090000648101445d\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kylie Jahshan - Comment\",\n",
      "      \"objectId\" : \"09000064810140e3\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kyana Onowa Jones - Comment\",\n",
      "      \"objectId\" : \"09000064810140f0\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cassie Jo Espinosa - Comment\",\n",
      "      \"objectId\" : \"09000064810144d4\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren E Walker - Comment\",\n",
      "      \"objectId\" : \"09000064810140f2\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Zalaznick - Comment\",\n",
      "      \"objectId\" : \"09000064810144db\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810140f7\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katherine Annette Boudreaux - Comment\",\n",
      "      \"objectId\" : \"09000064810144eb\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"BETTINA MARIE KIRBY - Comment\",\n",
      "      \"objectId\" : \"0900006481014512\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen - Comment\",\n",
      "      \"objectId\" : \"09000064810144fb\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Bowles - Comment\",\n",
      "      \"objectId\" : \"0900006481014913\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Song - Comment\",\n",
      "      \"objectId\" : \"0900006481014544\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481014551\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Callyn Arielle Mckeen - Comment\",\n",
      "      \"objectId\" : \"090000648101493e\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Ranstrom - Comment\",\n",
      "      \"objectId\" : \"090000648101493f\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mervi Rantala - Comment\",\n",
      "      \"objectId\" : \"0900006481014943\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chuck White - Comment\",\n",
      "      \"objectId\" : \"0900006481014585\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Colleen Meyer - Comment\",\n",
      "      \"objectId\" : \"09000064810145bc\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Massimo Cavalieri d'Oro - Comment\",\n",
      "      \"objectId\" : \"09000064810145c0\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandra Loucille Mary Britton - Comment\",\n",
      "      \"objectId\" : \"09000064810145c9\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dita Baranek - Comment\",\n",
      "      \"objectId\" : \"09000064810145cf\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pamela Louise Martin - Comment\",\n",
      "      \"objectId\" : \"09000064810145f1\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brittany Holmes - Comment\",\n",
      "      \"objectId\" : \"09000064810145f7\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rhiannon Amy Bloomfield - Comment\",\n",
      "      \"objectId\" : \"090000648101460b\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"purvi shukla - Comment\",\n",
      "      \"objectId\" : \"0900006481014a24\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"paul r popovici - Comment\",\n",
      "      \"objectId\" : \"090000648101460d\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alex N Tsukernik - Comment\",\n",
      "      \"objectId\" : \"0900006481014a36\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daisy Leeann Tyler - Comment\",\n",
      "      \"objectId\" : \"0900006481014636\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dorniece Nichelle Stephen - Comment\",\n",
      "      \"objectId\" : \"0900006481014a91\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Hatheway - Comment\",\n",
      "      \"objectId\" : \"0900006481014699\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula A Boyer - Comment\",\n",
      "      \"objectId\" : \"0900006481014bca\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kris Harker - Comment\",\n",
      "      \"objectId\" : \"0900006481014bcc\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon Killay - Comment\",\n",
      "      \"objectId\" : \"090000648101469e\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cynthia M Scalici - Comment\",\n",
      "      \"objectId\" : \"0900006481014d1c\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lian - Comment\",\n",
      "      \"objectId\" : \"0900006481014d34\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annemieke Krop - Comment\",\n",
      "      \"objectId\" : \"0900006481014e22\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stanley Partin - Comment\",\n",
      "      \"objectId\" : \"0900006481014e97\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Aranibar - Comment\",\n",
      "      \"objectId\" : \"0900006481014e98\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diane Baxter-MacArthur - Comment\",\n",
      "      \"objectId\" : \"0900006481014fd8\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"randall smith - Comment\",\n",
      "      \"objectId\" : \"0900006481014706\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ROSALBA D'AGOSTINO - Comment\",\n",
      "      \"objectId\" : \"0900006481015057\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chander kumar soni soni - Comment\",\n",
      "      \"objectId\" : \"090000648101471b\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cindy de la Garza - Comment\",\n",
      "      \"objectId\" : \"090000648101471c\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sabina Linda Gross - Comment\",\n",
      "      \"objectId\" : \"0900006481015082\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1079\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"danielle aguilera - Comment\",\n",
      "      \"objectId\" : \"09000064810150ab\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1079\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer C. Schmitz - Comment\",\n",
      "      \"objectId\" : \"09000064810147a2\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ms.. T. Christon - Comment\",\n",
      "      \"objectId\" : \"09000064810150e0\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeanette Suzzanne Seidel - Comment\",\n",
      "      \"objectId\" : \"0900006481015113\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Canfield - Comment\",\n",
      "      \"objectId\" : \"09000064810147da\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"tiffany Le - Comment\",\n",
      "      \"objectId\" : \"09000064810147e7\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amanda Simao - Comment\",\n",
      "      \"objectId\" : \"0900006481015126\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-12T21:57:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Fernando G Hernandez - Comment\",\n",
      "      \"objectId\" : \"09000064810147ef\",\n",
      "      \"postedDate\" : \"2012-07-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-13T16:23:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandy Lowe PETA - Comment\",\n",
      "      \"objectId\" : \"0900006481014815\",\n",
      "      \"postedDate\" : \"2012-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-13T16:28:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Joan Noon PETA - Comment\",\n",
      "      \"objectId\" : \"090000648101513a\",\n",
      "      \"postedDate\" : \"2012-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-13T19:09:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren L.  Peta - Comment\",\n",
      "      \"objectId\" : \"090000648101483f\",\n",
      "      \"postedDate\" : \"2012-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1090\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-13T20:20:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"English Animal Clinic - Comment\",\n",
      "      \"objectId\" : \"090000648101487b\",\n",
      "      \"postedDate\" : \"2012-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1090\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1091\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-13T20:36:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MG Lloyd Hughes - Comment\",\n",
      "      \"objectId\" : \"09000064810148ad\",\n",
      "      \"postedDate\" : \"2012-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1091\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1092\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sabrina Hanley - Comment\",\n",
      "      \"objectId\" : \"09000064810148ba\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1092\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1093\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Frank Hanley - Comment\",\n",
      "      \"objectId\" : \"09000064810148be\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1093\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1094\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laurel Brewer - Comment\",\n",
      "      \"objectId\" : \"0900006481015224\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1094\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"cassie ann Bianchi - Comment\",\n",
      "      \"objectId\" : \"0900006481015229\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Roland Goyette - Comment\",\n",
      "      \"objectId\" : \"0900006481015246\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1097\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101524b\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1097\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie Dyer - Comment\",\n",
      "      \"objectId\" : \"0900006481015525\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael M Tat - Comment\",\n",
      "      \"objectId\" : \"0900006481015526\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Anne Stevens - Comment\",\n",
      "      \"objectId\" : \"090000648101552d\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1101\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julija Merljak - Comment\",\n",
      "      \"objectId\" : \"0900006481015539\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1101\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1102\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Phoebe Price - Comment\",\n",
      "      \"objectId\" : \"0900006481015286\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1102\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1103\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gaye Mallinson - Comment\",\n",
      "      \"objectId\" : \"0900006481015291\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1103\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1104\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jacob Johnston - Comment\",\n",
      "      \"objectId\" : \"0900006481015292\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1104\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ben Frank Ramcharan - Comment\",\n",
      "      \"objectId\" : \"0900006481015296\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janet Rogers - Comment\",\n",
      "      \"objectId\" : \"0900006481015568\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jesse pena - Comment\",\n",
      "      \"objectId\" : \"090000648101556b\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandra - Comment\",\n",
      "      \"objectId\" : \"09000064810152c1\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stacey Lynn Gluchman - Comment\",\n",
      "      \"objectId\" : \"09000064810152c9\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joanne S Beeson - Comment\",\n",
      "      \"objectId\" : \"0900006481015584\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1110\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1111\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Nicole Threadingham - Comment\",\n",
      "      \"objectId\" : \"090000648101558a\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1111\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1112\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"megan Cashman - Comment\",\n",
      "      \"objectId\" : \"09000064810152e1\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1112\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1113\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Malithi Wijayathilaka - Comment\",\n",
      "      \"objectId\" : \"0900006481015591\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1113\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1114\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Loren de Souza Almeida - Comment\",\n",
      "      \"objectId\" : \"09000064810152fd\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1114\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1115\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"cristina eve ashley - Comment\",\n",
      "      \"objectId\" : \"09000064810155b0\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1115\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1116\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Marie McDaniel - Comment\",\n",
      "      \"objectId\" : \"09000064810155c1\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1116\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1117\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diane Alcibar - Comment\",\n",
      "      \"objectId\" : \"09000064810155c9\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1117\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1118\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kate Louise Jarvis - Comment\",\n",
      "      \"objectId\" : \"0900006481015350\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1118\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1119\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol - Comment\",\n",
      "      \"objectId\" : \"09000064810155ee\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1119\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1120\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Everett and Melody Halligan - Comment\",\n",
      "      \"objectId\" : \"090000648101538f\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1120\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1121\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Angotti - Comment\",\n",
      "      \"objectId\" : \"09000064810153a4\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1121\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1122\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Iacopo giopp - Comment\",\n",
      "      \"objectId\" : \"0900006481015625\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1122\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1123\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Francesca Kristen Hunter - Comment\",\n",
      "      \"objectId\" : \"09000064810153ac\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1123\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1124\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Loree Cygrymus - Comment\",\n",
      "      \"objectId\" : \"09000064810153b1\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1124\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1125\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica A Grantier - Comment\",\n",
      "      \"objectId\" : \"090000648101563c\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1125\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1126\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"maytee berumen - Comment\",\n",
      "      \"objectId\" : \"09000064810153bc\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1126\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1127\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jaclyn Rohan - Comment\",\n",
      "      \"objectId\" : \"09000064810153c1\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1127\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1128\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Júlia Kršková - Comment\",\n",
      "      \"objectId\" : \"09000064810153c9\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1128\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1129\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Parr - Comment\",\n",
      "      \"objectId\" : \"09000064810153dc\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1129\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1130\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynette Joy Wiens - Comment\",\n",
      "      \"objectId\" : \"09000064810153fa\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1130\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1131\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elenia Landau - Comment\",\n",
      "      \"objectId\" : \"09000064810156c7\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1131\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1132\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mariette Ann Eriksson - Comment\",\n",
      "      \"objectId\" : \"0900006481015443\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1132\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1133\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Elane James - Comment\",\n",
      "      \"objectId\" : \"0900006481015472\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1133\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1134\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CLAUDETTE BABINEAU - Comment\",\n",
      "      \"objectId\" : \"0900006481015497\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1134\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1135\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslyn Louise Keil - Comment\",\n",
      "      \"objectId\" : \"090000648101579c\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1135\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1136\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heather Simpkins - Comment\",\n",
      "      \"objectId\" : \"09000064810157a4\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1136\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1137\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah Yvonne Claros - Comment\",\n",
      "      \"objectId\" : \"09000064810159c3\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1137\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1138\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bev Pope - Comment\",\n",
      "      \"objectId\" : \"09000064810157b1\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1138\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1139\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NANCY IRACEMA SHARFF - Comment\",\n",
      "      \"objectId\" : \"0900006481015a2d\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1139\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1140\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"marilyn evenson - Comment\",\n",
      "      \"objectId\" : \"0900006481015806\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1140\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1141\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stacey Leah Scriven - Comment\",\n",
      "      \"objectId\" : \"0900006481015809\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1141\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1142\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brooke Nicole Schmitt - Comment\",\n",
      "      \"objectId\" : \"090000648101581e\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1142\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1143\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"lory decallonne - Comment\",\n",
      "      \"objectId\" : \"0900006481015a6f\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1143\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1144\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebekah Kreckman - Comment\",\n",
      "      \"objectId\" : \"0900006481015a77\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1144\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adelle K Powers - Comment\",\n",
      "      \"objectId\" : \"0900006481015aad\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1146\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebekah DeHaven - Comment\",\n",
      "      \"objectId\" : \"0900006481015acc\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1146\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1147\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bronson Boehmer - Comment\",\n",
      "      \"objectId\" : \"090000648101586e\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1147\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1148\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jacqui Barnette - Comment\",\n",
      "      \"objectId\" : \"0900006481015870\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1148\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1149\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ann-Christin Mayer - Comment\",\n",
      "      \"objectId\" : \"0900006481015aff\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1149\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gerry Collins - Comment\",\n",
      "      \"objectId\" : \"0900006481015b0d\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anni H. - Comment\",\n",
      "      \"objectId\" : \"0900006481015b40\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1151\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1152\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"angela fazzari - Comment\",\n",
      "      \"objectId\" : \"0900006481015b60\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1152\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1153\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chelsey Lea Tilley - Comment\",\n",
      "      \"objectId\" : \"0900006481015b64\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1153\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1154\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gary J. Foss - Comment\",\n",
      "      \"objectId\" : \"0900006481015ba7\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1154\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1155\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sylvie Sylvie Rochat - Comment\",\n",
      "      \"objectId\" : \"0900006481015d72\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1155\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1156\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marilyn Jean Wilson - Comment\",\n",
      "      \"objectId\" : \"0900006481015d7d\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1156\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1157\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-17T22:20:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kim Burns - Comment\",\n",
      "      \"objectId\" : \"0900006481015bbc\",\n",
      "      \"postedDate\" : \"2012-07-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1157\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1158\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Anne Hulett - Comment\",\n",
      "      \"objectId\" : \"0900006481015bd1\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1158\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1159\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna LaChance - Comment\",\n",
      "      \"objectId\" : \"0900006481015bef\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1159\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1160\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leonardo Martins Marsola - Comment\",\n",
      "      \"objectId\" : \"0900006481015bf7\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1160\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1161\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adrienne Miriani - Comment\",\n",
      "      \"objectId\" : \"0900006481015c2d\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1161\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1162\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alicia Pacheco - Comment\",\n",
      "      \"objectId\" : \"0900006481015e18\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1162\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1163\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amanda Louise Salvner - Comment\",\n",
      "      \"objectId\" : \"0900006481015c30\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1163\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1164\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"eve danner lentz - Comment\",\n",
      "      \"objectId\" : \"0900006481015c3e\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1164\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claudia Rose Bosgra - Comment\",\n",
      "      \"objectId\" : \"0900006481015e72\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1165\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1166\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adarsh Ayyar - Comment\",\n",
      "      \"objectId\" : \"0900006481015e8c\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1166\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1167\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Graham - Comment\",\n",
      "      \"objectId\" : \"0900006481015e8e\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1167\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1168\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jenny Bramlette - Comment\",\n",
      "      \"objectId\" : \"0900006481015e9c\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1168\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1169\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kerry dika - Comment\",\n",
      "      \"objectId\" : \"0900006481015eab\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1169\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1170\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cassidy Rieanna Chiarotti - Comment\",\n",
      "      \"objectId\" : \"0900006481015eb7\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1170\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1171\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa Anne Wheeler - Comment\",\n",
      "      \"objectId\" : \"0900006481015edf\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1171\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1172\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kyle c newell - Comment\",\n",
      "      \"objectId\" : \"0900006481015f23\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1172\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1173\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jonathan deutsch - Comment\",\n",
      "      \"objectId\" : \"0900006481015f75\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1173\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1174\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle E. Rice - Comment\",\n",
      "      \"objectId\" : \"090000648101616d\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1174\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1175\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Tatton - Comment\",\n",
      "      \"objectId\" : \"0900006481015f85\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1175\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1176\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara S Jamhour - Comment\",\n",
      "      \"objectId\" : \"090000648101618b\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1176\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1177\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Monica Larsen - Comment\",\n",
      "      \"objectId\" : \"09000064810161b9\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1177\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1178\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jerald M Cogswell - Comment\",\n",
      "      \"objectId\" : \"09000064810161ca\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1178\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1179\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Geoffrey Pyne Campbell - Comment\",\n",
      "      \"objectId\" : \"09000064810161e1\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1179\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1180\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Robinson - Comment\",\n",
      "      \"objectId\" : \"090000648101606b\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1180\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1181\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristina Ann Kirstin - Comment\",\n",
      "      \"objectId\" : \"090000648101606e\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1181\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1182\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carin Slowik - Comment\",\n",
      "      \"objectId\" : \"090000648101623d\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1182\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1183\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Krystie Grubba - Comment\",\n",
      "      \"objectId\" : \"09000064810160de\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1183\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1184\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"H. Hippen - Comment\",\n",
      "      \"objectId\" : \"0900006481016269\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1184\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1185\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"IZUMI YOSHIDA - Comment\",\n",
      "      \"objectId\" : \"090000648101650e\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1185\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1186\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nannina Hardie - Comment\",\n",
      "      \"objectId\" : \"09000064810162b6\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1186\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1187\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"laura thomazon - Comment\",\n",
      "      \"objectId\" : \"090000648101652c\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1187\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1188\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Magnus Tell - Comment\",\n",
      "      \"objectId\" : \"090000648101653f\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1188\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1189\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MARIA CRISTINA BELGO - Comment\",\n",
      "      \"objectId\" : \"090000648101633e\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1189\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1190\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Reetta Hannele Hänninen - Comment\",\n",
      "      \"objectId\" : \"090000648101634e\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1190\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1191\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"aisha Khachinyan - Comment\",\n",
      "      \"objectId\" : \"09000064810165fb\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1191\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1192\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzanna van der Voort - Comment\",\n",
      "      \"objectId\" : \"0900006481016630\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1192\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1193\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stefan Kozinski - Comment\",\n",
      "      \"objectId\" : \"09000064810163f0\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1193\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1194\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"joe s berard - Comment\",\n",
      "      \"objectId\" : \"0900006481016683\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1194\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1195\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pattricia Salinas - Comment\",\n",
      "      \"objectId\" : \"0900006481016406\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1195\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1196\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristin Lee Doane - Comment\",\n",
      "      \"objectId\" : \"09000064810166a3\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1196\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1197\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"aisling mary oflynn - Comment\",\n",
      "      \"objectId\" : \"09000064810166c6\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1197\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1198\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Marie Fransen-Conroy - Comment\",\n",
      "      \"objectId\" : \"0900006481016454\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1198\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1199\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-18T21:06:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elena Gambino - Comment\",\n",
      "      \"objectId\" : \"090000648101646a\",\n",
      "      \"postedDate\" : \"2012-07-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1199\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1200\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T19:02:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Philip Morris International Management S.A. (Hogan Lovells US LLP) - Comment\",\n",
      "      \"objectId\" : \"0900006481036585\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1200\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1201\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T19:06:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"People for the Ethical Treatment of Animals (PETA) - Comment\",\n",
      "      \"objectId\" : \"090000648103cb28\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1201\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1202\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Tucciarone - Comment\",\n",
      "      \"objectId\" : \"0900006481016477\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1202\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1203\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christina Denise McDowell - Comment\",\n",
      "      \"objectId\" : \"0900006481016704\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1203\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1204\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Özlem Dayanık - Comment\",\n",
      "      \"objectId\" : \"0900006481016706\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1204\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1205\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sean Walter Keegan - Comment\",\n",
      "      \"objectId\" : \"0900006481016731\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1205\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1206\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"KARIN VARGAS - Comment\",\n",
      "      \"objectId\" : \"09000064810164b0\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1206\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1207\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Letitia - Comment\",\n",
      "      \"objectId\" : \"09000064810164f4\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1207\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1208\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"steven martin calder - Comment\",\n",
      "      \"objectId\" : \"09000064810167a3\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1208\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1209\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101692a\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1209\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1210\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-23T22:13:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"clayton curtis higginbotham - Comment\",\n",
      "      \"objectId\" : \"0900006481016943\",\n",
      "      \"postedDate\" : \"2012-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1210\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1211\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-25T21:31:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brandi Franzman - Comment\",\n",
      "      \"objectId\" : \"0900006481016849\",\n",
      "      \"postedDate\" : \"2012-07-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1211\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1212\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-25T21:31:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mary hirsch - Comment\",\n",
      "      \"objectId\" : \"0900006481016961\",\n",
      "      \"postedDate\" : \"2012-07-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1212\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1213\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-25T21:31:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danielle DiFonzo - Comment\",\n",
      "      \"objectId\" : \"0900006481016968\",\n",
      "      \"postedDate\" : \"2012-07-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1213\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1214\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-25T21:31:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"erin garcia - Comment\",\n",
      "      \"objectId\" : \"0900006481016980\",\n",
      "      \"postedDate\" : \"2012-07-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1214\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1215\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-25T21:31:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Osk Petursdottir - Comment\",\n",
      "      \"objectId\" : \"0900006481016883\",\n",
      "      \"postedDate\" : \"2012-07-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1215\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1216\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-25T21:31:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Haley Jones - Comment\",\n",
      "      \"objectId\" : \"09000064810169e1\",\n",
      "      \"postedDate\" : \"2012-07-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1216\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1217\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Izzy Alexandra - Comment\",\n",
      "      \"objectId\" : \"09000064810169eb\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1217\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1218\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481016d61\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1218\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1219\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481016d78\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1219\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1220\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gladys Castillo - Comment\",\n",
      "      \"objectId\" : \"0900006481016a50\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1220\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1221\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"PAMELA LOVITT - Comment\",\n",
      "      \"objectId\" : \"0900006481016a82\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1221\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1222\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elizabeth Bryan Beaston - Comment\",\n",
      "      \"objectId\" : \"0900006481016ab3\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1222\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1223\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bee Menkes - Comment\",\n",
      "      \"objectId\" : \"0900006481016abf\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1223\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1224\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca - Comment\",\n",
      "      \"objectId\" : \"0900006481016af7\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1224\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1225\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Blake Bentley - Comment\",\n",
      "      \"objectId\" : \"0900006481016e49\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1225\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1226\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jackson samareh - Comment\",\n",
      "      \"objectId\" : \"0900006481016e76\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1226\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1227\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"elisa bacherini - Comment\",\n",
      "      \"objectId\" : \"0900006481016e8e\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1227\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1228\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Y. D. Jordan - Comment\",\n",
      "      \"objectId\" : \"0900006481016bcf\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1228\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1229\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"francesca scribano - Comment\",\n",
      "      \"objectId\" : \"0900006481016bd0\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1229\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1230\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"francesca scribano - Comment\",\n",
      "      \"objectId\" : \"0900006481016bd1\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1230\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1231\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charlene Wightman - Comment\",\n",
      "      \"objectId\" : \"0900006481016ece\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1231\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1232\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Jane Garneski - Comment\",\n",
      "      \"objectId\" : \"0900006481016bf1\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1232\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1233\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashleigh Kristina Dent - Comment\",\n",
      "      \"objectId\" : \"0900006481016eea\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1233\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1234\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"malou søndergaard - Comment\",\n",
      "      \"objectId\" : \"0900006481016f18\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1234\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1235\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Navidad - Comment\",\n",
      "      \"objectId\" : \"0900006481016c19\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1235\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1236\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"sirkku salovaara - Comment\",\n",
      "      \"objectId\" : \"0900006481016c39\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1236\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1237\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juraj Kalus - Comment\",\n",
      "      \"objectId\" : \"0900006481016f6f\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1237\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1238\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"valerie glaise barrat - Comment\",\n",
      "      \"objectId\" : \"0900006481016c61\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1238\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1239\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natalie Costa - Comment\",\n",
      "      \"objectId\" : \"0900006481016c80\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1239\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1240\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Faith Phillips - Comment\",\n",
      "      \"objectId\" : \"0900006481016c8c\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1240\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1241\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amber McDonald - Comment\",\n",
      "      \"objectId\" : \"0900006481017164\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1241\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1242\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kendra alena bench - Comment\",\n",
      "      \"objectId\" : \"0900006481017664\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1242\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1243\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Hoelzeman - Comment\",\n",
      "      \"objectId\" : \"09000064810171c4\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1243\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1244\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mecca Fratto - Comment\",\n",
      "      \"objectId\" : \"090000648101769b\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1244\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1245\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Done - Comment\",\n",
      "      \"objectId\" : \"090000648101769d\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1245\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1246\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DIana - Comment\",\n",
      "      \"objectId\" : \"09000064810171f0\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1246\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1247\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danette M Wilson - Comment\",\n",
      "      \"objectId\" : \"09000064810176c3\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1247\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1248\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Liza McAlister - Comment\",\n",
      "      \"objectId\" : \"09000064810176da\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1248\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1249\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anastasia Theodoridoy - Comment\",\n",
      "      \"objectId\" : \"090000648101724f\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1249\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1250\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annika Hellen Rosendahl - Comment\",\n",
      "      \"objectId\" : \"09000064810176df\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1250\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1251\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elisabeth Elly Linnea Ljung - Comment\",\n",
      "      \"objectId\" : \"09000064810172ed\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1251\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1252\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elisabeth Elly Linnea Ljung - Comment\",\n",
      "      \"objectId\" : \"09000064810172f0\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1252\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1253\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lina Maria Samuelsson - Comment\",\n",
      "      \"objectId\" : \"09000064810176f0\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1253\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1254\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kim Ann Springer - Comment\",\n",
      "      \"objectId\" : \"0900006481017303\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1254\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1255\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kaitlin Christine Faudie - Comment\",\n",
      "      \"objectId\" : \"0900006481017711\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1255\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1256\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T16:35:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tamra Lyn Thurby - Comment\",\n",
      "      \"objectId\" : \"0900006481017725\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1256\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 5,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-1257\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:56:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DEBERA - Comment\",\n",
      "      \"objectId\" : \"090000648101734c\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1257\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1258\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:56:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natalie Arroyo - Comment\",\n",
      "      \"objectId\" : \"0900006481017734\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1258\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1259\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:56:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kevin Richard Brend - Comment\",\n",
      "      \"objectId\" : \"09000064810177c4\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1259\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1260\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:56:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kerstin Maria Wulff - Comment\",\n",
      "      \"objectId\" : \"09000064810173b9\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1260\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1261\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:56:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Staci Marie Rakowiecki - Comment\",\n",
      "      \"objectId\" : \"090000648101787c\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1261\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1262\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracey Ann Carlisle - Comment\",\n",
      "      \"objectId\" : \"0900006481017a5e\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1262\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1263\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sofie Malin Karlsson - Comment\",\n",
      "      \"objectId\" : \"0900006481017bb4\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1263\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1264\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amber Joy Hillanbrand - Comment\",\n",
      "      \"objectId\" : \"0900006481017bef\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1264\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1265\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gayle Aalderink - Comment\",\n",
      "      \"objectId\" : \"0900006481017d3d\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1265\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1266\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Caroline Bell - Comment\",\n",
      "      \"objectId\" : \"0900006481017d41\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1266\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1267\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shea E. Gingerich - Comment\",\n",
      "      \"objectId\" : \"0900006481017d4b\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1267\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1268\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"daria j a - Comment\",\n",
      "      \"objectId\" : \"0900006481017c2b\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1268\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1269\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gerry Collins - Comment\",\n",
      "      \"objectId\" : \"0900006481017d64\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1269\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1270\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ken Cohn - Comment\",\n",
      "      \"objectId\" : \"0900006481017d66\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1270\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1271\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kim Brush - Comment\",\n",
      "      \"objectId\" : \"0900006481017c4d\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1271\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1272\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jess B Westberg - Comment\",\n",
      "      \"objectId\" : \"0900006481017db7\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1272\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1273\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lilia Vanesa Chunir - Comment\",\n",
      "      \"objectId\" : \"0900006481017dbb\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1273\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1274\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marshall Christopher Thill - Comment\",\n",
      "      \"objectId\" : \"0900006481017cc6\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1274\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1275\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annabelle Maria Dunbar - Comment\",\n",
      "      \"objectId\" : \"0900006481017e3a\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1275\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1276\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"S TR - Comment\",\n",
      "      \"objectId\" : \"0900006481017e70\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1276\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1277\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tiffany - Comment\",\n",
      "      \"objectId\" : \"090000648101816d\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1277\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1278\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dawn Sabin - Comment\",\n",
      "      \"objectId\" : \"0900006481017eec\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1278\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1279\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Morgana Christensen Powell - Comment\",\n",
      "      \"objectId\" : \"09000064810181e2\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1279\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1280\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jessica l - Comment\",\n",
      "      \"objectId\" : \"09000064810181e3\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1280\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1281\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cynthia Santana - Comment\",\n",
      "      \"objectId\" : \"090000648101820b\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1281\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1282\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MICHELLE l HARRIS - Comment\",\n",
      "      \"objectId\" : \"0900006481018264\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1282\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1283\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maja Dutrieux - Comment\",\n",
      "      \"objectId\" : \"0900006481017f91\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1283\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1284\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Gruba - Comment\",\n",
      "      \"objectId\" : \"0900006481017fd0\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1284\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1285\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kevin Allen Blakemore - Comment\",\n",
      "      \"objectId\" : \"0900006481018502\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1285\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1286\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sonya L Gendron - Comment\",\n",
      "      \"objectId\" : \"0900006481018503\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1286\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1287\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katarzyna Biskupska - Comment\",\n",
      "      \"objectId\" : \"0900006481018636\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1287\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1288\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janice joyce Patrick - Comment\",\n",
      "      \"objectId\" : \"0900006481018481\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1288\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1289\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brianna Erin Tevnan - Comment\",\n",
      "      \"objectId\" : \"09000064810184cc\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1289\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1290\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mari Rodriguez - Comment\",\n",
      "      \"objectId\" : \"0900006481018756\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1290\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1291\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mindi Kuzminski - Comment\",\n",
      "      \"objectId\" : \"090000648101879b\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1291\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1292\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chloe Sherman-Pepe - Comment\",\n",
      "      \"objectId\" : \"090000648101879d\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1292\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1293\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"laura calvo velilla - Comment\",\n",
      "      \"objectId\" : \"0900006481018881\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1293\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1294\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-26T21:57:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jesse Carl Brown - Comment\",\n",
      "      \"objectId\" : \"09000064810188ca\",\n",
      "      \"postedDate\" : \"2012-07-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1294\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1295\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Ann Skinner - Comment\",\n",
      "      \"objectId\" : \"090000648101914d\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1295\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1296\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C Cooke - Comment\",\n",
      "      \"objectId\" : \"09000064810191b4\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1296\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1297\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rani Borges Sakakibara Reinato - Comment\",\n",
      "      \"objectId\" : \"0900006481019770\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1297\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1298\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer R Haskell - Comment\",\n",
      "      \"objectId\" : \"09000064810197d3\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1298\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1299\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brittany Jay Tamillo - Comment\",\n",
      "      \"objectId\" : \"090000648101935f\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1299\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1300\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzanne Renee Shevell - Comment\",\n",
      "      \"objectId\" : \"0900006481019868\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1300\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1301\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol Ann Swan - Comment\",\n",
      "      \"objectId\" : \"0900006481019869\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1301\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1302\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emily Powers - Comment\",\n",
      "      \"objectId\" : \"0900006481019884\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1302\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1303\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"taline isberian - Comment\",\n",
      "      \"objectId\" : \"09000064810198a3\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1303\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1304\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anne Feingold - Comment\",\n",
      "      \"objectId\" : \"09000064810198b0\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1304\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1305\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lara Busby - Comment\",\n",
      "      \"objectId\" : \"09000064810198d1\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1305\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1306\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shauna C Garcia - Comment\",\n",
      "      \"objectId\" : \"090000648101990a\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1306\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1307\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shabnam Bormand - Comment\",\n",
      "      \"objectId\" : \"0900006481019416\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1307\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1308\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481019911\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1308\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1309\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jill Laughlin - Comment\",\n",
      "      \"objectId\" : \"090000648101943e\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1309\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1310\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marieke Willemijn Post - Comment\",\n",
      "      \"objectId\" : \"0900006481019936\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1310\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1311\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olga Alexandrovna Markiv - Comment\",\n",
      "      \"objectId\" : \"09000064810194b0\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1311\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1312\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anton Viktorovich Tairov - Comment\",\n",
      "      \"objectId\" : \"09000064810194b2\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1312\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1313\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alex Shore - Comment\",\n",
      "      \"objectId\" : \"0900006481019ed8\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1313\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1314\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Russell WINFIELD - Comment\",\n",
      "      \"objectId\" : \"090000648101a055\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1314\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1315\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Samantha Johnson - Comment\",\n",
      "      \"objectId\" : \"0900006481019bc2\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1315\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1316\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diana Vecchio - Comment\",\n",
      "      \"objectId\" : \"0900006481019bd9\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1316\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1317\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary C Doonis - Comment\",\n",
      "      \"objectId\" : \"090000648101a210\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1317\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1318\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donna Lynn Kovarik - Comment\",\n",
      "      \"objectId\" : \"090000648101a223\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1318\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1319\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Arleen J Rutten - Comment\",\n",
      "      \"objectId\" : \"090000648101a337\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1319\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1320\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diana Johanson - Comment\",\n",
      "      \"objectId\" : \"0900006481019cb1\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1320\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1321\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Magdalena Mazurek - Comment\",\n",
      "      \"objectId\" : \"090000648101a666\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1321\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1322\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jadeth Wolf - Comment\",\n",
      "      \"objectId\" : \"090000648101a6a0\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1322\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1323\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven C Robbins - Comment\",\n",
      "      \"objectId\" : \"090000648101a96f\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1323\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1324\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tom Prichard - Comment\",\n",
      "      \"objectId\" : \"090000648101a757\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1324\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1325\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101a787\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1325\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1326\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alyssa Kay Pyman - Comment\",\n",
      "      \"objectId\" : \"090000648101a7be\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1326\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1327\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Krawchuk - Comment\",\n",
      "      \"objectId\" : \"090000648101a7ce\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1327\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1328\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101a7cf\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1328\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1329\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"f f f - Comment\",\n",
      "      \"objectId\" : \"090000648101aaa8\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1329\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1330\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christy Kiley - Comment\",\n",
      "      \"objectId\" : \"090000648101aaab\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1330\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1331\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda McCracken - Comment\",\n",
      "      \"objectId\" : \"090000648101aadb\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1331\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1332\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Ann Leptich - Comment\",\n",
      "      \"objectId\" : \"090000648101aae4\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1332\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1333\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Robinson - Comment\",\n",
      "      \"objectId\" : \"090000648101abc9\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1333\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1334\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101a8d6\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1334\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1335\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"maria ruth cunningham - Comment\",\n",
      "      \"objectId\" : \"090000648101ac18\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1335\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1336\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"tyrone eugene cunningham - Comment\",\n",
      "      \"objectId\" : \"090000648101ac1d\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1336\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1337\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jennifer lynne walker - Comment\",\n",
      "      \"objectId\" : \"090000648101ac63\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1337\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1338\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Matthew Steven Russell - Comment\",\n",
      "      \"objectId\" : \"090000648101ade5\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1338\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1339\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gemma Lye - Comment\",\n",
      "      \"objectId\" : \"090000648101accf\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1339\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1340\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"dostana - Comment\",\n",
      "      \"objectId\" : \"090000648101acf1\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1340\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1341\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101ae61\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1341\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1342\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Avalon C - Comment\",\n",
      "      \"objectId\" : \"090000648101b329\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1342\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1343\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cristal Ann Lawler - Comment\",\n",
      "      \"objectId\" : \"090000648101b096\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1343\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1344\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"stephen cinoski - Comment\",\n",
      "      \"objectId\" : \"090000648101b58e\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1344\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1345\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rhowena MacCuish - Comment\",\n",
      "      \"objectId\" : \"090000648101b5a6\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1345\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1346\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Terri Freedman - Comment\",\n",
      "      \"objectId\" : \"090000648101b60b\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1346\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1347\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Natasha Leah Mckay - Comment\",\n",
      "      \"objectId\" : \"090000648101b635\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1347\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1348\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Roman Liufa - Comment\",\n",
      "      \"objectId\" : \"090000648101bab7\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1348\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1349\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"leeder - Comment\",\n",
      "      \"objectId\" : \"090000648101bb4c\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1349\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1350\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Elizabeth Kennedy - Comment\",\n",
      "      \"objectId\" : \"090000648101bc65\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1350\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1351\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101b8d5\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1351\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1352\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sam Ouellette - Comment\",\n",
      "      \"objectId\" : \"090000648101c23d\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1352\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1353\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Rose Bucciarelli - Comment\",\n",
      "      \"objectId\" : \"090000648101c246\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1353\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1354\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karin Braunsberger - Comment\",\n",
      "      \"objectId\" : \"090000648101c55d\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1354\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1355\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ramona Stoicescu - Comment\",\n",
      "      \"objectId\" : \"090000648101c24d\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1355\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1356\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lioba Multer - Comment\",\n",
      "      \"objectId\" : \"090000648101c562\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1356\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1357\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"joan r butcher - Comment\",\n",
      "      \"objectId\" : \"090000648101c253\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1357\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1358\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonnie Joan Wagner-Westbrook - Comment\",\n",
      "      \"objectId\" : \"090000648101c257\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1358\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1359\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101c573\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1359\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1360\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Slavick - Comment\",\n",
      "      \"objectId\" : \"090000648101c25b\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1360\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1361\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"michele b belisle - Comment\",\n",
      "      \"objectId\" : \"090000648101c576\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1361\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1362\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael A. Procino - Comment\",\n",
      "      \"objectId\" : \"090000648101c57b\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1362\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1363\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Evalyn F Segal, PhD - Comment\",\n",
      "      \"objectId\" : \"090000648101c582\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1363\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1364\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr William Morris - Comment\",\n",
      "      \"objectId\" : \"090000648101c584\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1364\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1365\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Drs Thomas and Barbara Talamo and Susang-Talamo - Comment\",\n",
      "      \"objectId\" : \"090000648101c59d\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1365\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1366\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert L Wheeler, M.D. - Comment\",\n",
      "      \"objectId\" : \"090000648101c279\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1366\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1367\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gayle Patterson, MD(Ret.) - Comment\",\n",
      "      \"objectId\" : \"090000648101c27f\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1367\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1368\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Wayne Neal Johnson - Comment\",\n",
      "      \"objectId\" : \"090000648101c5c5\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1368\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1369\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dennis Black - Comment\",\n",
      "      \"objectId\" : \"090000648101c28e\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1369\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1370\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"M A Henry - Comment\",\n",
      "      \"objectId\" : \"090000648101c5d2\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1370\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1371\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Juliette Trope - Comment\",\n",
      "      \"objectId\" : \"090000648101c290\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1371\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1372\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maxwell Sobel - Comment\",\n",
      "      \"objectId\" : \"090000648101c5d5\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1372\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1373\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richard Bruess - Comment\",\n",
      "      \"objectId\" : \"090000648101c5e0\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1373\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1374\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Elizabeth Thurby - Comment\",\n",
      "      \"objectId\" : \"090000648101c5f4\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1374\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1375\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Fulcheri - Comment\",\n",
      "      \"objectId\" : \"090000648101c5fa\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1375\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1376\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jennifer atwood - Comment\",\n",
      "      \"objectId\" : \"090000648101c2ab\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1376\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1377\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cristina Bocirnea - Comment\",\n",
      "      \"objectId\" : \"090000648101c605\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1377\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1378\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"fernando sanchez camporredondo - Comment\",\n",
      "      \"objectId\" : \"090000648101c2b4\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1378\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1379\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gloria Gayle Dunn - Comment\",\n",
      "      \"objectId\" : \"090000648101c2ba\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1379\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1380\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Alan Rifkin - Comment\",\n",
      "      \"objectId\" : \"090000648101c61c\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1380\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1381\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-27T22:05:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Jason Newsom - Comment\",\n",
      "      \"objectId\" : \"090000648101c2d3\",\n",
      "      \"postedDate\" : \"2012-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1381\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1382\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Valeria Alejandra Quevedo - Comment\",\n",
      "      \"objectId\" : \"090000648101c2cd\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1382\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1383\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alejandra Parodi Martínez - Comment\",\n",
      "      \"objectId\" : \"090000648101c64b\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1383\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1384\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maricarmen Villalobos Guadarrama - Comment\",\n",
      "      \"objectId\" : \"090000648101c2e1\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1384\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1385\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Luz Maria Guevara - Comment\",\n",
      "      \"objectId\" : \"090000648101c2e2\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1385\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1386\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer L Bero - Comment\",\n",
      "      \"objectId\" : \"090000648101c2e5\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1386\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1387\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101c2e7\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1387\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1388\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Sebastian Everett Caine - Comment\",\n",
      "      \"objectId\" : \"090000648101c65f\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1388\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1389\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ann Holmes Carter - Comment\",\n",
      "      \"objectId\" : \"090000648101c66c\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1389\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1390\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eric Weisman, DHS - Comment\",\n",
      "      \"objectId\" : \"090000648101c670\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1390\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1391\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mitra - Comment\",\n",
      "      \"objectId\" : \"090000648101c2f2\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1391\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1392\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"PRABHU SATYA - Comment\",\n",
      "      \"objectId\" : \"090000648101c677\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1392\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1393\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erica Susi Noble - Comment\",\n",
      "      \"objectId\" : \"090000648101c67e\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1393\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1394\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sheila Calderon - Comment\",\n",
      "      \"objectId\" : \"090000648101c32b\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1394\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1395\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marta Knowles - Comment\",\n",
      "      \"objectId\" : \"090000648101c33c\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1395\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1396\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thomas Fronczak - Comment\",\n",
      "      \"objectId\" : \"090000648101c6df\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1396\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1397\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"sharron lee laplante MD, MPH - Comment\",\n",
      "      \"objectId\" : \"090000648101c353\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1397\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1398\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Marie Giordano - Comment\",\n",
      "      \"objectId\" : \"090000648101c6fd\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1398\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1399\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle Kosik - Comment\",\n",
      "      \"objectId\" : \"090000648101c700\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1399\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1400\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thomas Craig Brown - Comment\",\n",
      "      \"objectId\" : \"090000648101c378\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1400\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1401\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dorothy Mae Buttlar - Comment\",\n",
      "      \"objectId\" : \"090000648101c385\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1401\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1402\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cindy McDaniel - Comment\",\n",
      "      \"objectId\" : \"090000648101c388\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1402\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1403\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzanne Kirby - Comment\",\n",
      "      \"objectId\" : \"090000648101c71d\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1403\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1404\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"BRUNO AUGUSTO MATSUKURA - Comment\",\n",
      "      \"objectId\" : \"090000648101c72a\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1404\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1405\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Joan Rodman - Comment\",\n",
      "      \"objectId\" : \"090000648101c741\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1405\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1406\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven Wayne Strode - Comment\",\n",
      "      \"objectId\" : \"090000648101c742\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1406\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1407\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Bremer - Comment\",\n",
      "      \"objectId\" : \"090000648101c754\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1407\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1408\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Jane Flower - Comment\",\n",
      "      \"objectId\" : \"090000648101c3d0\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1408\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1409\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-30T22:14:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Louise Thorp - Comment\",\n",
      "      \"objectId\" : \"090000648101c3dc\",\n",
      "      \"postedDate\" : \"2012-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1409\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1410\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Probst - Comment\",\n",
      "      \"objectId\" : \"090000648101c3ef\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1410\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1411\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"hadel toma - Comment\",\n",
      "      \"objectId\" : \"090000648101c799\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1411\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1412\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kevin scott slauson - Comment\",\n",
      "      \"objectId\" : \"090000648101c7b8\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1412\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1413\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael John Collier - Comment\",\n",
      "      \"objectId\" : \"090000648101c406\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1413\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1414\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Solongo Amarsanaa - Comment\",\n",
      "      \"objectId\" : \"090000648101c7e4\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1414\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1415\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anita Pereira - Comment\",\n",
      "      \"objectId\" : \"090000648101c442\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1415\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1416\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michele L Deisering - Comment\",\n",
      "      \"objectId\" : \"090000648101c7e9\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1416\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1417\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nandita Shah - Comment\",\n",
      "      \"objectId\" : \"090000648101c7f9\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1417\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1418\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Ann Neidich - Comment\",\n",
      "      \"objectId\" : \"090000648101c450\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1418\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1419\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"D. C Cieplensky - Comment\",\n",
      "      \"objectId\" : \"090000648101c845\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1419\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1420\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Abhimanyu PS - Comment\",\n",
      "      \"objectId\" : \"090000648101c856\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1420\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1421\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark Jeffrey Davis, MD - Comment\",\n",
      "      \"objectId\" : \"090000648101cd56\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1421\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1422\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Scott George Crowder - Comment\",\n",
      "      \"objectId\" : \"090000648101ceef\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1422\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1423\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Pierre Jacques Cloutier - Comment\",\n",
      "      \"objectId\" : \"090000648101caa5\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1423\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1424\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emilia Boccagna - Comment\",\n",
      "      \"objectId\" : \"090000648101cf53\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1424\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1425\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janice Bernard - Comment\",\n",
      "      \"objectId\" : \"090000648101cb21\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1425\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1426\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Darcie Everett - Comment\",\n",
      "      \"objectId\" : \"090000648101cb25\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1426\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1427\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Reza Daugherty - Comment\",\n",
      "      \"objectId\" : \"090000648101cb33\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1427\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1428\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kara Elizabeth Ramsey - Comment\",\n",
      "      \"objectId\" : \"090000648101cb4d\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1428\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1429\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Settle-LaDonna - Comment\",\n",
      "      \"objectId\" : \"090000648101cb55\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1429\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1430\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diane Kali Holmes - Comment\",\n",
      "      \"objectId\" : \"090000648101d154\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1430\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1431\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emelie Hängsel - Comment\",\n",
      "      \"objectId\" : \"090000648101d1b1\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1431\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1432\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Mize Kammler - Comment\",\n",
      "      \"objectId\" : \"090000648101d1b7\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1432\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1433\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Verena Boylan - Comment\",\n",
      "      \"objectId\" : \"090000648101cbdd\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1433\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1434\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen F Archer, MD - Comment\",\n",
      "      \"objectId\" : \"090000648101cbec\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1434\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1435\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Edward Hanson - Comment\",\n",
      "      \"objectId\" : \"090000648101d1de\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1435\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1436\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101d266\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1436\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1437\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diana Chapin-Tsai - Comment\",\n",
      "      \"objectId\" : \"090000648101ccd2\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1437\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1438\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Knud Borge Pedersen - Comment\",\n",
      "      \"objectId\" : \"090000648101d352\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1438\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1439\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T20:20:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Cindee Gardner - Comment\",\n",
      "      \"objectId\" : \"090000648101d385\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1439\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1440\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susana Mendez - Comment\",\n",
      "      \"objectId\" : \"090000648101d3ce\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1440\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1441\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Al K. DeRoy - Comment\",\n",
      "      \"objectId\" : \"090000648101d525\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1441\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1442\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mia Sison - Comment\",\n",
      "      \"objectId\" : \"090000648101d900\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1442\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1443\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Terry B Waggoner - Comment\",\n",
      "      \"objectId\" : \"090000648101d905\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1443\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1444\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. W. Sparling - Comment\",\n",
      "      \"objectId\" : \"090000648101d6c5\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1444\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1445\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joel Kay - Comment\",\n",
      "      \"objectId\" : \"090000648101d77a\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1445\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1446\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ken W Kurtz - Comment\",\n",
      "      \"objectId\" : \"090000648101d79c\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1446\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1447\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dave and Rita Rex Cross - Comment\",\n",
      "      \"objectId\" : \"090000648101d7bb\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1447\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1448\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Manley - Comment\",\n",
      "      \"objectId\" : \"090000648101d7d1\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1448\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1449\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Drew - Comment\",\n",
      "      \"objectId\" : \"090000648101dbc3\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1449\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1450\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rooshin Dalal - Comment\",\n",
      "      \"objectId\" : \"090000648101dc32\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1450\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1451\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Graca Paulino Noronha - Comment\",\n",
      "      \"objectId\" : \"090000648101dc4e\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1451\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1452\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eric Burns - Comment\",\n",
      "      \"objectId\" : \"090000648101d8b5\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1452\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1453\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michele Marie Johnson - Comment\",\n",
      "      \"objectId\" : \"090000648101dd1f\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1453\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1454\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Darlene B Rue - Comment\",\n",
      "      \"objectId\" : \"090000648101e155\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1454\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1455\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lexia Holland - Comment\",\n",
      "      \"objectId\" : \"090000648101e1ed\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1455\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1456\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ivana Schwarcz Schwarcz - Comment\",\n",
      "      \"objectId\" : \"090000648101df1f\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1456\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1457\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-31T22:12:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"catherine anne scheraldi - Comment\",\n",
      "      \"objectId\" : \"090000648101e364\",\n",
      "      \"postedDate\" : \"2012-07-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1457\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1458\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marge Peppercorn - Comment\",\n",
      "      \"objectId\" : \"090000648101e38c\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1458\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1459\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"victor khayat - Comment\",\n",
      "      \"objectId\" : \"090000648101e0a1\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1459\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1460\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vinny Karnovski - Comment\",\n",
      "      \"objectId\" : \"090000648101e0b6\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1460\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1461\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Selina Ortiz - Comment\",\n",
      "      \"objectId\" : \"090000648101e0da\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1461\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1462\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Guerrera - Comment\",\n",
      "      \"objectId\" : \"090000648101e417\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1462\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1463\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stacy De-Lin - Comment\",\n",
      "      \"objectId\" : \"090000648101e418\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1463\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1464\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pamela Diane Laham - Comment\",\n",
      "      \"objectId\" : \"090000648101e568\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1464\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1465\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katie - Comment\",\n",
      "      \"objectId\" : \"090000648101e4d8\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1465\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1466\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Fábio Alberto Silva - Comment\",\n",
      "      \"objectId\" : \"090000648101e60a\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1466\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1467\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"K Seddon - Comment\",\n",
      "      \"objectId\" : \"090000648101e4fb\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1467\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1468\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stefany Rosmeri Alarcon - Comment\",\n",
      "      \"objectId\" : \"090000648101e92d\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1468\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1469\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michele Johnson, M.D. - Comment\",\n",
      "      \"objectId\" : \"090000648101e949\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1469\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1470\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leroy Fleischer - Comment\",\n",
      "      \"objectId\" : \"090000648101e687\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1470\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1471\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa R Sheridan - Comment\",\n",
      "      \"objectId\" : \"090000648101e77f\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1471\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1472\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sairy Stepanian - Comment\",\n",
      "      \"objectId\" : \"090000648101e785\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1472\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1473\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Bradley - Comment\",\n",
      "      \"objectId\" : \"090000648101ea89\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1473\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1474\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heidi Linke - Comment\",\n",
      "      \"objectId\" : \"090000648101e7f3\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1474\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1475\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carlos Echevarria - Comment\",\n",
      "      \"objectId\" : \"090000648101e86d\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1475\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1476\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Marfleet - Comment\",\n",
      "      \"objectId\" : \"090000648101eb1d\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1476\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1477\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-01T22:00:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Quade Prescott - Comment\",\n",
      "      \"objectId\" : \"090000648101eb40\",\n",
      "      \"postedDate\" : \"2012-08-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1477\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1478\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Penny Joanna johnson - Comment\",\n",
      "      \"objectId\" : \"090000648101eb99\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1478\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1479\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristen Michelle Thompson - Comment\",\n",
      "      \"objectId\" : \"090000648101ec20\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1479\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1480\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael - Comment\",\n",
      "      \"objectId\" : \"090000648101ee10\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1480\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1481\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101ece9\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1481\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1482\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heather Danielle Schultz - Comment\",\n",
      "      \"objectId\" : \"090000648101ef4d\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1482\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1483\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Debi Zimmermann - Comment\",\n",
      "      \"objectId\" : \"090000648101efa2\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1483\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1484\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jordan Turner - Comment\",\n",
      "      \"objectId\" : \"090000648101f156\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1484\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1485\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eynne S Ray - Comment\",\n",
      "      \"objectId\" : \"090000648101f18c\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1485\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1486\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"rafeak - Comment\",\n",
      "      \"objectId\" : \"090000648101f007\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1486\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1487\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Inna Trotsai Trotsai - Comment\",\n",
      "      \"objectId\" : \"090000648101f044\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1487\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1488\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101f048\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1488\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1489\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Omar Al-Wahabi - Comment\",\n",
      "      \"objectId\" : \"090000648101f1a4\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1489\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1490\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Ines Acosta - Comment\",\n",
      "      \"objectId\" : \"090000648101f0bb\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1490\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1491\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica LeeAnn Fitzpatrick - Comment\",\n",
      "      \"objectId\" : \"090000648101f1f0\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1491\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1492\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Dinnocenzo - Comment\",\n",
      "      \"objectId\" : \"090000648101f506\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1492\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1493\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sally Thompson - Comment\",\n",
      "      \"objectId\" : \"090000648101f50c\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1493\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1494\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kelly - Comment\",\n",
      "      \"objectId\" : \"090000648101f517\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1494\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1495\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"todd feinman - Comment\",\n",
      "      \"objectId\" : \"090000648101f52f\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1495\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1496\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Derinda Diann Nilsson - Comment\",\n",
      "      \"objectId\" : \"090000648101f219\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1496\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1497\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jaymie Shanker - Comment\",\n",
      "      \"objectId\" : \"090000648101f5a4\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1497\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1498\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr Brenda Ann Bernhardt - Comment\",\n",
      "      \"objectId\" : \"090000648101f24b\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1498\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1499\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katerina Tsioli - Comment\",\n",
      "      \"objectId\" : \"090000648101f5c1\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1499\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1500\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolyn Boor - Comment\",\n",
      "      \"objectId\" : \"090000648101f27c\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1500\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1501\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sunil Pai - Comment\",\n",
      "      \"objectId\" : \"090000648101f282\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1501\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1502\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elena Ciobanu - Comment\",\n",
      "      \"objectId\" : \"090000648101f2d6\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1502\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1503\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ryan Sean Carey - Comment\",\n",
      "      \"objectId\" : \"090000648101f2d8\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1503\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1504\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Abi Cresswell - Comment\",\n",
      "      \"objectId\" : \"090000648101f2ef\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1504\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1505\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Abi Cresswell - Comment\",\n",
      "      \"objectId\" : \"090000648101f2f0\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1505\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1506\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lilka Gilman - Comment\",\n",
      "      \"objectId\" : \"090000648101f668\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1506\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 6,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-1507\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tami Araya - Comment\",\n",
      "      \"objectId\" : \"090000648101f309\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1507\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1508\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chip macgill - Comment\",\n",
      "      \"objectId\" : \"090000648101f31f\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1508\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1509\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Grace Elizabeth Minton - Comment\",\n",
      "      \"objectId\" : \"090000648101f320\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1509\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1510\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gaurav Maheshwari - Comment\",\n",
      "      \"objectId\" : \"090000648101f326\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1510\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1511\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-02T22:07:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Daniela Kmentova - Comment\",\n",
      "      \"objectId\" : \"090000648101f6a5\",\n",
      "      \"postedDate\" : \"2012-08-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1511\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1512\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"c j stepehns - Comment\",\n",
      "      \"objectId\" : \"090000648101f6ff\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1512\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1513\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marjorie Cramer - Comment\",\n",
      "      \"objectId\" : \"090000648101f350\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1513\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1514\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mallory Deane Campbell - Comment\",\n",
      "      \"objectId\" : \"090000648101f901\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1514\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1515\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Allison Parks - Comment\",\n",
      "      \"objectId\" : \"090000648101f922\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1515\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1516\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Naomi Lee Hood - Comment\",\n",
      "      \"objectId\" : \"090000648101f923\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1516\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1517\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Harriet Jean Bryan - Comment\",\n",
      "      \"objectId\" : \"090000648101f93e\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1517\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1518\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elaine Hannah Gerber - Comment\",\n",
      "      \"objectId\" : \"090000648101fda3\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1518\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1519\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Elizabeth Gingrich - Comment\",\n",
      "      \"objectId\" : \"090000648101fa67\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1519\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1520\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Damayanti Valle - Comment\",\n",
      "      \"objectId\" : \"090000648101fb78\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1520\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1521\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648101fbc4\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1521\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1522\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hillary Coward - Comment\",\n",
      "      \"objectId\" : \"090000648101fc99\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1522\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1523\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donna Lee Bowling - Comment\",\n",
      "      \"objectId\" : \"090000648101fef7\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1523\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1524\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dar Ann Bertsch - Comment\",\n",
      "      \"objectId\" : \"0900006481020698\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1524\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1525\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648102093f\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1525\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1526\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"sari deboer - Comment\",\n",
      "      \"objectId\" : \"0900006481020760\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1526\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1527\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"LACI LINDER - Comment\",\n",
      "      \"objectId\" : \"09000064810208a9\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1527\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1528\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David and Rita Rex Cross - Comment\",\n",
      "      \"objectId\" : \"09000064810208bc\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1528\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1529\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tracy Elizabeth Lawson - Comment\",\n",
      "      \"objectId\" : \"0900006481020b36\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1529\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1530\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynn Lawson - Comment\",\n",
      "      \"objectId\" : \"0900006481020d3f\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1530\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1531\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Espi Renee Duarte - Comment\",\n",
      "      \"objectId\" : \"0900006481020eac\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1531\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1532\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chiara Jade Abell - Comment\",\n",
      "      \"objectId\" : \"0900006481020ccf\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1532\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1533\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Sales O'Brien - Comment\",\n",
      "      \"objectId\" : \"090000648102109d\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1533\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1534\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pamela S Ayers - Comment\",\n",
      "      \"objectId\" : \"09000064810210ae\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1534\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1535\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"b d - Comment\",\n",
      "      \"objectId\" : \"09000064810219ed\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1535\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1536\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wanda V Trotta - Comment\",\n",
      "      \"objectId\" : \"090000648102181b\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1536\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1537\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marianne Curtis - Comment\",\n",
      "      \"objectId\" : \"0900006481021838\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1537\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1538\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Yvonne Graf - Comment\",\n",
      "      \"objectId\" : \"0900006481021b7b\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1538\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1539\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gia Canalli - Comment\",\n",
      "      \"objectId\" : \"09000064810218f7\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1539\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1540\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jaclyn karen conroy - Comment\",\n",
      "      \"objectId\" : \"0900006481021ece\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1540\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1541\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol and Richard Park - Comment\",\n",
      "      \"objectId\" : \"0900006481021f02\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1541\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1542\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481021f27\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1542\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1543\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Aleta Bruzzese - Comment\",\n",
      "      \"objectId\" : \"09000064810220c8\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1543\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1544\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emily Anne McGregor - Comment\",\n",
      "      \"objectId\" : \"09000064810226e9\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1544\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1545\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lillith Lascoue - Comment\",\n",
      "      \"objectId\" : \"0900006481022969\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1545\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1546\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Castillo - Comment\",\n",
      "      \"objectId\" : \"09000064810227c5\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1546\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1547\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brynn Andrea Longenecker - Comment\",\n",
      "      \"objectId\" : \"09000064810228fd\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1547\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1548\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynn R Antil - Comment\",\n",
      "      \"objectId\" : \"090000648102316a\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1548\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1549\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sue Nielsen, MD - Comment\",\n",
      "      \"objectId\" : \"09000064810230bc\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1549\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1550\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary E. Chapa, MA - Comment\",\n",
      "      \"objectId\" : \"0900006481023232\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1550\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1551\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JANEE M TAYLOR - Comment\",\n",
      "      \"objectId\" : \"0900006481023741\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1551\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1552\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-03T22:13:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura - Comment\",\n",
      "      \"objectId\" : \"090000648102342b\",\n",
      "      \"postedDate\" : \"2012-08-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1552\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1553\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emma Thompson - Comment\",\n",
      "      \"objectId\" : \"0900006481021e42\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1553\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1554\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Louise Young - Comment\",\n",
      "      \"objectId\" : \"090000648102347b\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1554\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1555\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sue White - Comment\",\n",
      "      \"objectId\" : \"09000064810234a3\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1555\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1556\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cuevas - Comment\",\n",
      "      \"objectId\" : \"0900006481024191\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1556\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1557\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer G Reich - Comment\",\n",
      "      \"objectId\" : \"0900006481024222\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1557\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1558\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine - Comment\",\n",
      "      \"objectId\" : \"0900006481024290\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1558\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1559\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Clarissa Naomi Tote - Comment\",\n",
      "      \"objectId\" : \"09000064810240f9\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1559\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1560\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna Piecha - Comment\",\n",
      "      \"objectId\" : \"0900006481024513\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1560\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1561\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Teagan Raye Stratton - Comment\",\n",
      "      \"objectId\" : \"0900006481024489\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1561\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1562\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"JEWEL COURVILLE - Comment\",\n",
      "      \"objectId\" : \"0900006481024ddd\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1562\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1563\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ClearWay Minnesota - Comment\",\n",
      "      \"objectId\" : \"0900006481024cb7\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1563\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1564\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Group Research &amp; Development, British American Tobacco (Investments) Ltd. - Comment\",\n",
      "      \"objectId\" : \"0900006481024f49\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1564\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1565\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"May Friedman - Comment\",\n",
      "      \"objectId\" : \"0900006481025032\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1565\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1566\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chris Robertson - Comment\",\n",
      "      \"objectId\" : \"0900006481025043\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1566\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1567\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marlene Elaine Lebel - Comment\",\n",
      "      \"objectId\" : \"0900006481025045\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1567\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1568\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paige Tabor - Comment\",\n",
      "      \"objectId\" : \"09000064810251fa\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1568\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1569\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan K. Dunaway - Comment\",\n",
      "      \"objectId\" : \"0900006481025200\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1569\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1570\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Jones - Comment\",\n",
      "      \"objectId\" : \"0900006481025062\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1570\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1571\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"VASANT K CHARY - Comment\",\n",
      "      \"objectId\" : \"0900006481025064\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1571\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1572\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481025065\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1572\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1573\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481025077\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1573\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1574\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Molendyk - Comment\",\n",
      "      \"objectId\" : \"090000648102507a\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1574\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1575\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Francesca Ailien Argiro - Comment\",\n",
      "      \"objectId\" : \"090000648102526e\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1575\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1576\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dawn Gemme - Comment\",\n",
      "      \"objectId\" : \"090000648102507e\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1576\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1577\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maristela Consani  - Comment\",\n",
      "      \"objectId\" : \"0900006481025286\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1577\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1578\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Candice Ellen Shaffer - Comment\",\n",
      "      \"objectId\" : \"09000064810252a0\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1578\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1579\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tina - Comment\",\n",
      "      \"objectId\" : \"09000064810250b5\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1579\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1580\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"alyssa cunniff - Comment\",\n",
      "      \"objectId\" : \"09000064810250b6\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1580\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1581\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pamela Cathy Lee - Comment\",\n",
      "      \"objectId\" : \"09000064810250ba\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1581\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1582\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Hamlin Stetler - Comment\",\n",
      "      \"objectId\" : \"09000064810252a8\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1582\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1583\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-10T21:36:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Crystal Anne Aguilar - Comment\",\n",
      "      \"objectId\" : \"09000064810250c4\",\n",
      "      \"postedDate\" : \"2012-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1583\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1584\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lori Rebecca Haislip - Comment\",\n",
      "      \"objectId\" : \"09000064810252b4\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1584\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1585\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Judith Gottesman, MSW - Comment\",\n",
      "      \"objectId\" : \"09000064810252b9\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1585\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1586\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristy Militello - Comment\",\n",
      "      \"objectId\" : \"09000064810250d2\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1586\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1587\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hugo Dominguez - Comment\",\n",
      "      \"objectId\" : \"09000064810250e0\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1587\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1588\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810252be\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1588\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1589\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pauline Iriy Erera - Comment\",\n",
      "      \"objectId\" : \"09000064810252c3\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1589\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1590\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Debbie - Comment\",\n",
      "      \"objectId\" : \"09000064810250e5\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1590\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1591\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Keith S. Turner - Comment\",\n",
      "      \"objectId\" : \"09000064810250e9\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1591\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1592\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Edward Jasiewicz - Comment\",\n",
      "      \"objectId\" : \"09000064810252cc\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1592\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1593\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gina M Caracci - Comment\",\n",
      "      \"objectId\" : \"0900006481025327\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1593\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1594\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cherise Lopez - Comment\",\n",
      "      \"objectId\" : \"0900006481025329\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1594\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1595\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jami Lea Chapman - Comment\",\n",
      "      \"objectId\" : \"090000648102532a\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1595\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1596\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Desiree Ryan - Comment\",\n",
      "      \"objectId\" : \"0900006481025518\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1596\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1597\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Walden - Comment\",\n",
      "      \"objectId\" : \"0900006481025331\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1597\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1598\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tresa Laura Walden - Comment\",\n",
      "      \"objectId\" : \"090000648102551c\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1598\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1599\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Schouten - Comment\",\n",
      "      \"objectId\" : \"090000648102551d\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1599\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1600\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon L Wallenberg - Comment\",\n",
      "      \"objectId\" : \"090000648102533c\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1600\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1601\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Pierre - Comment\",\n",
      "      \"objectId\" : \"0900006481025522\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1601\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1602\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Polina Ermoshkina - Comment\",\n",
      "      \"objectId\" : \"0900006481025341\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1602\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1603\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon Wushensky - Comment\",\n",
      "      \"objectId\" : \"090000648102536e\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1603\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1604\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Annamarie Wood - Comment\",\n",
      "      \"objectId\" : \"0900006481025371\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1604\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1605\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Hillard - Comment\",\n",
      "      \"objectId\" : \"0900006481025528\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1605\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1606\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carlos - Comment\",\n",
      "      \"objectId\" : \"0900006481025531\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1606\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1607\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-13T22:22:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gayle Ellen Edelman-Tolchin - Comment\",\n",
      "      \"objectId\" : \"0900006481025534\",\n",
      "      \"postedDate\" : \"2012-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1607\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1608\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mallory Kristine Blackburn - Comment\",\n",
      "      \"objectId\" : \"090000648102553e\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1608\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1609\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julia Patrick Dolan - Comment\",\n",
      "      \"objectId\" : \"090000648102555f\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1609\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1610\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julia Callicrate - Comment\",\n",
      "      \"objectId\" : \"09000064810253ad\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1610\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1611\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sassy Albee - Comment\",\n",
      "      \"objectId\" : \"09000064810253af\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1611\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1612\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jessica Michele Cunha - Comment\",\n",
      "      \"objectId\" : \"0900006481025562\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1612\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1613\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tessie F. Sarmiento - Comment\",\n",
      "      \"objectId\" : \"0900006481025401\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1613\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1614\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. David L Gilbertson - Comment\",\n",
      "      \"objectId\" : \"0900006481025564\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1614\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1615\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Douglas Glaeser - Comment\",\n",
      "      \"objectId\" : \"0900006481025407\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1615\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1616\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-14T22:06:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Cohen - Comment\",\n",
      "      \"objectId\" : \"0900006481025419\",\n",
      "      \"postedDate\" : \"2012-08-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1616\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1617\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"ceci m clanahan - Comment\",\n",
      "      \"objectId\" : \"0900006481025572\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1617\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1618\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brittany Michelle Halley - Comment\",\n",
      "      \"objectId\" : \"0900006481025430\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1618\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1619\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren Christine Ault - Comment\",\n",
      "      \"objectId\" : \"0900006481025437\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1619\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1620\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mahvish Zehra - Comment\",\n",
      "      \"objectId\" : \"0900006481025586\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1620\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1621\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Todd Mc - Comment\",\n",
      "      \"objectId\" : \"0900006481025587\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1621\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1622\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"susan mary - Comment\",\n",
      "      \"objectId\" : \"0900006481025439\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1622\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1623\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rick - Comment\",\n",
      "      \"objectId\" : \"0900006481025596\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1623\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1624\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie Andonian Bouwsma - Comment\",\n",
      "      \"objectId\" : \"0900006481025452\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1624\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1625\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sara Laycock - Comment\",\n",
      "      \"objectId\" : \"090000648102559d\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1625\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1626\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Errikka Chandra Jordan - Comment\",\n",
      "      \"objectId\" : \"09000064810255a7\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1626\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1627\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"margo alexander - Comment\",\n",
      "      \"objectId\" : \"09000064810255af\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1627\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1628\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Eden McQuade - Comment\",\n",
      "      \"objectId\" : \"0900006481025463\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1628\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1629\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sheri Silver - Comment\",\n",
      "      \"objectId\" : \"09000064810255bc\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1629\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1630\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julie Lines - Comment\",\n",
      "      \"objectId\" : \"0900006481025465\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1630\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1631\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary - Comment\",\n",
      "      \"objectId\" : \"0900006481025477\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1631\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1632\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Denise Wright - Comment\",\n",
      "      \"objectId\" : \"0900006481025479\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1632\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1633\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Jean Meranto - Comment\",\n",
      "      \"objectId\" : \"090000648102547c\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1633\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1634\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481025498\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1634\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1635\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carly - Comment\",\n",
      "      \"objectId\" : \"090000648102561c\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1635\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1636\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eric Smith - Comment\",\n",
      "      \"objectId\" : \"090000648102549d\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1636\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1637\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melody Ann Blanco - Comment\",\n",
      "      \"objectId\" : \"0900006481025623\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1637\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1638\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Lee Leach - Comment\",\n",
      "      \"objectId\" : \"0900006481025636\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1638\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1639\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:19:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"nichelle c lee - Comment\",\n",
      "      \"objectId\" : \"090000648102563e\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1639\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1640\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-21T21:21:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine Berglund Hayes - Comment\",\n",
      "      \"objectId\" : \"0900006481025674\",\n",
      "      \"postedDate\" : \"2012-08-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1640\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1641\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"katerina karneris - Comment\",\n",
      "      \"objectId\" : \"0900006481025699\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1641\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1642\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"RITA LEANN SMITH - Comment\",\n",
      "      \"objectId\" : \"09000064810256ab\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1642\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1643\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pat Rose - Comment\",\n",
      "      \"objectId\" : \"0900006481025b23\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1643\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1644\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J. Lombardi - Comment\",\n",
      "      \"objectId\" : \"0900006481025b6e\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1644\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1645\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chad Andrew Meadows - Comment\",\n",
      "      \"objectId\" : \"0900006481025bf9\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1645\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1646\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"HeeJung No - Comment\",\n",
      "      \"objectId\" : \"0900006481025786\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1646\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1647\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rick O'Bryan - Comment\",\n",
      "      \"objectId\" : \"0900006481025c5e\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1647\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1648\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"alan t. woodruff - Comment\",\n",
      "      \"objectId\" : \"09000064810257ef\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1648\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1649\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Bernadette Santora - Comment\",\n",
      "      \"objectId\" : \"0900006481025d1e\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1649\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1650\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonnie - Comment\",\n",
      "      \"objectId\" : \"0900006481025d21\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1650\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1651\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janine Baldwin - Comment\",\n",
      "      \"objectId\" : \"0900006481025d38\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1651\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1652\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Trent Curtis - Comment\",\n",
      "      \"objectId\" : \"09000064810258e3\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1652\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1653\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ray L Iasiello - Comment\",\n",
      "      \"objectId\" : \"0900006481025e84\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1653\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1654\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard - Comment\",\n",
      "      \"objectId\" : \"0900006481025eaa\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1654\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1655\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynee Zajac Beck - Comment\",\n",
      "      \"objectId\" : \"0900006481025eb2\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1655\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1656\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alexis Elizabeth Ann Gohring - Comment\",\n",
      "      \"objectId\" : \"09000064810261d4\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1656\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1657\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Victoria Gaynor - Comment\",\n",
      "      \"objectId\" : \"0900006481026273\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1657\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1658\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathy Balcom - Comment\",\n",
      "      \"objectId\" : \"09000064810262fb\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1658\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1659\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Victoria Cooper - Comment\",\n",
      "      \"objectId\" : \"0900006481026324\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1659\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1660\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T16:38:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Rose - Comment\",\n",
      "      \"objectId\" : \"0900006481026007\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1660\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1662\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katie P Symons - Comment\",\n",
      "      \"objectId\" : \"0900006481026079\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1662\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1663\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katie P Symons - Comment\",\n",
      "      \"objectId\" : \"0900006481026086\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1663\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1664\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Agatha Borecki - Comment\",\n",
      "      \"objectId\" : \"0900006481026097\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1664\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1665\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandra Jean Sagitto - Comment\",\n",
      "      \"objectId\" : \"0900006481026403\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1665\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1666\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dorothy Jean Rich - Comment\",\n",
      "      \"objectId\" : \"0900006481026411\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1666\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1667\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melanei J Gonzales - Comment\",\n",
      "      \"objectId\" : \"09000064810260e1\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1667\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1668\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marissa Taylor - Comment\",\n",
      "      \"objectId\" : \"09000064810260e7\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1668\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1669\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angie K Thompson - Comment\",\n",
      "      \"objectId\" : \"09000064810260f7\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1669\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1670\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda L Weitzel - Comment\",\n",
      "      \"objectId\" : \"0900006481026488\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1670\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1671\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064810264d1\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1671\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1672\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Molina - Comment\",\n",
      "      \"objectId\" : \"0900006481026917\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1672\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1673\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"anna obuck - Comment\",\n",
      "      \"objectId\" : \"0900006481026934\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1673\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1674\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"marsha f. armstrong - Comment\",\n",
      "      \"objectId\" : \"0900006481026604\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1674\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1675\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kev smith - Comment\",\n",
      "      \"objectId\" : \"090000648102662d\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1675\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1676\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joanne Lynn Adey - Comment\",\n",
      "      \"objectId\" : \"09000064810269dc\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1676\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1677\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lenora Saa - Comment\",\n",
      "      \"objectId\" : \"09000064810269f9\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1677\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1678\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elena Marie Fetch - Comment\",\n",
      "      \"objectId\" : \"0900006481026a01\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1678\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1679\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deirdre Fritts - Comment\",\n",
      "      \"objectId\" : \"0900006481026691\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1679\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1680\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rachel Kooy - Comment\",\n",
      "      \"objectId\" : \"0900006481026697\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1680\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1681\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"joe brennan - Comment\",\n",
      "      \"objectId\" : \"0900006481026a2f\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1681\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1682\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rita A. Holt - Comment\",\n",
      "      \"objectId\" : \"0900006481026a49\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1682\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1683\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Urmil Dhanda - Comment\",\n",
      "      \"objectId\" : \"0900006481026a51\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1683\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1684\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julia Beckley - Comment\",\n",
      "      \"objectId\" : \"0900006481026a75\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1684\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1685\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Frank - Comment\",\n",
      "      \"objectId\" : \"0900006481026ad1\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1685\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1686\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Audrey M DeSanzo - Comment\",\n",
      "      \"objectId\" : \"0900006481026856\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1686\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1687\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Judy Hart - Comment\",\n",
      "      \"objectId\" : \"0900006481026864\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1687\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1688\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rafael Leyva - Comment\",\n",
      "      \"objectId\" : \"0900006481026865\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1688\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1689\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:20:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mario L Medina - Comment\",\n",
      "      \"objectId\" : \"0900006481026c09\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1689\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1690\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:37:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jodi wick - Comment\",\n",
      "      \"objectId\" : \"0900006481026c96\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1690\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1691\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:37:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lou Vale - Comment\",\n",
      "      \"objectId\" : \"0900006481026ca1\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1691\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1692\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-22T21:37:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Azzalina - Comment\",\n",
      "      \"objectId\" : \"0900006481026ca9\",\n",
      "      \"postedDate\" : \"2012-08-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1692\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1693\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Ellen Knight - Comment\",\n",
      "      \"objectId\" : \"0900006481026d46\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1693\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1694\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie S Smith - Comment\",\n",
      "      \"objectId\" : \"0900006481027118\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1694\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1695\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Rosencrans - Comment\",\n",
      "      \"objectId\" : \"0900006481027127\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1695\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1696\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"andrea rose - Comment\",\n",
      "      \"objectId\" : \"0900006481026dc1\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1696\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1697\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paul Christian Herbig - Comment\",\n",
      "      \"objectId\" : \"0900006481027159\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1697\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1698\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Raymond Lewis - Comment\",\n",
      "      \"objectId\" : \"0900006481026dcb\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1698\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1699\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ashley Rhea Talamine - Comment\",\n",
      "      \"objectId\" : \"0900006481026ddf\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1699\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1700\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Virginia Fiorentino - Comment\",\n",
      "      \"objectId\" : \"0900006481027191\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1700\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1701\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"lori herz - Comment\",\n",
      "      \"objectId\" : \"0900006481026e00\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1701\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1702\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marilyn Rios - Comment\",\n",
      "      \"objectId\" : \"0900006481026e10\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1702\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1703\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathy Simonik - Comment\",\n",
      "      \"objectId\" : \"09000064810271ba\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1703\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1704\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Saachi - Comment\",\n",
      "      \"objectId\" : \"0900006481026e2b\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1704\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1705\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:04:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maryann LaNew - Comment\",\n",
      "      \"objectId\" : \"0900006481026f58\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1705\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1707\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:07:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jonathan Grill - Comment\",\n",
      "      \"objectId\" : \"090000648102b314\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1707\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1708\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:07:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marilyn - Comment\",\n",
      "      \"objectId\" : \"090000648102c164\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1708\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1709\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:33:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Clara M Beeler - Comment\",\n",
      "      \"objectId\" : \"090000648102c277\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1709\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1710\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"George A Walberg - Comment\",\n",
      "      \"objectId\" : \"090000648102c29f\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1710\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1711\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leia Ann Hahn - Comment\",\n",
      "      \"objectId\" : \"090000648102c5d4\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1711\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1712\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hollee Nicole Martin - Comment\",\n",
      "      \"objectId\" : \"090000648102c656\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1712\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1713\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-24T21:33:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sanjay Nagrani - Comment\",\n",
      "      \"objectId\" : \"090000648102c68f\",\n",
      "      \"postedDate\" : \"2012-08-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1713\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1714\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Estefania Arellano - Comment\",\n",
      "      \"objectId\" : \"090000648102c3f4\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1714\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1715\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"090000648102c449\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1715\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1716\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Ellen Huey - Comment\",\n",
      "      \"objectId\" : \"090000648102c760\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1716\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1717\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Lee Peterson-Malesci - Comment\",\n",
      "      \"objectId\" : \"090000648102c77f\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1717\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1718\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elaine Kurpiel - Comment\",\n",
      "      \"objectId\" : \"090000648102c4a7\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1718\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1719\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Betty Okrent - Comment\",\n",
      "      \"objectId\" : \"090000648102c4d6\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1719\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1720\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Mowrey - Comment\",\n",
      "      \"objectId\" : \"090000648102c7e7\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1720\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1721\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Colleen Ross - Comment\",\n",
      "      \"objectId\" : \"090000648102c8ac\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1721\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1722\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carole Ann Menninger - Comment\",\n",
      "      \"objectId\" : \"090000648102c9b9\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1722\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1723\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara E Hilliard - Comment\",\n",
      "      \"objectId\" : \"090000648102cd35\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1723\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1724\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tina Marie Bailey - Comment\",\n",
      "      \"objectId\" : \"090000648102cd62\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1724\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1725\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carole Lorraine Sipos - Comment\",\n",
      "      \"objectId\" : \"090000648102caba\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1725\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1726\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mike Davis - Comment\",\n",
      "      \"objectId\" : \"090000648102ce09\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1726\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1727\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John F. Jasper - Comment\",\n",
      "      \"objectId\" : \"090000648102cc4e\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1727\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1728\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kathryn werk - Comment\",\n",
      "      \"objectId\" : \"090000648102cc9f\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1728\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1729\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jaime Smith - Comment\",\n",
      "      \"objectId\" : \"090000648102d147\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1729\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1730\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T16:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"robert werk - Comment\",\n",
      "      \"objectId\" : \"090000648102d173\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1730\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1731\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzy Brignall - Comment\",\n",
      "      \"objectId\" : \"090000648102d175\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1731\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1732\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephen Werk - Comment\",\n",
      "      \"objectId\" : \"090000648102d187\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1732\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1733\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Jaspar - Comment\",\n",
      "      \"objectId\" : \"090000648102d1ad\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1733\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1734\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Caroline fraser - Comment\",\n",
      "      \"objectId\" : \"090000648102d00d\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1734\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1735\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brian Field - Comment\",\n",
      "      \"objectId\" : \"090000648102d1d8\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1735\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1736\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheryl Ternes - Comment\",\n",
      "      \"objectId\" : \"090000648102d1e9\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1736\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1737\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tara S Schuneman - Comment\",\n",
      "      \"objectId\" : \"090000648102d202\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1737\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1738\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tammy Lacy - Comment\",\n",
      "      \"objectId\" : \"090000648102d204\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1738\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1739\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Josey Humbert - Comment\",\n",
      "      \"objectId\" : \"090000648102d067\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1739\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1740\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Emanuel - Comment\",\n",
      "      \"objectId\" : \"090000648102d666\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1740\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1741\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elise Phillips Margulis - Comment\",\n",
      "      \"objectId\" : \"090000648102d6ec\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1741\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1742\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michele Mercer - Comment\",\n",
      "      \"objectId\" : \"090000648102d859\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1742\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1743\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alice - Comment\",\n",
      "      \"objectId\" : \"090000648102d8e4\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1743\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1744\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie Ann Zumpano - Comment\",\n",
      "      \"objectId\" : \"090000648102d8f2\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1744\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1745\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Edward smith - Comment\",\n",
      "      \"objectId\" : \"090000648102dab6\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1745\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1746\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Larisa Speers - Comment\",\n",
      "      \"objectId\" : \"090000648102ddc5\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1746\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1747\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine Elizabeth Reid - Comment\",\n",
      "      \"objectId\" : \"090000648102ddc8\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1747\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1748\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angie Ostrowski - Comment\",\n",
      "      \"objectId\" : \"090000648102db3d\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1748\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1749\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol - Comment\",\n",
      "      \"objectId\" : \"090000648102de1b\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1749\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1750\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Edwina Regina Smith - Comment\",\n",
      "      \"objectId\" : \"090000648102de8d\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1750\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1751\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven - Comment\",\n",
      "      \"objectId\" : \"090000648102dc5a\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1751\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1752\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Heather Ramirez - Comment\",\n",
      "      \"objectId\" : \"090000648102dfd4\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1752\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1753\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Virginia Dato - Comment\",\n",
      "      \"objectId\" : \"090000648102e1cb\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1753\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1754\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ewa Roselli - Comment\",\n",
      "      \"objectId\" : \"090000648102e669\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1754\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1755\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Artemis Sanfo Louyakis - Comment\",\n",
      "      \"objectId\" : \"090000648102e341\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1755\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1756\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christian A Dyott - Comment\",\n",
      "      \"objectId\" : \"090000648102e3a6\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1756\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1757\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karl Fagerstrom - Comment\",\n",
      "      \"objectId\" : \"090000648102e3ad\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1757\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1758\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-27T21:35:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Consumer Advocates for Smoke-free Alternatives Association (CASAA) - Comment\",\n",
      "      \"objectId\" : \"090000648102ed0f\",\n",
      "      \"postedDate\" : \"2012-08-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1758\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 7,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-D-0071-1759\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American College of Preventive Medicine - Comment\",\n",
      "      \"objectId\" : \"090000648102fa3f\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1759\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1760\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Molly Weigel - Comment\",\n",
      "      \"objectId\" : \"090000648102eee9\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1760\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1761\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Scott Douglas Ballin - Comment\",\n",
      "      \"objectId\" : \"090000648102f02f\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1761\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1762\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Caryl Mansfield Sawyer - Comment\",\n",
      "      \"objectId\" : \"090000648102f085\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1762\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1763\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nina Colleen Laughery - Comment\",\n",
      "      \"objectId\" : \"090000648102f0ca\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1763\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1764\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carlos A Moreno - Comment\",\n",
      "      \"objectId\" : \"090000648102fc85\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1764\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1765\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Partnership for Prevention - Comment\",\n",
      "      \"objectId\" : \"090000648102fd7b\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1765\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1766\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Audrey Mannolini - Comment\",\n",
      "      \"objectId\" : \"0900006481030178\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1766\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1767\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Howard Packer - Comment\",\n",
      "      \"objectId\" : \"0900006481030221\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1767\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1768\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura - Comment\",\n",
      "      \"objectId\" : \"0900006481030270\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1768\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1769\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Louis - Comment\",\n",
      "      \"objectId\" : \"090000648102ff89\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1769\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1770\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sorana Maria Vladu - Comment\",\n",
      "      \"objectId\" : \"09000064810302e9\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1770\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1771\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Regina Nicole Milano - Comment\",\n",
      "      \"objectId\" : \"090000648102ffc5\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1771\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1772\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jackie B Umphlet - Comment\",\n",
      "      \"objectId\" : \"0900006481030487\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1772\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1773\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jamie - Comment\",\n",
      "      \"objectId\" : \"0900006481030918\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1773\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1774\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Burian - Comment\",\n",
      "      \"objectId\" : \"09000064810305ce\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1774\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1775\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"GLORIA RESA - Comment\",\n",
      "      \"objectId\" : \"09000064810305fc\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1775\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1776\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"mira matilda li stenfors - Comment\",\n",
      "      \"objectId\" : \"0900006481030620\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1776\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1777\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Mayo - Comment\",\n",
      "      \"objectId\" : \"0900006481030b3d\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1777\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1778\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jim Goulet - Comment\",\n",
      "      \"objectId\" : \"0900006481030bb3\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1778\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1779\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"KARLA SANTACRUZ - Comment\",\n",
      "      \"objectId\" : \"0900006481030757\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1779\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1780\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-28T21:33:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Association of County and City Health Officials (NACCHO) - Comment\",\n",
      "      \"objectId\" : \"0900006481030772\",\n",
      "      \"postedDate\" : \"2012-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1780\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1782\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marco Antonio Regil - Comment\",\n",
      "      \"objectId\" : \"0900006481030776\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1782\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1783\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claudia Berenice Avina - Comment\",\n",
      "      \"objectId\" : \"09000064810307a0\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1783\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1784\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Council on Science and Health (ACSH) - Comment\",\n",
      "      \"objectId\" : \"09000064810307a2\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1784\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1785\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Glaucia Batista Brannock - Comment\",\n",
      "      \"objectId\" : \"09000064810307ba\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1785\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1786\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dillon Lee Brannock - Comment\",\n",
      "      \"objectId\" : \"09000064810307d5\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1786\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1787\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sienna - Comment\",\n",
      "      \"objectId\" : \"0900006481030df6\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1787\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1788\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Russ - Comment\",\n",
      "      \"objectId\" : \"09000064810311d9\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1788\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1789\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lars Martin RamstrÃ¶m - Comment\",\n",
      "      \"objectId\" : \"090000648103121c\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1789\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1790\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Benedict Adams - Comment\",\n",
      "      \"objectId\" : \"090000648103123b\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1790\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1791\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"What A Smoke, LLC - Comment\",\n",
      "      \"objectId\" : \"0900006481031263\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1791\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1792\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adriana Saldana Guzman - Comment\",\n",
      "      \"objectId\" : \"0900006481031502\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1792\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1793\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006481031545\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1793\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1794\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"R.J. Reynolds Tobacco Company - Comment\",\n",
      "      \"objectId\" : \"0900006481031369\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1794\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1795\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T15:22:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Imperial Tobacco, Ltd. - Comment\",\n",
      "      \"objectId\" : \"090000648103138a\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1795\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1798\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:18:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Altria Client Services - Comment\",\n",
      "      \"objectId\" : \"0900006481031a58\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1798\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1799\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:18:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Monica Mary Lucas - Comment\",\n",
      "      \"objectId\" : \"0900006481031d7b\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1799\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1800\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:18:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Smokefree Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"0900006481032153\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1800\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1801\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:18:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alicia M Christian - Comment\",\n",
      "      \"objectId\" : \"090000648103201d\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1801\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1804\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:29:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"paul david wallace - Comment\",\n",
      "      \"objectId\" : \"0900006481032f24\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1804\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1805\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T16:29:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CHERYL CALDWELL - Comment\",\n",
      "      \"objectId\" : \"0900006481033596\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1805\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1807\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Manz - Comment\",\n",
      "      \"objectId\" : \"09000064810335ba\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1807\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1808\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephanie Dayle Shaw - Comment\",\n",
      "      \"objectId\" : \"0900006481033998\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1808\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1809\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"rhonda davis - Comment\",\n",
      "      \"objectId\" : \"09000064810339c3\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1809\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1810\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"CB Distributors Inc - Comment\",\n",
      "      \"objectId\" : \"09000064810339df\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1810\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1811\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"neal v wassmuth - Comment\",\n",
      "      \"objectId\" : \"09000064810339e2\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1811\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1812\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"neal v wassmuth - Comment\",\n",
      "      \"objectId\" : \"09000064810339ee\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1812\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1813\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charlie Farah - Comment\",\n",
      "      \"objectId\" : \"090000648103370b\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1813\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1814\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"debbie a houlis - Comment\",\n",
      "      \"objectId\" : \"0900006481033acd\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1814\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-1815\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-08-29T18:55:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gabriel Corza - Comment\",\n",
      "      \"objectId\" : \"0900006481033b90\",\n",
      "      \"postedDate\" : \"2012-08-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-1815\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2012-D-0071-0582\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-05-23T16:28:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Terri LeMoyne - Comment\",\n",
      "      \"objectId\" : \"09000064810126d6\",\n",
      "      \"postedDate\" : \"2012-06-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-D-0071-0582\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 52,\n",
      "    \"pageNumber\" : 8,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1802,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 9,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1802,\n",
      "    \"totalPages\" : 8,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2011-N-0467-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-09-13T13:25:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Grace Visiting Nurses - Comment\",\n",
      "      \"objectId\" : \"0900006480f16f66\",\n",
      "      \"postedDate\" : \"2011-09-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-10-06T20:56:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert John Rajala - Comment\",\n",
      "      \"objectId\" : \"0900006480f20feb\",\n",
      "      \"postedDate\" : \"2011-10-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-22T21:07:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f59e47\",\n",
      "      \"postedDate\" : \"2011-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-22T21:07:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wesly Vawter - Comment\",\n",
      "      \"objectId\" : \"0900006480f6058d\",\n",
      "      \"postedDate\" : \"2011-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-11-22T21:07:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cathryn Haley Ford - Comment\",\n",
      "      \"objectId\" : \"0900006480f70b9e\",\n",
      "      \"postedDate\" : \"2011-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anthony Billups - Comment\",\n",
      "      \"objectId\" : \"0900006480f71b3c\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Association of Attorneys General - Request for Extension\",\n",
      "      \"objectId\" : \"0900006480f72343\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert James Brassell, Jr., N.P. - Comment\",\n",
      "      \"objectId\" : \"0900006480f7a095\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jon Diamond - Comment\",\n",
      "      \"objectId\" : \"0900006480f7a6a6\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Manny Balani - Comment\",\n",
      "      \"objectId\" : \"0900006480f7a925\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tanya Smith - Comment\",\n",
      "      \"objectId\" : \"0900006480f7ac6c\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven Kryworuka - Comment\",\n",
      "      \"objectId\" : \"0900006480f7ac76\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Audrey Schadt - Comment\",\n",
      "      \"objectId\" : \"0900006480f7aec5\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Todd - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b10b\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Steven Woo - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b17b\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Summer Holton - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b246\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"amanda michelle campbell - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b30a\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gerardo Adam Borger - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b30b\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Montana Ruark - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b692\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jonathan Bradley Chaffee - Comment\",\n",
      "      \"objectId\" : \"0900006480f7b987\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"M Diane Starner-Gillespie - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c26f\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Denise Ann Pierson - Comment\",\n",
      "      \"objectId\" : \"0900006480f7bf06\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ely Margolis - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c0cd\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharon Mary Fischer - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c934\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Paul Gemelli - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c975\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tanya Smith - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c9a5\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Douglas J Arnold - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c742\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-19T23:05:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jaimie Wisniowski - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c854\",\n",
      "      \"postedDate\" : \"2011-12-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:10:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nathaniel R Harris - Comment\",\n",
      "      \"objectId\" : \"0900006480f7c8fd\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:10:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"chase jones - Comment\",\n",
      "      \"objectId\" : \"0900006480f7cd59\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:10:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert E Mears - Comment\",\n",
      "      \"objectId\" : \"0900006480f7cd66\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:12:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J F - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d08a\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:23:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Matthew Ray Morrison - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d377\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:23:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Philip Freudenberger - Comment\",\n",
      "      \"objectId\" : \"0900006480f7d7f6\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T16:31:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480f7ddbf\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-12-20T17:01:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annette Rogers - Comment\",\n",
      "      \"objectId\" : \"0900006480f7ea1e\",\n",
      "      \"postedDate\" : \"2011-12-20T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-02T20:35:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"HBI International - Comment\",\n",
      "      \"objectId\" : \"0900006480f9d1aa\",\n",
      "      \"postedDate\" : \"2012-02-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2011-N-0467-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-02-23T19:00:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Wholesale Marketers Association (AWMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480f7e893\",\n",
      "      \"postedDate\" : \"2011-12-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2011-N-0467-0056\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 38,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 38,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 38,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 38,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 38,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-N-0294-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T16:52:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064809e760b\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0002\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0003\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T17:34:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren Mary McKim, R.N. - Comment\",\n",
      "      \"objectId\" : \"09000064809e77a2\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0003\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0004\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T17:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Martinasek - Comment\",\n",
      "      \"objectId\" : \"09000064809e7789\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0004\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0005\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T17:47:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danielle Y. Tindol - Comment\",\n",
      "      \"objectId\" : \"09000064809e77e0\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0005\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0006\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T17:54:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"George E. Troutfetter - Comment\",\n",
      "      \"objectId\" : \"09000064809e7856\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0006\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0007\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:07:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christie J. Lundy (Missouri Department of Mental Health) - Comment\",\n",
      "      \"objectId\" : \"09000064809e7a45\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0007\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0008\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:10:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gaylene R. Lee - Comment\",\n",
      "      \"objectId\" : \"09000064809e7876\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0008\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:14:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William A. Siebold - Comment\",\n",
      "      \"objectId\" : \"09000064809e7a48\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0009\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0010\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:17:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ira M. Huff (ECF) - Comment\",\n",
      "      \"objectId\" : \"09000064809e78de\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0010\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0011\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:22:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hollie Milam - Comment\",\n",
      "      \"objectId\" : \"09000064809e7abc\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0011\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0012\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:27:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle L. Maile - Comment\",\n",
      "      \"objectId\" : \"09000064809e7b27\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0012\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0013\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:40:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C R P - Comment\",\n",
      "      \"objectId\" : \"09000064809e7f05\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0013\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0014\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T18:46:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Judith A. Pecho (Country Oasis LLC) - Comment\",\n",
      "      \"objectId\" : \"09000064809e7fde\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0014\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0015\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T19:34:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stuart Holmes - Comment\",\n",
      "      \"objectId\" : \"09000064809e8355\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0015\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0016\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T19:37:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064809e7cc3\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0016\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0017\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T19:40:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert R. Fluck (American Association for Respiratory Care) - Comment\",\n",
      "      \"objectId\" : \"09000064809e84ed\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0017\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0018\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T19:48:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064809e85a8\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0018\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0019\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T19:57:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thomas M. Schaltenbrand - Comment\",\n",
      "      \"objectId\" : \"09000064809e8c29\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0019\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0020\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:11:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert J. Forsyth (FKG Oil Co.) - Comment\",\n",
      "      \"objectId\" : \"09000064809e86c5\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0020\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0021\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:12:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katherine K. Beevers (AARC) - Comment\",\n",
      "      \"objectId\" : \"09000064809e85eb\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0021\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0022\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:12:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carole A. Scaggs - Comment\",\n",
      "      \"objectId\" : \"09000064809e8c2c\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0022\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0023\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:12:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathy Patterson - Comment\",\n",
      "      \"objectId\" : \"09000064809e86ee\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0023\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0024\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:17:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lesley A. Smith - Comment\",\n",
      "      \"objectId\" : \"09000064809e8d1a\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0024\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0025\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:24:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeff A. Suty - Comment\",\n",
      "      \"objectId\" : \"09000064809e8d1e\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0025\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0026\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:39:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carl Anderson - Comment\",\n",
      "      \"objectId\" : \"09000064809e8ec1\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0026\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0027\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:47:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Howard G. Lazzarini, RRT - Comment\",\n",
      "      \"objectId\" : \"09000064809e91eb\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0027\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0028\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-03T20:52:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol R. Southard - Comment\",\n",
      "      \"objectId\" : \"09000064809e91ef\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0028\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0029\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-04T03:42:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Louise C. Grim - Comment\",\n",
      "      \"objectId\" : \"09000064809e9287\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0029\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0030\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-04T03:49:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marlene Bakken - Comment\",\n",
      "      \"objectId\" : \"09000064809e921e\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0030\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0031\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-04T03:53:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064809e8890\",\n",
      "      \"postedDate\" : \"2009-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0031\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0032\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-05T21:27:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert J. Maynard - Comment\",\n",
      "      \"objectId\" : \"09000064809e9573\",\n",
      "      \"postedDate\" : \"2009-07-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0032\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0033\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T02:42:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carol Ann Burkhart, R.N., MS - Comment\",\n",
      "      \"objectId\" : \"09000064809ea3fd\",\n",
      "      \"postedDate\" : \"2009-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0033\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0034\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T02:58:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beth A. Hoeffner (Orange County Department of Health) - Comment\",\n",
      "      \"objectId\" : \"09000064809ea914\",\n",
      "      \"postedDate\" : \"2009-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0034\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0035\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T03:02:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alvin Perkins, M.D. - Comment\",\n",
      "      \"objectId\" : \"09000064809ea8b8\",\n",
      "      \"postedDate\" : \"2009-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0035\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0036\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T03:10:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzanne M. Binau - Comment\",\n",
      "      \"objectId\" : \"09000064809ead94\",\n",
      "      \"postedDate\" : \"2009-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0036\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0037\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T03:16:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"George A. Garcia, RRT, AEC - Comment\",\n",
      "      \"objectId\" : \"09000064809eada6\",\n",
      "      \"postedDate\" : \"2009-07-06T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0037\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0038\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T22:36:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erkinger - Comment\",\n",
      "      \"objectId\" : \"09000064809eafaa\",\n",
      "      \"postedDate\" : \"2009-07-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0038\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0039\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T22:42:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"09000064809eb441\",\n",
      "      \"postedDate\" : \"2009-07-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0039\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0040\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-07T22:56:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen D. Welton - Comment\",\n",
      "      \"objectId\" : \"09000064809eb59c\",\n",
      "      \"postedDate\" : \"2009-07-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0040\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0041\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paul E. Kuhn - Comment\",\n",
      "      \"objectId\" : \"09000064809ec3f2\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0041\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0042\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anthony W Fox MD - Comment\",\n",
      "      \"objectId\" : \"09000064809eba4c\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0042\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0043\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Haime - Comment\",\n",
      "      \"objectId\" : \"09000064809ec663\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0043\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0044\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ward - Comment\",\n",
      "      \"objectId\" : \"09000064809ebc0b\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0044\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0045\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erwin III Franke - Comment\",\n",
      "      \"objectId\" : \"09000064809ec9d5\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0045\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0046\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Helen E Eschenbacher - Comment\",\n",
      "      \"objectId\" : \"09000064809ecd0e\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0046\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0047\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael Siegel - Comment\",\n",
      "      \"objectId\" : \"09000064809ed51d\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0047\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0048\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Latham &amp; Watkins, LLP - Comment\",\n",
      "      \"objectId\" : \"09000064809ed7ac\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0048\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0049\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thurman Allen Merritt - Comment\",\n",
      "      \"objectId\" : \"09000064809ed8e6\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0049\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0050\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-10T20:51:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolyn N Gaughan - Comment\",\n",
      "      \"objectId\" : \"09000064809ee4af\",\n",
      "      \"postedDate\" : \"2009-07-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0050\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0051\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-13T15:01:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marcus A. Button, MD - Comment\",\n",
      "      \"objectId\" : \"09000064809ee9ae\",\n",
      "      \"postedDate\" : \"2009-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0051\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0052\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-13T15:01:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"james u lllxxx - Comment\",\n",
      "      \"objectId\" : \"09000064809ee7d0\",\n",
      "      \"postedDate\" : \"2009-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0052\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0053\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-13T15:01:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cherrie B Hughes - Comment\",\n",
      "      \"objectId\" : \"09000064809eeb70\",\n",
      "      \"postedDate\" : \"2009-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0053\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0054\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-13T15:01:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marlene Bakken - Comment\",\n",
      "      \"objectId\" : \"09000064809eec81\",\n",
      "      \"postedDate\" : \"2009-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0054\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0055\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-13T15:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynda R Farley - Comment\",\n",
      "      \"objectId\" : \"09000064809ef9e5\",\n",
      "      \"postedDate\" : \"2009-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0055\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0056\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-13T19:22:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sue Sierra - Comment\",\n",
      "      \"objectId\" : \"09000064809f0222\",\n",
      "      \"postedDate\" : \"2009-07-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0056\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0057\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-14T14:10:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"University of Wisconsin Center for Tobacco Research and Intervention - Comment\",\n",
      "      \"objectId\" : \"09000064809efc6b\",\n",
      "      \"postedDate\" : \"2009-07-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0057\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0058\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-16T15:51:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Arnold Barzydlo - Comment\",\n",
      "      \"objectId\" : \"09000064809efcd2\",\n",
      "      \"postedDate\" : \"2009-07-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0058\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0059\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-16T15:51:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Badenhop II - Comment\",\n",
      "      \"objectId\" : \"09000064809f12e4\",\n",
      "      \"postedDate\" : \"2009-07-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0059\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0060\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-16T15:51:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeff - Comment\",\n",
      "      \"objectId\" : \"09000064809f1e93\",\n",
      "      \"postedDate\" : \"2009-07-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0060\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0061\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-16T15:51:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Timothy Richard Henry Pratt - Comment\",\n",
      "      \"objectId\" : \"09000064809f1789\",\n",
      "      \"postedDate\" : \"2009-07-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0061\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0062\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-16T15:51:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Clinton Lee Reed - Comment\",\n",
      "      \"objectId\" : \"09000064809f17b4\",\n",
      "      \"postedDate\" : \"2009-07-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0062\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0063\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-20T01:53:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Philip Morris USA, Inc., and U.S. Smokeless Tobacco Company LLC (Sidley Austin LLP) - Comment\",\n",
      "      \"objectId\" : \"09000064809f3164\",\n",
      "      \"postedDate\" : \"2009-07-19T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0063\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0064\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-20T14:44:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Iger Duarte - Comment\",\n",
      "      \"objectId\" : \"09000064809f315d\",\n",
      "      \"postedDate\" : \"2009-07-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0064\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0066\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-20T14:44:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jerry J. Campbell - Comment\",\n",
      "      \"objectId\" : \"09000064809f526c\",\n",
      "      \"postedDate\" : \"2009-07-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0066\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-20T15:31:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jeremy Vann - Comment\",\n",
      "      \"objectId\" : \"09000064809f5c6a\",\n",
      "      \"postedDate\" : \"2009-07-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-20T18:25:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ramona Bennett - Comment\",\n",
      "      \"objectId\" : \"09000064809f62e2\",\n",
      "      \"postedDate\" : \"2009-07-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0065\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-22T03:04:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda C Swoboda - Comment\",\n",
      "      \"objectId\" : \"09000064809f555e\",\n",
      "      \"postedDate\" : \"2009-07-20T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0065\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0069\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-22T03:06:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ray Withersppon - Comment\",\n",
      "      \"objectId\" : \"09000064809f69b4\",\n",
      "      \"postedDate\" : \"2009-07-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0069\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0070\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-22T18:25:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gina Marie Boudreau - Comment\",\n",
      "      \"objectId\" : \"09000064809f7e35\",\n",
      "      \"postedDate\" : \"2009-07-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0070\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0071\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-22T18:25:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kim Kennerly Harmon - Comment\",\n",
      "      \"objectId\" : \"09000064809f7fb4\",\n",
      "      \"postedDate\" : \"2009-07-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0071\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0072\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-23T14:19:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Darrel E Nance - Comment\",\n",
      "      \"objectId\" : \"09000064809f87ce\",\n",
      "      \"postedDate\" : \"2009-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0072\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0073\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-23T14:19:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonnie Lee Gilbert - Comment\",\n",
      "      \"objectId\" : \"09000064809f882d\",\n",
      "      \"postedDate\" : \"2009-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0073\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0074\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-23T14:19:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert - Comment\",\n",
      "      \"objectId\" : \"09000064809f84d7\",\n",
      "      \"postedDate\" : \"2009-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0074\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0075\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-23T18:42:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gail L Rezai - Comment\",\n",
      "      \"objectId\" : \"09000064809f9551\",\n",
      "      \"postedDate\" : \"2009-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0075\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0076\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-23T18:42:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katie Elaine Slavin - Comment\",\n",
      "      \"objectId\" : \"09000064809f8bdc\",\n",
      "      \"postedDate\" : \"2009-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0076\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0077\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-23T18:42:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gail L Rezai - Comment\",\n",
      "      \"objectId\" : \"09000064809f9556\",\n",
      "      \"postedDate\" : \"2009-07-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0077\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0078\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-24T18:14:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bob - Comment\",\n",
      "      \"objectId\" : \"09000064809f93a5\",\n",
      "      \"postedDate\" : \"2009-07-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0078\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0079\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-24T18:14:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jerry Campbell - Comment\",\n",
      "      \"objectId\" : \"09000064809f9bb0\",\n",
      "      \"postedDate\" : \"2009-07-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0079\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0080\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-24T18:14:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael Siegel - Comment\",\n",
      "      \"objectId\" : \"09000064809fa134\",\n",
      "      \"postedDate\" : \"2009-07-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0080\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0081\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-24T20:31:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Audrey Benenati - Comment\",\n",
      "      \"objectId\" : \"09000064809fa908\",\n",
      "      \"postedDate\" : \"2009-07-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0081\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0082\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-27T13:32:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beth Thompson - Comment\",\n",
      "      \"objectId\" : \"09000064809fa64d\",\n",
      "      \"postedDate\" : \"2009-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0082\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0083\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-27T13:32:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beth Thompson - Comment\",\n",
      "      \"objectId\" : \"09000064809fa9ca\",\n",
      "      \"postedDate\" : \"2009-07-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0083\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0084\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-07-30T15:55:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ed Heavey - Comment\",\n",
      "      \"objectId\" : \"09000064809fce20\",\n",
      "      \"postedDate\" : \"2009-07-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0084\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0085\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-05T20:59:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dawn Marantz Dunn - Comment\",\n",
      "      \"objectId\" : \"0900006480a00dd9\",\n",
      "      \"postedDate\" : \"2009-08-05T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0085\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0086\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-07T15:33:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jed Rose, Duke University Medical Center\",\n",
      "      \"objectId\" : \"09000064809fcdd7\",\n",
      "      \"postedDate\" : \"2009-08-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0086\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0087\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-07T15:33:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Juliette Tworsey, none\",\n",
      "      \"objectId\" : \"09000064809fead6\",\n",
      "      \"postedDate\" : \"2009-08-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0087\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0088\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-07T15:33:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anita Stanley - Comment\",\n",
      "      \"objectId\" : \"09000064809fcee1\",\n",
      "      \"postedDate\" : \"2009-08-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0088\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0089\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-07T15:33:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Masiello - Comment\",\n",
      "      \"objectId\" : \"09000064809fcfe0\",\n",
      "      \"postedDate\" : \"2009-08-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0089\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0090\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-07T15:33:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"UT Health Science Center - Comment\",\n",
      "      \"objectId\" : \"0900006480a00096\",\n",
      "      \"postedDate\" : \"2009-08-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0090\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0091\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-07T15:33:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Ojo - Comment\",\n",
      "      \"objectId\" : \"0900006480a00f7a\",\n",
      "      \"postedDate\" : \"2009-08-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0091\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0092\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-10T14:22:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J L Harrib - Comment\",\n",
      "      \"objectId\" : \"0900006480a043e9\",\n",
      "      \"postedDate\" : \"2009-08-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0092\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0093\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-11T16:12:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kerry Scott Lane MD - Comment\",\n",
      "      \"objectId\" : \"0900006480a0570a\",\n",
      "      \"postedDate\" : \"2009-08-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0093\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0094\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-12T19:22:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine D Bell - Comment\",\n",
      "      \"objectId\" : \"0900006480a04068\",\n",
      "      \"postedDate\" : \"2009-08-12T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0094\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0095\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-13T13:19:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynda Shaw Haworth - Comment\",\n",
      "      \"objectId\" : \"0900006480a08074\",\n",
      "      \"postedDate\" : \"2009-08-13T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0095\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0096\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-17T16:46:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a0a97f\",\n",
      "      \"postedDate\" : \"2009-08-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0096\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0097\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-18T15:10:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"alben barkley strong - Comment\",\n",
      "      \"objectId\" : \"0900006480a0bacb\",\n",
      "      \"postedDate\" : \"2009-08-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0097\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0098\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-24T00:28:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Lung Association (ALA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a04ab1\",\n",
      "      \"postedDate\" : \"2009-08-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0098\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0099\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-24T02:32:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bucks Youth Against Tobacco (BYAT) - Comment\",\n",
      "      \"objectId\" : \"0900006480a0cc0b\",\n",
      "      \"postedDate\" : \"2009-08-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0099\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0100\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-24T02:48:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alliance for Health, Economic and Agriculture Development (AHEAD) - Comment\",\n",
      "      \"objectId\" : \"0900006480a0d2e0\",\n",
      "      \"postedDate\" : \"2009-08-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0100\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0105\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kyra Harris - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e56a\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0105\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0106\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Claudelle Marie Crowe - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e580\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0106\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0107\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Luann Lewis - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e181\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0107\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert C. Dickerson, II - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e183\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0109\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deborah R Pendrey - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e586\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0109\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0110\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erwin F. Sawall, Jr - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e189\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0110\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0111\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Eaton - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e18c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0111\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0112\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rob - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5a4\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0112\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0113\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie Malcolmson - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5a7\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0113\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0114\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzanne Oelke - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5a8\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0114\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0115\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Harriet Joy Helman - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5aa\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0115\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0116\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Roger Woitte - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e199\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0116\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0117\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chris Mcginn - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e19a\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0117\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0118\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah Catherine Panullo - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5b1\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0118\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0119\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael Lahey - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e19c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0119\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0120\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kayvan Zainabadi - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e19d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0120\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0121\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lex Nell - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5b3\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0121\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0122\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Siddharth Mehrotra - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e19e\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0122\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0123\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e19f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0123\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0124\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Keith Forrest - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5b4\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0124\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0125\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa J Ferguson - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1a8\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0125\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0126\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"BETTY N N BUNCH - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5cd\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0126\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0127\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Derek Stockdale - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1b3\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0127\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0128\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Mihok - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5cf\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0128\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0129\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mike Turner - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5d2\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0129\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0130\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"S. Etherton - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1b6\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0130\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0131\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Herb Joseph - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5d6\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0131\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0132\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J. Capozzelli - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5e3\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0132\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0133\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Neal Madnick - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5e5\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0133\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0134\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Florence Wagner - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1b9\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0134\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0135\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ronice Musako - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e5e7\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0135\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0136\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kendra Stoll - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1be\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0136\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0137\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ian H Terrell - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1c0\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0137\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0138\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anthony Ferrandino - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e60d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0138\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0139\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Turnquist - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e60e\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0139\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0140\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John J. Fitzgerald - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e614\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0140\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0141\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Misch - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e615\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0141\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0142\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:11:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Den Mark Wichar - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e616\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0142\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0143\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Robertson - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1dd\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0143\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0144\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Fleurette Marie Sweeney - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1e3\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0144\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charles Benjamin Schultz - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1e7\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0146\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Luis Prado - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e626\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0146\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0147\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jonathan Golijov - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1ea\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0147\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0148\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"James Tornatore - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1f7\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0148\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0149\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Bodwell - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e1f9\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0149\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Angela Fazzari - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e206\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Markovic - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e658\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0151\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0152\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Corey E. Olsen - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e210\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0152\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0153\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Timothy S Zulawski - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e215\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0153\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0154\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Baker Kurtz - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e21e\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0154\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0155\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andreas Ohland - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e65d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0155\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0156\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathryn Grainger - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e65e\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0156\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0157\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Virginia H. Bennett - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e229\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0157\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0158\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Tilley - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e6d6\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0158\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0159\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Perry - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e6fb\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0159\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0160\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert Alan Resnik - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e6fc\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0160\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0161\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joseph Francis Labuda - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e6fd\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0161\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0162\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen Bonatti - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e6fe\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0162\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0163\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lewis Jon Kuhlman - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e711\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0163\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0164\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richard and Nancy Huff - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e255\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0164\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Kinahan - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e715\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0165\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0166\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e731\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0166\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0167\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hollie Rintoul - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e735\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0167\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0168\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Peterson - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e25d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0168\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0169\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"peter sean Mulshine - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e748\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0169\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0170\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Miguel Ramos - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e749\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0170\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0171\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Roy Matteson - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e74b\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0171\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0172\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca Hazelbaker Deschamps - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e271\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0172\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0173\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Robert David Feinauer - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e7ab\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0173\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0174\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sarah McLaughlin - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e27c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0174\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0175\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Linda Bodian - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e27f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0175\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0176\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Devon MacDermott - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e28b\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0176\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0177\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amber Tidwell, M.A. - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e2a8\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0177\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0178\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Judith A Rosen - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eab1\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0178\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0179\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dustin Shane - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e2bb\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0179\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0180\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cynthia Essig - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e2fb\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0180\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0181\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e2fd\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0181\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0182\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. Richard DiIlio - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e301\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0182\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0183\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Gordon - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ec9d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0183\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0184\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Adam Boudreaux - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e30d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0184\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0185\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathleen Bartolomeo - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ec9f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0185\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0186\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dogan Ozkan - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e30f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0186\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0187\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. T. Randall - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eca3\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0187\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0188\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:12:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michael Molder - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e31a\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0188\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0189\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Giovanni Silva - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e31d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0189\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0190\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marcia Bailey - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e324\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0190\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0191\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dorothy Reichardt - Comment\",\n",
      "      \"objectId\" : \"0900006480a0edd8\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0191\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0192\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wilfred Potter - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e32f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0192\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0193\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Phyllis Hugins - Comment\",\n",
      "      \"objectId\" : \"0900006480a0edeb\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0193\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0194\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Scott Davis - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e33a\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0194\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0195\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bett - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e33c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0195\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0196\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Thomas Tan - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ee02\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0196\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0197\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carly Schmitt - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e33f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0197\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0198\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jack Prichard - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e34e\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0198\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0199\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Charles Rhodes - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ee8d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0199\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0200\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jason Berteotti - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ee93\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0200\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0201\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Allan S. Taylor - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e378\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0201\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0202\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michele Shimizu - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e37f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0202\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0203\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Clifford C Hritz - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eeae\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0203\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0204\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rev. Kathy A Costanzo - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eeb0\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0204\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0205\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nicole Ann Baumgartner - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e397\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0205\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0206\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Manuel C Carreira - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e39c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0206\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0207\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark Heffington, MD FAAFP - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e3a9\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0207\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0208\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David L Lyle - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e3aa\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0208\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0209\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Celana Ahtye - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eec8\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0209\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0210\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Meg Gilman - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eeda\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0210\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0211\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Barbara Caton - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eede\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0211\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0212\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Georgia Griffin - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e3dc\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0212\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0213\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrew Kessel - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e3df\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0213\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0214\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura Helfman, MD - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef08\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0214\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0215\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Francis M. Collins, MD, FACP, FACE - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e3f3\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0215\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0216\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lauren Murdock - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef0a\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0216\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0217\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vanessa Beyers - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef0c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0217\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0218\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristi Mahy - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e3f7\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0218\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0219\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Holly A Gietl - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e42a\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0219\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0220\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alexis Soulios - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef58\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0220\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0221\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jenny Chung - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e430\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0221\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0222\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ilari Rantala - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e432\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0222\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0223\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elizabeth M Frederick - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef5f\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0223\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0224\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lori Marie Buhlman - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e45b\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0224\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0225\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolyn Steinhoff - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e45c\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0225\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0226\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sharla G. Bertram - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef66\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0226\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0227\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Douglas Warren Kinney - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ef92\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0227\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0228\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christina Graybill - Comment\",\n",
      "      \"objectId\" : \"0900006480a0e4c7\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0228\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0229\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sonia Holmes, MD - Comment\",\n",
      "      \"objectId\" : \"0900006480a0eff6\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0229\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0230\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:13:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Corcoran - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f571\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0230\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0231\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:14:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erin Schminke - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f22d\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0231\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0232\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:14:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Doreen Theresia Schommer - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f742\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0232\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0233\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:14:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolyn Bigger - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f275\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0233\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0234\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-26T21:14:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Olivia Agyekumwaa Boateng - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f744\",\n",
      "      \"postedDate\" : \"2009-08-26T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0234\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0235\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-27T19:55:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : true,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tom Neylon - Comment\",\n",
      "      \"objectId\" : \"0900006480a10280\",\n",
      "      \"postedDate\" : \"2009-08-27T00:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0235\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0236\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Randy Pearson - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f840\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0236\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0237\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathy Popoff - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f8d6\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0237\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0238\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"SUSAN I SCHOEPHOESTER - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f8ed\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0238\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0239\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynn Walker - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f334\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0239\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0240\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa E Berger - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f35b\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0240\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0241\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Davies - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f3ad\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0241\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0242\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ann Watters - Comment\",\n",
      "      \"objectId\" : \"0900006480a0f438\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0242\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0243\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Stephen Greenberg - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fc10\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0243\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0244\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lucy Winona Lily Midelfort - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fc49\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0244\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0245\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shannon E. Holcomb - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fc66\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0245\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0246\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ligia Zambrano - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fc67\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0246\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0247\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tony Bell - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fd51\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0247\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0248\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"E.Frances Caulfield - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fc91\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0248\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0249\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenna Davis - Comment\",\n",
      "      \"objectId\" : \"0900006480a1023b\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0249\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0250\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jacoba Van Sitteren - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fecc\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0250\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0251\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bob Flynn - Comment\",\n",
      "      \"objectId\" : \"0900006480a0fef1\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0251\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0252\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Parker - Comment\",\n",
      "      \"objectId\" : \"0900006480a1024b\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0252\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0253\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kristie Persinger - Comment\",\n",
      "      \"objectId\" : \"0900006480a1024c\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0253\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0254\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elaine Elmer - Comment\",\n",
      "      \"objectId\" : \"0900006480a10252\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0254\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0255\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alex Rice - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ff1b\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0255\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 513,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 513,\n",
      "    \"totalPages\" : 3,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-N-0294-0256\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gerrit Crouse, PhD - Comment\",\n",
      "      \"objectId\" : \"0900006480a1026e\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0256\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0257\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deirdre Ann Dingman - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ff9f\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0257\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0258\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eleanor C. Eagan - Comment\",\n",
      "      \"objectId\" : \"0900006480a102a7\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0258\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0259\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Keiron P. Clapcott - Comment\",\n",
      "      \"objectId\" : \"0900006480a0ffd8\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0259\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0260\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Phillipe Price - Comment\",\n",
      "      \"objectId\" : \"0900006480a10589\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0260\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0261\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ian Campbell Cree - Comment\",\n",
      "      \"objectId\" : \"0900006480a103c8\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0261\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0262\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a103fa\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0262\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0263\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:53:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Diana Arezzo, Ph.D. - Comment\",\n",
      "      \"objectId\" : \"0900006480a10414\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0263\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0264\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Danny Dyche - Comment\",\n",
      "      \"objectId\" : \"0900006480a105ee\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0264\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0265\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kosic Bibic Nada - Comment\",\n",
      "      \"objectId\" : \"0900006480a105ef\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0265\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0266\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr Jeanne C Folks - Comment\",\n",
      "      \"objectId\" : \"0900006480a106c5\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0266\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0267\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Catherine G Houtakker - Comment\",\n",
      "      \"objectId\" : \"0900006480a10d25\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0267\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0268\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Deilyn Berdichevskaya - Comment\",\n",
      "      \"objectId\" : \"0900006480a11d40\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0268\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0269\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kelly Fenson-Hood - Comment\",\n",
      "      \"objectId\" : \"0900006480a1297d\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0269\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0270\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"James &amp; Judy Brady - Comment\",\n",
      "      \"objectId\" : \"0900006480a12b3d\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0270\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0271\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Debra Burke - Comment\",\n",
      "      \"objectId\" : \"0900006480a12bd5\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0271\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0272\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kathryn Silver - Comment\",\n",
      "      \"objectId\" : \"0900006480a12c07\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0272\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0273\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a12c4b\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0273\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0274\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tammie G Longhitano - Comment\",\n",
      "      \"objectId\" : \"0900006480a1370f\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0274\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0275\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Campaign for Tobacco-Free Kid - Comment\",\n",
      "      \"objectId\" : \"0900006480a159f8\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0275\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0276\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-28T15:54:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolynn Hamlet - Comment\",\n",
      "      \"objectId\" : \"0900006480a1624e\",\n",
      "      \"postedDate\" : \"2009-08-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0276\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0277\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-31T19:14:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bradley Eardley - Comment\",\n",
      "      \"objectId\" : \"0900006480a17b64\",\n",
      "      \"postedDate\" : \"2009-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0277\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0278\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-31T19:14:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gayle Rose Parker - Comment\",\n",
      "      \"objectId\" : \"0900006480a1855e\",\n",
      "      \"postedDate\" : \"2009-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0278\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0279\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-31T19:14:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gayle Rose Parker - Comment\",\n",
      "      \"objectId\" : \"0900006480a18579\",\n",
      "      \"postedDate\" : \"2009-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0279\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0280\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-31T19:14:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret Hornick - Comment\",\n",
      "      \"objectId\" : \"0900006480a185b6\",\n",
      "      \"postedDate\" : \"2009-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0280\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0281\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-31T19:14:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christopher Raymond Morin - Comment\",\n",
      "      \"objectId\" : \"0900006480a187b5\",\n",
      "      \"postedDate\" : \"2009-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0281\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0282\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-08-31T19:14:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark Kessler - Comment\",\n",
      "      \"objectId\" : \"0900006480a1836a\",\n",
      "      \"postedDate\" : \"2009-08-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0282\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0283\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-01T13:40:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Suzanne R Quaid - Comment\",\n",
      "      \"objectId\" : \"0900006480a19b84\",\n",
      "      \"postedDate\" : \"2009-09-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0283\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0284\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-03T14:34:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vermont Quit Network - Comment\",\n",
      "      \"objectId\" : \"0900006480a1a9ad\",\n",
      "      \"postedDate\" : \"2009-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0284\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0285\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-03T14:34:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kevin Ziegler - Comment\",\n",
      "      \"objectId\" : \"0900006480a1abab\",\n",
      "      \"postedDate\" : \"2009-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0285\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0286\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-03T16:40:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Lung Association (ALA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a1a8c4\",\n",
      "      \"postedDate\" : \"2009-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0286\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0287\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-03T16:42:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"State of New Jersey, Department of Human Services, Division of Addiction Services - Comment\",\n",
      "      \"objectId\" : \"0900006480a1a8c5\",\n",
      "      \"postedDate\" : \"2009-09-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0287\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0288\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-04T14:10:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca S Smith MD - Comment\",\n",
      "      \"objectId\" : \"0900006480a1d18e\",\n",
      "      \"postedDate\" : \"2009-09-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0288\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0289\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-04T19:30:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Academy of Pediatrics - Comment\",\n",
      "      \"objectId\" : \"0900006480a1d782\",\n",
      "      \"postedDate\" : \"2009-09-04T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0289\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0290\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-08T15:34:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa Koehler - Comment\",\n",
      "      \"objectId\" : \"0900006480a1cc52\",\n",
      "      \"postedDate\" : \"2009-09-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0290\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0291\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-08T15:34:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ronnie Altic - Comment\",\n",
      "      \"objectId\" : \"0900006480a1dc66\",\n",
      "      \"postedDate\" : \"2009-09-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0291\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0292\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-08T15:34:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chip Shirley - Comment\",\n",
      "      \"objectId\" : \"0900006480a1e093\",\n",
      "      \"postedDate\" : \"2009-09-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0292\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0293\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-09T13:26:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shan Magnuson - Comment\",\n",
      "      \"objectId\" : \"0900006480a1e5b7\",\n",
      "      \"postedDate\" : \"2009-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0293\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0294\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-09T13:34:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cynthia A Chaney - Comment\",\n",
      "      \"objectId\" : \"0900006480a1e5b8\",\n",
      "      \"postedDate\" : \"2009-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0294\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0295\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-09T13:58:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cameron Trower - Comment\",\n",
      "      \"objectId\" : \"0900006480a1e5d9\",\n",
      "      \"postedDate\" : \"2009-09-09T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0295\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0296\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-10T20:06:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Tina Thomure - Comment\",\n",
      "      \"objectId\" : \"0900006480a203ca\",\n",
      "      \"postedDate\" : \"2009-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0296\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0297\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-10T20:06:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Leslie A Best - Comment\",\n",
      "      \"objectId\" : \"0900006480a205cd\",\n",
      "      \"postedDate\" : \"2009-09-10T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0297\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0298\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C. Brock - Comment\",\n",
      "      \"objectId\" : \"0900006480a206fd\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0298\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0299\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Campaign for Tobacco-Free Kids - Comment\",\n",
      "      \"objectId\" : \"0900006480a1ff3a\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0299\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0300\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonoymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a1ffd9\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0300\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0301\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Americans For Nonsmokers' Rights - Comment\",\n",
      "      \"objectId\" : \"0900006480a211e9\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0301\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0302\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Georgi Velev - Comment\",\n",
      "      \"objectId\" : \"0900006480a20fb2\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0302\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0303\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lisa A Sansalone - Comment\",\n",
      "      \"objectId\" : \"0900006480a219fc\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0303\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0304\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carlos Torres - Comment\",\n",
      "      \"objectId\" : \"0900006480a21a28\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0304\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0305\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melanie Alexea - Comment\",\n",
      "      \"objectId\" : \"0900006480a21d54\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0305\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0306\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shelly L Jackson - Comment\",\n",
      "      \"objectId\" : \"0900006480a21ef1\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0306\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0307\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Joan Bowers - Comment\",\n",
      "      \"objectId\" : \"0900006480a21ef2\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0307\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0308\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Association Of Public Health Physicians - Comment\",\n",
      "      \"objectId\" : \"0900006480a21b39\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0308\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0309\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mary Elizabeth Schaeffer - Comment\",\n",
      "      \"objectId\" : \"0900006480a21ef6\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0309\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0310\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gwendolen Hannan - Comment\",\n",
      "      \"objectId\" : \"0900006480a21ff3\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0310\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0311\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shirley Kathleen Chaney - Comment\",\n",
      "      \"objectId\" : \"0900006480a21ff4\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0311\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0312\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T16:08:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erica Bersin - Comment\",\n",
      "      \"objectId\" : \"0900006480a220c5\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0312\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0313\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Donald Anthony Wolochow, MD - Comment\",\n",
      "      \"objectId\" : \"0900006480a221f1\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0313\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0314\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shana Stone - Comment\",\n",
      "      \"objectId\" : \"0900006480a21c50\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0314\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0315\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Paula Jo Anderson - Comment\",\n",
      "      \"objectId\" : \"0900006480a224aa\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0315\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0316\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Cermak - Comment\",\n",
      "      \"objectId\" : \"0900006480a21c95\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0316\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0317\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lee Chen - Comment\",\n",
      "      \"objectId\" : \"0900006480a21c96\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0317\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0318\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Center for Regulatory Effectiveness - Comment\",\n",
      "      \"objectId\" : \"0900006480a225df\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0318\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0319\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hybebah June Chevalier - Comment\",\n",
      "      \"objectId\" : \"0900006480a21cab\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0319\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0320\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Annie Tegen - Comment\",\n",
      "      \"objectId\" : \"0900006480a226f2\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0320\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0321\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-14T19:39:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a22957\",\n",
      "      \"postedDate\" : \"2009-09-14T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0321\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0322\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T17:45:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Lung Association - Comment\",\n",
      "      \"objectId\" : \"0900006480a20adf\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0322\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0323\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T17:49:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Bakery, Confectionery, Tobacco Workers and Grain Millers International Union - Comment\",\n",
      "      \"objectId\" : \"0900006480a224da\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0323\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0324\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Elizabeth Belanger - Comment\",\n",
      "      \"objectId\" : \"0900006480a229f7\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0324\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0325\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chester Miller - Comment\",\n",
      "      \"objectId\" : \"0900006480a22f32\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0325\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0326\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Free Enterprise - Comment\",\n",
      "      \"objectId\" : \"0900006480a22f6b\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0326\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0327\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carl Stein - Comment\",\n",
      "      \"objectId\" : \"0900006480a22b4f\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0327\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0328\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hugh Alexander Ross - Comment\",\n",
      "      \"objectId\" : \"0900006480a22cca\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0328\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0329\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Melissa Katherine Walton-Shirley - Comment\",\n",
      "      \"objectId\" : \"0900006480a24230\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0329\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0330\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-16T21:08:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Smith - Comment\",\n",
      "      \"objectId\" : \"0900006480a2427f\",\n",
      "      \"postedDate\" : \"2009-09-16T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0330\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0331\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T14:35:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Public Health- Seattle &amp; King County - Comment\",\n",
      "      \"objectId\" : \"0900006480a24df0\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0331\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0332\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T14:35:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Helen Eschenbacher - Comment\",\n",
      "      \"objectId\" : \"0900006480a2513a\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0332\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0333\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T14:35:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Star Scientific, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a2524e\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0333\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0334\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T14:56:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jim Meyer - Comment\",\n",
      "      \"objectId\" : \"0900006480a25265\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0334\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0335\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T16:15:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The American Farm Bureau Federation - Comment\",\n",
      "      \"objectId\" : \"0900006480a25286\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0335\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0336\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T18:21:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alexander McLeod Stewart - Comment\",\n",
      "      \"objectId\" : \"0900006480a2569d\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0336\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0337\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T18:21:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Vivian Smith - Comment\",\n",
      "      \"objectId\" : \"0900006480a256a1\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0337\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0338\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-17T20:43:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"KAREN E DELANEY - Comment\",\n",
      "      \"objectId\" : \"0900006480a25d98\",\n",
      "      \"postedDate\" : \"2009-09-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0338\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0339\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-18T15:52:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Marty Eckrem - Comment\",\n",
      "      \"objectId\" : \"0900006480a26100\",\n",
      "      \"postedDate\" : \"2009-09-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0339\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0340\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-18T15:52:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carl Bartecchi - Comment\",\n",
      "      \"objectId\" : \"0900006480a25ecf\",\n",
      "      \"postedDate\" : \"2009-09-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0340\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0341\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-18T15:52:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chinelo Oyakhilome - Comment\",\n",
      "      \"objectId\" : \"0900006480a25ed3\",\n",
      "      \"postedDate\" : \"2009-09-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0341\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0342\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patton Boggs LLP - Comment\",\n",
      "      \"objectId\" : \"0900006480a263af\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0342\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0343\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Association of Tobacco Outlets, Inc. (NATO) - Comment\",\n",
      "      \"objectId\" : \"0900006480a26430\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0343\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0344\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Washington State Department of Health - Comment\",\n",
      "      \"objectId\" : \"0900006480a270f9\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0344\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0345\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jan K Harris - Comment\",\n",
      "      \"objectId\" : \"0900006480a27d35\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0345\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0346\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"C. Agusta Callaway - Comment\",\n",
      "      \"objectId\" : \"0900006480a279f2\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0346\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0347\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Subash C Patel - Comment\",\n",
      "      \"objectId\" : \"0900006480a27d76\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0347\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0348\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jennifer Elaine Moreno - Comment\",\n",
      "      \"objectId\" : \"0900006480a27ab0\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0348\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0349\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cheyenne International - Comment\",\n",
      "      \"objectId\" : \"0900006480a2813b\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0349\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0350\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"International Tobacco Partners, LTD. - Comment\",\n",
      "      \"objectId\" : \"0900006480a28258\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0350\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0351\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Beth Alexandria Hoeffner - Comment\",\n",
      "      \"objectId\" : \"0900006480a282b7\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0351\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0352\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"shirley simmons - Comment\",\n",
      "      \"objectId\" : \"0900006480a2831f\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0352\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0353\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2833b\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0353\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0354\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-21T19:01:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a285a4\",\n",
      "      \"postedDate\" : \"2009-09-21T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0354\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0355\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T16:37:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ivy Pearlstein - Comment\",\n",
      "      \"objectId\" : \"0900006480a284ab\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0355\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0356\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T16:37:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rebecca L Greenwald - Comment\",\n",
      "      \"objectId\" : \"0900006480a28628\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0356\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0357\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T16:37:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jack Samuels - Comment\",\n",
      "      \"objectId\" : \"0900006480a28a81\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0357\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0358\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T16:37:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Julia M Perez - Comment\",\n",
      "      \"objectId\" : \"0900006480a28724\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0358\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0360\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T16:41:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Skyler Stoudt - Comment\",\n",
      "      \"objectId\" : \"0900006480a28c70\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0360\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0361\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T16:41:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Theresa Ann Whitt - Comment\",\n",
      "      \"objectId\" : \"0900006480a287a9\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0361\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0362\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T21:00:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shorewood Packaging - Comment\",\n",
      "      \"objectId\" : \"0900006480a29069\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0362\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0363\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T21:00:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Oksales, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a291c5\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0363\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0364\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T21:00:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"johann Pierre - Comment\",\n",
      "      \"objectId\" : \"0900006480a291de\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0364\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0365\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-22T21:00:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anna C Holster - Comment\",\n",
      "      \"objectId\" : \"0900006480a2921f\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0365\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0366\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:29:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bernice Gerig Carver - Comment\",\n",
      "      \"objectId\" : \"0900006480a2924c\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0366\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0367\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:30:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Barleycorn - Comment\",\n",
      "      \"objectId\" : \"0900006480a292bc\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0367\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0368\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:30:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a298ec\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0368\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0369\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:30:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Damian Eve - Comment\",\n",
      "      \"objectId\" : \"0900006480a298ed\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0369\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0370\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:30:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a298f2\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0370\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0371\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:30:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Peggy N. Voelz - Comment\",\n",
      "      \"objectId\" : \"0900006480a29934\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0371\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0372\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-23T14:30:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lynetta J Moore - Comment\",\n",
      "      \"objectId\" : \"0900006480a29afe\",\n",
      "      \"postedDate\" : \"2009-09-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0372\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0373\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patton Boggs LLP - Comment\",\n",
      "      \"objectId\" : \"0900006480a2940e\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0373\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0374\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina State University - Comment\",\n",
      "      \"objectId\" : \"0900006480a29484\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0374\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0375\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ricky E Jones - Comment\",\n",
      "      \"objectId\" : \"0900006480a29491\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0375\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0376\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Philip J. Autry - Comment\",\n",
      "      \"objectId\" : \"0900006480a2a762\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0376\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0377\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hoa Nguyen - Comment\",\n",
      "      \"objectId\" : \"0900006480a294f1\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0377\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0378\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2a7c5\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0378\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0379\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Legacy Foundation - Comment\",\n",
      "      \"objectId\" : \"0900006480a2aa25\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0379\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0380\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark S. Powell - Comment\",\n",
      "      \"objectId\" : \"0900006480a2aa3d\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0380\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0381\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T15:31:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christine D. Weiss - Comment\",\n",
      "      \"objectId\" : \"0900006480a2b1d7\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0381\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0382\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-24T19:43:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Native Commerical Tobacco Abuse Prevention Network - Comment\",\n",
      "      \"objectId\" : \"0900006480a2b441\",\n",
      "      \"postedDate\" : \"2009-09-24T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0382\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0383\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Heart Association - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ab4d\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0383\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0384\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Edythe D. London, Ph.D. et al - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ab5c\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0384\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0385\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Christopher R. Morin - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ba23\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0385\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0386\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina State University - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bb8d\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0386\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0387\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Focke &amp; Co., Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bcc0\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0387\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0388\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Teri Doochin - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bcc1\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0388\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0389\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kentucky Farm Bureau - Comment\",\n",
      "      \"objectId\" : \"0900006480a2acdc\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0389\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0390\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Karen-Lynette Bauer - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bd7f\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0390\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0391\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janet A. Holden - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c25f\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0391\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0392\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Herb Joseph - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bd88\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0392\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0393\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-25T21:17:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Aurolyn Luykx - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c261\",\n",
      "      \"postedDate\" : \"2009-09-25T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0393\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0394\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2b7dc\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0394\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0395\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margie J Borchers - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bdbe\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0395\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0396\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Frances G. Hoenigswald - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c272\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0396\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0397\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Isa Kaluhikaua - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c27c\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0397\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0398\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Kilgore - Comment\",\n",
      "      \"objectId\" : \"0900006480a2be51\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0398\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0399\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mark Feldman - Comment\",\n",
      "      \"objectId\" : \"0900006480a2be52\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0399\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0400\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kimberly Tilley - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c284\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0400\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0401\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ann Watters - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c28d\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0401\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0402\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"S. Etherton - Comment\",\n",
      "      \"objectId\" : \"0900006480a2be57\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0402\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0403\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Katharine A. Miller, PhD - Comment\",\n",
      "      \"objectId\" : \"0900006480a2be9b\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0403\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0404\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"E. S. SCHLOSS - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c2a5\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0404\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0405\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Valerie Johnstone - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c2ab\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0405\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0406\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Squaxin Island Tribe - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bebb\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0406\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0407\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Baker Kurtz - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c2b4\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0407\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0408\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Timothy Myers - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c2d0\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0408\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0409\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"S. James Marie - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bef8\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0409\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0410\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Margaret M Hannigan - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c2d4\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0410\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0411\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"University of Kentucky - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bfab\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0411\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0412\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American College of Chest Physicians - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c30d\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0412\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0413\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"jeff hopkins - Comment\",\n",
      "      \"objectId\" : \"0900006480a2bff4\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0413\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0414\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Laura A meek - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c0a3\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0414\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0415\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"robert j holsem - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c343\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0415\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0416\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c366\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0416\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0417\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Montes - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c58a\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0417\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0418\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dr. H. Paul Denton - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c381\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0418\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0419\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rene Minshew - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c68d\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0419\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0420\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ben H-E - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c3e2\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0420\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0421\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Potter Morris Potter - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c3f4\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0421\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0422\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Narinder Dhaliwal - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c432\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0422\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0423\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:53:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dian Kiser - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c439\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0423\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0424\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Craig Dodge - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c44a\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0424\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0425\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c45d\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0425\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0426\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrea Peterson - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c463\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0426\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0427\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jason Hering - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c77e\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0427\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0428\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"john oda - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c491\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0428\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0429\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"virginia sullivan - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c4db\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0429\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0430\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Patricia Davis Chang - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c7ff\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0430\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0431\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Richard D. Baldwin, M.D. - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c802\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0431\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0432\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anya M Kroth - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c970\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0432\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0433\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Luke Gilson - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c9c8\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0433\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0434\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carter Keane - Comment\",\n",
      "      \"objectId\" : \"0900006480a2c9e1\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0434\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0435\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Joe McVay - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ca01\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0435\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0436\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ben Thomas - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ca05\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0436\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0437\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Megan Rising - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cb61\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0437\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0438\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Latino Tobacco Control Network - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cb62\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0438\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0439\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Phil Hopkins - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cb64\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0439\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0440\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolyn Mazure - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cb68\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0440\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0441\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"John Jonik - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cea6\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0441\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0442\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Timothy Henry Paich - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cb9f\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0442\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0443\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy Pope - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ceaf\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0443\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0444\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Rick Mulder - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cc15\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0444\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0445\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Malcolm Avery Brown - Comment\",\n",
      "      \"objectId\" : \"0900006480a2cc1b\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0445\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0446\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kara Highfill - Comment\",\n",
      "      \"objectId\" : \"0900006480a2d559\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0446\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0447\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nada Kosic Bibic - Comment\",\n",
      "      \"objectId\" : \"0900006480a2d55a\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0447\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0448\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2dd8f\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0448\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0449\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sandra Gail Cortright - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ddeb\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0449\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0450\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-28T20:54:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Erin Ruoff - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ccfe\",\n",
      "      \"postedDate\" : \"2009-09-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0450\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0451\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NYC Department of Health and Mental Hygiene - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e631\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0451\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0452\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Group Research and Development of British American Tobacco (Investments) Limited - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e102\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0452\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0453\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Wholesale Marketers Association (AWMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e635\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0453\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0454\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emily Doutre - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e118\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0454\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0455\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"paul Wayne Williams - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e131\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0455\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0456\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kenneth Moellman, Jr. - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ee15\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0456\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0457\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alyson C. Ward M.S. CHES - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ee16\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0457\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0458\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Sands - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e161\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0458\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0459\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Amy Sands - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e163\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0459\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0460\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Johnelle Claire Lamarque - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e1bb\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0460\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0461\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michelle R Stucker - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e1bd\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0461\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0462\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:52:57Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alcohol and Tobacco Tax and Trade Bureau, U.S. Department of the Treasury - Comment\",\n",
      "      \"objectId\" : \"0900006480a2ff6e\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0462\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0463\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:53:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Janae Duncan - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e1f8\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0463\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0464\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:53:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"David Nicholos Kane - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e1fb\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0464\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0465\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:53:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Swisher International, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e1ff\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0465\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0466\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T15:53:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"NC Dept of Agriculture &amp; Consumer Services - Comment\",\n",
      "      \"objectId\" : \"0900006480a3038f\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0466\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0467\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"harley david sahrpe - Comment\",\n",
      "      \"objectId\" : \"0900006480a30478\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0467\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0468\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Cancer Society Cancer Action Network - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e224\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0468\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0469\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Shirley Read - Comment\",\n",
      "      \"objectId\" : \"0900006480a30629\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0469\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0470\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Association of State and Territorial Health Officials (ASTHO) - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e236\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0470\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0471\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Chambers &amp; Owen - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e298\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0471\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0472\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Kathryn Harvey - Comment\",\n",
      "      \"objectId\" : \"0900006480a30967\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0472\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0473\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dipanjali Ponna - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e2b0\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0473\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0474\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Center for Tobacco Grower Research, University of Tennessee - Comment\",\n",
      "      \"objectId\" : \"0900006480a3098b\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0474\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0475\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Group Research and Development of British American Tobacco (Investments) Limited - Comment\",\n",
      "      \"objectId\" : \"0900006480a309e1\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0475\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0476\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Anonymous - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e36b\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0476\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0477\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Democracy Institute - Comment\",\n",
      "      \"objectId\" : \"0900006480a30b20\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0477\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0478\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Public Health Advocacy Institute at Northeastern University School of Law - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e3b7\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0478\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0479\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bonnie K Henderson-Martin RNOCN - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e3bd\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0479\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0480\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"City &amp; County of San Francisco - Comment\",\n",
      "      \"objectId\" : \"0900006480a30d39\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0480\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0481\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Toxic-Tobacco Law Coalition - Comment\",\n",
      "      \"objectId\" : \"0900006480a30d3d\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0481\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0482\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Commonwealth Brands, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a30d40\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0482\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0483\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nyo Yamonn - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e3f1\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0483\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0484\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Partnership for Prevention - Comment\",\n",
      "      \"objectId\" : \"0900006480a30d83\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0484\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0486\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jan M Flynn - Comment\",\n",
      "      \"objectId\" : \"0900006480a30f49\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0486\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0487\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Eastman Chemical Company - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e422\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0487\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0488\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Virginia Tech - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e435\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0488\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0489\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nancy E Cummings - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e44d\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0489\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0490\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:16:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Samuel Garten - Comment\",\n",
      "      \"objectId\" : \"0900006480a31008\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0490\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0491\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:17:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Medical Association (AMA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a31009\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0491\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0492\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-29T20:17:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina Farm Bureau Federation - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e46d\",\n",
      "      \"postedDate\" : \"2009-09-29T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0492\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0493\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"University of Georgia - Comment\",\n",
      "      \"objectId\" : \"0900006480a3104d\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0493\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0494\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Association for Cancer Research (AACR) - Comment\",\n",
      "      \"objectId\" : \"0900006480a3104f\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0494\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0495\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Brenda Nevidjon - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e472\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0495\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0496\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Community Pharmacists Association (NCPA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e481\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0496\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0497\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Pharmacists Association (APhA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a31325\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0497\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0498\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Oncology Nursing Society (ONS) - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e48e\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0498\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0499\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"University of California, Center for Tobacco Control Research and Education - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e494\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0499\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0500\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:56Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Lorillard Tobacco Company - Comment\",\n",
      "      \"objectId\" : \"0900006480a31329\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0500\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0501\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:07:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Washington Legal Foundation - Comment\",\n",
      "      \"objectId\" : \"0900006480a3132b\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0501\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0502\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"megan - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e4a1\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0502\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0503\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Corporate Accountability International - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e4bb\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0503\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0504\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Alan Blum - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e4d3\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0504\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0505\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Schweitzer-Mauduit International, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e4ed\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0505\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0506\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Smokefree Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e4ef\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0506\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0507\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Andrew Schultz - Comment\",\n",
      "      \"objectId\" : \"0900006480a2e4f2\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0507\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 513,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 513,\n",
      "    \"totalPages\" : 3,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2009-N-0294-0508\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:08:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Jewelie Smith - Comment\",\n",
      "      \"objectId\" : \"0900006480a3191c\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0508\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0359\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T16:34:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"University of California San Francisco (UCSF)/UC Hastings College of the Law Consortium on Law, Science &amp; Health Policy - Comment\",\n",
      "      \"objectId\" : \"0900006480a28c6e\",\n",
      "      \"postedDate\" : \"2009-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0359\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0509\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T17:54:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"kim jin gu - Comment\",\n",
      "      \"objectId\" : \"0900006480a31922\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0509\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0510\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-09-30T17:54:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Petroleum Marketers Association of America (PMAA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a31943\",\n",
      "      \"postedDate\" : \"2009-09-30T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0510\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0609\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-10T19:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North American Quitline Consortium (NAQC) - Comment\",\n",
      "      \"objectId\" : \"0900006480a258f3\",\n",
      "      \"postedDate\" : \"2009-11-10T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0609\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0610\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-10T21:03:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"People for the Ethical Treatment of Animals (PETA) - Comment\",\n",
      "      \"objectId\" : \"0900006480a32cd2\",\n",
      "      \"postedDate\" : \"2009-11-10T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0610\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0611\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-10T21:23:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Northeastern University School of Law - Comment\",\n",
      "      \"objectId\" : \"0900006480a554dc\",\n",
      "      \"postedDate\" : \"2009-11-10T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0611\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0621\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-10T21:38:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hardec's Wholesale Distributing - Comment\",\n",
      "      \"objectId\" : \"0900006480a30d8e\",\n",
      "      \"postedDate\" : \"2009-11-10T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0621\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0622\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-10T21:42:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"MeadWestvaco Corporation - Comment\",\n",
      "      \"objectId\" : \"0900006480a30d92\",\n",
      "      \"postedDate\" : \"2009-11-10T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0622\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-0623\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2009-11-10T21:47:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Academy of Family Physicians (AAFP) - Comment\",\n",
      "      \"objectId\" : \"0900006480a30fce\",\n",
      "      \"postedDate\" : \"2009-11-10T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-0623\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-1145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2010-01-19T23:19:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Vending Company, Inc. (Wimberly, Lawson, Stickel, Schneider &amp; Stine) - Comment\",\n",
      "      \"objectId\" : \"0900006480a7b1f4\",\n",
      "      \"postedDate\" : \"2010-01-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-1145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-1150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2011-03-18T21:18:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"R. J. Reynolds Tobacco Company - Comment\",\n",
      "      \"objectId\" : \"0900006480bff3ce\",\n",
      "      \"postedDate\" : \"2011-03-18T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-1150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2009-N-0294-1151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-09-22T16:21:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"R.J. Reynolds Tobacco Company - Comment\",\n",
      "      \"objectId\" : \"0900006480bb2176\",\n",
      "      \"postedDate\" : \"2012-09-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2009-N-0294-1151\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 513,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 13,\n",
      "    \"pageNumber\" : 3,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 513,\n",
      "    \"totalPages\" : 3,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 513,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 4,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 513,\n",
      "    \"totalPages\" : 3,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0386-0009\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-09-11T15:04:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Campaign for Tobacco Free Kids\",\n",
      "      \"objectId\" : \"0900006481b4db25\",\n",
      "      \"postedDate\" : \"2015-09-11T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0386-0009\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2012-N-0386-0002\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2012-07-03T15:48:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Susan Cringoli - Comment\",\n",
      "      \"objectId\" : \"090000648105ce77\",\n",
      "      \"postedDate\" : \"2012-07-03T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2012-N-0386-0002\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 1,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 1,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 1,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2017-N-6565-14940\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-07T16:59:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mark Girtler\",\n",
      "      \"objectId\" : \"09000064831c096d\",\n",
      "      \"postedDate\" : \"2018-06-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-14940\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-6565-15067\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-08T00:37:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dino Mannari\",\n",
      "      \"objectId\" : \"0900006483221963\",\n",
      "      \"postedDate\" : \"2018-06-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-15067\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-6565-15068\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-08T00:38:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648324cbe2\",\n",
      "      \"postedDate\" : \"2018-06-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-15068\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2017-N-6565-15165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2018-06-09T01:56:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Anonymous\",\n",
      "      \"objectId\" : \"090000648327525e\",\n",
      "      \"postedDate\" : \"2018-06-08T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2017-N-6565-15165\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 4,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 4,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 4,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 4,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 4,\n",
      "    \"totalPages\" : 1,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2013-N-0521-0108\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-07T19:25:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Kevin Elhalwani, Starbuzz Tobacco Inc. - Comment\",\n",
      "      \"objectId\" : \"09000064813fa7cb\",\n",
      "      \"postedDate\" : \"2013-10-07T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0108\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0134\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-17T21:54:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Robert L. Johnson, III, House of Representatives, State of Mississippi - Comment\",\n",
      "      \"objectId\" : \"0900006481451331\",\n",
      "      \"postedDate\" : \"2013-10-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0134\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0135\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-17T22:09:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Long Distribution - Comment\",\n",
      "      \"objectId\" : \"09000064814511c9\",\n",
      "      \"postedDate\" : \"2013-10-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0135\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0136\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-17T22:19:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pennsylvania Food Merchants Association (PFMA) - Comment\",\n",
      "      \"objectId\" : \"0900006481451337\",\n",
      "      \"postedDate\" : \"2013-10-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0136\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0137\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-17T22:29:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Martin and Snyder Product Sales Company - Comment\",\n",
      "      \"objectId\" : \"0900006481451335\",\n",
      "      \"postedDate\" : \"2013-10-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0137\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0138\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-17T22:33:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina Farm Bureau Federation, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481451336\",\n",
      "      \"postedDate\" : \"2013-10-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0138\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0139\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-18T00:18:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina Legislative Black Caucus - Comment\",\n",
      "      \"objectId\" : \"0900006481453500\",\n",
      "      \"postedDate\" : \"2013-10-17T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0139\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0140\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T21:57:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Paul Hornback, Commonwealth of Kentucky State Senate - Comment\",\n",
      "      \"objectId\" : \"0900006481459037\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0140\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0141\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T21:58:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Thom Tillis, Office of the Speaker, House of Representatives State of North Carolina - Comment\",\n",
      "      \"objectId\" : \"090000648145696c\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0141\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0142\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T21:59:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Bobby Moak, House of Representatives, State of Mississippi - Comment\",\n",
      "      \"objectId\" : \"090000648145696e\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0142\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0143\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T22:00:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Fraternal Order of Police (FOP) - Comment\",\n",
      "      \"objectId\" : \"0900006481456cb6\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0143\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0144\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T22:01:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Smoker Friendly - Comment\",\n",
      "      \"objectId\" : \"0900006481459082\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0144\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0145\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T22:26:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Transcorp Carriers Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481459cb2\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0145\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0146\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T22:27:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"d.s.p., USA, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481459cb3\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0146\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0147\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T22:28:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Wilson Stone, Commonwealth of Kentucky, House of Representatives - Comment\",\n",
      "      \"objectId\" : \"0900006481459cb0\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0147\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0148\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-22T22:29:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Governor Pat McCrory, State of North Carolina - Comment\",\n",
      "      \"objectId\" : \"0900006481459cb4\",\n",
      "      \"postedDate\" : \"2013-10-22T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0148\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0150\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-23T22:07:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Dominion Packing, Inc. - Comment\",\n",
      "      \"objectId\" : \"090000648145c53d\",\n",
      "      \"postedDate\" : \"2013-10-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0150\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0151\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-23T22:09:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Curry Todd, House of Representatives, State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"090000648145c670\",\n",
      "      \"postedDate\" : \"2013-10-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0151\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0152\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-23T22:12:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Hugh E Weathers, Commissioner of Agriculture for the State of South Carolina - Comment\",\n",
      "      \"objectId\" : \"090000648145c671\",\n",
      "      \"postedDate\" : \"2013-10-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0152\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0153\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-23T22:14:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Troopers Coalition (NTC) - Comment\",\n",
      "      \"objectId\" : \"090000648145c672\",\n",
      "      \"postedDate\" : \"2013-10-23T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0153\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0154\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-27T23:38:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"TPC Printing Packaging - Comment\",\n",
      "      \"objectId\" : \"0900006481461c1d\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0154\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0155\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-27T23:43:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maryland Retailers Association (MRA) - Comment\",\n",
      "      \"objectId\" : \"090000648145bb40\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0155\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0156\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-27T23:50:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Gummer Wholesale, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481461c1f\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0156\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0157\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-27T23:56:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Nashville Display - Comment\",\n",
      "      \"objectId\" : \"0900006481462d32\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0157\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0158\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:07:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Roger Kahn, M.D., State Senator - Comment\",\n",
      "      \"objectId\" : \"0900006481462d33\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0158\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0159\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:11:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Carolina Container - Comment\",\n",
      "      \"objectId\" : \"0900006481462d34\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0159\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0160\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:14:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Indiana Retail Council, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481462d35\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0160\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0161\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:18:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Desert Empire Transfer and Storage - Comment\",\n",
      "      \"objectId\" : \"0900006481462d36\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0161\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0162\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:23:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"VitUsa Products, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481462d37\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0162\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0163\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:31:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Celadon Group, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481462d38\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0163\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0164\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:31:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ontario Convenience Stores Association (OCSA) - Comment\",\n",
      "      \"objectId\" : \"0900006481462d39\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0164\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0165\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:35:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Southco - Comment\",\n",
      "      \"objectId\" : \"0900006481462d3a\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0165\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0166\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:40:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Dolores Gresham, State Senator, State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"0900006481462d3b\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0166\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0167\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:44:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"L. J. Rogers Trucking - Comment\",\n",
      "      \"objectId\" : \"0900006481462d3c\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0167\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0168\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:48:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"American Wholesale Marketers Association (AWMA) - Comment\",\n",
      "      \"objectId\" : \"0900006481462d3d\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0168\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0169\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:52:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bannister Company (BANCO) - Comment\",\n",
      "      \"objectId\" : \"0900006481462d3e\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0169\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0170\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:55:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Sunrise - Comment\",\n",
      "      \"objectId\" : \"0900006481462d3f\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0170\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0171\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T00:59:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"DSC Logistics - Comment\",\n",
      "      \"objectId\" : \"0900006481462d40\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0171\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0172\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:03:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Steve Stivers, House of Representatives - Comment\",\n",
      "      \"objectId\" : \"0900006481462d41\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0172\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0173\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:17:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"J. King's - Comment\",\n",
      "      \"objectId\" : \"0900006481462d42\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0173\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0174\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:21:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mid-Atlantic Petroleum Distributors' Association (MAPDA) - Comment\",\n",
      "      \"objectId\" : \"0900006481462d43\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0174\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0175\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:22:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Benjamin S. Barnes, Maryland House of Delegates - Comment\",\n",
      "      \"objectId\" : \"0900006481462d44\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0175\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0176\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:25:51Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Baugh and Michaels, LLC - Comment\",\n",
      "      \"objectId\" : \"0900006481462d45\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0176\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0177\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:29:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Maryland Association of Tobacco and Candy Distributors, Inc. - Comment\",\n",
      "      \"objectId\" : \"0900006481462d46\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0177\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0178\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:33:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Michael A. Pitts, House of Representatives, State of Carolina - Comment\",\n",
      "      \"objectId\" : \"0900006481462d47\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0178\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0179\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:38:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Papa's Cache Sabrasa - Comment\",\n",
      "      \"objectId\" : \"0900006481462d48\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0179\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0180\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:42:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Discount Playhouse, Inc - Comment\",\n",
      "      \"objectId\" : \"0900006481462d49\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0180\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0181\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:45:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Belmont Realty Corporation - Comment\",\n",
      "      \"objectId\" : \"0900006481462d65\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0181\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0182\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:48:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Mike Jackson, Speaker Pro Tempore State of Oklahoma - Comment\",\n",
      "      \"objectId\" : \"09000064814572ef\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0182\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0183\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:49:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable George Dunbar, House of Representative Commonwealth of Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"09000064814572f1\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0183\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0184\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:53:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"A. H. Jamra Company - Comment\",\n",
      "      \"objectId\" : \"0900006481462d66\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0184\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0185\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T01:59:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Bakery, Confectionery, Tobacca Workers and Grain Millers International Union (BCTGM) - Comment\",\n",
      "      \"objectId\" : \"0900006481462d67\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0185\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0186\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T02:03:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Don White, State Senator, Senate of Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"0900006481462d68\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0186\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0187\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T02:08:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Douglas E. Facemire, Senate of West Virgina - Comment\",\n",
      "      \"objectId\" : \"0900006481462d69\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0187\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0188\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T02:17:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Craig P. Blair, Senate of West Virgina - Comment\",\n",
      "      \"objectId\" : \"0900006481462d6a\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0188\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0189\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T02:25:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Clark S. Barnes, Senate of West Virgina - Comment\",\n",
      "      \"objectId\" : \"0900006481462d6b\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0189\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0190\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T02:25:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Henry L. Marsh, III, Senate of Virginia - Comment\",\n",
      "      \"objectId\" : \"0900006481462d6c\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0190\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0191\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-10-28T02:30:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Leon J. Howard, House of Represntatives, State of South Carolina - Comment\",\n",
      "      \"objectId\" : \"0900006481462d6d\",\n",
      "      \"postedDate\" : \"2013-10-27T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0191\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0203\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:48:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ohio Wholesale Marketers Association - Comment\",\n",
      "      \"objectId\" : \"090000648146e2cb\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0203\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0204\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:49:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Senator Michael Walters\",\n",
      "      \"objectId\" : \"090000648143e0b1\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0204\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0213\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:53:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"William Kyles, et al National Black Chamber of Commerce - Comment\",\n",
      "      \"objectId\" : \"090000648146e306\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0213\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0214\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:54:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Commissioner James R. Comer, Kentucky Department of Agriculture - Comment\",\n",
      "      \"objectId\" : \"090000648146e307\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0214\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0215\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:54:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Wendell Willard, Georgia House of Representatives - Comment\",\n",
      "      \"objectId\" : \"090000648146e308\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0215\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0216\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:55:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Fran Millar, George State Senate - Comment\",\n",
      "      \"objectId\" : \"090000648146e309\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0216\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0217\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-02T19:55:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Thomas Sankey, Commonwealth of Pennsylvania House of Representatives - Comment\",\n",
      "      \"objectId\" : \"090000648146e30a\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0217\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0228\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:51:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Virginia AFL- CIO - Comment\",\n",
      "      \"objectId\" : \"090000648147b65d\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0228\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0229\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:52:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Janice Bowling, Senate Chamber, State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"090000648147b65e\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0229\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0230\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:53:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable John W. Matthews, Senate of South Carolina - Comment\",\n",
      "      \"objectId\" : \"090000648147b65f\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0230\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0231\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:53:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Steve Thompson, State Senate, State of Georgia - Comment\",\n",
      "      \"objectId\" : \"090000648147b660\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0231\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0232\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:54:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Trey Kelley, House of Representatives State of Georgia - Comment\",\n",
      "      \"objectId\" : \"090000648147b661\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0232\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0233\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:54:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"McLane Company, Inc (Stahl, Bernal &amp; Davies, LLP) - Comment\",\n",
      "      \"objectId\" : \"090000648147b6bc\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0233\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0234\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:55:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Steve Henson, State Senate, State of Georgia - Comment\",\n",
      "      \"objectId\" : \"090000648147b6bd\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0234\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0235\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:56:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Taghleef Industries, Inc. - Comment\",\n",
      "      \"objectId\" : \"090000648147b6be\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0235\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0236\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-13T19:57:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Cranwell, Moore, &amp; Emick - Comment\",\n",
      "      \"objectId\" : \"090000648147b6bf\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0236\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0237\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-15T01:03:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Black Chamber of Commerce et al - Comment\",\n",
      "      \"objectId\" : \"090000648147b6c0\",\n",
      "      \"postedDate\" : \"2013-11-13T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0237\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0238\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-15T01:30:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Mississippi Petroleum Marketers and Convenience Stores Association (MPMCSA) - Comment\",\n",
      "      \"objectId\" : \"09000064814800e9\",\n",
      "      \"postedDate\" : \"2013-11-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0238\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0239\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-15T01:30:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Mike Regan, House of Representatives Commonwealth of Pennsylavania - Comment\",\n",
      "      \"objectId\" : \"09000064814800ea\",\n",
      "      \"postedDate\" : \"2013-11-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0239\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0240\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-15T01:31:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Mike Brubaker, Senate of Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"09000064814800eb\",\n",
      "      \"postedDate\" : \"2013-11-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0240\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0241\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-15T01:31:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Elder Vogel Jr., Senate of Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"09000064814800ec\",\n",
      "      \"postedDate\" : \"2013-11-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0241\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0244\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-16T00:31:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Paul Battles, House of Representatives - Comment\",\n",
      "      \"objectId\" : \"090000648148471e\",\n",
      "      \"postedDate\" : \"2013-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0244\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0245\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-16T00:32:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Timothy J. Solobay, Sentae of Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"090000648148471f\",\n",
      "      \"postedDate\" : \"2013-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0245\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0246\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-16T00:32:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Rosalyn R. Dance, Commonwealth of Virginia House of Delegates - Comment\",\n",
      "      \"objectId\" : \"0900006481484720\",\n",
      "      \"postedDate\" : \"2013-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0246\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0247\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-16T00:33:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"State of Connecticut General Assembly - Comment\",\n",
      "      \"objectId\" : \"0900006481484721\",\n",
      "      \"postedDate\" : \"2013-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0247\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0248\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-16T00:33:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Minnesota Wholesale Marketers Association - Comment\",\n",
      "      \"objectId\" : \"0900006481484722\",\n",
      "      \"postedDate\" : \"2013-11-15T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0248\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0249\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-17T20:23:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Jeffrey P. Pyle, House of Representatives Commonwealth of Pennslyvania Comment\",\n",
      "      \"objectId\" : \"0900006481485d6c\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0249\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0250\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-17T20:24:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Andy Barr, House of Representatives Comment\",\n",
      "      \"objectId\" : \"0900006481485d6d\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0250\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0251\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-17T20:24:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable William M. Stanley, Senate of Virginia Comment\",\n",
      "      \"objectId\" : \"0900006481485d6e\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0251\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0252\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-17T20:25:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Daniel T. Blue, Jr., North Carolina General Assembly Comment\",\n",
      "      \"objectId\" : \"0900006481485d6f\",\n",
      "      \"postedDate\" : \"2013-11-17T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0252\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0274\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-20T02:57:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 5 re S. Abraham &amp; Sons, Inc (SAS) (Multiple Submitters=71 Total - Form Letter Comment\",\n",
      "      \"objectId\" : \"090000648148b275\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0274\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0275\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-20T03:01:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"National Organization of Black Law Enforcement Executives (NOBLE) - Comment\",\n",
      "      \"objectId\" : \"090000648148b276\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0275\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0276\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-20T03:03:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Speedway, LLC - Comment\",\n",
      "      \"objectId\" : \"090000648148b277\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0276\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0277\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-20T03:08:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Thomas M. McKee House of Representatives Commonwealth of Kentucky - Comment\",\n",
      "      \"objectId\" : \"090000648148b278\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0277\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0242\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-21T23:51:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"State Attorneys General et al - Comment\",\n",
      "      \"objectId\" : \"09000064814800ed\",\n",
      "      \"postedDate\" : \"2013-11-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0242\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0283\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T00:11:14Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from East Lexington Store\",\n",
      "      \"objectId\" : \"090000648148f6af\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0283\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0284\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T00:12:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Core-Mark International\",\n",
      "      \"objectId\" : \"090000648148f6b0\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0284\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0285\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T00:12:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Layne's Country Store\",\n",
      "      \"objectId\" : \"090000648148f6b1\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0285\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0286\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T00:13:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Farner-Bocken Company\",\n",
      "      \"objectId\" : \"090000648148f6b2\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0286\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0278\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T00:18:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Henry's Foods Inc\",\n",
      "      \"objectId\" : \"090000648148b279\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0278\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0292\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T19:22:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lorillard Tobacco Company, Inc\",\n",
      "      \"objectId\" : \"090000648148eafc\",\n",
      "      \"postedDate\" : \"2013-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0292\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0293\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-22T19:22:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lorillard Tobacco Company, Inc\",\n",
      "      \"objectId\" : \"090000648148eaa0\",\n",
      "      \"postedDate\" : \"2013-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0293\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0303\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-25T22:59:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Reynolds American Inc Services Company (RAIS)\",\n",
      "      \"objectId\" : \"09000064814951c9\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0303\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0305\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T19:08:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Missouri Wholesale Distributors Association\",\n",
      "      \"objectId\" : \"090000648149da76\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0305\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0306\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T19:11:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Brian White, House of Representatives\",\n",
      "      \"objectId\" : \"090000648149da77\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0306\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0307\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T19:14:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Mike Gambrell, House of Representatives State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da78\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0307\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0308\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T19:16:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Nathan Ballentine, House of Representatives State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da7a\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0308\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0310\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T20:03:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Andrew Patrick, House of Representatives, State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da7d\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0310\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0309\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T20:04:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Raye Felder, House of Representatives, State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da7c\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0309\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0311\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T20:05:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Todd Rutherford, House of Representatives, State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da7e\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0311\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0312\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T20:08:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Ann Thayer, House of Representatives, State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da7f\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0312\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0313\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-11-27T20:12:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Bill Sandifer, House of Representatives, State of South Carolina\",\n",
      "      \"objectId\" : \"090000648149da80\",\n",
      "      \"postedDate\" : \"2013-11-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0313\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0314\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T01:58:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tobacco Control Legal Consortium\",\n",
      "      \"objectId\" : \"09000064814a13b0\",\n",
      "      \"postedDate\" : \"2013-12-01T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0314\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0319\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Keller and Heckman LLP\",\n",
      "      \"objectId\" : \"0900006481484134\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0319\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0320\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jessica Reid\",\n",
      "      \"objectId\" : \"0900006481483474\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0320\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0321\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:03Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Leia Minaker\",\n",
      "      \"objectId\" : \"0900006481483290\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0321\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0322\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Michael Sholinbeck\",\n",
      "      \"objectId\" : \"0900006481482c50\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0322\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0323\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Rebecca Castagno, Bead Diva Boutique\",\n",
      "      \"objectId\" : \"0900006481480711\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0323\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0324\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Larry  Cohen\",\n",
      "      \"objectId\" : \"090000648147fd13\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0324\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0325\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Scott Christensen, One Stop Smoke Shop\",\n",
      "      \"objectId\" : \"090000648147f8ff\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0325\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0326\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lori Benincasa\",\n",
      "      \"objectId\" : \"090000648147f332\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0326\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0327\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tobacco Growers Association of NC\",\n",
      "      \"objectId\" : \"090000648147f2f4\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0327\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0328\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Trish McDermott\",\n",
      "      \"objectId\" : \"090000648147e91e\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0328\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0329\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ronald Cooper\",\n",
      "      \"objectId\" : \"090000648147e69b\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0329\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0330\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert McMillen\",\n",
      "      \"objectId\" : \"090000648147dd19\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0330\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0331\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jeffrey Middleton\",\n",
      "      \"objectId\" : \"090000648147c2b9\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0331\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0332\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:08Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from GSK Consumer Healthcare\",\n",
      "      \"objectId\" : \"090000648147b8e7\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0332\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0333\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Emlee H. Jones Comment\",\n",
      "      \"objectId\" : \"090000648146dfac\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0333\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0338\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-02T21:48:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from The Honorable Rob Johnson Oklahoma State Senate\",\n",
      "      \"objectId\" : \"0900006481453f15\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0338\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0289\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-03T00:06:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 6 re American Heart Association (Multiple Submitters=838 Total)  Form Letter Comment\",\n",
      "      \"objectId\" : \"090000648148fbdb\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0289\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0351\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-09T01:54:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Community Anti-Drug Coalitions of America (CADCA) - Comment\",\n",
      "      \"objectId\" : \"090000648149dce8\",\n",
      "      \"postedDate\" : \"2013-12-08T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0351\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0316\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-09T01:59:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from United States Chamber of Commerce\",\n",
      "      \"objectId\" : \"0900006481492fff\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0316\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0353\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-27T16:59:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Philip Morris International (PMI)\",\n",
      "      \"objectId\" : \"090000648148dd5e\",\n",
      "      \"postedDate\" : \"2013-12-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0353\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0355\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-27T18:37:21Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Randy McNally State Senate State of Tennessee\",\n",
      "      \"objectId\" : \"0900006481439fab\",\n",
      "      \"postedDate\" : \"2013-12-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0355\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0354\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-27T18:39:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Leslie Nelson Capitol Service Stations\",\n",
      "      \"objectId\" : \"0900006481439e56\",\n",
      "      \"postedDate\" : \"2013-12-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0354\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0356\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2013-12-27T19:19:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Moe Kawser\",\n",
      "      \"objectId\" : \"0900006481439fb4\",\n",
      "      \"postedDate\" : \"2013-12-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0356\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0357\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-05T21:59:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Toluope Alabi\",\n",
      "      \"objectId\" : \"090000648143a6ed\",\n",
      "      \"postedDate\" : \"2014-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0357\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0358\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-05T22:04:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Clifford A Rosenberger Ohio House of Representatives\",\n",
      "      \"objectId\" : \"090000648145103a\",\n",
      "      \"postedDate\" : \"2014-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0358\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0359\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-05T22:08:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bakery Confectionery Tobacco Workers and Grain Millers International Union BCTGM\",\n",
      "      \"objectId\" : \"090000648145e1a5\",\n",
      "      \"postedDate\" : \"2014-01-05T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0359\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0361\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:36:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Honorable Kenneth W Jones Mississippi State Senate\",\n",
      "      \"objectId\" : \"0900006481448690\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0361\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0362\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:45:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Roger Vogler APL Logistics\",\n",
      "      \"objectId\" : \"090000648144c396\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0362\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0363\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:46:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Phillip Gardiner\",\n",
      "      \"objectId\" : \"090000648144da42\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0363\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0365\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:52:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Bryan Cutler Pennsylvania House of Representatives\",\n",
      "      \"objectId\" : \"090000648146121f\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0365\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0364\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:52:35Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Jimmy Matlock State Representative State of Tennessee\",\n",
      "      \"objectId\" : \"090000648144f13c\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0364\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0366\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:55:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Ryan T McDougle State of Virginia\",\n",
      "      \"objectId\" : \"0900006481463a6d\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0366\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0367\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T01:57:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Luke E Torian Commonwealth of Virginia House of Delegates\",\n",
      "      \"objectId\" : \"0900006481467ea3\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0367\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0368\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:00:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Bryce E Reeves Senate State of Virginia\",\n",
      "      \"objectId\" : \"09000064814686fb\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0368\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0369\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:02:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Celanese Corporation\",\n",
      "      \"objectId\" : \"09000064814688fd\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0369\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0370\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:03:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from ClearWay Minnesota\",\n",
      "      \"objectId\" : \"090000648146cd21\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0370\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0371\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:06:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Onzlee Ware State of Virginia House of Delegates\",\n",
      "      \"objectId\" : \"090000648146d035\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0371\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0372\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:09:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mississippi Petroleum Marketers and Convenience Stores Association MPMCSA\",\n",
      "      \"objectId\" : \"09000064814705a0\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0372\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0373\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:10:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alabama District Attorneys Association\",\n",
      "      \"objectId\" : \"0900006481472f21\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0373\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0374\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:16:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from State Attorneys General Tom Horne et al\",\n",
      "      \"objectId\" : \"0900006481473d45\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0374\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0375\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:32:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from California Society of Addiction Medicine\",\n",
      "      \"objectId\" : \"0900006481477ee4\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0375\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0376\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:33:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Holiday Companies\",\n",
      "      \"objectId\" : \"0900006481478d64\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0376\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0377\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:35:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Larry Cohen Prevention Institute\",\n",
      "      \"objectId\" : \"0900006481478f64\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0377\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0378\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:40:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dragana Bolcic Jankovic and Lois Biener Center for Survey Research University of Massachusetts Boston\",\n",
      "      \"objectId\" : \"0900006481479015\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0378\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0379\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:41:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Andrea Myers Kocolene Marketing LLC\",\n",
      "      \"objectId\" : \"090000648147ab78\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0379\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0380\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:42:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mariam Hinds\",\n",
      "      \"objectId\" : \"090000648147b69c\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0380\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0381\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:43:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kate Scherschel\",\n",
      "      \"objectId\" : \"090000648147b6a5\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0381\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0382\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:45:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Andrew Van Denover\",\n",
      "      \"objectId\" : \"090000648147b9b6\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0382\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0383\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:46:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alison Bloch\",\n",
      "      \"objectId\" : \"090000648147baa8\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0383\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0384\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:47:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sam Jacobson\",\n",
      "      \"objectId\" : \"090000648147bc12\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0384\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0385\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:49:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Federal Law Enforcement Officers Association FLEOA\",\n",
      "      \"objectId\" : \"0900006481486065\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0385\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0386\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:50:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jonathan Chaffee ACASA\",\n",
      "      \"objectId\" : \"0900006481486f98\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0386\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0387\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:53:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joanne D'Silva\",\n",
      "      \"objectId\" : \"09000064814919ee\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0387\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0388\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:55:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Roswell Park Cancer Institute\",\n",
      "      \"objectId\" : \"0900006481491bca\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0388\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0389\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-15T02:57:17Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Missouri Wholesale Distributors Association MWDA\",\n",
      "      \"objectId\" : \"0900006481491bf5\",\n",
      "      \"postedDate\" : \"2014-01-14T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0389\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0348\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:17:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable John Stevens Senate Chamber, State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"090000648144b442\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0348\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0347\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:17:32Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"New England Convenience Store Association - Comment\",\n",
      "      \"objectId\" : \"090000648144b42e\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0347\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0269\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:39:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable William Lamberth State Representative, State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"0900006481439727\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0269\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0335\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:44:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Michigan Distributors and Vendors Association - Comment\",\n",
      "      \"objectId\" : \"090000648145c5d0\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0335\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0334\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:44:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Wisconsin Association of Distributors - Comment\",\n",
      "      \"objectId\" : \"090000648145c5be\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0334\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0299\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:56:11Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from United Warehouses and Herche Transfer\",\n",
      "      \"objectId\" : \"0900006481445338\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0299\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0340\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T20:58:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Jeff McClain, Ohio House of Representatives - Comment\",\n",
      "      \"objectId\" : \"0900006481450fe8\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0340\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0206\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T21:15:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Andrew Blix, RN, BSN, Daiquiri Frieling, RN, BSN, Dawn Lyke, RN, BSN, Sarah Whipple, RN, BSN\",\n",
      "      \"objectId\" : \"090000648143ecef\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0206\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0300\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T21:23:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Saddle Creek Logistics Service\",\n",
      "      \"objectId\" : \"09000064814476af\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0300\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0317\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T21:41:04Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Global Intellectual Property Center (GIPC)\",\n",
      "      \"objectId\" : \"090000648149304c\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0317\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0339\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T21:44:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Colorado Health Alliance - Comment\",\n",
      "      \"objectId\" : \"0900006481451226\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0339\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0212\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T22:40:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Brenda Walter\",\n",
      "      \"objectId\" : \"0900006481442a2e\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0212\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0205\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T22:59:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Michael  Wray\",\n",
      "      \"objectId\" : \"090000648143e0fa\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0205\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0268\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T22:59:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina State Grange - Comment\",\n",
      "      \"objectId\" : \"090000648143126a\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0268\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0297\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:06:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Judy Jackle\",\n",
      "      \"objectId\" : \"0900006481443297\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0297\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0272\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:10:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Joe Hune State Senator State of Michigan - Comment\",\n",
      "      \"objectId\" : \"0900006481445029\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0272\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0298\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:25:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dominion Packaging, Inc.\",\n",
      "      \"objectId\" : \"0900006481443de1\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0298\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0270\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-18T23:50:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Frank D. Foster State Representative, Michigan House of Representatives - Comment\",\n",
      "      \"objectId\" : \"0900006481439f23\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0270\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0271\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:03:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Pitman Warehousing Campbell's Express - Comment\",\n",
      "      \"objectId\" : \"0900006481444000\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0271\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0291\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:06:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ayman Ashwaiheen\",\n",
      "      \"objectId\" : \"090000648142835b\",\n",
      "      \"postedDate\" : \"2013-11-22T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0291\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0342\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:30:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Frank Niceley State Senator State of Tennessee - Comment\",\n",
      "      \"objectId\" : \"090000648144f997\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0342\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0267\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:40:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Ruth E. Malone (University of California, San Francisco) - Comment\",\n",
      "      \"objectId\" : \"090000648142e50b\",\n",
      "      \"postedDate\" : \"2013-11-19T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0267\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0208\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:40:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Jim Tozzi, Center for Regulatory Effectiveness\",\n",
      "      \"objectId\" : \"090000648144199b\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0208\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0207\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T00:41:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Jeff Bogdan, Federal Warehouse Companies\",\n",
      "      \"objectId\" : \"0900006481441949\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0207\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0341\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:23:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Richard Alloway, II State Senator, State of Pennsylvania - Comment\",\n",
      "      \"objectId\" : \"090000648144fae2\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0341\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0343\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:26:52Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Albert Screenprint Inc.\",\n",
      "      \"objectId\" : \"090000648144ea10\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0343\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0349\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:27:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ohio Association of Convenience Stores\",\n",
      "      \"objectId\" : \"0900006481449d96\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0349\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0210\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:31:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Steve Weeks\",\n",
      "      \"objectId\" : \"0900006481441a55\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0210\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0209\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:31:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Andrea  Jackson, Tobacco Beverage Companies\",\n",
      "      \"objectId\" : \"0900006481441a23\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0209\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0211\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:37:12Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment From Bruce Gibbons\",\n",
      "      \"objectId\" : \"0900006481441e8b\",\n",
      "      \"postedDate\" : \"2013-11-02T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0211\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0318\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:37:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"North Carolina General Assembly - Comment\",\n",
      "      \"objectId\" : \"090000648148f624\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0318\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0350\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:39:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Joelle Lester, Tobacco Control Legal Consortium\",\n",
      "      \"objectId\" : \"090000648148f6f3\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0350\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0352\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T01:44:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from the Honorable Craig Ford, Alabama House of Representatives, Office of the Minority Leader\",\n",
      "      \"objectId\" : \"090000648146ff91\",\n",
      "      \"postedDate\" : \"2013-12-27T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0352\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0301\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:01:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from National Association of Tobacco Outlets, Inc. (NATO)\",\n",
      "      \"objectId\" : \"090000648144868a\",\n",
      "      \"postedDate\" : \"2013-11-25T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0301\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0337\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:16:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Commonwealth of Pennsylvania House of Representatives - Comment\",\n",
      "      \"objectId\" : \"090000648145402e\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0337\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0336\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:20:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"State of Tennessee House of Representatives - Comment\",\n",
      "      \"objectId\" : \"090000648145af53\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0336\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0344\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:43:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"The Honorable Del Marsh, Alabama State Senate - Comment\",\n",
      "      \"objectId\" : \"090000648144e819\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0344\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0257\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-19T02:44:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Timothy Holiday - Comment\",\n",
      "      \"objectId\" : \"0900006481412756\",\n",
      "      \"postedDate\" : \"2013-11-18T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0257\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0390\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T17:20:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Maryland Retailers Association (MRA)\",\n",
      "      \"objectId\" : \"0900006481461c1e\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0390\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0391\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T17:20:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David Ransom Friedman\",\n",
      "      \"objectId\" : \"090000648147968c\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0391\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0392\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T17:23:50Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kris Minard\",\n",
      "      \"objectId\" : \"09000064814876d0\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0392\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0393\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T17:24:23Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Paul Francis\",\n",
      "      \"objectId\" : \"0900006481488345\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0393\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0394\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T17:26:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cancer Prevention and Treatment Fund\",\n",
      "      \"objectId\" : \"0900006481488398\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0394\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0395\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T17:32:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from BOTEC Analysis Corporation\",\n",
      "      \"objectId\" : \"09000064814889da\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0395\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0396\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T18:15:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Alameda County Tobacco Control Coalition\",\n",
      "      \"objectId\" : \"090000648148adbc\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0396\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0397\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T19:01:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from National Association of County and City Health Officials NACCHO\",\n",
      "      \"objectId\" : \"090000648148c3c0\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0397\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0398\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T19:03:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Society for Research on Nicotine and Tobacco SRNT\",\n",
      "      \"objectId\" : \"090000648148c989\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0398\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0399\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-01-24T19:16:48Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Association for Nonsmokers Minnesota ANSR\",\n",
      "      \"objectId\" : \"090000648148cae6\",\n",
      "      \"postedDate\" : \"2014-01-24T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0399\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0401\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T17:25:37Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Solano County Tobacco Education Coalition\",\n",
      "      \"objectId\" : \"090000648148cb50\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0401\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0402\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T17:32:58Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Erika Mansur\",\n",
      "      \"objectId\" : \"090000648148cc76\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0402\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0403\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T17:37:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ochsner Health System\",\n",
      "      \"objectId\" : \"090000648148ccd2\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0403\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0404\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T17:40:43Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Yesenia Molinar\",\n",
      "      \"objectId\" : \"090000648148d11b\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0404\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0405\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T17:41:13Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Ross Amundson\",\n",
      "      \"objectId\" : \"090000648148d172\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0405\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0406\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T17:51:42Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Jasjit Ahluwalia\",\n",
      "      \"objectId\" : \"090000648148d38f\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0406\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0407\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T19:48:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Day One\",\n",
      "      \"objectId\" : \"090000648148d913\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0407\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0408\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T20:28:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Center for Tobacco Surveillance &amp; Evaluation Research\",\n",
      "      \"objectId\" : \"090000648148e90f\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0408\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0409\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T20:36:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Association of State and Territorial Health Officials (ASTHO)\",\n",
      "      \"objectId\" : \"090000648148e979\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0409\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0410\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T20:44:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Micky Hammon\",\n",
      "      \"objectId\" : \"090000648148e9a5\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0410\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0411\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T20:48:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Rice\",\n",
      "      \"objectId\" : \"090000648148eb4c\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0411\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0412\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T21:02:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Dr. David Derby\",\n",
      "      \"objectId\" : \"090000648148eeae\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0412\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0413\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-28T21:14:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert McMillen\",\n",
      "      \"objectId\" : \"090000648148ef7c\",\n",
      "      \"postedDate\" : \"2014-03-28T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0413\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0414\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T14:35:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Citizens' Commission to Protect the Truth\",\n",
      "      \"objectId\" : \"090000648148efb2\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0414\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0415\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T14:40:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tennessee Fuel &amp; Convenience Store Association\",\n",
      "      \"objectId\" : \"090000648148f067\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0415\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0416\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T14:43:06Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Battelle Memorial Institute\",\n",
      "      \"objectId\" : \"090000648148f069\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0416\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0417\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:08:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from North Dakota Tobacco Prevention and Control Advisory Committee\",\n",
      "      \"objectId\" : \"090000648148f0bc\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0417\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0418\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:23:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kola Okuyemi\",\n",
      "      \"objectId\" : \"090000648148f557\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0418\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0419\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:36:38Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Commissioner Loretta J. Smith\",\n",
      "      \"objectId\" : \"090000648148f6c7\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0419\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0420\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:40:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from National Alliance for Hispanic Health\",\n",
      "      \"objectId\" : \"090000648148f7a6\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0420\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0421\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:47:09Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Stanton Glantz\",\n",
      "      \"objectId\" : \"090000648148f9aa\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0421\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0422\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:50:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Steve Heilig\",\n",
      "      \"objectId\" : \"090000648148fb66\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0422\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0423\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:51:46Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Judith Gerard\",\n",
      "      \"objectId\" : \"090000648148fe49\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0423\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0424\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:55:27Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Bob Doyle\",\n",
      "      \"objectId\" : \"0900006481490322\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0424\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0425\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T15:59:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from New York Association of Convenience Stores\",\n",
      "      \"objectId\" : \"0900006481490a36\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0425\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0426\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:07:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Thoracic Society\",\n",
      "      \"objectId\" : \"0900006481491525\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0426\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0427\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:29:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Donald Kenkel\",\n",
      "      \"objectId\" : \"0900006481491619\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0427\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0428\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:33:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Surendra B. Adhikari\",\n",
      "      \"objectId\" : \"090000648149161c\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0428\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0429\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:38:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from NJOY Inc\",\n",
      "      \"objectId\" : \"09000064814916bc\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0429\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0430\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:44:24Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Phillip Gardiner\",\n",
      "      \"objectId\" : \"09000064814916e6\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0430\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0431\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:47:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Lung Association\",\n",
      "      \"objectId\" : \"090000648149188d\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0431\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0432\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:50:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Troy Balderson\",\n",
      "      \"objectId\" : \"0900006481491c07\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0432\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0433\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:56:02Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Mark Gottlieb\",\n",
      "      \"objectId\" : \"0900006481491d2a\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0433\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0434\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T16:58:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Washington State Department of Health\",\n",
      "      \"objectId\" : \"0900006481491e4b\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0434\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0435\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:00:15Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Petroleum Marketers Association of America\",\n",
      "      \"objectId\" : \"0900006481491e74\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0435\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0436\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:01:19Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Cathy McDonald\",\n",
      "      \"objectId\" : \"0900006481491f07\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0436\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 292,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : true,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 250,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 292,\n",
      "    \"totalPages\" : 2,\n",
      "    \"lastPage\" : false,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ {\n",
      "    \"id\" : \"FDA-2013-N-0521-0437\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:03:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Paul Krueth\",\n",
      "      \"objectId\" : \"0900006481491f5b\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0437\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0438\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:04:05Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from American Association for Cancer Research and American Society of Clinical Oncology\",\n",
      "      \"objectId\" : \"0900006481492137\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0438\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0439\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:04:59Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Respiratory Health Association\",\n",
      "      \"objectId\" : \"0900006481492242\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0439\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0440\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:13:25Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from NYC Department of Health &amp; Mental Hygiene\",\n",
      "      \"objectId\" : \"09000064814922ef\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0440\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0441\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:15:10Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from United Parcel Service, Inc. (UPS)\",\n",
      "      \"objectId\" : \"0900006481492435\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0441\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0442\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:22:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Gary Giovino\",\n",
      "      \"objectId\" : \"0900006481492469\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0442\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0443\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T17:23:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Campaign for Tobacco Free Kids and 24 other Organizations\",\n",
      "      \"objectId\" : \"09000064814929b2\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0443\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0444\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:18:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Minnesota Retailers Association\",\n",
      "      \"objectId\" : \"0900006481492b21\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0444\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0445\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:18:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Minnesota Retailers Association\",\n",
      "      \"objectId\" : \"0900006481492b3b\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0445\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0446\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:23:16Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from New York State Department of Health\",\n",
      "      \"objectId\" : \"0900006481492b9f\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0446\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0447\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:24:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Tobacco Technical Assistance Consortium\",\n",
      "      \"objectId\" : \"0900006481492b94\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0447\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0448\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:45:01Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Legacy\",\n",
      "      \"objectId\" : \"0900006481492ba3\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0448\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0449\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:49:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Miranda Spitznagle\",\n",
      "      \"objectId\" : \"0900006481492be2\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0449\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0450\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-03-31T19:55:07Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from NYC Coalition for a Smoke-Free City\",\n",
      "      \"objectId\" : \"0900006481492c85\",\n",
      "      \"postedDate\" : \"2014-03-31T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0450\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0451\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T13:49:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Society for Public Health Education\",\n",
      "      \"objectId\" : \"0900006481492cd9\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0451\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0452\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T13:54:20Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from La Clinica de La Raza, Inc.\",\n",
      "      \"objectId\" : \"0900006481492e41\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0452\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0453\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T13:58:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sherman's 1400 Broadway NYC, Ltd.\",\n",
      "      \"objectId\" : \"0900006481492eb0\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0453\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0454\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T13:59:22Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Terri Richardson\",\n",
      "      \"objectId\" : \"0900006481492f70\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0454\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0455\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:01:34Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from National African American Tobacco Prevention Network (NAATPN)\",\n",
      "      \"objectId\" : \"0900006481492f7c\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0455\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0456\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:02:40Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Louisiana Campaign for Tobacco-Free Living (TFL)\",\n",
      "      \"objectId\" : \"0900006481492fa8\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0456\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0457\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:03:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Attorneys General of South Carolina and Virginia\",\n",
      "      \"objectId\" : \"0900006481493032\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0457\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0458\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:10:33Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Universal Corporation (McGuireWoods, LLP)\",\n",
      "      \"objectId\" : \"0900006481493051\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0458\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0459\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:12:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from SMARTT Coalition\",\n",
      "      \"objectId\" : \"090000648149308f\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0459\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0460\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:14:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from US Senator Richard Blumenthal\",\n",
      "      \"objectId\" : \"0900006481493183\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0460\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0461\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:15:28Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Coalition for a Tobacco-Free Hawaii\",\n",
      "      \"objectId\" : \"09000064814931b9\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0461\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0462\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:16:53Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Grace Meng\",\n",
      "      \"objectId\" : \"0900006481493227\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0462\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0463\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:17:29Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Connie Stewart\",\n",
      "      \"objectId\" : \"09000064814932b3\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0463\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0464\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T14:18:36Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Coalition of Independent Tobacco Manufacturers of America (CITMA)\",\n",
      "      \"objectId\" : \"09000064814932ba\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0464\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0465\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T15:40:49Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Colorado Tobacco Education, Prevention and Cessation Grant Program Review Committee\",\n",
      "      \"objectId\" : \"0900006481493320\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0465\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0466\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T15:53:44Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Lauren Sawyer\",\n",
      "      \"objectId\" : \"09000064814933c4\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0466\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0467\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T15:58:39Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Robert Walker\",\n",
      "      \"objectId\" : \"09000064814933e1\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0467\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0468\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T16:00:30Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Colorado Department of Public Health and Environment\",\n",
      "      \"objectId\" : \"090000648149346f\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0468\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0469\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T16:01:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Pebbles Fagan\",\n",
      "      \"objectId\" : \"0900006481493604\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0469\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0470\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T16:39:45Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Schlesinger Law Offices\",\n",
      "      \"objectId\" : \"09000064814936d7\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0470\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0471\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T16:43:00Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from David Fleming\",\n",
      "      \"objectId\" : \"090000648149385b\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0471\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0472\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T16:50:55Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Steve Kinsey\",\n",
      "      \"objectId\" : \"0900006481493916\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0472\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0473\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T16:52:41Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Kyle Rozema\",\n",
      "      \"objectId\" : \"0900006481493955\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0473\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0474\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T17:07:47Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from African American Tobacco Control Leadership Council\",\n",
      "      \"objectId\" : \"090000648149398b\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0474\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0475\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T17:09:31Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Sven Jordt\",\n",
      "      \"objectId\" : \"09000064814939a5\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0475\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0476\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2014-04-01T17:17:54Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Seth Ammerman\",\n",
      "      \"objectId\" : \"0900006481493a0a\",\n",
      "      \"postedDate\" : \"2014-04-01T04:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0476\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0288\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-01-28T13:39:18Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Write-In Campaign 1 Multiple Submitters Total 25,411 Form Letter Comment Part 2 of 2\",\n",
      "      \"objectId\" : \"090000648146e140\",\n",
      "      \"postedDate\" : \"2013-11-21T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0288\"\n",
      "    }\n",
      "  }, {\n",
      "    \"id\" : \"FDA-2013-N-0521-0315\",\n",
      "    \"type\" : \"comments\",\n",
      "    \"attributes\" : {\n",
      "      \"documentType\" : \"Public Submission\",\n",
      "      \"lastModifiedDate\" : \"2015-01-28T13:39:26Z\",\n",
      "      \"highlightedContent\" : \"\",\n",
      "      \"withdrawn\" : false,\n",
      "      \"agencyId\" : \"FDA\",\n",
      "      \"title\" : \"Comment from Altria Client Services, Inc\",\n",
      "      \"objectId\" : \"09000064814951ca\",\n",
      "      \"postedDate\" : \"2013-12-02T05:00:00Z\"\n",
      "    },\n",
      "    \"links\" : {\n",
      "      \"self\" : \"https://api.regulations.gov/v4/comments/FDA-2013-N-0521-0315\"\n",
      "    }\n",
      "  } ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 292,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 42,\n",
      "    \"pageNumber\" : 2,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 292,\n",
      "    \"totalPages\" : 2,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ {\n",
      "        \"docCount\" : 292,\n",
      "        \"value\" : \"FDA\"\n",
      "      } ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : true,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 3,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 292,\n",
      "    \"totalPages\" : 2,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : false\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n",
      "<html><body><p>{\n",
      "  \"data\" : [ ],\n",
      "  \"meta\" : {\n",
      "    \"aggregations\" : {\n",
      "      \"agencyId\" : [ ],\n",
      "      \"postedDate\" : [ ]\n",
      "    },\n",
      "    \"filters\" : { },\n",
      "    \"hasNextPage\" : false,\n",
      "    \"hasPreviousPage\" : false,\n",
      "    \"numberOfElements\" : 0,\n",
      "    \"pageNumber\" : 1,\n",
      "    \"pageSize\" : 250,\n",
      "    \"totalElements\" : 0,\n",
      "    \"totalPages\" : 0,\n",
      "    \"lastPage\" : true,\n",
      "    \"firstPage\" : true\n",
      "  }\n",
      "}</p></body></html>\n"
     ]
    }
   ],
   "source": [
    "# This cell will get all the comments ids from the above scrapped document object ids\n",
    "commentsIds = []\n",
    "for doc_objectId in document_objectId:\n",
    "    for num in range(1, 35): # check for 35 pages for each doc id\n",
    "        url = \"https://api.regulations.gov/v4/comments?filter[commentOnId]=\"+doc_objectId+\"&page[size]=250&page[number]=\"+str(num)+\"&sort=lastModifiedDate,documentId&api_key=\"+ api_key\n",
    "        url_content = BeautifulSoup(requests.get(url).content, 'lxml')\n",
    "        print(url_content)\n",
    "        try:\n",
    "            comment_json = json.loads(url_content.body.p.text)['data'] \n",
    "            if comment_json==[]: break # break the loop if their is seq of empty pages\n",
    "            commentsIds.append([i['id'] for i in comment_json]) \n",
    "        except: break\n",
    "commentsIds = list(set([j for i in commentsIds for j in i if j!=[]])) # remove similar comment ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# this cell will get comments from each comment id and store it into dict formate\n",
    "comments = {} #declaring dictionary\n",
    "for comment_id in commentsIds:\n",
    "    url = \"https://api.regulations.gov/v4/comments/\"+comment_id+\"?include=attachments&api_key=\"+ api_key\n",
    "    url_content = BeautifulSoup(requests.get(url).content, 'lxml')\n",
    "    try: comments[comment_id]= json.loads(url_content.body.p.text)[\"data\"][\"attributes\"][\"comment\"]\n",
    "    except: pass"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>commentIds</th>\n",
       "      <th>comments</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FDA-2012-D-0071-0709</td>\n",
       "      <td>http://www.regulations.gov/#!documentDetail;D=...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>FDA-2009-N-0294-0063</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>FDA-2013-N-0521-0432</td>\n",
       "      <td>Comments on use of menthol in cigarettes by Oh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>FDA-2017-N-4678-0015</td>\n",
       "      <td>RJR consumer perceptions studies are poorly de...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>FDA-2012-D-0071-0456</td>\n",
       "      <td>Please remove any language recommending or all...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>953</th>\n",
       "      <td>FDA-2012-D-0071-1266</td>\n",
       "      <td>See attached file(s)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>954</th>\n",
       "      <td>FDA-2015-N-1514-0389</td>\n",
       "      <td>I am a pediatrician and strongly believe that ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>955</th>\n",
       "      <td>FDA-2012-D-0071-0112</td>\n",
       "      <td>These deadly tests are included in the guidanc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>956</th>\n",
       "      <td>FDA-2012-D-0071-0461</td>\n",
       "      <td>Please do not require animal testing to show w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>957</th>\n",
       "      <td>FDA-2017-N-4678-0029</td>\n",
       "      <td>See Attached</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>958 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "               commentIds                                           comments\n",
       "0    FDA-2012-D-0071-0709  http://www.regulations.gov/#!documentDetail;D=...\n",
       "1    FDA-2009-N-0294-0063                                               None\n",
       "2    FDA-2013-N-0521-0432  Comments on use of menthol in cigarettes by Oh...\n",
       "3    FDA-2017-N-4678-0015  RJR consumer perceptions studies are poorly de...\n",
       "4    FDA-2012-D-0071-0456  Please remove any language recommending or all...\n",
       "..                    ...                                                ...\n",
       "953  FDA-2012-D-0071-1266                               See attached file(s)\n",
       "954  FDA-2015-N-1514-0389  I am a pediatrician and strongly believe that ...\n",
       "955  FDA-2012-D-0071-0112  These deadly tests are included in the guidanc...\n",
       "956  FDA-2012-D-0071-0461  Please do not require animal testing to show w...\n",
       "957  FDA-2017-N-4678-0029                                       See Attached\n",
       "\n",
       "[958 rows x 2 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Save the comments\n",
    "df = pd.DataFrame(list(comments.items()), columns=[\"commentIds\", 'comments'])\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "df1=pd.read_csv('comments1.csv')\n",
    "df2=pd.read_csv('comments.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>commentIds</th>\n",
       "      <th>comments</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FDA-2012-D-0071-0272</td>\n",
       "      <td>If people are stupid enough to smoke then let ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>FDA-2012-D-0071-0391</td>\n",
       "      <td>We know what tobacco does already....this is s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>FDA-2013-N-0521-0306</td>\n",
       "      <td>Comment from the Honorable Brian White, House ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>FDA-2009-N-0294-0059</td>\n",
       "      <td>I believe this product needs to be banned alto...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>FDA-2012-D-0071-0243</td>\n",
       "      <td>Please do not allow language that encourages o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2399</th>\n",
       "      <td>FDA-2012-D-0071-1266</td>\n",
       "      <td>See attached file(s)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2400</th>\n",
       "      <td>FDA-2015-N-1514-0389</td>\n",
       "      <td>I am a pediatrician and strongly believe that ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2401</th>\n",
       "      <td>FDA-2012-D-0071-0112</td>\n",
       "      <td>These deadly tests are included in the guidanc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2402</th>\n",
       "      <td>FDA-2012-D-0071-0461</td>\n",
       "      <td>Please do not require animal testing to show w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2403</th>\n",
       "      <td>FDA-2017-N-4678-0029</td>\n",
       "      <td>See Attached</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2404 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                commentIds                                           comments\n",
       "0     FDA-2012-D-0071-0272  If people are stupid enough to smoke then let ...\n",
       "1     FDA-2012-D-0071-0391  We know what tobacco does already....this is s...\n",
       "2     FDA-2013-N-0521-0306  Comment from the Honorable Brian White, House ...\n",
       "3     FDA-2009-N-0294-0059  I believe this product needs to be banned alto...\n",
       "4     FDA-2012-D-0071-0243  Please do not allow language that encourages o...\n",
       "...                    ...                                                ...\n",
       "2399  FDA-2012-D-0071-1266                               See attached file(s)\n",
       "2400  FDA-2015-N-1514-0389  I am a pediatrician and strongly believe that ...\n",
       "2401  FDA-2012-D-0071-0112  These deadly tests are included in the guidanc...\n",
       "2402  FDA-2012-D-0071-0461  Please do not require animal testing to show w...\n",
       "2403  FDA-2017-N-4678-0029                                       See Attached\n",
       "\n",
       "[2404 rows x 2 columns]"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df=pd.concat([df1,df2],axis=0)\n",
    "df = df.drop('Unnamed: 0', 1)\n",
    "df.reset_index(drop=True,inplace=True)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>commentIds</th>\n",
       "      <th>comments</th>\n",
       "      <th>Duplicated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FDA-2012-D-0071-0272</td>\n",
       "      <td>If people are stupid enough to smoke then let ...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>FDA-2012-D-0071-0391</td>\n",
       "      <td>We know what tobacco does already....this is s...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>FDA-2013-N-0521-0306</td>\n",
       "      <td>Comment from the Honorable Brian White, House ...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>FDA-2009-N-0294-0059</td>\n",
       "      <td>I believe this product needs to be banned alto...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>FDA-2012-D-0071-0243</td>\n",
       "      <td>Please do not allow language that encourages o...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2399</th>\n",
       "      <td>FDA-2012-D-0071-1266</td>\n",
       "      <td>See attached file(s)</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2400</th>\n",
       "      <td>FDA-2015-N-1514-0389</td>\n",
       "      <td>I am a pediatrician and strongly believe that ...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2401</th>\n",
       "      <td>FDA-2012-D-0071-0112</td>\n",
       "      <td>These deadly tests are included in the guidanc...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2402</th>\n",
       "      <td>FDA-2012-D-0071-0461</td>\n",
       "      <td>Please do not require animal testing to show w...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2403</th>\n",
       "      <td>FDA-2017-N-4678-0029</td>\n",
       "      <td>See Attached</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1971 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                commentIds                                           comments  \\\n",
       "0     FDA-2012-D-0071-0272  If people are stupid enough to smoke then let ...   \n",
       "1     FDA-2012-D-0071-0391  We know what tobacco does already....this is s...   \n",
       "2     FDA-2013-N-0521-0306  Comment from the Honorable Brian White, House ...   \n",
       "3     FDA-2009-N-0294-0059  I believe this product needs to be banned alto...   \n",
       "4     FDA-2012-D-0071-0243  Please do not allow language that encourages o...   \n",
       "...                    ...                                                ...   \n",
       "2399  FDA-2012-D-0071-1266                               See attached file(s)   \n",
       "2400  FDA-2015-N-1514-0389  I am a pediatrician and strongly believe that ...   \n",
       "2401  FDA-2012-D-0071-0112  These deadly tests are included in the guidanc...   \n",
       "2402  FDA-2012-D-0071-0461  Please do not require animal testing to show w...   \n",
       "2403  FDA-2017-N-4678-0029                                       See Attached   \n",
       "\n",
       "      Duplicated  \n",
       "0          False  \n",
       "1          False  \n",
       "2          False  \n",
       "3          False  \n",
       "4          False  \n",
       "...          ...  \n",
       "2399       False  \n",
       "2400        True  \n",
       "2401        True  \n",
       "2402       False  \n",
       "2403       False  \n",
       "\n",
       "[1971 rows x 3 columns]"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = df.drop_duplicates( keep='last')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop('Duplicated', 1)\n",
    "df.to_csv('Final_Tobacco_Regulations_Data.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
